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U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 
P&k Health Smvke 
‘.rtStCstlAs”Or*t.LI*.ND*“UI1ot.”,(t~ 
“.s*l*GI”* DL mie, 
MC I 5 1986 
The mnorable George Bush 
President of the Senetc 
W..hington. D.C. 20510 
Desr Mr. President: 
It is my pleasure to transmit to the Congress the 1986 Surgeon Gener.1’. 
Report on the halt? consequence. of smking, . . mandated by Section g(s) of 
the Public Re.lth Cxgsrette S-king Act of 1969. 
me “e.lth Consequence* of involunt.ry Smking 
The current volume, entitled 
, exuine. the scientific 
evidence on the he.lth effect. re.“lttng from mn.mker exposure to 
envirollaenr.1 tob.cc” snake. 
The issue of whether or mt tob.cco slake is c.rcinogeaic for humans was 
conclusively resolved mre thss 20 ye.=. *go when the first report on *staking 
*ad heslth w.. issued in 1964. Eased on the c”rrent report, the judgment c.n 
11)y be tude that exposure to envim-nt.1 tob.cco s-kc csn E.“.c disesse, 
including lung cancer, in mnstmkers. It is *la clear th.t simple .ep.r.cioa 
of smkers snd mns~ker. within the ..Y sirspsce uy reduce but canmt 
elimin.te mnsmker exposure to envirorucnt.1 tobacco slake. 
Ihe report .lw review. *II extensive body of evidence which e.t.bli.he. .O 
incressed risk of reapir.tory illness snd reduced lung function in infsnt. .nd 
very y~“ng children of p.rent. rbD .oke. Ihi. effect is ~)re pmmuaced if 
both pxent. sake than if only one p.rent sakes. A. . phy.ici.n. I believe 
th.t p.reot. should refr.in from -king *round s-11 children both s. . r.n. 
of protecting their children’. heslth and to set . pd l rqle for the child. 
Today, only 30 percent of the adult populstion in the United gt.te. .re 
*mker.-the 1are.C level of soking in the country since World Ysr II, 
reflecting th.t the grest msjority of the populstion h.. never mked or hr. 
*“cce**f”lly quit. 
Accompsnying this decline in over.11 prevslence of cigsrette smking h.. 
been sn Lcrersed cancera for protecting the he.lth .nd well being of 
mnsmxker., s. evidenced by the number of lr. and reyl.tion. restricting 
soking in public plsces. Todsy, 40 gtste. snd the District of Dlubi. hsve 
enacted some fotn of legislstion to restrict swking in public. Increasingly, 
these lr. pertsin to protecting mnswkcrs in uny different setting., 
including the varkplsce. 
B..ed on the evidence presented in this report. the choice to slake .hD”ld 









The ibnorable Thomas P. O’Neill, or. 
Speaker of the H3u.e 
of Representatives 
Washington, D.C. 20515 
Oear Hr. Speaker: 
It is my pleasure co rransmit to the Congress the 1986 Surgeon 
General’s Report an the health consequences of sroking, . . mandated by 
Section B(a) of the Public Health Cigarette Smklng Act of 1969. The 
current volume. entitled The Health Consequences of Involuntary Swking, 
examines the ocieotific evidence on the health effects resulting from 
nonsmoker exposure to environmental tobacco smoke. 
The issue of whether or mt tobscco awke is csrcimgenic for humans 
~88 conclusively resolved m)re thsn 20 yesrs .go when the first report on 
smking and heslth YBB issued in 1964. Based on the current report. the 
judgment c.n now be made chat exposure to environmental tobscco sswke csn 
cause disease. including lung cancer, in mnsmkers. It is also c1e.r 
that simple separation of smkers and nonsrmkers within the s.me airap.ce 
msy reduce but csnnot eliminate mnsmDker exposure to environment.1 
tobscco amke. 
The report also reviews sn extensive body of evidence which 
establishes .n incressed risk of respiratory illness and reduced lung 
function in infants .nd very young children of psrenta who smoke. This 
effect ia mire pmmunced if both p.rents anote th.n if only one parent 
amkes. As . physician, I believe that parents should refrsin from 
smoking emend sm.11 children both as . means of protecting their 
children’s heslth and to set . pod ersmple for the child. 
Today, only 30 percent of the adult popul.tion in the United St.Ces 
are srtokers-the lovest level of waking in the country since YDrld Usr 
II, reflecting thst the great mjority of the populscion h.. never smked 
or has successfully quit. 
Accompanying this decline in overall prevalence of cigarette swking 
h.s been an incre.sed concern for protecting the health snd well being of 
nonsmokers, as evidenced by the number of lens snd regulstians restricting 
smking in public places. Today, 40 St.tea .nd the District of Columbia 
have enacted some form of legislation to restrict smoking in public. 
Increasingly, these 1~s pertain to protecting nonawkers in m.ny 
different setting., including the workplace. 
Based on the evidence presented in this report, the choice to srmke 
should mt interfere with the mnslmker’s choice for an environment free 
of tobacco woke. 
Sincerely, 
W fl,a. 
Otis R. Bowen, M.D. 
secretary 
FOREWORD 
The data reviewed in 17 previous U.S. Public Health Service 
reports on the health consequences of smoking have conclusively 
established cigarette smoking as the largest single preventable cause 
of premature death and disability in the United States. 
The question whether tobacco smoke is harmful to smokers was 
answered more than 20 years ago. As a result, many scientists began 
to question whether the low levels of exposure to environmental 
tobacco smoke (ETS) received by nonsmokers could also be harmful. 
The current Report, The Health Consequences of Involuntary 
Smoking, examines the evidence that even the lower exposure to 
smoke received by the nonsmoker carries with it a health risk. Use of 
the term “involuntary smoking” denotes that for many nonsmokers, 
exposure to ETS is the result of an unavoidable consequence of being 
in proximity to smokers. It is the first Report in the health 
consequences of smoking series to establish a health risk due to 
tobacco smoke exposure for individuals other than the smoker, and 
represents the work of more than 60 distinguished physicians and 
scientists, both in this country and abroad. 
After careful examin ation of the available evidence, the following 
overall conclusions can be reached: 
1. Involuntary smoking is a cause of disease, including lung 
cancer, in healthy nonsmokers. 
2. The children of parents who smoke, compared with the 
children of nonsmoking parents, have an increased frequency 
of respiratory infections, increased respiratory symptoms, and 
slightly smaller rates of increase in lung function as the lung 
matures. 
3. Simple separation of smokers and nonsmokers within the 
same air space may reduce, but does not eliminate, exposure 
of nonsmokers to environmental tobacco smoke. 
Exposure to environmental tobacco smoke occurs at home, at the 
worksite, in public, and in other places where smoking is permitted. 
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The quality of the indoor environment must be a concern of all who 
control and occupy that environment. Protection of individuals from 
exposure to environmental tobacco smoke is therefore a responsibili- 
ty shared by all: 
As parents and adults we must protect the health of our 
children by not exposing them to environmental tobacco 
smoke. 
As employers and employees we must ensure that the act of 
smoking does not expose the nonsmoker to tobacco smoke. 
For smokers, it is their responsibility to assure that their 
behavior does not jeopardize the health of others. 
For nonsmokers, it is their responsibility to provide a supportr 
ive environment for smokers who are attempting to stop. 
Actions taken by individuals, employers, and employee organixa- 
tions reflect the growing concern for protecting nonsmokers. The 
number of laws and regulations enacted at the national, State, and 
local level governing smoking in public has increased substantially 
over the past 10 years, and surveys conducted by numerous 
organizations show strong public support for these actions among 
both smokers and nonsmokers. 
As a Nation, we have made substantial progress in addressing the 
enormous toll inflicted by active smoking. Efforts to improve and 
protect individual health must be not only continued but strength- 
ened. On the basis of the evidence presented in this Report, it is clear 
that actions to protect nonsmokers from ETS exposure not only are 
warranted but are essential to protect public health. 
Robert E. Windom, M.D. 
Assistant Secretary for Health 
. . . 
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PREFACE 
This, the 1986 Report of the Surgeon General, is the U.S. Public 
Health Service’s 18th in the health consequences of smoking series 
and the 5th issued during my tenure as Surgeon General. 
Previous Reports have documented the tremendous health burden 
to society from smoking, particularly cigarette smoking. The evi- 
dence establishing cigarette smoking as the single largest preventa- 
ble cause of premature death and disability in the United States is 
overwhelming-totaling more than 50,000 studies from dozens of 
cultures. Smoking is now known to be causally related to a variety of 
cancers in addition to lung cancer; it is a cause of cardiovascular 
disease, particularly coronary heart disease, and is the major cause 
of chronic obstructive lung disease. It is estimated that smoking is 
responsible for well over 800,000 deaths annually in the United 
States, representing approximately 15 percent of all mortality. 
Thirty years ago, however, the scientific evidence linking smoking 
with early death and disability was more limited. By 1964, the year 
the Advisory Committee to the Surgeon General issued the first 
report on smoking and health, a substantial body of evidence had 
accumulated upon which a judgment could be made that smoking 
was a cause of disease in active smokers. Subsequent reports over the 
last 20 years have expanded our understanding and knowledge about 
smoking behavior, the toxicity and carcinogenicity of tobacco smoke, 
and the specific disease risks resulting from exposure to this agent. 
This Report is the first issued since 1964 that identifies a chronic 
disease risk resulting from exposure to tobacco smoke for individuals 
other than smokers. It is now clear that disease risk due to the 
inhalation of tobacco smoke is not limited to the individual who is 
smoking, but can extend to those who inhale tobacco smoke emitted 
into the air. This Report represents a detailed review of the health 
effects resulting from nonsmoker exposure to environmental tobacco 
smoke (ETS). ETS is the combination of smoke emitted from a 
burning tobacco product between puffs (sidestream smoke) and the 
smoke exhaled by the smoker. The 1986 Report, The Health 
Consequences of Involuntary Smoking, is a critical review of all the 
available scientific evidence pertaining to the health effects of ETS 
exposure on nonsmokers. The term “involuntary smoking” is used to 
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note that such exposures often occur as an unavoidable consequence 
of being in close proximity to smokers. 
Lung Cancer and Environmental Tobacco Smoke 
The appropriate framework for an examination of the lung cancer 
risk from involuntary smoking is that of a lowdose exposure to a 
known human carcinogen. Over 30 years of research have conclu- 
sively established cigarette smoke as a carcinogen. This Report 
presents evidence that the chemical composition of side&earn 
smoke is qualitatively similar to the mainstream smoke inhaled by 
the active smoker, and that both mainstream and sidestream smoke 
act as carcinogens in bioassay systems. Data related to environmen- 
tal levels of tobacco smoke constituents and from measures of 
nicotine absorption in nonsmokers suggest that nonsmokers are 
exposed to levels of environmental tobacco smoke that would be 
expected to generate a lung cancer risk, epidemiological studies of 
populations exposed to ETS have documented an increased risk for 
lung cancer in those nonsmokers with increased exposure. 
It is rare to have such detailed exposure data or human epidemic 
logic studies on disease occurrence when attempting to evaluate the 
risk of low-dose exposure to an agent with established toxicity at 
higher levels of exposure. The relative abundance of data reviewed 
in this Report, their cohesiveness, and their biologic plausibility 
allow a judgment that involuntary smoking can cause lung cancer in 
nonsmokers. Although the number of lung cancers due to involun- 
tary smoking is smaller than that due to active smoking, it still 
represents a number sufficiently large to generate substantial public 
health concern. 
It is certain that a substantial proportion of the lung cancers that 
occur in nonsmokers are due to EXS exposure; however, more 
complete data on the dose and variability of smoke exposure in the 
nonsmoking U.S. population will be needed before a quantitative 
estimate of the number of such cancers can be made. 
Children and Infants 
This Report also documents a relationship between parental 
smoking and the respiratory health of infants and children (under 2 
years of age). Infants of parents who smoke have an increased risk of 
hospitalization for bronchitis and pneumonia when compared with 
infants of nonsmoking parents. There is a relationship between 
parental smoking and an increased frequency of respiratory symp 
tams in children. A slower rate of growth in lung function has been 
observed in children of smoking parents. In many studies, if both 
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parents smoke, a stronger relationship exists than if only one parent 
smokes. 
What future respiratory burden these findings may represent for 
these children later in life is not known. As a former pediatric 
surgeon, I strongly urge parents to refrain from smoking in the 
presence of children as a means of protecting not only their 
children’s current health status but also their own. 
Diseases Other Than Lung Cancer 
Several studies have provided data on the relationship between 
ETS and cancers other than lung cancer and on ETS exposure and 
cardiovascular disease. However, further research in these areas will 
be required to determine whether an association exists between ETS 
exposure and an increased risk of developing these diseases. 
Policies Restricting Smoking in Public Places 
The growth in our understanding of the disease risk associated 
with involuntary smoking has been accompanied by a change in the 
social acceptability of smoking and by a growing body of legislation, 
regulation, and voluntary action that addresses where smoking may 
occur in public. Forty States and the District of Columbia now have 
some form of legislation controlling or restricting smoking in various 
public settings. Some States limit smoking to only a few designated 
areas; however, States are increasingly developing and implement- 
ing comprehensive legislation that restricts smoking in many public 
settings, including the workplace. Nine States have restrictions that 
cover smoking not only by public employees but also by employees in 
the private sector. 
No systematic evaluation of the effects these measures may have 
on smoking behavior has been conducted, but there is little doubt 
that strong public sentiment exists for implementing such restric- 
tions. A number of national surveys conducted by voluntary health 
organizations, government agencies, and even the tobacco industry 
have documented that an overwhelming majority of both smokers 
and nonsmokers support restricting smoking in public. 
Public Health Policy and Involuntary Smoking 
The 1986 Surgeon General’s Report on the Health Consequences of 
Involuntary Smoking clearly documents that nonsmokers are placed 
at increased risk for developing disease as the result of exposure to 
environmental tobacco smoke. 
Critics often express that more research is required, that certain 
studies are flawed, or that we should delay action until more 
conclusive proof is produced, As both a physician and a public health 
xi 
official, it is my judgment that the time for delay is past; measures to 
protect the public health are required now. The scientific case 
against involuntary smoking as a health risk is more than sufficient 
to justify appropriate remedial action, and the goal of any remedial 
action must be to protect the nonsmoker from environmental 
tobacco smoke. 
The data contained in this Report on the rapid diffusion of tobacco 
smoke throughout an enclosed environment suggest that separation 
of smokers and nonsmokers in the same room or in different rooms 
that share the same ventilation system may reduce KTS exposure 
but will not eliminate exposure. The responsibility to protect the 
safety of the indoor environment is shared by all who occupy or 
control that environment. 
Changes in smoking policies regarding the workplace and other 
environments necessitated by the data presented in this Report 
should not be designed to punish the smoker. Successful implementa- 
tion of protection for the nonsmoker requires the support and 
cooperation of smokers, nonsmokers, management, and employees 
and should be developed through a cooperative effort of all groups 
affected. In addition, changes are often more effective when support 
and assistance is provided for the smoker who wants to quit. 
Cigarette smoking is an addictive behavior, and the individual 
smoker must decide whether or not to continue that behavior; 
however, it is evident from the data presented in this volume that 
the choice to smoke cannot interfere with the nonsmokers’ right to 
breathe air free of tobacco smoke. The right of smokers to smoke 
ends where their behavior affects the health and wellbeing of 
others; furthermore, it is the smokers’ responsibility to ensure that 
they do not expose nonsmokers to the potential harmful effects of 
tobacco smoke. 
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Development and Organization of the 1886 Report 
The 1966 Report was developed by the O ff&e on Smoking and 
Health of the U.S. Department of Health and Human Services as 
part of the Department’s responsibility, under Public Law 91-222, to 
report new and current information on smoking and health to the 
unitedstatescongress. 
The scientific content of this Report reflects the contributions of 
more than 66 scientists representing a variety of disciplines. 
Individual manuscripts were written by experts known for their 
understanding of and work in specific content areas. These manu- 
scripts were refined through a series of meetings attended by the 
authors, O ffice on Smoking Health staff and consultants, and the 
Surgeon General. 
Upon receipt of the final manuscripts from the authors, the O&e 
and its consultants edited and consolidated the individual manu- 
scripts into appropriate chapters. These- draft chapters were subjeo 
ted to an extensive outside peer review (see Acknowledgments for 
individuals and their affiliations) whereby each was reviewed by up 
to seven experts. Their comments were integrated and the entire 
volume was assembled. This revised edition of the Report was 
resubjected to review by 17 distinguished scientists outside the 
Federal Government, both in this country and abroad. Parallel to 
this review, the entire Report was also submitted to various 
institutes and agencies within the U.S. Public Health Service for 
review and comment. 
The 1966 Report contains a Foreword by the Assistant Secretary 
for Health, a Preface by the Surgeon General of the U.S. Public 
Health Service, and the following chapters: 
Chapter 1. Introduction, Overview, and Summary and Conclu- 
SiOM 
Chapter 2. Health Effects of Environmental Tobacco Smoke 
Exposure 
Chapter 3. Environmental Tobacco Smoke Chemistry and Expo 
sures of Nonsmokers 
Chapter 4. Deposition and Absorption of Tobacco Smoke Con&it+ 
uenta 
Chapter 5. Toxicity, Acute Irritant Effects, and Carcinogenicity 
of Environmental Tobacco Smoke 
Chapter 6. Policies Restricting Smoking in Public Places and the 
Workplace 
Overview 
Inhalation of tobacco smoke during active cigarette smoking 
remains the largest single preventable cause of death and disability 
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for the US. population. The health consequences of cigarette 
smoking and of the use of other tobacco products have been 
extensively documented in the 17 previous Reports in the health 
consequences of smoking series issued by the U.S. Public Health 
Service. cSgare* smoking is a major cause of cancer; it is most 
strongly associated with cancers of the lung and respiratory tract, 
but also causes cancers at other sites, including the pancreas and 
urinary bladder. It is the single greatest cause of chronic obstructive 
lung dka~3. It c8uf4f33 cardiovascular diseases, including coronary 
heart disease, aortic aneurysm, and atherosclerotic peripheral 
vascular disease. ~atermd cigarette smoking endangers fetal and 
neonatal health, it contributes to perinatal mortality, low birth 
weight, and complications during pregnancy. More than 3CQofl 
premature deaths occur in the United States each year that are 
directly attributable to tobacco use, particularly cigarette smoking. 
‘Ihis Eteport examines in detail the scientific evidence on involun- 
tary smoking as a potential cause of disease in nonsmokers. 
Nonsmokers’ exposure to environmental tobacco smoke is termed 
involuntary smoking in this Fteport because the expcsure generally 
occurs as an unavoidable consequence of being in proximity to 
smokers, particularly in enclosed indoor environments. The term 
“passive smoking” is also used throughout the scientific literature to 
describe this exposure. 
The magnitude of the disease risks for active smokers secondary to 
their “high dose” exposure to tobacco smoke suggests that the “lower 
dose” exposure to tobacco smoke received by involuntary smokers 
may also have risks. Although the risks of involuntary smoking are 
smaller than the risks of active smoking, the number of individuals 
injured by involuntary smoking is large both in absolute terms and 
in comparison with the number injured by some other agents in the 
general environment that are regulated to curtail their potential to 
cause human illness. 
This Report reviews the evidence on the characteristics of main- 
stream tobacco smoke and of environmental tobacco smoke, on the 
levels of exposure to environmental tobacco smoke that occur, and 
on the health effects of involuntary exposure to tobacco smoke. me 
composition of the tobacco smoke inhaled by active smokers and by 
involuntary smokers is examin ed for similarities and differences, 
and the concentrations of tobacco smoke components that can b 
immured in a variety of settings are explored, as is smoke deposition 
and absorption in the respiratory tract. The studies that &crib the 
risks of environmental tobacco smoke exposure for humans are 
carefully reviewed for their fmdings and their validity. ‘I’he evidence 
on the health effects of involuntary smoking is reviewed for biologic 
plausibility, and compared with extrapolations of the risks of active 
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smoking to the lower dose of exposure to tobacco smoke found in 
nonsmokers. This review leads to three major conclusions: 
1. Involuntary smoking is a cause of disease, including 
lung cancer, in healthy nonsmokers. 
2. The children of parents who smoke compared with the 
children of nonsmoking parents have an increased 
frequency of respiratoryinfections, increased respira- 
tory symptoms, and slightly smaller rates of increase in 
lung function as the lung matures. 
3. The simple separation of smokers and nonsmokers 
within the same air space may reduce, but does not 
eliminate, the exposure of nonsmokers to environmen- 
tal tobacco smoke. 
The subsequent chapters of this volume describe in detail the 
evidence that supports these conclusions; the evidence is briefly 
summarized here. 
Environmental Tobacco Smoke Constituents 
Important considerations in e xamining the risks of involuntary 
smoking are the composition of environmental tobacco smoke (ETS) 
and its toxicity and carcinogenicity relative to the tobacco smoke 
inhaled by active smokers. Mainstream cigarette smoke is the smoke 
drawn through the tobacco into the smoker’s mouth. Sidestream 
smoke is the smoke emitted by the burning tobacco between puffs. 
Environmental tobacco smoke results from the combination of 
sidestream smoke and the fraction of exhaled mainstream smoke not 
retained by the smoker. In contrast with mainstream smoke, ETS is 
diluted into a larger volume of air, and it ages prior to inhalation. 
The comparison of the chemical composition of the smoke inhaled 
by active smokers with that inhaled by invohmtary smokers suggests 
that the toxic and carcinogenic effects are qualitatively similar, a 
similarity that is not too surprising because both mainstream smoke 
and environmental tobacco smoke result from the combustion of 
tobacco. Individual mainstream smoke constituents, with appropri- 
ate testing, have usually been found in sidestream smoke as well. 
However, differences between sidestream smoke and mainstream 
smoke have been well documented. The temperature of combustion 
during side&ream smoke formation is lower than during main- 
stream smoke formation. As a result, greater amounts of many of the 
organic constituents of smoke, including some carcinogens, are 
generated when tobacco burns and forms side&ream smoke than 
when mainstream smoke is produced. For example, in contrast with 
mainstream smoke, side&ream smoke contains greater amounts of 
ammonia, benzene, carbon monoxide, nicotine, and the carcinogens 
7 
%napthylamine, 4aminobipheny1, N-nitrosamine, ~=I+ 
anthracene, and benzo-pyrene per milligram of tobacco burned. 
Although only limited bioassay data comparing mainstream smoke 
and sidestream smoke are available, one study has suggested that 
sidestream smoke may be more carcinogenic. 
Extent of Exposure 
~though siclestream smoke and mainstream smoke differ some- 
what qualitatively, the differing quantitative doses of smoke compo- 
nents inhaled by the active smoker and by the involuntary smoker 
are of greater importance in considering the risks of the two 
exposures. A number of different markers for tobacco smoke 
exposure and absorption have been identified for both active and 
involuntary smoking. No single marker quantifies, with precision, 
the exposure to each of the smoke constituents over the wide range 
of environmental settings in which involuntary smoking occurs. 
However, in environments without other significant sources of dust, 
respirable suspended particulate levels can be used as a marker of 
smoke exposure. Levels of nicotine and its metabolite cotinine in 
body fluids provide a sensitive and specific indication of recent whole 
smoke exposure under most conditions. 
Widely varying levels of environmental tobacco smoke can be 
measured in the home and other environments using markers. The 
time-activity patterns of nonsmokers, which indicate the time spent 
in environments containing EI’S, also vary widely. Thus, the extent 
of exposure to ETS is probably highly variable among individuals at 
a given point in time, and little is known about the variation in 
exposure of the same individual at different points in time. 
Llmg cancer 
The American Cancer Society estimates that there will be more 
than 135,000 deaths from lung cancer in the United States in 1986, 
and 85 percent of these lung cancer deaths are directly attributable 
to active cigarette smoking. Therefore, even if the number of lung 
cancer deaths caused by invohmtary smoking were much smaller 
than the number of lung cancer deaths caused by active smoking, the 
number of lung cancer deaths attributable to involuntary exposure 
would still represent a problem of sufficient magnitude to warrant 
substantial public health concern. 
Exposure to environmental tobacco smoke has been examined in 
numerous recent epidemiological studies as a risk factor for lung 
cancer in nonsmokers. These studies have compared the risks for 
subjects exposed to MS at home or at work with the risks for people 
not reported to be exposed in these environments. Because exposure 
to EIS is an almost universal experience in the more developed 
~~fhs, theee studies involve comparison ofmore expased and less 
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exposed people rather than comparison of exposed and unexposed 
people. Thus, the studies are inherently conservative in assessing the 
consequences of exposure to ETS. Interpretation of these studies 
must consider the extent to which populations with different E’JJS 
exposures have been identified, the gradient in EXS exposure from 
the low-er exposure to the higher exposure groups, and the magni- 
tude of the increased lung cancer risk that results from the gradient 
in ETS exposure. 
To date, questionnaires have been used to classify ETS exposure. 
Quantification of exposure by questionnaire, particularly lifetime 
exposure, is difficult and has not been validated. However, spousal 
and parental smoking status identify individuals 6th different 
levels of exposure to ETS. Therefore, investigation has focused on the 
children and nonsmoking spouses of smokers, groups for whom 
greater ETS exposure would be expected and for whom increased 
nicotine absorption has been documented relative to the children 
and nonsmoking spouses of nonsmokers. 
Of the epidemiologic studies reviewed in this Report that have 
examined the question of involuntary smoking’s association with 
lung cancer, most (11 of 13) have shown a positive association with 
exposure, and in 6 the association reached statistical significance. 
Given the difficulty in identifying groups with differing ET’S 
exposure, the low-dose range of exposure examined, and the small 
numbers of subjects in some series, it is not surprising that some 
studies have found no association and that in others the association 
did not reach a conventional level of statistical significance. The 
question is not whether cigarette smoke can cause lung cancer; that 
question has been answered unequivocally by examining the evi- 
dence for active smoking. The question is, rather, can tobacco smoke 
at a lower dose and through a different mode of exposure cause lung 
cancer in nonsmokers? The answer must be sought in the coherence 
and trends of the epidemiologic evidence available on this lowdose 
exposure to a known human carcinogen. In general, those studies 
with larger population sizes, more carefully validated diagnosis of 
lung cancer, and more careful assessment of M‘s exposure status 
have shown statistically significant associations. A number of these 
studies have demonstrated a dose-response relationship between the 
level of M‘S exposure and lung cancer risk. By using data on nicotine 
absorption by the nonsmoker, the nonsmoker’s risk of developing 
lung cancer observed in human epidemiologic studies can be 
compared with the level of risk expected from an extrapolation of the 
d-response data for the active smoker. This extrapolation yields 
estimates of an expected lung cancer risk that approximate the 
observed lung cancer risk in epidemiologic studies of involud~ 
smoking. 
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Cigarette smoke is well established as a human carcinogen. The 
chemical composition of ETS is qualitatively similar to mainstream 
smoke and sidestream smoke and also acts as a carcinogen in 
bioassay systems. For many nonsmokers, the quantitative exposure 
to ETS is large enough to expect an increased risk of lung cancer to 
occur, and epidemiologic studies have demonstrated an increased 
lung cancer risk with involuntary smoking. In examining a low-dose 
exposure to a known carcinogen, it is rare to have such an 
abundance of evidence on which to make a judgment, and given this 
abundance of evidence, a clear judgment can now be made: exposure 
to ETS is a cause of lung cancer. 
The data presented in this Report establish that a substantial 
number of the lung cancer deaths that occur among nonsmokers can 
be attributed to involuntary smoking. However, better data on the 
extent and variability of E!lS exposure are needed to estimate the 
number of deaths with confidence. 
Respiratory Disease 
Acute and chronic respiratory diseases have ah30 been linked to 
hvol~ntary exposure to tobacco smoke; the evidence is strongest in 
infants. htig the first 2 years of life, infants of parents who smoke 
me more Likely than infants of nonsmoking parents to be hospital- 
ized for bronchitis and pneumonia. Children whose parents smoke 
aho develop respiratory symptoms more frequently, and they show 
small, but measurable, differences on tests of lung function when 
compared with children of nonsmoking parents. 
Respiratory infections in young children represent a direct health 
burden for the children and their parents; moreover, these infec- 
tions, and the reductions in pulmonary function found in the school- 
age children of smokers, may increase susceptibility to develop lung 
disease as an adult. 
Several studies have reported small decrements in the average 
level of lung function in nonsmoking adults exposed to ETS. These 
differences may represent a response of the lung to chronic exposure 
to the irritants in ETS, but it seems unlikely that ETS exposure, by 
itself, is responsible for a substantial number of cases of clinically 
significant chronic obstructive lung disease. The small magnitude of 
the changes associated with EX’S exposure suggesta that only 
Miti~uals with unusual susceptibility would be at risk of develop 
kg ClinicallY adent disease from E’I% exposure alone. However, 
ETS exposure IMY be a factor that contributes to the development of 
clinical disease in individuals with other causes of lug mjury. 
cardiovascular Disease 
A few studies have examined the relationship hebeen invohrn~ 
tarY smoking and cardiovascular disease, but no firm conclusion on 
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the relationship can be made owing to the limited number of deaths 
in the studies. 
Perhaps the most common effect of tobacco smoke exposure is 
tissue irrit&.ion. The eyes appear to be especially sensitive to 
irritation by EX’S, but the nose, throat, and airway may also be 
af%cted by smoke exposure. Irritation has been demonstrated to 
occur at levels that are similar to those found in real-life situations. 
The level of irritation increases with an increasing concentration of 
smoke and duration of exposure. In addition, participants in surveys 
report irritation and annoyance due to smoke in the environment 
under real-life conditions. 
Determinante of Espoi3ure 
&pc++ure to EX’S has been documented to be common in the 
United States, but additional data on the extent and determi,nanta of 
exposure are needed to identify individu& within the population 
who have the highest exposure and are at greatest risk. Studies with 
biological markers and measurements of EXS components in indoor 
air confirm that measurable exposure to l3TS is widespread. How- 
ever, within exposed populations, levels of cotinine excretion and 
presumably El% exposure vary greatly. 
In a room or other indoor area, the size of the space, the number of 
smokers, the amount of ventilation, and other factors determine the 
concentration of tobacco smoke in the air. The technology for the 
cost-effective atration of tobacco smoke from the air is not currently 
available, and because of their small size, the smoke particles remain 
suspended in the air for long periods of time; thus, the only way to 
remove smoke from indoor air is to increase the exchange of indoor 
air with clean outdoor air. The number of air changea per hour 
required to maintain acceptable indoor air quality is much higher 
when smoking is allowed than when smoking is prohibited. 
Environmental tobacco smoke originates at the lighted tip of the 
cigarette, and exposure to M‘s is greatest in proximity to the 
smoker. However, the smoke rapidly disseminates throughout any 
airspace contiguous with the space in which the smoking is taking 
place. Dissemination of smoke is not uniform, and substantial 
gradienti in ETS levels have been demonstrated in different parta of 
the same airspace. The time course of tobacco smoke dissemination 
is rapid enough to ensure the spread of smoke throughout an 
airspace within an S-hour workday. In the home, the presence of 
even one smoker can GgnEcantly increase levels of respirable 
suspended particulates. 
These data lead to the conclusion that the simple separation of 
smokers and nonsmokers within the same airspace will reduce, but 
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not eliminate, exposure to El%, particularly in those settings where 
exposure is prolonged, such as the working environment. 
The exposure of an individual nonsmoker to ETS is also deter- 
m&xl by that person’s time-activity pattern; that is, the amount of 
he spent in various locations. For adults, the duration of the 
spent in smoke-contaminated environments at work or at home is 
the principal dete rminant of E!!‘8 exposure, along with the levels of 
smoke in those environments. For infants and very young children, 
the smoking habit of the primary caretaker, as well as that person’s 
time-activity pattern, is likely to play a major role in de&mining 
ETS exposure. 
Policies Restricting Smoking 
Pohcies regulating cigarette smoking with the objective of reduc- 
ing e~l~ion or fire risk, or of safeguarding the quality of manufac- 
tured products, have been in force in a number of States since the 
late 1800s. More recently, and with steadily increasing frequency, 
pohcies regulating smoking on the basis of the health risk or the 
irritation of involuntary smoking have been promulgated. 
State and local governments have enacted laws and regulations 
restricting smoking in public places. These policies have been 
implemented with few problems and at little cost to the respective 
governments. !I’he public awareness of these policies that results 
from the media coverage surrounding their implementation proba- 
bly facilitates their selfenforcement. Public awareness may best be 
fostered by encouraging the establishment of these changes at the 
local level. 
Policies limiting smoking in the worksite have also become 
increasingly widespread and more restrictive. However, changes in 
worksite policies have evolved largely through voluntary rather 
than governmental action. In a steadily increasing number of 
worksites, smoking has been prohibited completely or limited to 
relatively few areas within the worksite. The creation of a smoke- 
free workplace has proceeded successfully when the policy has been 
jointly developed by employees, employee organizations, and man- 
agement; instituted in phases; and accompanied by support and 
assistarm for the smokers to quit smoking. 
This trend to protect nonsmokers from ETS exposure may have an 
added public health benefithelping those smokers who are at- 
tempting to quit to be more successful and not encouraging smoking 
by people entering the workforce. 
Summary and Conclusions of the 1988 Report 
The three major conclusions of this report are the following: 
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1. Involuntary smoking is a cause of disease, including 
lung cancer, in healthy nonsmokers. 
2. The children of parents who smoke compared with the 
children of nonsmoking parente have an iucreased 
frequency of respiratory iufectiouq iucreased respira- 
tory symptoms, and slightly smaller rates of increase in 
lung function as the lung matures. 
3. The simple separation of smokers and nousmokers 
withiu the same air space may reduce, but doea not 
eliminate, the exposure of nonsmokers to enviroumen- 
tal tobacco smoke. 
,Individual chapter summaries and conclusions follow. 
Health Effects of Euviroumental Tobacco Smoke Exposure 
1. Involuntary smoking can cause lung cancer in nonsmokers. 
2. Although a substantial number of the lung cancers that occur 
in nonsmokers can be attributed to involuntary smoking, more 
data on the dose and distribution of ETS exposure in the 
population are needed in order to accurately estimate the 
magnitude of risk in the U.S. population. 
3. The children of parents who smoke have an increased frequen- 
cy of hospitalization for bronchitis and pneumonia during the 
first year of life when compared with the children of nonsmok- 
ers. 
4. The children of parents who smoke have an increased frequen 
cy of a variety of acute respiratory illnesses and infections, 
including chest illnesses before 2 years of age and physician- 
diagnosed bronchitis, tracheitis, and laryngitis, when com- 
pared with the children of nonsmokers. 
5. Chronic cough and phlegm are more frequent in children 
whose parents smoke compared with children of nonsmokers. 
The implications of chronic respiratory symptoms for respira- 
tory health as an adult are unknown and deserve further 
study. 
6. The children of parents who smoke have small differences in 
tests of pulmonary function when compared with the children 
of nonsmokers. Although this decrement is insufficient to 
cause symptoms, the possibility that it may increase suscepti- 
bility to chronic obstructive pulmonary disease with exposure 
to other agents in adult life, e.g., active smoking or cccupation- 
al exposures, needs investigation. 
7. Healthy adults exposed to environmental tobacco smoke may 
have small changes on pulmonary function testing, but are 
unlikely to experience clinically significant deficits in pulmo- 
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nary function as a result of exposure to environmental tobacco 
smoke alone. 
8. A number of studies report that chronic middle ear effusions 
are more common in young children whose parents smoke than 
in children of nonsmoking parents. 
9. Validated questionnaires are needed for the assessment of 
recent and remote exposure to environmental tobacco smoke in 
the home, workplace, and other environments. 
10. The associations between cancers, other than cancer of the 
lung, and involuntary smoking require further investigation 
before a determina tion can be made about the relationship of 
involuntary smoking to these cancers. 
11. Further studies on the relationship between involuntary 
smoking and cardiovascular disease are needed in order to 
determine whether involuntary smoking increases the risk of 
cardiovaaculardisease. 
Environmental Tobacco Smoke Chemistry and Expcwwes of 
Nonsmokera 
1. Undiluted sidestream smoke is characterixed by significantly 
higher concentrations of many of the toxic and carcinogenic 
compounds found in mainstream smoke, including ammonia, 
volatile amines, volatile nitr osamines, certain nicotine decom- 
position products, and aromatic amines. 
2. Environmental tobacco smoke can be a substantial contributor 
to the level of indoor air pollution concentrations of respirable 
particles, benzene, acrolein, N-nitrosamine, pyrene, and carbon 
monoxide. E!l’S is the only source of nicotine and some N- 
nitrosamine compounds in the general environment. 
3. Measured exposures to respirable suspended particulates are 
higher for nonsmokers who report exposure to environmental 
tobacco smoke. Exposures to ETS occur widely .in the non- 
smoking population. 
4. The small particle size of environmental tobacco smoke places 
it in the diffusioncontrolled regime of movement in air for 
deposition and removal mechanisms. Because these submicron 
particles will follow air streams, convective currents will 
dominate and the distribution of ETS will occur rapidly 
through the volume of a room. As a result, the simple 
separation of smokers and nonsmokers within the same 
airspace may reduce, but will not eliminate, exposure to ETS. 
5. It has been demonstrated that ETS has resulted in elevated 
respirable suspended particulate levels in enclosed places. 
14 
Deposition and Absorption of Tobacco Smoke Constituenta 
1. Absorption of tobacco-speciSc smoke constituents (i.e., nicotine) 
from environmental tobacco smoke exposures has been docu- 
mented in a number of samples of the general population of 
developed countries, suggesting that measurable exposure tc 
environmental tobacco smoke is common. 
2. Mean levels of nicotine and cotinine in body fluids increase 
with self-reported EX’S exposure. 
3. Because of the stability of cotinine levels measured at different 
times during exposure and the availability of noninvasive 
sampling techniques, cotinine appears to be the shortcterm 
marker of choice in epidemiological studies. 
4. Both mathematical modeling techniques and experimental 
data suggest that 10 to 20 percent of the particulate fraction of 
side&ream smoke would be deposited in the airway. 
5. The development of specific chemical assays for human expo 
sure to the components of cigarette tar is an important 
research goal. 
Toxicity, Acute Irritant Effects, and Carcinogenicity of 
Environmental Tobacco Smoke 
1. The main effects of the irritants present in ETS occur in the 
conjunctiva of the eyes and the mucous membranes of the nose, 
throat, and lower respiratory tract These irritant effects are a 
frequent cause of complaints about poor air quality due to 
environmental tobacco smoke. 
2. Active cigarette smoking is associated with prominent changes 
in the number, type, and function of respiratory epithelial and 
inflammatory cells; the potential for environmental tobacco 
smoke exposure to produce similar changes should be investi- 
gated. 
3. Animal models have demonstrated the carcinogencity of ciga- 
rette smoke, and the limited data that exist suggest that more 
carcinogenic activity per milligram of cigarette smoke concen- 
trate may be contained in sidestream smoke than in main- 
stream cigarette smoke. 
Policies Restricting Smoking in Public Places and the 
Workplace 
1. Beginning in the 19708, an increasing number of public and 
private sector institutions have adopted policies to protect 
individuals from environmental tobacco smoke exposure by 
restricting the circumstances in which smoking is permitted. 
2. Smoking in public places has been regulated primarily by 
government actions, which have occurred at Federal, State, 
15 
and local levels. All but nine States have enacted laws 
regulating smoking in at least one public place. Since the mid- 
19706, there has been an increase in the rate of enactment and 
in the comprehensiveness of State legislation. Local govern- 
ments have enacted smoking ordinances at an increasing rate 
since 1980, more than SO cities and counties have smoking laws 
in effect. 
9. Smoking at the workplace is regulated by a combination of 
government action and private initiative. Legislation in 12 
States regulates smoking by government employees, and 9 
St&s and more than 70 communities regulate smoking in the 
private sector workplace. Approximately 96 percent of busi- 
nesses have adopted smoking policies. The increase in work- 
place smoking policies has been a trend of the 1980s. 
4. Smoking policies may have multiple effects. In addition to 
reducing environmental tobacco smoke exposure, they may 
alter smoking behavior and public attitudes about tobacco use. 
Over time, this may contribute to a reduction in smoking in the 
United States. To the present, there has been relatively little 
systematic evaluation of policies restricting smoking in public 
places or at the workplace. 
5. On the basis of case reports and a small number of systematic 
studies, it appears that workplace smoking policies improve air 
quality, are met with good compliance, and are well accepted 
by both smokers and nonsmokers. Policies appear to be 
followed by a decrease in smokers’ cigarette consumption at 
work and an increase in enrollment in company-sponsored 
smoking cessation programs. 
6. Laws restricting smoking in public places have been imple- 
mented with few problems and at little cost to State and local 
government. Their impact on smoking behavior and attitudes 
has not yet been evaluated. 
7. Public opinion polls document strong and growing support for 
restricting or banning smoking in a wide range of public places. 
Changes in attitudes about smoking in public appear to have 
preceded legislation, but the interrelationship of smoking 
attitudes, behavior, and legislation are complex. 
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In 1964, the fmt Report of the Surgeon General on smoking and 
health (TJS PHS 1964) determined that cigarette smoking was a 
cause of lung cancer in men and probably a cause of lung cancer in 
women. That Report also noted causal relationships between smok- 
ing and other cancers, as well as chronic lung disease. Subsequent 
Reports have described associations, both causal and noncausal, 
between tobacco smoking and a wide range of acute and chronic 
d&eases. Epidemiological investigations have documented the effects 
of tobacco smoking in humans; complementary laboratory investiga- 
tions have elucidated some of the mechanisms through which 
tobacco smoke causes disease. 
More recently, the effects of the inhalation of environmental 
tobacco smoke by nonsmokers have become a pressing public health 
concern. Nonsmokers, as well as active smokers, inhale environmen- 
tal tobacco smoke, the mixture of sidestream smoke and exhaled 
mainstream smoke. Various terms have been applied to the inhala- 
tion of environmental tobacco smoke by nonsmokers; the terms 
“involuntary smoking” and “passive smoking” are the most preva- 
lent and are often used interchangeably by researchers and the 
public. 
Many of the known toxic and carcinogenic agents found in 
mainstream cigarette smoke have also been demonstrated to be 
present in sidestream smoke. Furthermore, the combustion condi- 
tions under which sidestream smoke is produced result in the 
generation of larger amounts of many of these toxic and carcinogenic 
agents per gram of tobacco burned than the conditions under which 
mainstream smoke is generated (see Chapter 3). The characteristics 
of environmental tobacco smoke also differ from those of main- 
stream smoke because the sidestream smoke ages before it is inhaled 
and the mainstream smoke exhaled by the active smoker is modified 
during its residence in the lung. There is no evidence to suggest that 
environmental tobacco smoke has a qualitatively lower toxicity or 
carcinogenicity than mainstream smoke per milligram of smoke 
inhaled. In fact, the available evidence suggests that sidestream 
smoke contains higher concentrations of many known toxic and 
carcinogenic agents per milligram of smoke and is more tumorgenic 
than mainstream smoke in animal testing (Wynder and Hoff’mann 
1967). As a result, involuntary smoking should not be viewed as a 
qualitatively different exposure from active smoking, but rather as a 
lowdose exposure to a known hazardous agent-cigarette smoke. 
Evaluation of Low-Dose Tobacco Smoke Exposures 
Assessment of the health effects of any environmental exposure 
poses methodological problems, particularly when exposure levels 
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are low and therefore the magnitude of the expected effect is small. 
me ev&ation of an effect due to a low-dose exposure such as 
environment& tobacco smoke requires the investigation of popula- 
tions with differences in exposure large enough so that an effect 
could be anticipated. The population studied must also be of 
sufficient size to quantitate the effects in the range of interest with 
pr&&n. Failure to fulfill these requirements may produce a false- 
negative result in a study of a low-dose exposure. 
Exposure to environmental tobacco smoke is a nearly universal 
experience in the more developed countries, so the identification of a 
truly unexposed population is very difficult. Epidemiological studies 
of involuntary smoking have attempted to identify populations with 
lower exposure and higher exposure to environmental tobacco 
smoke, most notably by examining nonsmokers exposed to tobacco 
smoke generated by the smokers of their family. The effects of 
environmental tobacco smoke have been investigated in a number of 
populations throughout the world. The diversity of these populations 
is likely to be accompanied by a similar diversity of their exposure to 
envircnmental tobacco smoke. Thus, the gradient in exposure to 
environmental tobacco smoke between the “exposed” and %onex- 
posed” groups is likely to vary widely among the reported studies. 
For example, the husband’s smoking status may be a strong 
predictor of total exposure to ETS in traditional societies, such as 
Japan and Greece, where the wife’s exposure outside the home is 
limited. In contrast, the husband’s smoking status in the United 
States, where substantial exposure may occur outside the home, may 
not be as predictive. 
Sample size considerations are of particular concern for the 
epidemiological studies of lung cancer and involuntary smoking. 
Because the frequency of lung cancer in nonsmokers is low, many of 
these studies often included small numbers of nonsmokers and 
lacked the statistical power necessary to fmd the modest effect 
expected from this lowdose exposure. Given the constraints of 
sample size and the varying gradients of exposure, it would be 
expected that some studies would fmd no association between 
involuntary smoking and lung cancer, and that other studies would 
find associations that lacked statistical significance. Nonunifomity 
of the data, however, does not imply a lack of effect; rather, it is the 
coherence and trends of the evidence that must be judged. Thus, this 
Rep0l-t examines the entire body of evidence on the health effects of 
involuntary smoking, as the basis for its conclusions. 
In evaluating the hazards posed by an air pollutant such as 
environmental tobacco smoke, laboratory, toxicological, human 
exposure, and epidemiological investigations provide relevant data. 
Each approach has limitations, but the insights each prov&s Me 
Complementary. Epidemiological investigations describe the effects 
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in human populations, but their results must be interpreted in the 
context of the other types of investigations. 
Risk assessment techniques have also been used to characterize 
the potential adverse health effects of human exposures to environ- 
mental pollutants, particularly those at low levels. The four steps of 
risk assessment have been described by the National Academy of 
Sciences as hazard identification, dose-response assessment, expo- 
sure assessment, and risk characterization (NAS 1983). Risk assess+ 
ment has also been used to describe the consequences of exposure to 
ETS. However, unlike many environmental exposures for which risk 
assessment represents the only approach for estimating human risk, 
the health effects of ETS exposure can be examined directly using 
epidemiological methods. Although this Report reviews several risk 
assessmenta done by individual researchers on ETS, its conclusions 
are based on the laboratory, toxicological, and epidemiological 
evidence. 
Extrapolation of Active Smoking Data to Environmental 
Tobacco Smoke Exposure 
Comparison of Mainstream Smoke and Sidestream Smoke 
A detailed comparison of mainstream and side&ream smoke can 
be found in Chapter 3. Mainstream smoke (MS) is the term applied to 
the complex mixture that is inhaled by the smoker from the 
mouthpiece of a cigarette, cigar, or pipe with each puff. Side&ream 
smoke (SS) is the aerosol that comes from the burning end of the 
cigarette, pipe, or cigar between puffs. Environmental tobacco smoke 
(ETS) is the term applied to the combination of SS and exhaled MS, 
which is diluted and aged in an area where smoking has taken place. 
Most of the existing data on mainstream and sidestream smoke 
characteristics relate to cigarette smoking and relatively little 
information is available pertaining to cigar and pipe smoking. 
&cause both MS and SS are generated from the tip of the burning 
tobacco product, it is not surprising that their compositions are 
similar. Of the thousands of compounds identified in tobacco smoke, 
many have been identified as present in both MS and SS. Among 
these are carcinogens, gases such as carbon monoxide and the oxides 
of nitrogen, and nicotine. Since there is a wealth of information 
relating to the toxicity and carcinogenicity of MS, it should be 
emphasized again that ETS cannot be treated as a new environmen- 
tal agent for the purpose of assessing health risks. The presence of 
the same agents in MS and SS leads to the conclusion that ETS has a 
toxic and carcinogenic potential that would not be expected to be 
qualitatively different from that of MS. Quantitative differences 
between the active smoker’s exposure to MS and the involuntary 
smoker’s exposure to ETS are likely to be. the more important 
23 
determjnant of the differing magnitudes of risks associated with 
them3 two exposures. 
werences in the composition of MS and SS primarily reflect 
their generation at different temperatures in different oxygen 
environments. also, SS is diluted very rapidly, under most circum- 
ww, and has the opportunity to age before inhalation. The 
h~luntary smoker usually inhales E’IS, not SS, the aerosol that 
comes from the tip of a burning cigarette. In considering the 
&u&e&tics of SS, it must be emphasii that much of the 
existing data about the composition of MS and SS is derived from 
studies carried out in special chambers rather than by sampling MS 
and SS generated by smokers. In these chamber studies, SS has been 
sampled by a probe located close to the burning tip. This experimen- 
tal situation clearly differs from that of a room with one or more 
smokers freely smoking. In that situation, SS is mixed with exhaled 
MS, diluted and aged. Nevertheless, these &amber studies provide 
very useful information about the compounds present in the SS. 
These studies have established that SS in comparison with MS has a 
higher PHI, smaller particle size, and more carbon monoxide, 
benzene, toluene, acrolein, acetone, pyridine, ammonia, methyl- 
amine, nicotine, aniline, cadmium, radon daughters, beru@ajpyrene 
and benzIa]anthracene. 
Comparison of the relative concentrations of the various compo- 
nents of SS and MS smoke prcvides limited insights concerning the 
toxicological potential of ETS in comparison with active smoking. As 
described above, SS characteristics, as measured in a &amber, do 
not represent those of E!I’S, as inhaled by the nonsmoker under 
nonexperimental conditions. Further, the dose-response relation- 
sbips between specific tobacco smoke components and specific 
diseases are not sufficiently established for the necesssq extrapola- 
tions from active smoking to environmental tobacco smoke exposure 
for individual agents. For that reason the extrapolations in this 
section are confined to the doseresponse relationships of whole 
smoke for those diseases with established dose-response relation- 
ships. 
With regard to the potential of EX’S to cause lung cancer, 
UdilUted SS has 20 to 100 times greater concentrations of. highly 
carcinogenic volatile. N-nitrosamin es than MS (Brunnemam et al. 
1978) as well as higher concentrations of benxopyrenes and 
benzCa]anthracenes. 
For mum&want effecta on airways and the lung parenchyma, 
the agents responsible for the development of acute and chronic 
respiratory disease have not been identified, although many tobacco 
smoke components have been shown tc cause lung injury (US DHHS 
19&Q). Presumably, both vapor phase (gaseous) and particulate phase 
kW components of MS are involved. Both airways disease and 
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parenchymal disease are probably a response to the total burden of 
respiratory insults, some of which, like active smoking, may be 
sufficient by themselves to cause physiologic impairment and 
ultimately, clinical disease. Others, such as ETS, may contribute to 
the total burden but be insufficient, individually, to cause clinical 
disease. 
Deposition of Mainstream Smoke and Side&ream Smoke and 
Environmental Tobacco Smoke Dose Estimutes 
The dose of tobacco smoke delivered to the airways and alveoli 
depends, among other factors, on the volume of MS, SS, or E’I’S 
inhaled, on the rate and depth of inhalation, and on the sixe, shape, 
and density of the individual particles or droplets. Patterns of 
deposition of MS in the lungs have been described, but similar 
information about deposition patterns for ETS is not yet available. 
Without such data, it is necessary to extrapolate from the informa- 
tion on MS. 
The major factors that affect the pattern of deposition and 
retention for particles are particle size distriiution and breathing 
pattern. The particle sire range and mean aerodynamic diameter for 
particulates in sidestream smoke are similar to those of mainstream 
smoke (particle sire range of 0.01 to 0.8 pm for sidestream smoke and 
0.1 to 1.0 v for mainstream smoke, and mean aerodynamic 
diameter 0.32 p for sidestream smoke and 0.4 pm for mainstream 
smoke) (see Cbapters 3 and 4). ‘l’he deposition site is determined 
largely by the size of the particles, with large particles being 
deposited preferentially in the nasopbarynx and large conducting 
airways. Smaller particles are deposited more peripherally, and very 
small particles tend to be exhaled and to have a very low deposition 
fraction. The particulates of ETS, because of their size range, are 
likely to be deposited peripherally. 
The breathing patterns for the inhalation of MS and EYI’S are also 
different; MS is inbaled intermittently by the smoker with an 
intense inhalation, often followed by a breathhold that resulta in a 
more equal distribution. Environmental tobacco smoke, on the other 
hand, is inhaled continuously with tidal breaths when the passive 
smoker is at rest and with deeper inhalations when the passive 
smoker is physically active. Breatbholding does not normally occur 
with tidal breathing. 
Estimates of the equivalent exposure, in terms of cigarettes per 
day, resulting from ETS, as compared with MS, vary quite widely 
and depend on the way in which the estimates were made. Bepace 
and Lowrey (1985) estimated that nonsmokers in the United States 
are exposed to from 0 to 14 mg of tobacco tar (average 1.4 rag) per 
day. Vutuc (1984) estimated that the exposure to environmental 
cigarette smoke is equivalent to 0.1 to 1 cigarette per day actively 
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smoked. Estimates of ETS exposure, based on cotinine measure- 
ments, suggest that involuntary smokers absorb about 0.5 to 1 
percent of the nicotine that active smokers absorb (Jarvis et al. 1984, 
Haley and Hoffmann 1965; Wald et al. 1984; Russell et al. 1966). 
Dose-Response Ret!ationships and Threshold for Risk 
-response relationships for active smoking can provide in- 
sights into the expected magnitude of disease resulting from the 
exposure of nonsmokers to ETS. These data are reviewed to 
de&mine whether disease can be expected in association with E’I’S. 
Data from cohort and cas+control studies demonstrate dose- 
response relationships for lung cancer, which extend to the lowest 
levels of reported active smoking. The dose-response relationship of 
active smoking with lung cancer risk has been described by several 
investigators in several different date sets (Whittemore and Altshu- 
ler 1976; Doll and Pet0 1978; Pathak et al. 1986). Although the 
mathematical forms of these models vary, none have included a 
threshold level of active smoking that must be passed for lung cancer 
tc develop. 
The dose-response relationship for active smoking and lung cancer 
has been used to project the lung cancer risk for nonsmokers (Vutuc 
1964). Such projections yield risk estimates of 1.03 to 1.36 for 
exposures, considered to be reasonable estimates of involuntary 
smoking exposures, i.e., 0.1 t.c 1.0 cigarettes per day. The reference 
population for these risk estimates is the risk for nonsmokers as a 
group, including those with higher and those with lower exposures to 
environmental tobacco smoke. In contrast, the reference population 
for the risk estimates in studies of involuntary smoking is the lung 
cancer risk in only that group of nonsmokers who have lower 
exposure to EITS. Comparisons of lung cancer risk estimates from 
active smoking studies with those from involuntary smoking studies 
require reference to the same exposure group for proper mterpreta- 
tion. In general, the lung cancer experience .of all nonsmokers (i.e., 
those with higher and lower involuntary smoking exposure com- 
bined) has been used to establish the reference rate of lung cancer 
occurrence (i.e., set as a risk of 1) in studies of active smoking. The 
use of all nonsmokers as the reference group averages the lower 
risks of nonsmokers with less ETS exposure with the higher risks of 
those with more ETS exposure. Thus, with the relative risk for the 
entire group of nonsmokers set to unity, the relative risk for 
nonsmokers with lower exposure is below 1 and that for the group 
with higher exposure is above 1. As a consequence, relative risk 
estimates from studies of involuntary exposure cannot be directly 
compared with risk estimates extrapolated from active smoking, 
unh c(qm%on to a single level of exposure is possible. Failure to 
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consider the differences between the reference populations explains 
the apparent discrepancy noted by Vutuc. 
Consider, for example, the mortality study reported by Hirayama 
(1981a). In this study, the relative risk of lung cancer for nonsmoking 
wives of smoking husbands (current and former) compared with 
nonsmoking wives of nonsmoking husbands (as calculated from 
Figure 1 in Hirayama 1981a) was 1.78. If the relative risk for 
nonsmoking wives of nonsmoking husbands were expressed in 
relation to the combined group of nonsmoking women, then a value 
of 0.63 is obtained, while with a similar calculation, that for 
nonsmoking wives of smoking husbands (both current and former), 
yields a value of 1.12. Thus, when the appropriate comparison is 
made, the risk estimates developed by extrapolation of the active 
smoking data (1.03 to 1.36) closely approximate those actually found 
in a study of lung cancer risk due to involuntary smoking. 
Dose-response relationships between active smoking and the level 
of lung function, the rate of decline of lung function in adult life, and 
the development of chronic airflow obstruction are well established 
(US DHHS 1984). Different measures of dose have provided the 
strongest correlation with functional decline in different studies. 
Pack-years, a cumulative dose measure, was the strongest predictor 
of the level of forced expiratory volume in 1 second (FEVI) in the 
Tucson epidemiologic study (Burrows, Knudson, Cline et al. 1977). 
Duration of smoking and the amount smoked were found to be the 
best predictors in male subjects in a study of three U.S. communities 
(Reck et al. 1981), and pack-years was the best predictor in female 
subjects. In both of these studies, however, the estimated dose 
accounted for only about 15 percent of the variation of age- and 
height-adjusted FEW1 levels. The relatively low predictive capability 
of cigarette smoking variables in these studies most likely reflects a 
lack of information on the dete rminants of individual susceptibility 
to tobacco smoke. Further, exposure variables obtained by question- 
naire, such as the number of cigarettes smoked daily, may only 
roughly approximate the dose delivered to target sites in the 
respiratory tract. Many factors, such as puff volume, lung volume at 
which inhalation starts, and airways geometry will influence the 
smoke dose and its distribution within the lungs. Extrapolation from 
the results of these studies to the pulmonary effects of exposure to 
ETS is, therefore, likely to be inaccurate. 
Another approach for assessing lowdose exposures is to consider 
the information available from studies involving children and 
teenagers who have recently taken up smoking. Even with brief 
smoking experience, cross-set tional studies of active cigarette smok- 
ing by children and adolescents have demonstrated an increased 
frequency of respiratory symptoms (Rawbone et al. 1978; Rush 1974; 
Bewley et al. 1973; Seely et al. 1971) and small but statistically 
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significant reductions in lung function (Seely et al. 1971; Peters and 
Ferris 1967; Lim 1973; Walter et al. 1974; &&house 1975; Woolcock 
et aL 1984). Longitudinal studies involving children and adolescents 
have demonstrated that a physiologic impairment attributable to 
smoking may be found in some children by age 14 and may be 
present after only 1 year of smoking 10 or more cigarettes per week 
in children with previously normal airways (woolcock et al. 1934), 
and that relatively small amounts of cigarette use may lead to 
significant effects on FEVl and on the growth of lung function in 
adolescents (Figure 1) (‘l’ager et al. 1935). 
When considering the risk of lowdose exposures for the develop 
ment of chronic respiratory disease, the existence of a spectrum of 
risk and a distribution of dose within the population should be taken 
into consideration. The characteristics of the part of the population 
most susceptible to involuntary smoke exposure is still being 
clarified. Evidence is accumulating that airways hyperrespon- 
siveness, atopy, childhood respiratory illness, and occupational 
exposures may all influence response to ETS. Current understanding 
of lung injury suggests that individuals with one or more of these 
characteristics that place them at the most sensitive end of the 
susceptibility curve may be the most likely to develop symptoms or 
functional changes es a result of ETS exposure. Dose of ETS also 
varies in the population, and the coincidence of high dose and 
increased susceptibility may convey a particularly high risk. Fur- 




Carcinogenesis refers to the process by which a normal cell is 
transformed into a malignant cell with uncontrolled replication. 
Carcinogenesis has been conceptualixed as a multistage process 
involving a sequence of alterations in cellular DNA that terminate 
with the development of a malignant cell. Agents acting early in this 
sequence are referred tc as initiators; those actii later are referred 
to as promoters. Compounds with both initiating activity and 
promoting activity have been identified in tobacco smoke. 
Carcinogenesis reflects DNA damage; although some repair may 
take place, biological models have not suggested that there is a 
threshold of damage that must be exceeded. Rather, carcinogenesis 
has been considered to involve a series of changes, each occurring at 
a rate dependent on the dose of a damaging agent. Higher doses 
increase the probability that the entire sequence will be completed, 
but lower doses may also lead to mahgnancy. 
l 
0 10,ooo 20300 30,ooo 4o.wo 50,ooo 60,ooo 70,Doo 30,ooo 






















0 lO,ooa 2a.ooo 30,ooo 40,ow 5o.ooo ewoo 70,ooo 3o.ooo 
Number of cigarettes consumed 
FIGURE l.-Relationship between levels of predicted for 
FEW, (A) and FEFSWIJ (B) at examination 8 and 
cumulative number of cigareti smoked 
during examinations 4 through 8 
NOTEzMenandwome.nmmbined@J-44). 
SOURCE: Tagor et al. (1936). 
29 
with the PiZZ or other phenotypes, are modest particulate exposures 
likely to increase the risk for disease to an appreciable extent. 
The development of acute and chronic airzoay disease or symptoms 
of cough, phlegm production, and wheeze may require a considerably 
smaller exposure than changes in the lung parenchyma, and it is not 
unreasonable to hypothesize that these symptoms may be related to 
repeated and continuous exposure to EYES in the susceptible individu- 
al. Strong evidence that lowdose active smoking causes increased 
rates of respiratory symptoms and functional impairment comes 
from the studies of children and adolescents discussed earlier 
(Woolcock et al. 1984; Tager et al. 1985). Because of the length of 
exposure, it is likely that these reflect airway rather than parenchy- 
mal effects. 
Another pathophysiological mechanism by which exposure to EX’S 
may increase an individual’s risk for the development of chronic 
airflow obstruction is through respiratory viral infections. Mounting 
evidence indicates that the very young child (under 2 years of age) 
exposed to ETS is at increased risk for lower respiratory tract viral 
infections (Harlap and Davies 1974; Colley 1974; Colley et al. 1974; 
Leeder et al. 1976a; Fergusson et al. 1981; Dutau et al. 1979; Pedreira 
et al. 1985). There is also increasing, though still inconclusive, 
epidemiologic evidence that respiratory viral infections in early life 
may be associated with an accelerated decline in F’EVl and, 
therefore, an increased risk for the development of chronic airflow 
obstruction in adult life in smokers (Burrows, Knudson, Lebowitz 
1977; Samet et al. 1983). By increasing the occurrence of viral 
infections of the lower respiratory tract in early life, exposure to ETS 
in childhood may have an appreciable, but indirect, effect on the risk 
for the development of chronic airflow obstruction in adult life. The 
structural basis for this increased susceptibility has not yet been 
elucidated, however. Furthermore, the child whose parents smoke is 
also more likely to take up smoking than is the child of nonsmoking 
parents. Thus, the child made susceptible to the effecta of active 
smoking by prior PITS exposure is also more likely to become an 
active smoker. 
The possibility that exposure to constituents of tobacco smoke in 
utero may exert a prenatal effect must also be considered. This 
exposure is clearly not the same as ETS exposure, since the lungs of 
the fetus are not being exposed to ETS; rather, the developing fetal 
lung is exposed to compounds absorbed by the mother and delivered 
to the fetus transplacentally. Evidence of an in utero effect in 
pregnant rats has been reported by Collins and coworkers (1985). 
These investigators reported that pregnant rats exposed to smoke 
from day 5 to day 20 of gestation, in comparison with control rats, 
showed reduced lung volume at term and saccules that were reduced 
in number and increased in size as a result of the reduced formation 
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Lung Disease 
The noncarcinogenic pathophysiologic effects of active smoking on 
the respiratory tract can be separated into (1) effects on the airways 
and (2) effects on the lung parenchyma. In the airways, the 
structural changes include inflammation in the small airways and 
mucous gland hypertrophy and hyperplasia. In the parenchyma, the 
main structural change is alveolar wall destruction. Both the 
airways and the parenchymal changes are caused by active smoking, 
but the interrelationships of these changes are not clear. They may 
be independent pathophysiologic pi, linked only by their joint 
association with tobacco smoking. 
As discussed earlier, there is evidence showing an approximately 
linear d-response relationship between F’EWl level and amount 
smoked; however, the d-response relationships have not been as 
well described for the underlying pathophysiologic changes in the 
airways or in the lung parenchyma. Host factors and other environ- 
mental factors presumably interact with active smoking to affect an 
individual’s risk for the development of disease. In this regard, 
present evidence would suggest that only 10 to 15 percent of smokers 
develop clinically significant airflow obstruction, although parenchy- 
mal and airways changes can be demonstrated in a substantially 
higher percentage at autopsy (US DHHS 1984). 
Extrapolation from the evidence on active smoking to the likely 
effect of exposure to environmental tobacco smoke on the airways 
and parenchyma suggests that pathophysiologic effeds on both the 
airways and the lung parenchyma might be expected. Because the 
dose of smoke components from ETS exposure is small in comparison 
with the dose from active smoking, the extent of lung injury would 
most likely also be much smaller than that found in active smokers. 
Small changes in the lung may be below the threshold for detection 
on pulmonary function testing. If clinically significant chronic 
airflow obstruction occurs in nonsmokers exposed to EYES, the risk is 
likely to be concentrated among those individuals highly susceptible 
to the airway or parenchymal effects of cigarette smoke. This 
susceptible group may include individuals with bronchial hyperre 
sponsiveness and with other, as yet unidentified, genetic and familial 
risk factors. Identifying the risk factors for susceptibility to the 
airway and parenchymal effects of both mainstream smoke and EL’S 
is an important priority. The dose of environmental tobacco smoke 
received by the nonsmoker is unlikely, by itself, to he sufficient to 
cause a clinically significant degree of purmchymul disease (em- 
physema) unless an individual is at the extreme end of the 
susceptibility distribution. Any particulate load is likely to increase 
the elaatase burden in the lungs by causing an influx of neutrophils. 
However, only in the individual with very inadequate lung defenses, 
specificaIly severe deficiency of protease inhibitor (pi) associated 
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of saccule partitions. These hypoplastic lungs showed an internal 
surface area that was decreased. Whether this study in rats has any 
relevance to humans is not yet clear, but this issue deserves further 
investigation. 
Whether continued exposure to EX’S during childhood, while the 
lung is remodeling and growing, affects the process of growth and 
remodeling is not yet clear. In general, rapidly dividing cells and 
immature organs are more susceptible to the effects of enviromnen- 
tal toxins than are cells undergoing a normal rate of division and 
mature organs. Apart from the evidence, cited above, linking lower 
respiratory tract viral infections in very early life to an accelerated 
decline of F’EVl in adult life, there is no information yet to link the 
rate of growth of lung function during childhood to the rate of 
decline of hmg function in adult life hecause the nw longitudi- 
nal studies have not heen done. More information is needed to 
describe the relationship of exposure to ETS at various times during 
childhood to the maximal level of lung function achieved at full lung 
growth. 
Mefiod~logical Considerations in Epidemiologic Studies 
Measumnent of Expure 
h mamsing the health effects of EX’S exposure, as with other 
enknmental pollutant8, accurate assessment of exposure is critical 
for obtaining estimates of this agent’s effects. Both random and 
systematic misclassification of the exposures of subjects in an 
investigation are of concern. Random misclassification refers to 
errors that occur at random; the consequence of such random 
misclassification is to bias toward fmding no effect. Systematic 
misclassification refers to nonrandom errors in exposure assessment; 
the consequence maybe to bias toward a greater or lesser effect than 
is actually present. Biased answers in response to a questionnaire 
may introduce systematic misclsssification. 
Some misclassification occurs in most observational (nonexperi- 
mental) epidemiological studies, and is inherent in all epidemiologi- 
cal studies of ETS. Tobacco smoking is ubiquitous in nearly all 
environments; few people escape being exposed to EX’S. Thus, the 
exposure variables for ETS in epidemiological studies do not 
separate nonexposed subjects from exposed subjects, rather, they 
identify groups with more or less exposure, or with a qualitative or 
semiquantitative gradient of exposure. 
In assessing exposure to ETS, the information should cover the 
biologically appropriate time period for the health effkct of interest 
and be collected in a form that permita the construction of 
biologically appropriate exposure measures. However, the collection 
of a full lifetime history of IZTS exposure, as in a study of 
malignancy, may not he feasible, and the accuracy of the informa- 
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tion may he limited. In evaluating the effects of ETS exposure, 
cumulative exposure, duration of exposure, and intensity of exposure 
may each influence the magnitude of effects, as may the timing of 
exposure in relation to age and level of development. 
Because of the difficulties inherent in assessing exposures through 
questio maims, increased emphasis has been placed on meamuing 
exposure through the use of molecular or biochemical markers. With 
available markers, this approach is limited to providing an indica- 
tion of recent (within 48 hours) exposure, which may not necessarily 
correlate with past exposure. A marker has not yet been devised for 
total integrated dose. Nevertheless, biological markers provide 
another method for classification of current exposure, and a stan- 
dard for validating questionnaires. 
The strengths and weaknesses of the existing methods of measur- 
ing exposure are further discussed below. 
Atmospheric Markers 
A number of different markers of atmospheric contamination by 
tobacco combustion products can be feasibly measured. Ideally, the 
atmospheric levels of the air contaminant or class of contaminants 
that are implicated in producing the adverse health effects would be 
measured. A variety of contaminants have been measured as 
indicators of ETS, but no single measure can adequately index all of 
its myriad components. Further, some contaminanta are produced by 
sources of environmental contamination other than tobacco smoke. 
Nicotine is ahsorbed only from tobacco and tobacco combustion 
products. 
Some of the pollutants that have heen measured include (1) carbon 
monoxide, (2) respirahle suspended particulates CRSP), (3) nicotine, 
(4) a number of aromatic hydrocarbons, such as benzene, toluene, 
benxopyrene, and phenols, and (5) acrolein. Some of these are in the 
vapor phase and some in the particulate phase. Some, such as 
nicotine, may exist in one phase (particulate) in MS and in the other 
(gas) phase in SS. Until more is learned about the contaminants and 
their physical state in ETS, the results of monitoring for a particular 
ETS component will be difficult to relate to ita diseasecausing 
potential. At a practical level, the technology for measuring nicotine 
levels and RSP levels is available and accurate. 
Personal Monitoring 
Both active and passive personal monitors can be used to measure 
an individual’s total exposure to an air contaminant at the breathing 
xone. Active personal monitoring systems .employ pumps to concen- 
trate the air contaminants on a collection medium for laboratory 
analysis or to deliver the air to a continuous monitor. Passive 
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personal monitoring systems use diffusion and permeation to 
concentrate gases on a collection medium for laboratory analysis. 
Personal monitoring should provide a more accurate estimate of the 
dose of a contaminant than area mOnitoring, because the actual air 
in the breathing zone is sampled and the subject’s time-activity 
pattern is inherently considered. 
As with area monitoring, the results for a particular component of 
ETS may not adequately characterize exposure to other components 
responsible for a particular disease or effect. Respirable suspended 
particulates can be measured with accuracy and give a reasonably 
accurate measurement of current exposure. 
Questionnaires 
me que&ionnaire has heen the most frequently used means of 
estimating exposures for epidemiological investigations. Question- 
naires typic&y have obtained information about the smoking habits 
of parents, spouses, or other family members and often about 
exposure outside the home. From this information, the subject is 
classified as exposed or not exposed to Errs, and the extent of 
exposure may be estimated. 
The questionnaire approach for exposure estimation has several 
potential limitations. First, the information obtained cannot exhaus- 
tively cover lifetime exposure to ETS; therefore, a completely 
accurate reconstruction of integrated dose over the years cannot be 
achieved. Second, in evaluating El% exposure in the home, the usual 
daily smoking of the smokers has often been used as a measure of 
exposure intensity at home. This assumption may not be correct, 
since smoking does not occur only in the home. For example, a one- 
pack-a-day smoker may smoke only five cigarettes a day in the home 
environment and smoke the rest at work or elsewhere outside the 
home. Third, quantitation of exposure in the workplace is inherently 
Sfficult because of changes in jobs and the varying exposure in any 
particular workplace. 
Despite these shortcomings, the information obtained by question- 
taires does discriminate between more exposed and less exposed 
ubjects. The evidence validating the questionnaire method is 
trongest for domestic exposure. In several studies, levels of cotinine 
m body fluids have varied with reported exposure to tobacco smoke 
at home (Greenberg et al. 1984; Wald and Ritchie 1984; Matsukura 
et al. 1984; Jarvis et al. 1984). In fact, residence with a smoker may 
identify a population that is more tolerant of ETS, and therefore 
more likely to be exposed outside the home. Evidence in support of 
this speculation is provided by a study of urinary cotinine levels in 
nonsmoking men in the United Kingdom (‘Wald and Ritchie 1984). In 
this study, the men married to women who smoked reported a 
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greater duration of exposure outside the home than men married to 
women who did not smoke. 
Until accurate and inexpensive exposure markers are available for 
cumulative ETS exposure, the questionnaire approach will remain 
the simplest means of obtaining exposure information. It is, there 
fore, important to consider the misclassification that can be intro 
duced by using this indirect measure of exposure, In studies of the 
effect of ETS exposure, two types of misclassification are of concern: 
misclassification of current or former smokers as never smokers and 
misclassification of the extent of ETS exposure. 
Because active smoking has a greater effect on the lungs than 
exposure to ETS? the inclusion of active smokers within a larger 
group of nonsmokers may lead to the fmding of a significant effect on 
lung function, which is actually attributable to active smoking 
rather than to involuntary smoking. Misclassification of undeclared 
active smoking is a particularly important source of error in studies 
involving teenagers. Misclassification of smoking status is also of 
concern in casecontrol studies of the association between exposure 
to M‘S and lung cancer. Information about smoking habits for these 
studies often comes from interviews with a surviving spouse or 
surrogate, who may have been a close family member, neighbor, or 
friend, or from a review of medical records. The smoking habits of 
the subject may he incorrectly reported. Classification of individuals 
who are current or former smokers as never smokers would lead to a 
spurious increase in the relative risk for lung cancer in nonsmokers 
exposed to ETS, because the smoking habits of spouses tend to be 
correlated. The extent of this bias in the case-control studies is 
uncertain. The proportion of people reported as never smokers, but 
who in fact did smoke in the past, is unknown. The proportion of 
current smokers who report themselves as nonsmokers can be 
estimated from studies using markers to validate questionnaires. 
Using biochemical markers of tobacco smoke ahsorption, the propor- 
tion would appear to he about 0.5 to 3 percent, depending on the 
population studied and the questionnaire used (Wald et al. 1981; 
Saloojee et al. 1982). 
Misclassification of the extent of ETS exposure can also occur, and 
may reduce the observed risk if a nonsmoking spouse of a smoker is 
not exposed to smoke at home. Friedman and colleagues (19831, 
reporting on a survey of 38,000 subjects, noted that 47 percent of 
nonsmoking women married to smokers reported that they were not 
exposed to tobacco smoke at home. 
Measurements of Absorption 
The difficulties inherent in estimating exposure and dose have 
provided the impetus for the development of biological markers for 
exposure to both MS and ETS. The marker that at present holds the 
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highest promise is cdhine, the mqjor metabolite of nicotine. 
Cotinine may he measured in saliva, blood, or urine. Numerous 
studies have demonstrated that there is good correlation between 
these measures of cotinine and the estimated exposure to tobacco 
smoke under laboratory conditions (Russell and Feyerabend 1975; 
HofEnann et al. 1984) and under conditions of daily life (Russell and 
Feyerabend 1975; Feyerabend et al. 1982; Foliart et al. 1983; Wald et 
al. 1984; Wald and Ritchie 1984; Jarvis et al. 1984; Matsukura et al. 
1984; Greenberg et al. 1984). Cotinine is probably the best marker for 
tobacco smoke intake because it is highly sensitive and specitlc for 
t&acc~ smoke and because it can be detected both in active smokers 
and in individuals exposed to EX’S. Further details about cotinine 
and other markem are to be found in Chapter 4. 
Pohntiully Gmfounding Variables 
In any epidemiological study, the confounding factors must be 
considered and their effects controlled. Confounding refers to the 
bii effect of a factor that independently influences the risk for 
the disease of concern and is also associated with the exposure under 
evaluation. Confounding is of particular concern when the effects of 
the exposure of interest are expe&d to be small. 
The potential confounding variables depend on the health outcome 
of interest. For lung cancer, occupational exposures, diet, and 
exposure to other combustion products are of concern. For acute and 
chronic pulmonary effects, potential confounders include airways 
hyperresponsiveness, other indoor air pollutants, outdoor air pollu- 
tion, respiratory tract infections, occupational exposure, and socio 
economic status, which may potentially influence disease risk 
through its environmental correlau23. While this list is extensive, it 
may not be inclusive; in any single investigation it may not be 
possible to meesure and control all potentially confounding vti- 
able& 
In general, the evidence on active smoking in combination with 
the dosimetrp of involuntary smoking leads to the conclusion that 
the effecta of ETS on a population will be substantially less than the 
effecta of active smoking. The effects of E!R3 on infants and young 
children are an important exception. 
The association of E’IS with an adverse effect in an individual 
study may reflect bias, chance, or a causal relationship. Statistical 
signiticance testing is used to quantitate the role of chance; by 
convention, a p (probability) value less than 0.05 is deemed statisti- 
cally significant. A p value less than 0.05 means that the observed 
results would occur by chance less than 5 times out of 100, if there is 
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truly no association between ETS and the effect. The choice of 0.05 is 
arbitrary, and as the significance level declines, the probability that 
the observation could have occurred by chance lessens. 
For effects of small magnitude, as may he anticipated for some 
consequences of exposure to ETS, a large study population may be 
necessary to demonstrate statistical significance. The absence of 
statistical significance for an association may refled an inadequate 
sample sixe and is not always indicative of the absence of an 
association. In this regard, reports describing the absence of effects 
of ETS should provide the calculations needed to demonstrate the 
study’s statistical power (ability to detect effects of the magnitude 
expected) or a confidence interval for the estimate of effect. 
An additional statistical issue is the directionality of statistical 
significance testing. Either one-sided or two-sided tests may he used, 
in the fmt, only effects in one direction are considered a possibility, 
whereas twosided tests consider the possibility of effects in opposing 
directions, i.e., increase or decrease of risk Given the strength of the 
evidence on active smoking and disease risk, one-sided testing in the 
direction of an adverse effect seems appropriate for most potential 
consequences of ETS. However, one-sided tests have not been 
performed in all investigations of ETS; the use of two-sided tests 
makes these studies conservative, as statistical significance will less 
often be attained. 
Respiratory System Effects of Involuntary Cigarette Smoke 
Exposure 
This section reviews the evidence on involuntary smoking and the 
adverse physiologic effects, respiratory symptoms, and respiratory 
diseases in nonsmoking adults and children. Health effects related to 
fetal exposure in utero from active smoking by the mother are not 
discussed. Lung growth and development may he influenced by in 
utero exposure, and the effects of such exposures have not been 
separated from those of exposure after birth. More complete 
treatments of this issue have heen published (US DHEW 1979; US 
DHHS 1980, Abel 1980; Weinberger and Weiss 1981). 
This section begins with a review of the data on infants and 
children who are exposed primarily through parental smoking. The 
health effects examin ed are increased respiratory illnesses, of both 
the upper and the lower respiratory tracts, increased chronic 
respiratory symptoms and illnesses, and alterations in lung growth 
and development. Studies of adults, whose exposures to environmen- 
tal tobacco smoke occur in a variety of settings, are examined with 
regard to symptoms and changes in measures of lung function. The 
potential for J3TS to produce bronchoconstriction in asthmatic and 
nonasthmatic subjects is also examined. 
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InfantsandChildren 
Acute Respimtory Illness 
Longitudinal Studies 
A number of studies, based on a variety of different designs, have 
examined the effects of involuntary smoking on the acute respira- 
tory illness experience of children (Table 1). Several different end 
points have been ev&&ed in these investigations: hospitalization 
for bronchitis or pneumonia as 888e88ed by hospital records (Harlap 
and Davies 1974; Rantakallio 1978); questionnaire assessment of 
hospitalization for bronchitis or pneumonia or of doctor’s visits 
(Colley 1971; Leeder et al. 1976a) or both G’ergusson et al. 1981; 
Fergusson and Horwood 1985); questionnaire assessment of reapira- 
tory illness within the last year (Cameron et al. 1969; Schenker et al. 
1983; Ware et al. 1984); chest illness before age 2 (Schenker et al. 
1983); hospitalization for respiratory syncytial virus 0 infection 
(Sims et al. 1978; pullan and Hey 1982); physiciandiagnosed 
bronchitis, tracheitis, or laryngitis (Pedreira et al. 1985); and 
tonsillectomy as an indication of recurrent respiratory infection 
(Said et al. 1978). These diverse end points range from illnesses 
associated with a specific etiologic agent, e.g., RSV bronchiolitis, to 
clinician&agnosed syndromes, e.g., bronchitis of undetermined 
etiology. 
The possibility of reporting bias must be considered for the studies 
that have used questionnaires to measure iUness experience. In most 
of these studies, parents, usually the mother, have responded for the 
child and reported on the child’s illness experience. Some investiga- 
tors have suggested that mothers with respiratory symptoms are 
more likely to report symptoms for their children and that stratifica- 
tion of subjects by the symptom status of their parents removes this 
element of recall bias (Lebowitz and Burrows 1976). Removal of 
symptomatic parents, however, may result in overcorrection for 
recall bias because cigarette smoking is associated with symptoms in 
the adult. This analytical strategy would not be expected to adjust 
for biased parental recall of early life events. Additionally, in all 
studies in which potential reporting bias was examined, control for 
parents’ status reduced, but did not eliminate, associations of 
involuntary smoking with health -outcomes (Colley et al. 1974; 
Leeder et al. 1976a,,b; Schenker et al. 1983; Ware et al. 198.4). 
Further, the consistency of these studies, in spite of differing study 
populations and methods, weighs against bias as the sole explanation 
for the effect of involuntary smoke exposure. 
Harlap and Davies (1974) studied 10,672 births in Israel between 
1965 ad 1968 and observed that infants, whose mothers, at a 
prenatal visit, reported that they smoked, had a 27.5 percent greater 
hospital admission rate for pneumonia and bronchitis than children 
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of nonsmoking mothers. In addition, they demonstrated a dose- 
response relationship between the amount of maternal smoking and 
the number of hospital admissions for these conditions. The infants 
were classified by the mothers’ prenatal smoking behavior and not 
by the mothers’ smoking behavior during the first year of the child’s 
life. Maternal smoking habits would probably have remained 
relatively stable across the short observation period. 
British. investigators (Colley et al. 1974) followed children born 
between 1963 and 1985 in London and also observed an increased 
frequency of bronchitis and pneumonia during the first year of life in 
the children of parents who smoked. This difference did not persist 
at 2 to 5 years of age. Tbis effect was independent of the parents’ 
personal reports of winter morning phlegm and increased with the 
amount of smoking by parents. The annual incidence of bronchitis 
and pneumonia during the first year of life also increased with a 
greater number of siblings. This variable was not controlled in the 
original analysis, however, Leeder and colleagues (1976b) subse 
quently reported that, in this same cohort, a dose-response relation- 
ship with parental smoking persisted for bronchitis and pneumonia 
in the first year of life, after control for parental respiratory 
symptoms, the sex of the child, the number of siblings, and a history 
of respiratory illness in the siblings. 
Fergusson and colleagues (1981) studied 1,265 New Zealand 
children from birth to age 3. They demonstrated an increase in 
bronchitis and pneumonia and in lower respiratory illness during 
the first 2 years of life in children whose mothers smoked compared 
with child.ren whose mothers did not smoke. Correction for maternal 
age, family size, and socioeconomic status did not affect the 
relationship between the amount of maternal smoking and the rate 
of respiratory illness. The effect of maternal smoking declined with 
increasing age of the child. 
In a second report (Fergusson and Horwood 1985) the followup was 
extended to include the first 6 years of life. The results conf%rmed the 
initial fmdings. Maternal, but not paternal, smoking was associated 
with a statistically significant increase in lower respiratory illnesses 
during the first 2 years of life. However, after age 2 there was no 
signif?cant effect of maternal smoking on respiratory illness occur- 
rence. 
Rmbkdlio (1978) followed more than 3,696 children during the 
first 5 years of life; half of the children had mothers who smoked 
cigarettes during pregnancy and half did not. The children of 
mothers who smoked had a 70 percent greater chance of hmpi&- 
tion for a respiratory illness than the children of nonsmoking 
mothers. 
Pedreira and associates (1985) prospsctively studied 1,144 infants 
and their families in the greater Washington, DC., area. Mate& 
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smoking was associated with an excess frequency of acute bronchitis, 
tracheitis, and lary&tis, as diagnosed by the pediatricians caring 
for these families. Episodes of croup, pneumonia, and bronchiolitis 
were not increased by maternal smoking. A family history of chronic 
respiratory symptoms ~88 also associated with excess respiratory 
illness. 
Ware and coworkers (1984) studied more than 10,009 children in 
six American cities. Maternal cigarette smoking was associated with 
increased parental reporting of a doctordiagnosed respiratory illness 
before the age of 2 years and of an acute respiratory illness within 
the past year. The prevalence of positive questionnaire responses 
increased consistently with the current daily cigarette consumption 
of the mother; the d-response relationships were unchanged by 
adjustment for maternal symptoms and educational status. 
Cross-Sectional Studies 
Schenker and coworkers (1983) studied 4,071 children between the 
ages of 5 and 14 years in a cross-sectional study in Pennsylvania. 
Both chest illness in the past year and severe chest illness before age 
2 were more frequently reported in nonsmoking children of parents 
who smoked. These investigators found that symptom and illness 
rates were higher in children of parents with respiratory symptoms. 
However, a significant effect of maternal smoking on these illness 
variables remained after adjustment for the parents’ own respira- 
tory symptom history. 
In a study of 1,355 children between 6 and 12 years of age in the 
Iowa public schools, Ekwo and coworkers (1983) found that the 
presence in the home of at least one parent who smoked was 
significantly associated with reported hospitalization of the child for 
a respiratory illness during the first 2 years of life. As in other 
studies, the effect was stronger for maternal smoking than for 
paternal smoking. 
Case-Control Studies 
In England, Sims and colleagues (1978) examined 35 children at 8 
years of age who had been hospitalized during infancy for RSV 
bronchiolitis and compared them with 35 control children of similar 
age. Maternal smoking was associated with a relative risk of 2.65 for 
hospitalization due to bronchiolitis. The sample size was small, and 
this effect of maternal smoking was not statistically significant. 
Pullan and Hey (1982) studied children who had been hospitalized 
with documented RSV infection in infancy. They found significantly 
greater smoking by their mothers at the time of the infection, 
compared with children hospitalized for other illnesses, including 
respiratory disease for which RSV infection was not documented. At 
43 
age 10, the children previously ill with RSV infection had an excess 
reported occurrence of wheeze and asthma and had lower levels of 
pulmonary function in comparison with the controls. The research- 
ers could not determine whether the RSV infection had caused 
persistent damage that affected the maturation of the lung or 
whether these children were already more susceptible to severe RSV 
infection because of pulmonary problems that antedated the RN 
infection. 
In summary, the results of these studies show excess acute 
respiratory illness in the children of parents who smoke, particularly 
in children under 2 years of age. This pattern is evident in studies 
conducted with different methodologies and in different locales. The 
increased risk of hospitalization for severe bronchitis or pneumonia 
associated with parental smoking ranges from 20 to 40 percent 
during the first year of life. Young children appear to represent a 
more susceptible population for the adverse effects of involuntary 
smoking than older children or adults. The timeactivity patterns of 
infants, which generally place them in proximity to their mothers, 
may lead to particularly high exposures to environmental tobacco 
smoke if the mother smokes. 
Acute respiratory illnesses during childhood may have long-term 
effects on lung growth and development, and might increase the 
susceptibility of the lung to the effects of active smoking and to the 
development of chronic obstructive lung disease (Samet et al. 1983; 
US DHHS 1984). 
Cough, Phlegm, and Wheezing 
A number of crossse&onal studies from different countries (Table 
2) have shown a positive association between parental cigarette 
smoking and the prevalence of chronic cough and chronic phlegm ,in 
children; some studies have shown a relationship for persistent 
wheeze. However, not all studies have shown a positive relationship 
for all symptoms. The results of some of these studies may have been 
confounded by the child’s own smoking habits (Colley et al. 1974, 
Bland et al. 1978; Kasuga et al. 1979). The association with parental 
smoking was not statistically &i&ant for all symptoms in all 
studies (Lebowits and Burrows 1976; Schilling et al. 1977; Schenker 
et al. 1983). However, the majority of studies showed an increase in 
symptom prevalence with an increase in the number of smoking 
parents in the home. 
A recent report (Charlton 1984) provides crosssectional data on 
parent-reported cough for 15,000 children, 8 to 19 years of age, in 
northern England. Chronic cough in the children was related to their 
age and to their own cigarette smoking status. However, with control 
of these factors by stratification, the number of parental smokers in 
the home was positively associated with the occurrence of chronic 
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TABLE Z.-Chronic respiratory symptoma in children in relation to involuntary smoke exposure 
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cough. The mother’s smoking had a greater effect than the father’s 
smoking. 
Burchfiel and colleagues (1986) have conducted a longitudinal 
study of 3,482 subjects from Tecumseh, Michigan. Subjects were 
initially between the ages of birth and 10 years and were followed up 
by questionnaire and examination 15 years after entry into the 
study. Age-specific incidence rates were calculated for a number of 
chronic respiratory symptoms, including cough, phlegm, wheeze, and 
bronchitis. Incidence rates for all symptoms were higher for children 
with two parental smokers when compared with children of non- 
smokers. Adjustment for potential confounding variables, including 
age, parental education, family size, and personal smoking, did not 
explain these results. 
British researchers &eeder et al. 1976b) studying a birth cohort 
over a 5-year period demonstrated an increased incidence of Nheez- 
ing among nonasthmatic children with two parents who smoked in 
comparison with children whose parents did not smoke, one parent 
who smoked, or parents whose smoking changed during the study 
(Leeder et al. 1976a). However, when this association was examined 
by logistic regression with control for. other factors, parental 
smoking was not a significant predictor of wheeze or of asthma. 
McConnochie and Roghmann (1984) performed a retrospective 
cohort study to examin e the influence of mild bronchitis in early 
childhood on wheezing symptoms 8 years later when the subjects had 
reached a mean age of 8.3 years. Involuntary smoking was a 
significant predictor of current wheezing (odds ratio 1.9). In a related 
study (McConnochie and Roghmann 1985) with these same children, 
involuntary smoking did not affect lower respiratory tract illness 
experience. 
In a study of 650 children aged 5 to 10 years (Weiss et al. 19801, a 
significant trend in the reported prevalence of chronic wheezing 
with current parental smoking was found; the rates were 1.9 
percent, 6.9 percent, and 11.8 percent for children with zero, one, and 
two parents who smoked, respectively. Although the data given are 
for all households, when the analysis was restricted to those 
households where neither parent reported symptoms, the results 
were identical. The stability of the fmdings with this restriction 
suggests that reporting bias introduced by parental symptoms W&B 
not responsible for the observed results. 
Schenker and coworkers (1983) e xamined the influence of parental 
smoking and symptoms on the reporting of chronic respiratory 
symptoms of cough, phlegm, and persistent wheezing in children. 
These investigators found that the mothers were more likely than 
the fathers and symptomatic mothers were more likely than 
asymptomatic mothers to report these symptoms in their children. 
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Parental smoking had no significant effects on chronic respiratory 
symptoms. 
L&,,~z m,j BU~OWB (1976) assessed the effects of household 
mea=’ smoking on respiratory 8ymptoms in 6% ‘hwm Chihhn 
younger b 15 y- of age. children from homes with current 
smoke= m higher symptom rates than those from homes with ex- 
smokers ad ee never smokers. However, the effect of household 
Bmow w w88 atistically significant only for persistent cough. 
h a general population s~u&, &hilling and ~lleagues (1977) 
reported no mhtion between wheeze and involuntary smoking. 
ware md ~i&,es (1984) enrolled 10,106 children between 6 and 
g Y- of we from six U.S. cities in a prospective study. The 
pmdene of persistent cough and persistent wheeze, measured at 
the second mtion, was higher in children whose parents 
smoked. ‘JJg effect was greater for maternal smoking than for 
paternal smoking. Symptom prevalence rates increased linearily 
tith the number of cigarettes smoked daily by the mother. In a 
multiple logistic model, the effect of maternal smoking persisted 
after adjustment for reported ilhess in the parents. 
Dodge (1982), studying third and fourth grade children in Arizona, 
found that symptoms, including wheeze, were related to both the 
presence of symptoms in the parents and the number of smokers in 
the household. 
In summary, children whose parents smoke had a 30 to 80 percent 
excess prevalence of chronic cough or phlegm compared with 
children of nonsmoking parents. For wheezing, the increase in risk 
varied from none to over sixfold among the studies reviewed. Many 
studies showed an exposurerelated increase in the percentage of 
children with reported chronic symptoms as the number of parental 
smokers in the home increased. Misclassification as nonsmokers of 
children who are actively smoking could bias the results of these 
studies. Adolescent 8mokers may be reluctant to accurately report 
their smoking habits, and more objective measures of exposure may 
not help to distinguish active experimentation with cigarettes from 
mvohmtary exposure to smoke Cl’ager 1986). Although miscla&fica- 
tion of children who are actively smoking as nonsmokers must be 
considered, many studies showing a positive association between 
P-nM smoldng amI symptoms in children, including children at 
4P bdke f%#.ficant experimentation with cigarettes is prevalent. 
h addition, many 8tudies (Bland et al. 1978; Weiss et al. 1980; 
Chm-hn 19% Schenker et al. 1983, Dodge 1982; Burchfiel et al. 
19%) found significant effects of parental smoking after ~~ide~g 
active smoking by the children. 
chronic resPbtorY symptoms represent an immediate health 
h&n for the child. However, the long-term simlcance of chrodc 
r@PhtorY sYmPbmS for the health of the child is unclear. &et 
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available data are cross-sectional, and followup studies of chroticdy 
symptomatic children are necessaq to determine the long-term 
health consequences of chronic respiratory symptoms. 
In recent YW, the effect of parental cigare&e smokjng on 
pulmonary function in children has been examined in crossgedional 
studies (Table 3) and a few longitudinal studies. The crmonal 
studies have demonstrated lower values on tests of pulmonary 
function (FEV75z, LEVI, FEFLJMS, and flows at low lung volumes) in 
children of mothers who smoked compared with cmdren of non- 
smoking mothers. The longitudinal studies (Table 4) have confirmed 
the cross-sectional results and provide some insight into the imp&+ 
tions of the cross-sectional data. 
Dose-response relationships have been found in both cross-se&on- 
al and longitudinal studies Stager et al. 1979; Weiss et al. 1980; Ware 
et al. 1964; Berkey et al. 1986); the level of function decreases with 
an increasing number of smokers in the home. As would be 
anticipated from the mother’s greater contact time with the child, 
maternal smoking tends to have a greater impact than pa&Id 
smoking. Younger children seem to experience greater effects than 
older children (Tager et al. 1979; Weiss et al. 1960), and in older 
children the effects of personal smoking may be additive with those 
of involuntary smoking (Tager et al. 1979,1985). 
As noted by Tager (1986), the effect of maternal smoking on lung 
function may vary with the child’s sex. Some studies have reported 
greater effects on flows at lower lung volumes in girls than in boys 
(Burchfiel et al. 1986; Tashkin et al. 19% Yamell and St. Leger 
1979; Veda.l et al. 1964). Flows at higher lung volumes seem more 
affected in boys (Burchfiel et al. 1986, Yarnell and St. Leger 1979; 
F&-key et al. 1986; Tad&in et al. 1964). Whether these sex effects 
represent differences in exposure, differences in susceptibility to 
environmental cigarette smoke, or differences in growth and devel- 
opment is unclear. 
Tager and colleagues (1983) followed 1,156 children for 7 years to 
determine the effect of maternal smoking on the growth of PRO- 
nary function in children (Figure 2). After correcting for previous 
level of FEVI, age, height, personal cigarette smoking, and correla- 
tion between mother’s and child’s pulmonary function level, mater- 
nal smoking was associated with a reduced annual increase in F’EVI 
and FEFs75, using two separate methods of analysis. If the effect of 
ma&d smoking is maintained to 20 years of age, then a 3 to 5 
percent reduction of FEV, and FEFz+75 due to maternal Smoking 
would be projected. The validity of this PrOjeCtion remains to be 
&&h&ed. Because few mothers changed their smoking habits, the 
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TABLE 3.-~uhonary ~UC&~UI in CII.WEW exposed to involuntary smoking 
Study Subjecta 
SchiIling et al. 
(1977) 
816 children, aged 7-17, 
Comwcticut and South 
ceroh united statm 
FEV, 88 percent pITdictA No e!Tect of parental amokin No control for db&ip ab Or 
comlntion of eihliug pllmoaur 
function; for dludren who 
nevw enlow vwu60 
elgdamtly lean in cbikhn 
with!Jmokhglnotbm 
T-r et al. 
om 







444 children, e&fed 619, 





r,oca children, aged MS, 
united stake 
371 houoehol&, complete 
hietnriee of parent Emokiug 
and pulmonery flmctlon of 
children, age >6, Tucson, 
Ak-hna. united ststa 
MMEF in etadad deviation 
units 
MMEF in etandard deviation 
unite 
m,, Fvc, vmuKJl vcdm 
VUdO 
FBV,, Fvc, o,, vmu7s 
derivedfromM?dEPVcune8, 
ea etaderd deviation units 
signll~t effect of parental 
Ml2Oki43 
slgnifimt effect of parental 
~Okhg 
FVC poaitivcly emocietedl flown 
negatively omocieti 
Noeffectofpnmbdemoking 
c!mtmued for oitahip aim and 
cadetion of sibling pulmowy 
fll&iOll 





chggahioa: may bs d 
dlfferenm in hdonr leveb of 
rlspa¶mcomprsdwithmors 
no*rly climebe 
L8bmitz et al. 
(1982) 
339 childreb Tuaon, 
Arimm, united stat83 
FEV,, I acorn No effect of pan&al wnokhg Higher lweb of puhoaaq 




subjocte Pulmonery function meanued Outcome 
668 chilhll, aged 8-10, 
Arir.om united St.&n 
No effect of parental smoking PotenW pnrticipation rate 
bias;cram+e&onaldatanot 
corkroIled for child hei& 
allmud FEx,/lP at e 8, 9, 
and 11 oonsietently gxater in 
nonomoking houoehobio tblm 
hreperent smoker hou&o@ 
0tatica.I tast not lligdbnt 
lil&khetal. 
ww 
Chen and Li 
wm 
Haaeelblad et al. 
(1981). 
1,080 noMmoking, 
nonasthmatic children, Lctl 
Al&e& united stateu 
671 children, aged 6-16, 
chine 
16,689 children, aged 5-17, 
eeven geqinphic regione, 
u0it.d state3 
L, Vmu7~ Vd FE&e-7s 
FEV, snd MMEF 
FEV, 88 percent pwdkted 
Delmamd0~,0~forboys, Noeffe&ofp&malemoking 
and FJZFrm, k,m,a for &la 
with mnoking mother at led 
Slltly decremd FEV, Adjuoted for child’s own 
fC4dMMEFiIlChUdWSl@XpOOd smotiae~gas~~ 
to peteal cigarette Emoke w-d v-mm 
Significant effect of mE4ternal Largenmnherofchihiren 
but not paternal smoking exchdedforinvdidpuImonq 
tiuxtion data or mieoing 
porental omoking data 




Ekwo et al. 
(1983) 
8,120 children, eged 6-10, 
oix U.S. cltlm 
117 femiliea, Tucaon, 
Arlmw united stat&i 
1,266 chuhn, eged 6-12, 
Iowe City, low4 unitad 
SW40 
FVC end FEV, en percent 
predicted 
FVC end FFW, 
FEV,, Fvc 
No effect for FEV, or PVC 
No effect of parental smoking 
No e.ffect of parental emoking 
Recent anelyeie demon&eted 
en effezt for FVC end FEV, 
Almemeaxd,lWendcaone 
rat&3hedIittIeeffect 
Data for thin outcome not 
epeciflallly enal- innasal 
blmchid reepfmlllvene4o emong 
imokm children 
Spineci et al. 2,386 echoolchildren, Turin, 
usw Italr 
statistialuy aigniiamt effect of 
metemel omoking 
No pemlve emoking effect 
diffemna betmen boyo and 
l&b 
c TABLE 4.-Pulmonary function in cm&n exposed to involuntary smoking; longitudina\ ddies 
Study Subjecta Pulmonary funOti0n mOamld Outcame c!ommenta 
‘l&r et al. 
u9w 
1,166 children, aged 6-10 at 
lnltial mvey, Enat Boston, 
Mamachuaetta, United 
St&M 
FEW,, FEFow Sicantly decreasai FEW, 
and FJ!Tws growth rate for 
chUdren of emoking mothem 
‘I-year followup; no eff$=-t of 
paternal amok&; magnitude 
roughIy 4 to 6 Pemnt 
ware et al. 10,000 children, aged 8-11, 
ww six U.S. cities 
WC, ml WC poeitively aooociaw with 
smoking; FEV, ne&ively 
amociated with omoke expooure 
FEV, dose-response with 
amount omoked hy mother; 
magnitude of e&ct estimate 6 
prant 
Berkey et al. 
mw 
7,834 children, agad 610, 
six U.S. cities 
WC, FEV, Slightly higher FVC level, 
slightly lower FXV, level in 
omcbexposed; gmwth of both 
decreased by smoke expomue 
coneistent with 3 penxlt 
de&it in FEV, growth 
Burchfiel et al. 
(l=w 
3,432 children, aged MO, 
Tecumeeh, Michigan, United 
Statee 
WC, FEV,, vrrdn FEV, level and growth 
decread by maternal smoking 
Dwe-reuponoe in maIe chlhimn 
with nuder of parental 
omokem 
LOwmt20% Mile go% Highest20% 
Dialibution Of syear mean FN, 
FIGURE 2.-Percenwe of children with mothers who were 
current cigarette smokers at initial 
examination (black columns) and sixth 
examination (white columns), according to 
distribution of mean age, height, and sex- 
corrected FEV, over the firat six examinations 
N(rPE:~20W,middle60%,andhiehat20%nefertoEhildraaarithvllluainthe~ollati(th,middla 
tliltxrfiftho, and upper onbflfth, rssp&vely. ofthe - FEY, diotributio~ nlmlbBnl i  parentheua todioate 
number of children in each gmup; the three circlen rap&went the BVeraga pbresnt pImdh?d value4 of FEW, for the 
the group; remlta for male and famals children were combined, because difference t&mm - vu not 
signifmt. 
SOURCE:  !hget et al. w33). 
study could not establish the ages at which children were most 
vulnerable to exposure to tobacco smoke. 
Ware and colleagues (1964) followed 10,106 white children for two 
successive annual examin ations as part of the Harvard Air Pollution 
Health Study in six U.S. cities. The forced vital capacity was 
significantly higher for children of mothers who were either current 
smokers or ex-smokers. However, children whose mothers were 
current smokers had a 0.6 percent lower mean FEVl at the first 
examination and 0.9 percent lower mean F’EVl at the second 
examination. Maternal smoking had a greater effect than paternal 
smoking, although the effects of both were sign&ant. The changes 
in level of FEYI observed were small. For exposure to a mother who 
smoked one pack of cigarettes per day, the FEVl was estimated to be 
decreased by less than 1 percent, or 10 to 20 mL for a child with an 
F’EVl between 1.5 and 2.5 liters. Projecting the effect cumulatively to 
age 20 yields an approximately 3 percent deficit. This effect is 
comparable to that observed by Tager and colleagues (1963). These 
small average effects may underestimate the effects on populations 
of susceptible children. 
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A mom e&hve analysis of longitudinal data from the Harvard 
cohort wm performed using a mathematical model to describe lung 
growth (Be&y et al. 1966). This ~IM&B~S included 7,834 Children 
beben 6 & 10 year6 of age who were evaluated from two to five 
hm over a ~-year period. The model estimated that a smoke 
expOeed child at age 8 would have an FE571 0.81 percent lower than a 
non-emokeexpoa3ed child, and growth of FEVI would be 0.17 percent 
lower per year. ~0th effects were statistidy significant. For ~I.I 8 
yw& child tith an F’EVl of 1.62 liters, these result-8 translate into 
a deficit of 13 J.UL in FEVI and of 3 mL in annual increase in MI. 
‘&e magnitude of the maternal smoking effect is consistent with a 
de&it in J?EVl of 2.8 percent in naturally attained growth, if the 
effect, ia sustained throughout ~hildhd. 
Burchfiel and colleagues (1966) have conducted a longitudinal 
study of 3,462 children observed over a E-year period in Tecumseh, 
&.&h&an. The mean increase in FXVI for nonsmoking boys between 
the ages of 10 and 19 years was 82.3, 76.2, and 74.5 mL per year for 
subjects with zero, one, and two smoking parents, respectively. Boys 
with one parent who smoked experienced 92.6 percent and boys with 
two parents who smoked experienced 90.5 percent of the growth in 
FEVl seen in male children with nonsmoking parents. EXfecta of 
parental smoking were not found in girls. 
The available data demonstrate that maternal smoking reduces 
lung function in young children. However, the absolute magnitude of 
the difference in lung function is tnnall on average. A Emall 
reduction of function, on the order of 1 to 5 percent of predicted 
value, would not be expected to have functional consequences. 
However, some children may be affected to a greater extent, and 
even small differences might be important for children who become 
active cigarette smokers as adults. 
A minority of adult cigarette smokers develop chronic obstructive 
lung disease, and factors influencing lung growth and development 
during childhood might predispose to disease in adulthood (Samet et 
al. 1983; Speizer and Tager 1979). In Figure 3 is depicted a model of 
growth and decline in pulmonary function from childhood through 
adulthood, as measured by the F’EXl. Pulmonary function peaks in 
early adult life and declines steadily thereafter in both smokers 
(curve B) and nonsmokers (curve A). In people who develop chronic 
lung disease (curve CL a more rapid decline has occurred. Childhood 
factors could predispose to the development of disease by reducing 
the functional level at which decline begins tjr by increasing 
SusCePtibfitV to cigarette smoke and increasing the rate of d-be. 
Thus, in this model, small decrements in the ’ Ily atwed 
led Of PuhnOnary function may be important in identifying &e 
susceptible smoker. However, the prerequisite longitudinal stu&es 
needed to test this hypothesis have not yet been conducted, 
FEV, as percent 
of value at 
age 2h25 
I I I L 
5 10 15 20 30 40 50 90 70 50 
Age (uem) 
FIGURE 3.-Theoretical curves representing varying rates 
of change in FJSV, by age 
SOURCE: SpeLer and Tager (1979). 
Bronchoconstriction 
Nonspecific bronchial responsiveness has been considered a poten- 
tial risk factor for the development of chronic obstructive lung 
disease in both adults and children (US DHHS 1984). This physiolog- 
ic trait may be influenced by environmental exposures such as 
involuntary smoking by children and active smoking by adults, and 
by respiratory infections at all ages. 
Asthma is a chronic disease characterized by bronchial hyperre 
sponsiveness. Epidemiologic studies of children have shown no 
consistent relationship between the report of a doctor’s diagnosis of 
asthma and exposure to involuntary smoking. Although one study 
showed an association between involuntary smoking and asthma 
(Gortmaker et al. 1982), others have not (Schenker et al. 1983; 
Horwood et al. 1985). This variability may reflect differing ages of 
the children studied, differing exposures, or uncontrolled bias. In 
several recent studies (Murray and Morrison 1986; O’Connor et al. 
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1986, web et al. 1985; Martinez et al. 198% Ekwo et al. 19831, 
noMpecific broncm responsiveness Was examined in relationship 
b ~voluntary smoking. The results of these ytusm .sugge”t that 
exposure b matid cigarette smoking b assocmted mth increased 
noMpecific wap req&ven~. Some ,repo* suggest that the 
hm respoevena is present only m chi&+% kWWn to be 
w-tic (Murray and Morrison 1986; o’~nnOr et al. 1986), 
whereas othm sw~ that the increased respo~iveness is seen in 
4 cmw (~kw~ et al. 1983; Martinez et al. 1985). The pathophysi- 
ological magi underlying the increased responsiveness and 
the lowm~m consequences of the increased responsiveness remain 
horn. m s&ion reviews the studies on asthma and on 
bronchial hyperresponsiven~. 
&rtln&er amj coworkers (1982) studied the relationship between 
paren~ ~&ing and the prevalence of asthma in children up to 17 
;years of age. Random community-based populations in Michigan 
(3,072 &U.ren) and Massachusetts (894 children) were surveyed. 
parents reported on their own smoking habits a&l on the asthma 
histories of t&r children. Biased reporting by parents who smoked 
~88 d by e=mimng the relationship between parena 
smoking and other conditions, and considered not to be present. 
A&IM prevakmce declines with age, and asthmatic children are 
unlikely to tolerate active smoking; therefore, misclassification of 
activelp smoking asthmatic children ss nonsmokers seems unlikely. 
In comparison with children of nonsmokers, children whose parents 
smoked were more likely to have asthma (relative risks of 1.5 and 1.8 
for Michigan and Massachusetts children, respectively) and sevely! 
asthma (relative risks of 2.0 and 2.4, respectively). The investigators 
estimated that between 18 and 23 percent of all childhood asthma 
and 28 and 34 percent of severe childhood asthma is attributable to 
exposure to maternal cigarette smoke. 
Schenker and coworkers (1983) studied 4,071 children between 5 
and 15 years of age in western Pennsylvania. These investigators 
found no relationship of parental smoking to the occurrence of 
asthma, after adjustment for potential confounding factors. 
Horwood and coworkers (1985) conducted a cohort study of 1,058 
children in New Zealand who were followed from birth to age 6 
ye- A fdy history of allergy and male sex were the ody 
significant predictors of incident cases of asthma. Neither parental 
smoking nor respiratory illnesses were predictive of the occurrence 
Of asthma in this investigation. 
A recently reported cross-sectional study by Murray and Morrison 
(1986) suggests a mechanism by which maternal cigarette smoking 
might influence the severity of childhood asthma. These mvestiga- 
h-s StUdkd 94 children, aged 7 to 17 years, with a history of asthma. 
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FIGURE 4.-P% in two groupa of children with a  history 
toms, a  13 percent lower FEYI, and a  23 percent lower FEFws than 
the children of nonsmoking mothers. Forty-one children, who had 
been able to discontinue med ication and had no recent respiratory 
illness, underwent a  histamine chal lenge test. There was a  fourfold 
greater responsiveness to hi&amine among the asthmatic children of 
mothers who smoked (Figure 4) compared with asthmatic children of 
nonsmoking mothers. Dose-response relationships were present for 
all outcome variables in this study: symptoms, pulmonary function, 
and airways responsiveness. The differences between children of 
smoking mothers and children of nonsmoking mothers were greatest 
in the older children. The father’s smoking behavior did not 
influence the child’s asthma severity. The sample of asthmatic 
children with mothers who smoked was small (N = lo), and only 41  of 
96  children had histamine chal lenge tests. G iven the heterogeneity 
of asthma, the variable nature of bronchial hyperreactivity in 
asthma, and the potential for biased selection, these results must be  
interpreted with caution. 
O’Connor and coworkers (1986) studied 286 children and young 
adults, 6  to 21 years of age, drawn from a  community-based sample, 
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and confirmed the findings of Murray and Morrison (1986). Bronchi- 
al responsiveness was measured with eucapneic hyperpnea to 
subfreezing air. Among the 265 subjects without asthma there was 
no significant relationship between maternal cigarette smoking and 
nonspecific bronchial responsiveness. However, in the 21 subjects 
6th adive asthma, maternal smoking was significantly associated 
with increased levels of bronchial responsiveness. 
In a study of 1,355 children 6 to 12 years of age, significant 
increases in FEW and FF,F25-7s were observed following isoproterenol 
administration in children whose parents smoked (E~wo et al. 1983). 
Increases after isoproterenol were not observed in children of 
nonsmoking parents. 
Weiss and coworkers (1985) evaluated 194 subjects between the 
ages of 12 and 16 drawn from the same population as those reported 
by O’Connor and coworkers (1986), with eucapneic hyperpnea to 
subfreezing air as a test for bronchial responsiveness and allergy 
skin tests as a test for atopy. Subjects defmed as atopic (any skin test 
wheal greater than or equal to 5 mm) had twice the frequency of 
lower respiratory illnesses in early childhood and were twice as 
likely to have a mother who smoked. However, there was no 
relationship between maternal smoking and increased bronchial 
responsiveness. 
Martinez and associates (1985) studied 170 9-yearold children in 
Italy. Nonspecific bronchial responsiveness to methacholine and 
allergy prick test positivity in these subjects was significantly 
associated with maternal cigarette smoking. 
These data suggest that maternal cigarette smoking may influence 
the severity of asthma; a mechanism for this effect may be through 
alteration of nonspecific bronchial responsiveness. Further investi- 
gation is needed to determine whether exposure to environmental 
cigarette smoke can induce asthma in children and whether ETS 
exposure increases the frequency or severity of attacks of broncho- 
constriction in asthmatics. The effect of involuntary smoking on 
increased bronchial responsiveness in asthmatics and in norm&h- 
matics has only recently been addressed. These initial data are 
provocative, but the magnitude of the effect, the target population at 
risk, the underlying mechanisms, and the long-term consequences 
have not been described. Furthermore, the complex interrelation- 
sops ==‘u3 respiratory illness, atopy, parental smoking, and 
tin-w responsiveness have not been clarified and require further 
study. 
Ear, Nose, and Thmat 
Five studies (Said et al. 1978; Iverson et al. 1985; Kraemer et al. 
1983; Black 1985; Pukander et al. 1985) show an excess of chronic 
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middle ear effusions and d&eases in children exposed to parental 
smoke. 
Said and colleagues (1978) questioned 3,920 children between IO 
and 20 years of age about prior tonsillectomy or adenoidectomy, 
considered an index of frequent upper respiratory or ear infections. 
The investigators reported that, in general, this surgery was 
performed before the children were 5 years old. The prevalence of 
prior surgery ~INXMS~ with the number of currently smoking 
parents in the home. 
Iverson and coworkers (1985) prospectively studied 337 children 
enrolled in all day-care institutions in a municipality over a 3month 
petid to evaluate the importance of involuntary smoking for middle 
ear effusion in children. Middle ear effusion was assessed with 
tympanometry, and the overall prevalence was found to be approxi- 
matsly 23 percent. Although various indoor environmental factors 
were assessed in this investigation, only parental smoking was 
significantly associated with middle ear effusion. The effect of 
parental smoking persisted with control for the number of siblings. 
The overall age-adjusted odds ratio was 1.6’ (95 percent confidence 
interval 1.0-2.6). In 5- to 7-year-old children, 10 to 36 percent of all 
chronic middle ear effusions could thus be attributed to smoking on 
the basis of these results. 
Kraemer and coworkers (1983) performed a cas+control study of 
76 children to examin e the relationship of environmental tobacco 
smoke exposure to the occurrence of persistent middle ear effusions. 
Frequent ear infections, nasal congestion, environmental tobacco 
smoke exposure, and atopy were all more frequent in children with 
ear effusions. The effect of involuntary smoking was observed only if 
nasal congestion was present, and was greatest in children who were 
atopic. 
Black (1985) performed a case-control study of glue ear with 150 
cases and 300 controls. Parental smoking was associated with a 
relative risk of 1.64 (95 percent C.I. 1.03-2.61) for glue ear. In 
Finland, Pukander and coworkers (1985) conducted a mntrol 
study of 264 2 to 3-year-old children with acute otitis media and 207 
control children and found an association between parental smoking 
and this acute illness. 
These studies are consistent in their demonstration of excess 
chronic middle ear effusions, a sign of chronic ear disease, in 
children exposed to parental cigarette smoke. Potential confounding 
factors for middle ear effusions should be examined carefully in 
future studies. The long-term implications of the excess middle ear 
problems deserve further study. 
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Acute Reqimtory Illness 
There are no studies of acute respiratory illness experience in 
adulta exposed to environmental cigarette smoke. 
cbugh, Phlegm, and wheezing 
Few studies have addressed the relationship of chronic respiratory 
symptoms in nonsmoking adults with environmental tobacco smoke 
exposure. Schilling and colleagues (1977) found that symptoms in 
adult men and women were related to personal smoking habits and 
that the occurrence of cough, phlegm, or wheeze in nonsmokers was 
not related to the smoking habits of their spouses. Schenker and 
colleagues (1982) confirmed these results in a telephone survey of 
5,000 adult women in western Pennsylvania. 
White and Froeb (1980) reported on 2,100 asymptomatic adults 
drawn from a population enrolled in a physical fitness program 
(Table 5). They reported statistically significant decreases in FEVl 
and maximum midexpiratory flow rate 0 as a percent of 
predicted in nonsmokers exposed to tobacco smoke in the work 
environment for at least 20 years compared with nonsmoking 
workers not exposed. The magnitude of effect was comparable to that 
of actively smoking 1 to 10 cigarettes per day. However, the absolute 
magnitude of the difference in mean levels of function between the 
smokeexpoeed group and the unexposed group was smalh 160 mL 
(5.5 percent) for FEW1 and 465 I& per second (13.5 percent) for 
MMEF. Carbon monoxide levels were measured in selected work- 
places and ranged from 3.1 to 25.8 ppm. The study population was 
se&selected, and the exposure classification was crude and did not 
account for people who changed jobs. It is unclear how the ex- 
smokers in the population were handled in the analysis. Kentner 
and coworkers (1984) performed a cross+ectionai investigation on 
1,351 workers and found no influence of involuntary smoking on 
pulmonary function. In this study, involuntary smoking at home and 
at work was considered. 
Comstock and colleagues (1981) examined 1,724 subjects drawn 
from two separate studies in Washington County, Maryland. Male 
and female nonsmokers married to smokers did not have a sign& 
CaMJy increased risk of having an FEWI less than 80 percent of 
Predicted or an F’EJVAWC ratio less than 70 percent. Schilling and 
colleagues (1977) also did not find an effect of involuntary smoking in 
adults. Effects were not examined within strata defined by age in 
either of these studies. 
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TABLE S.-Pulmonary function in adults exposed to involuntary smoking 
Study Subjecta Pulmonary function measured Outcome Comments 
White end Froeb 2,100 adults, Sen Diego, 
(1980) California, United States 
Fvc, FBV,, end MhfF m 
percent predictcd 
significant effect of office 
exposure to involuntary smoke 
Potential e&&ion biaq only 
current c@rette emoke 
expceure & treatment of 
exsmokere unclear 
Comtwk et al. 
a9811 
1,724 adulte, Washington 
County, Maryland United 
St&S 
FEV, 88 percent predicted No effect of wives’ smoking on 
hueband’s pulmonary function 
Includea edulte eged 20+ 
cmeweetional etudy 
Kauffmann et al. 
mw 
7,818 adulta, mlectd 
subgroups, seven cities, 
Frence 
FFW,, FVC, end MMEF All meeauw signiEcant effect 
in wives of smoking husbands; 
only MMEF signGent in 
husbands of smoking wives 
Not height edjw dear- 
reeponmtoamolmtof 
husbands’ smoking for MMEF 
in wivce; no effect below age 
40 
Brunekreef et al. 
w-w 
Kentner et al. 
(1984) 
173 adult.% subaroupe of 
larger study, the - 
Netherlands 
1,851 adult of&e workers, 
Germany 
Peak flow. in8Diratorv vital Significant effect in wives of 
smoking huebenda for peak 
flow FEW, cmmsctionally; no 
effect longitudinelly 
NO effect of work exposure on 
pulmonery function 
Chmectionel study 
Smell sample .3&e 
thmectional .&udy 
Kauffmann and colleagues (1983) suggested that the effects of 
exposure from a spouse who smoked may be manifest only after 
many years of exposure. These investigators asses& the effects of 
marriage to a smoker in 7,818 adults drawn from several cities in 
France. Among 1,985 nonsmoking women aged 25 to 59,58 percent 
of whom had husbands who smoked, the level of MMEF was 
significantly reduced in women married to smokers compared with 
women married to nonsmokers; this effect did not become apparent 
until age 40. The reduction was small, on average. 
Recently, studying another population, KaufXnann and colleagues 
(1986) suggd,ed that the FEWI/FVC ratio may be a more sensitive 
test for detecting differences between exposed and nonexpoeed 
subjects, particularly in those with symptoms of wheexing; however, 
this suggestion has not been evaluated in other populations. 
Rrunekreef and coworkers (1985), from the Netherlands, reported 
on 173 nonsmoking women who were participants in a larger 
longitudinal study of pulmonary function. The women were classi- 
fied by whether they were or were not exposed to tobacco smoke at 
study onset or at followup. Cross-sectionally, significant differences 
in pulmonary function were observed between smoke-expoeed and 
nonexposed women. However, the rate of decline of lung function 
king the followup period was not affected by tobacco smoke 
exposure in the home. This study had a small number of subjects and 
inadequate statistical power to detect effects of exposure on rate of 
decline that were not extremely large. 
Jones and colleagues (1983) selected women with either high or 
low FEVs from a population-based longitudinal study in Tecumseh, 
Michigan. Exposure to cigarette smoke at home from husbands who 
smoked was not significantly different in the two groups of women. 
Nonsmoking men who participated in the Multiple Risk Factor 
Intervention Trial had significantly lower levels of pulmonary 
function if their wives smoked in comparison with similar men 
whose wives did not smoke (Svendsen et al. 1985). 
The physiologic and clinical significance of the small changes in 
pulmonary function found in some studies of adults remains to be 
determined. The small magnitude of effect implies that a previously 
healthy individual would not develop chronic lung disease solely on 
the basis of involuntary tobacco smoke exposure in adult life. 
Whether particular characteristics increase susceptibility, such as 
Childhood exposures or illnesses, atopy, reduced pulmonary function 
from whatever cause, and increased airways responsiveness, rema,fns 
unknown. These sndl changes may also be markers of an irritant 
response, possibly transient, to the irritants known to be present in 




Only limited data have been published on the acute effects of 
inhalation of environmental tobacco smoke on pulmonary function 
in normal subjects (Table 6) and none on bronchial responsiveness. 
The available data have been obtained in exposure chambers under 
carefully monitored and controlled circumstances (Pimm et al. 1978; 
Shephard et al. 1979; Dahms et al. 1981). 
Pimm and colleagues (1978) exposed nonsmoking adults to smoke 
in an exposure chamber. Relatively constant levels of carbon 
monoxide (approximately 24 ppm) were achieved in the chamber 
during involuntary smoking. Peak blood carboxyhemoglobin levels 
were always less than 1 percent in these subjects before smoke 
exposure, but were significantly greater after the study exposure, 
Lung volumes, flow volume curves, and heart rates were measured 
for all subjects. Measurements were made at rest and following 
exercise under control and smoke-exposure conditions. Flow at 25 
percent of the vital capacity was reduced at rest in men and with 
exercise in women. Although statistically significant, the magnitude 
of the change was small: a 7 percent decrease in flow in men and 14 
percent in women. 
Shephard and coworkers (1979) utilized a similar cross-over design 
in a chamber of exactly the same size as that used by Pimm and 
associates. Their results were similar, with a small (3 to 4 percent) 
decrease in FVC, FEVI, Vti, and Vma~26. They concluded that these 
changes were of the magnitude anticipated from exposure to the 
smoke of less than one-half of a cigarette in 2 hours (the exposure 
anticipated for an involuntary smoker). 
Dahms and colleagues (1981) used a slightly larger chamber and 
an exposure with an estimated peak carbon monoxide level of 
approximately 20 parts per million. They found no change in FVC, 
FEVl, or FEFs76 in normal subjects after 1 hour of exposure. 
The active smoker manifests acute responses to the inhalation of 
cigarette smoke; thus, highdose involuntary exposure to tobacco 
smoke may plausibly induce similar responses in nonsmokers. The 
magnitude of these changes is quite small, even at moderate to high 
exposure levels, and it is unlikely that this change in airflow, per se, 
results in symptoms. 
Asthmatics 
Dahms and colleagues (1981) exposed 10 patients with bronchial 
asthma and 10 normal subjects to cigarette smoke in an environmen- 
tal chamber. Pulmonary function was measured at 15-minute 
intervals for 1 hour after smoke exposure. Blood carboxyhemoglobin 
levels were measured before and after the l-hour exposure. The 
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2 TABLE 6.-Acute effects on pulmonary function of passive exposure to cigarette smoke; normal 
subjects 
Study Type of expceure Magnitude of expmure Effecta Comments 
Pimm et al. 
(1978) 
Chamber 14.6 In, furniture 
sparse, smoking machine in 
mm 
Peak [Co] - 24 ppm; 
particulatea >4 mgfni’ 
Men: 6% increaee PVC, 11% 
increnee RV, 4% decrease 
0 m.zm during exercise 
Women: 7% decreaee V- 
after exercise; no effects on 
vc, TLC, PVC, FEW,., v,, 
No-km; timage age, men 
22.7, *omen 21.9; eham 
expomm ax control 
Shepherd et al. 
ww 
Dahma et al. 
ww 
A0 above 
Chamber SO m, climate 
controlled 
Low exposure: peak [CD] - 20 
ppm, particulate8 - mg/m’; 
high expowe: [Co] - 31 ppm 
Room levels not meanured; 
e&mated at peak [CO] - 20 
wm 
Low exposure: 3% decmaee 
FEW,, 4% decrease vm 6% 
decrease V- with exerch 
no increaeed effect with high 
=poeu~ 
0.9% increaee in Fvc, 
6.2% increaw in m,, 
2.2% llmenee in F+EF at 1 
hour 
Nonmokem: average age, men 
23, women 25; sham expoeure 
en control; iubjwt eatiited 
inhalation - l/2 cigar&e!2 
how 
10 nonsmokera; a2e range 24- 
63 yenm; not blinded; no aham 
expmure 
carboxyhemoglobin levels in subjects with asthma increased from 
0.82 to 1.20 percent. In normal subjects the increase was from 0.62 to 
1.05 percent. The increases in carboxyhemoglobin in the two study 
groups were not significantly different. Asthmatic subjects had a 
decrease in forced vital capacity @‘VC), FEVI, and MMEF to a level 
significantly different from their preexposure values. The decreases 
in asthmatic subjects were present at 15 minutes, but worsened over 
the course of the hour to approximately 75 percent of the preexpo 
sure values. Normal subjects had no change in pulmonary fundion 
with this level of exposure. In this study, subjects were not blinded as 
to the exposure and were selected because of complaints about smoke 
sensitivity. 
Shephard and colleagues (1979), in a very similar experiment, 
subjected 14 asthmatics to a Zhour cigarette smoke exposure in a 
closed room (14.6 ms). The carbon monoxide levels (24 ppm) were 
similar to those predicted in the study of Dahms and coworkers 
(1981). Blood carboxyhemoglobin levels were not measured. Subjects 
were randomized and blinded to sham (no smoke) and smoke 
exposure and tested on two separate occasions. Data were expressed 
as the percentage change from the sham exposure. Signi&ant 
changes in FVC and FEYI were not observed between the sham and 
the smoke exposure periods, although 5 of 12 subjects did report 
wheezing or tightness in the chest on the day of smoke exposure. 
Wiedemann and associates (1986) examined nonspecific bronchial 
responsiveness to methacholine in 9 asthmatic subjects and 14 
controls and the effect of acute involuntary smoking on nonspecific 
bronchial responsiveness. At the time of the study, all asthmatics 
were stable with normal or near normal pulmonary function. The 
subjects underwent baseline pulmonary function and methacholine 
challenge testing. On a separate day they were exposed to cigarette 
smoke for 1 hour at 40 to 50 ppm of carbon monoxide and underwent 
pulmonary function and methacholine challenge testing. J?uhnonary 
function was not influenced by exposure. Nonspecific bronchial 
responsiveness decreased significantly, rather than increasing, as 
would be anticipated following an irritant exposure. 
Acute exposure in a chamber may not adequately represent 
exposure in the general environment. Biases in observation and the 
in selection of subjects and the subjects’ own expectations may 
account for the widely divergent results. Studies of large numbers of 
individuals with measurement of the relevant physiologic and 
exposure parameters will be necessary to adequately address the 
effects of environmental tobacco smoke exposure on asthmatics. 
Ear, Nose, and Throat 
There are no studies of chronic ear, nose, and throat symptoms in 
adults with involuntary smoking exposure. 
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Lung Cancer 
This se&ion reviews the epidemiological evidence on invohmtary 
smoking and lung cancer in nonsmokers, which has been derived 
from retrospective and prospective epidemiological studies. First, 
common methodological issues that apply to all these Studies are 
considered. Second, for each type of study design, individual studies 
are reviewed for their methodological approach (Tables 7 and 81, 
findings associated with tobacco smoke exposure (Table 9, Figure 5), 
and strengths and limitations. Third, the lung cancer risk associated 
with involuntary smoking is e xamined as a low-dose exposure to 
cigarette smoke by combining the d-response relationships for 
active smoking with the exposure data for involuntary smoking to 
predict the expected lung cancer risk due to involuntary smoking. 
This expxted risk is then compared with the actual risks observed in 
studies of involuntary smoking. Finally, the existing epidemiologicsl 
evidence is summarized and the plausibility of the association 
between lung cancer and involuntary smoking is evaluated on the 
basis of our current knowledge. 
ObfBNd Risk 
Geneml iUethodological Issues 
For both retrospective and prospective studies, the common 
methodoltic concerns are disease misclassi&ation and miscla&fi- 
cation of the subject’s personal smoking status or exposure to ET& 
Disease misclassification, for example, refers to the incorrect classifi- 
cation of the lung as the primary site of a cancer that originated 
elsewhere. Disesss misclassification is of greatest concern in studies 
in which the diagn~is of lung cancer was not histologically 
confirmed. Such misclsssification tends to be random and to bias 
relative risk estimates toward unity (Copeland et al. 1977). Patients 
with lung cancer, or any disease associated with cigarette smoke 
exposure, may report exposure to ETS more frequently than controls 
becauseofbiasinrecall. 
Misclassification of the subject’s personal smoking status may 
occur in both retrospective and prospective studies; this misclassifi- 
cation refers to incorrectly classifying a subject as a nonsmoker 
when the subject is actually an ex-smoker or a current smoker, or to 
incorrectly chdfying the subject as a smoker when the subject is a 
nonsmoker. Biochemical markers such as cotinine and nicotine, 
which can be used to detect unadmitted active smokers, are sensitive 
only to a recent exposure to tobacco smoke; thus, they are not 
Ptiicuh+Q useful for identifying ex-smokers who deny their past 
SIIlOking hisb?k~. Mis&ss&ation of smokers or ex-smokers as 
nonsmokers may produce the appearance of an involuntary smoking 
effect when, in fact, the true relationship is with aeve smoking. 
&urcz of subjects 
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Misclassification of involuntary smoking exposure refers to the 
incorrect categorization of exposed subjects as nonexposed and of 
nonexposed subjects as exposed. Most studies of lung cancer to date 
have used the number of cigarettes smoked by spouses as a measure 
of exposure to involuntary smoking, and thus have disregarded 
duration of exposure, exposure from other sources, and factors that 
influence exposure, such as proximity to the smokers or size and 
ventilation of the room where the exposure occurred. Moreover, all 
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TABLE &-Description of case-control studies 
Study cmntry 
case 
Source end type 
control 
Source end type 
confirmed histology 
Iudexofpemd~ 
Respondent and Pathologicel/ mole: habita of 
type of interview cytological Adermarchoma spouam end others 
Trichopouka Greece 
et al. (1981, 
1983) 
C&set and can& 
hospitals, 77 NS (FJ 
Orthopedic hcepital; 225 
Ns; not matched 
Selfi not blinded 65% 




Hoepit+ 30 NS (8 M, Same hospitals, non-~ Self, and proxy 97% 54% among current spoues 
22 F) related diaeaaes; 313 NS bm, 23% women RYPe, amount Fk 
(180 M, 133 Q matched for control, 11%); parents 
age, sex, raw hmitd blinded 
Chsn and Hong Kong Four hoepit& Orthopedic, same hoepit& Self; not blinded 82% 45% Ndapouee 
Fun8 ww 64 NS 0 189 NS; not matched w=if-bi- 
quiwtiom at home 
andatwork 
Koo et al. Hong Kong Eight lmpitale; Population; 137 N& Self; not blinded 97% 69% Currentandr- 
wa 1981) 88 NS 0 matched for egm, race, sex, m b--k 
emioewllomlc status, YmwiP@-B 
lwldence dlstrlct other cohablti& 
am&em (amount 
PIW 
K&at and united statea Most from one NY Same hospital 0; non- Self; not blinded 10096 M%td cul7ent spouss 
Wynder (19S4) hoepi~ 134 NS; tabaamrelated dieeasq 78 14% F of @nrentww 
passive smoking data NS (25 M, 63 p); matched 134 NS fmoking habite 
on only 78 NS (26 M, for age, sex, raa+ hoepital, l?urrentwat 










Respondent and Patholo6icaV srook habit8 of 
type of inte.rvlew ~hw Adenocarcinonm qouam and othara 
wu et al. 
w=) 
Population; 62 N9; matched self; not blinded 100% 100% current and former 
for age, ram sex, spa- (amount, 











134 NS 0 
Same haepitale, o~lorectal 
cancer patients; 402 NS; 
matched for age, hospital, 
IlonsmoLiDg status 
self (cab& 12%; 
control, ?) and 
prory; blinded 
100% 66% Current spouse or 
cohabitant (total 
and at home: 
amu& ~3); other 
ew-re, a-w 
hrdday (at home, 




d TABLE &-Continued 
Study Country 
case 
Source and type 
Control 
Source end type 
confirmed hb3bi~ 
Index of paudve 
Respondent and Patholcgical/ smoke:, habite of 
type of interview cytological Adenocarcinoma spousee and others 
Lee et al. 
wm 
United Ha&al-beeed; 47 NS 
KlllgdOlll (15 M, 32 l9 
Same hmpitals, 96 NS (30 Self, hospital 1 1 current spoum 
M, 66 F); matched for age, inpetient (smoking habit 
sex, marital status, hoepital interview; duriag admission 
spouse, followup yr ad maximum 
intarvie-w; not during marrio& 
fqecified other expceure at 
home, at work, 
dur@ travel end 
leisure 
Akiba et al. 
ww 
Japan Hllhlma and 
Nagasekl bomb 
survivors; 103 NS (19 
M, 84 F) 
Same cohort, noncancer or self (c-am, 10%; 67% 7 curlent spoum 
chronic respiratory disease; control, 12%) end bow llee de 
380 NS (110 M, 270 IQ prow, not blinded aBgestop,yra 
matched for age, eeq city cohabitiS; perenta 





Sweden National census of 
Sweden end Swedish 
TwlnFhgi&y; 
67 NS 0 
Two controls from each 
soume; 347 Ns; matched 
for year of bii, vital 
status at followup end for 
twin regktry control 
Self, and proxy 





99% 57% spouse lived with 
longeat kImour& 
Yd; parenb 
TABLE 9.-Results from selected prospective and cast+ 
control studies; lung cancer risk associated with 
spowes’ smoking 
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of the published studies have baaed involuntary smoking exposure 
measures on questionnaires without validation of these data with 
biochemical markers or environmentally measured concentrations 
of tobacco smoke constituents. M isclassification of involuntary 
emoking exposure is likely to be random and to bias the effect 
measures toward the null (Copeland et al. 1977). 
M isclassification of exposure to environmental tobacco smoke is 
inherent in epidemiological studies of involuntary smoking. Tobacco 
smoking has not been re&icted in most indoor environments until 
recently, and exposure has been almost inevitable in the home, the 
workplace, or other locations. Studies with the biological markem 
nicotine and cotinine confirm that tobacco smoke exposure is 
widespread; detectable levels of these markers are found even in 
people without reported recent exposure. Thus, the exposure vari- 
ables emp loyed in epidemiological studies do not separate nonex- 
posed subjects from exposed subjeds; instead, they discriminate 
more exposed groups from less exposed groups. As a  result, the 
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epidemiological approach is conservative in estimating the effects of 
involuntary smoking. A truly nonexposed but otherwise equivalent 
comparison population has not been identified. The extent of the 
resulting bias cannot be readily estimated and probably varies with 
the exposure under consideration, which may be one reason for the 
variability in risk estimates obtained by different studies. 
Information bias is an added concern in cas+control studies, since 
neither interviewer nor respondent bias can be ruled out. It is not 
feasible to blind interviewers to the case or control status of 
respondents because of the usually obvious manifestations of lung 
cancer and because of the setting in which some of the interviews are 
conducted. Moreover, blinding of interviewers and respondents to 
the study hypothesis is difficult because the majority of questions are 
concerned with exposure to tobacco smoke. The direction of the 
information bias may be dependent on the type of respondent. Self- 
respondents may be more apt to interpret their d&ease as related to 
exposure to tobacco smoke and thus overreport the exposure. 
However, the direction of the information bias is less clear when 
interviews are conducted with surrogate respondents. The ability of 
a surrogate to provide accurate information may depend on the 
relationship of the surrogate respondent to the subject, whether the 
surrogate lived with the subject during the time frame of the 
questions asked, the degree of detail requested, and the amount of 
time elapsed since the event in question @or&s 1982; Pickle et al. 
1983; Lerchen and Samet 1986). Surrogate respondents may mini- 
mize the reporting of their own smoking because of guilt, or may 
overreport about involuntary smoking exposure in an attempt to 
explain their relative’s illness. Thus, depending on the direction of 
the information bias, it may dilute or strengthen the effect being. 
measured (Sackett 1979). In general, however, the information on 
smoking status and on amount smoked provided by surrogatea has 
been found to be fairly comparable to that provided by the 
individuals themselves (Blot and McLaughlin 1985). 
F’inally, participants and nonparticipants in case-control studies 
may be inherently different with respect to their exposure to 
involuntary smoking because their awareness of the hypothesis 
under study may motivate the decision to participate. However, 
participants in cas+control studies are generally not informed of the 
hypothesis under study. 
Spousal Exposure: Prospective Studies 
The Japanese Cohort Study 
Hirayama (1981a, 1983, 1984a) has presented data from a large 
cohort study that included 91,540 nonsmoking married women who 
were residents of 29 health districts in Japan. Subjects were 49 years 
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of age or older at enrollment in 1965; infOrm&iO~ W88 collected on 
smoking and drinking habits, diet (e.g., green-yellow vegetables, 
meat), occupation, and other health-related variables. 
me initial report on invohmtary smoking ~88 baaed on 14 gears of 
f&owup (lg6&1979). The husbands’ smoking histories were avail- 
able for 174 of 240 lung cancer cases identified among the non- 
smoking &ed women (Hirayama 1981a); this number increased 
to 2~ with 2 additional years of followup -yama 1983, 1984a). 
&db p&thing to the association of spouses’ lung cancer risk 
with the husbands’ smoking were essentially identical in the first 
and second reports. 
On the basis of the smoking habits of the husbands at entry, the 
206 nonsmoking women were classified as married to a nonsmoker, 
an ex-smoker, or a current smoker. The lung cancer mortality ratios 
&d&jzed by husband’s age were 1.90,1.36,1.42,1.58, and 1.91 for 
women whose husbands were nonsmokers, ex-smokers, and daily 
smokers of 1 to 14,15 to 19, and 20 or more cigarettes, respectively 
(one-sided p for trend, 0.002). Similarly sign&ant dose-response 
trends were observed when the mortality ratios were standardized 
by age of the wives, by occupation of the husbands (agricultural, 
industrial, other), by age and occupation of the husbands, and by the 
time period of observation (19661977 versus 1978-1981). The risk of 
lung cancer &ong nonsmoking wives of smokers was reduced to 0.7 
(two-sided p=O.O5) if they ate green-yellow vegetables daily com- 
pared with 1.0 if they ate such vegetables less often than daily 
(Hirayama 1984b). No other characteristic of the wives (e.g., drinking 
habits, parity, occupation, nonvegetahle dietary items) or of the 
husbands (e.g., drinking habits) was significantly predictive of lung 
cancer risk. 
Nonsmoking men whose wives were smokers also showed an 
elevated lung cancer risk. On the basis of 67 lung cancers in 
nonsmoking married men, the lung cancer mortality ratios were 
1.00,2.14, and 2.31 if their wives had never smoked or had smoked 1 
to 19 cigarettes or 20 or more cigarettes per day, respectively (one- 
sided p for trend, 0.023) (Hirayama 198413). 
This study has been critically discussed in correspondence since its 
initial publication. Because a detailed breakdown of the at-risk 
population was not presented in the initial report, the lung cancer 
mortality rate was thought by some to be higher in the unmarried 
nonsmoking women than in the nonsmoking women marriedto 
smokers CRutsch 1981; Grundmann et al. 1981). This impression was 
clarified by the researcher (Hirayama 1981b,c,d) and shown to be the 
result of incorrect interpretation of data in the original paper. Other 
potential problems cited were sampling bias in the study cohort, 
misclassification in the diagnosis of lung cancer, misclassification of 
the nonsmoking status of wives, misclassification of involuntary 
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smoking exposure, failure to control for potential confounders, and 
inadequate statistical treatment of data. Each of these points of 
criticism is discussed below. 
MacDonald (1981a,b) questioned the representativeness of the 29 
health districts selected in the study cohort and suggested that, 
industrial pollution, such as asbestos exposure from shipbuilding 
industries specific to the selected health districts, may have biased 
the results. However, the levels of exposure to this factor would have 
to coincide with the husbands’ smoking level to explain the effect 
observed. Such an association seems unlikely. If the cohort were not 
representative, the generalizibility but not the validity of the 
findings would be challenged (Criqui 1979). 
The accuracy of the diagnosis of primary lung cancer on the basis 
of death certificates and the adequacy of the data without informa- 
tion on the histology of the tumor were questioned (Grundmann et 
al. 1981; MacDonald 1981a). From a sample of 23 cases, Hirayama 
(1981b) reported that the distribution by histology of lung cancer in 
nonsmoking women whose husbands smoked was similar to that in 
women who smoked. Failure to discriminate in some cases between 
primary and metatastic lesions to the lung may be a potential 
problem with disease diagnosis. Although Hirayama was unable to 
assess the accuracy of the diagnosis listed on the death certificate, 
there is no reason to believe that error in recording the causes of 
death of wives was influenced by the smoking habits of their 
husbands, and any m isclassification is likely to be random. Inclusion 
of nonlung cancer cases would tend to bias the risk ratio toward 
unity or no effect (Barron 1977; Greenland 1980). 
The relatively high risks observed for nonsmokers whose husbands 
smoked led to speculation that Japanese women may report them- 
selves as nonsmokers when they actually smoke (Lehnert 1934). 
However, some assurance of the reliability of the smoking data 
provided by the Japanese women comes from an investigation in 
Hiroshima and Nagasaki (Akiba et al. 1986) that found strong 
concordance between smoking status reported by the women them- 
selves and that reported by their next of km. 
Classifying nonsmoking women solely on the basis of the smoking 
habits of their current husbands probably does not quantify their 
exposure with precision because it accounts for only one of the many 
possible sources of tobacco smoke exposure. Moreover, using the 
number of cigarettes smoked per day by the husbands as a measure 
of exposure dose assumes that the husbands’ increasing daily 
cigarette consumption is directly related to an increasing ETS 
exposure of the wives (Kornegay and Kastenbaum 1981; Lee 1982b). 
The analyses were further criticized for not accounting for 
potential confounding factors such as socioeconomic status (SES) and 
exposure to indoor air pollutants (e.g., from heating and cooking 
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smrces) (Sterling 1981). However, Hirayama showed a fairly consis- 
tent relationship between involuntary smoking exposure and lung 
mcer across SES categories. The role of indoor air pollutants could 
not be addressed directly in the study, but data from one health 
distrkt in the study indicated no association between heating or 
cooking practices and the smoking habits of the husbands (Hirayama 
1981b). 
The researcher’s failure to specifically describe the methods for 
age standardixation in the initial report led to speculation that the 
statistical methods used were incorrect (Kornegay and Kastenbaum 
1981; Mantel 1981; Tsokos 1981; Lee 1981); however, the calculations 
were later confirmed (Harris and DuMouchel 1981; Hammond and 
EM&off 1981). The choice of stratification variables used for age 
standardixation was also criticixed because the husbands’ ages 
instead of the wives’ ages and U&year age groups instead of narrower 
ones were used (Tsokos 1981; MacDonald 1981b). Later publications 
confhmed that similar results were obtained regardless of, the 
method of standardixation (Hirayama 1984a). 
The American Cancer Society Cohort Study 
A second prospective study (Garfinkel 1981) that examined the 
effects of involuntary smoking was the American Cancer Society 
(ACS) study of about 1 million people living in 25 States. A self- 
admimstered questionnaire on education, residence, occupational 
exposure, and smoking and medical history was completed by the 
study subjects upon enrollment. 
This report on involuntary smoking was based on 12 years of 
followup (1966-1972) and included 176,739 nonsmoking married 
women whose husbands’ smoking habits were available and whose 
husbands were never smokers or current smokers. In the total cohort 
of nonsmoking women, 564 lung cancer deaths occurred, and data on 
the husbands’ smoking habits were available for 153 (27.1 percent). 
Wives of ex-smokers and of cigar or pipe smokers were excluded from 
the analysis. 
A small, statistically nonsignificant increased risk for lung cancer 
was found for nonsmokers married to smokers. The mortality ratios 
for lung cancer in nonsmoking women were 1.0,1.27, and 1.10 when 
the husbands were nonsmokers, daily smokers of fewer than 20 
cigarettes, and daily smokers of 20 ‘or more cigarettes, respectively. 
The results were essentially unchanged after accounting for the 
potential confounding effects of age, race, education, residence, and 
husband’s occupational exposure. 
The ACS study, like the Japanese study, was not designed to study 
the long-term effects of involuntary smoking. However, the ACS 
study does provide an estimate of the extent of misclassification of 
lung cancer. On the basis of medical record verification, the death 
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certificate diagnosis of lung cancer in nonsmoking women was 
incorrect for 12 percent of the cases. Although confirmation of 
diagnosis was sought only for the first 6 years of followup, the 
available data suggest that some misclassification of lung cancer 
occurred. To the extent that passive smoking is related to lung 
cancer in nonsmokers, inclusion of nonlung cancers would tend to 
dilute a true effect. 
A limitation of the ACS study is the nonavailability of smoking 
information on the husbands of a large proportion of the nonsmoking 
women who died of lung cancer. Because smoking habits are 
correlated with various social characteristics, this large loas of 
information may have created a bias in this study. The researcher 
stated that an index of tobacco smoke exposure based only on 
smoking habits of current husbands may be particularly inadequate 
for the United States, with its high rate of divorce and substantial 
proportion of women working outside the home. This speculation is 
supported by data from a group of 37,881 nonsmokers and ex- 
smokers who were members of a health plan in California. Friedman 
and colleagues (1963) stated that 47 percent of the nonsmoking 
women and 39 percent of the nonsmoking men married to smokers 
reported no exposure at home. Moreover, being married to a 
nonsmoker did not assure the absence of exposure to tobacco smoke, 
since 40 percent of the nonsmoking women and 49 percent of the 
nonsmoking men married to nonsmokers reported some exposure to 
tobacco smoke during the week. Thus, random misclassification 
could have biased the results toward unity and led to an underesti- 
mate of the effect of passive smoking. 
The Scottish Study 
Gillis and colleagues (1984) conducted a prospective cohort study of 
16,171 Scottish men and women, aged 45 to 64 years, from two urban 
areas, who attended a multiphasic health screening clinic between 
1972 and 1976. A questionnaire on smoking habits and symptoms of 
respiratory and cardiovascular diseases was completed at entry into 
the study. 
The preliminary analysis of involuntary smoking, representing 6 
to 10 years of followup, was based on the 2,744 nonsmokers among 
the 8,128 subjects who lived as couples and could be paired according 
to smoking habits. Subjects who lived alone or whose partner did not 
participate and ex-smokers who had stopped smoking for 5 years or 
more were excluded. The nonsmokers were classified as nonsmokers 
not exposed to environmental tobacco smoke or as nonsmokers 
exposed to environmental tobacco smoke, according to the smoking 
habits of their spouses. 
A higher age-standardized lung cancer mortality rate was reported 
for nonsmoking men exposed to tobacco smoke (13 per 10,006) than 
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for nonsmoking men not exposed (4 per 10,000); however, no 
statistical tests were conducted because of the small number of 
cancers. Lung cancer rates were similar for nonsmoking women 
regardless of the status of their exposure to tobacco smoke (4 per 
10,000). The extremely small number of observed lung cancer deaths 
(6 men, 8 women) limit the interpretation of the study’s findings. 
Spu8al Expomre: Case-Control Studies 
Table 8 summa&es the car+control studies that have examined 
the relationship between involuntary smoking exposure and lung 
cancer. 
The Greek Study 
Trichopoulos and colleagues (1981, 1983; Trichopoulos 1964) 
examined the effect of involuntary smoking on lung cancer risk in a 
case-control study of 51 Caucasian female lung cancer patients 
(excluding adenocarcinoma and terminal bronchiolar carcinomas) 
from three chest hospitals and 163 female controls from an 
orthopedic hospital in Athens, Greece. All subjects were interviewed 
in person by one physician who questioned them regarding their 
personal smoking habits and those of their current and former 
husbands. Thirty-five percent of the cases were diagnosed only on 
the basis of clinical or radiologic information; the remainder were 
cytologically (37 percent) or histologically (28 percent) confirmed. 
Nonsmoking women were classified by the smoking habits of their 
current or former husbands. Husbands were nonsmokers if they had 
never smoked or had stopped smoking more than 20 years previous- 
ly, ex-smokers if they stopped 5 to 20 years previously, and current 
smokers if they were smoking or had stopped less than 5 years before 
the interview. Being never married, widowed, or divorced was 
equated as being married to a nonsmoker or an ex-smoker, depend- 
ing on the length of time in the category. 
The initisl report was based on 40 nonsmoking cases and 149 
nonsmoking controls. The odds ratios (0R.s) for women married to 
nonsmokers, ex-smokers, current smokers of 1 to 20 cigarettes per 
by, and current smokers of 21 or more cigarettes per day were 1.0, 
1.9,2.4, and 3.4, respectively (two-sided p for trend, < 0.02). In a later 
report on 77 nonsmoking cases and 225 nonsmoking controls, the 
ORa were somewhat lower: 1.0, 1.9, 1.9, and 2.5, respectively 
t’lltchopoulos et al. 1983; Trichopoulos 1984). 
The findings of this study were questioned because the diagnosis of 
cancer was not pathologically confirmed for 35 percent of the cases 
(Hammond and Selikoff 1981; Lee 1982b). The inclusion of cases that 
were not lung cancers would tend to dilute the results toward the 
null because they may not be related to involuntary smoking. 
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Terminal bronchial (alveolar) carcinoma and adenocarcinoma of the 
lung were excluded from the pathologically confirmed group; this 
exclusion may have been premature (Hammond and Selikoff 1981; 
Kabat and Wynder 19&Q), as the causal association between personal 
smoking and adenocarcinoma of the lung is well established (IARC 
1986). Because the controls were selected from a different hospital 
than were the cases, selection bias cannot be ruled out. Interviewer 
bias is also possible, since all subjects were interviewed by a single 
physician who knew the case or control status of each subject, and 
also knew the hypothesis under investigation. 
The index of exposure to tobacco smoke used in this study included 
the smoking habits of former and current husbands. Since the 
definition of ex-smokers excluded those who had stopped smoking 
recently (within the last 5 years), it was unanticipated that the risks 
observed for women whose husbands were ex-smokers (i.e., quit 5 to 
20 years previously) were as high as for those whose husbands were 
current smokers. Additional information on the smoking habits of 
these ex-smokers would be valuable. 
The Louisiana Study 
The cas+control study by Correa and colleagues (1983) was based 
on 1,338 primary lung cancer cases, of which 97 percent were 
pathologically confirmed. Controls (N= 1,393) were matched to cases 
by race, sex, and age (+5 years) and were patients at the same 
hospitals as cases but without a diagnosis related to tobacco smoking. 
Standard&d interviews were conducted with the subjects (76 
percent of cases, 89 percent of controls) or their next of kin. 
Questions on occupation, residency, personal smoking and drinking 
habits, and smoking habits (including type of tobacco smoked and 
amount and duration of smoking) of the current spouse and parents 
were asked. 
Thirty nonsmoking ever-married lung cancer (excluding bron- 
chioalveolar cell) patients (8 men, 22 women) and 313 ever-married 
nonsmoking controls (189 men, 133 women) were classified according 
to their spouse’s total lifetime pack-years and current daily amount 
smoked at the time of interview. After adjusting for sex, ORs of 1.60, 
1.48, and 3.11 were observed when spouses had smoked none, 1 to 40 
pack-years, and 41 or more pack-years, respectively (two-sided 
p< 0.05). The results based on current daily number of cigarettes 
smoked by spouses were similar. 
The study is limited by the small number of nonsmoking cases, but 
the consistency of the results for men and women strengthens the 
findings. Misclassification of involuntary smoking is possible because 
only smoking habits of the current husband were assessed, ignoring 
the effect of divorce, remarriage, and exposure from coworkers. 
Exposure from parents during childhood was determined, but case 
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numbers were too small for a mea&gful analysis of this factor 
among nonsmokers. 
The Hong Kong Studies 
me high rates of lung cancer, particularly adenocarcinoma of the 
lung, among women of Chinese descent in Hong Kong are unexpect- 
d in the face of their low rates of tobacco smoking. The role of 
involuntary sm&.ng was investigated in two studies conducted in 
Hong Kong (Chan et al. 1979; Ghan and Fung 1982; KOO et al. 1983, 
1984). 
Chm and colleagues (1979) examined the role of involuntary 
smoking among 84 female lung cancer patients and 139 orthopedic 
control patients, none of whom had ever smoked. Of the 34 
nonsmoking cases, 69 (82 percent) were pathologically confirmed, 
and 38 of these 69 cases were adenocarcinoma of the lung. The 
controls were from the same hospitals as the cases, but were not 
individually matched to the cases on any characteristics. 
Cases and controls were questioned regarding their residence, 
education, occupation, cooking practices, and personal smoking 
habit. One question on exposure to others’ tobacco smoke was 
included: “Are you exposed to the tobacco smoke of others at home or 
at work?” The researchers reported that the controls lived with 
smoking husbands more frequently (47.5 percent) than the cases 
(46.5 percent) (OR 0.771, but did not explain how this question was 
used to classifs the habits of the spouse alone. The method used to 
classify currently unmarried respondents (i.e., never married, wid- 
owed, divorced) with regard to exposure to their spouses’ smoking 
was not described, and it is not known if the nonsmoking cases and 
controls were comparable in terms of current marital and employ-, 
ment status. Thus, insufficient information on the measure used to 
assess El% exposure, and on the comparability of the nonsmoking 
cases and controls, limits interpretation of this study’s results. 
The study by Koo and colleegues (1983,1934) involved 200 Chinese 
female lung cancer patients who were identified from eight hospitals 
in Hong Kong; almost all cases were pathologically confirmed (97 
percent). Among these women, 68 had never smoked, of whom 52 (59 
percent) had adenocarcinomas of the lung. An equal number of 
“healthy” population controls, individually matched to cases by age 
(f5 years), socioeconomic status, and district of residence, were 
interviewed. Among the controls, 137 had never smoked. 
Using a sernistructured questionnaire, taped interviews were 
obtained and information on residence, occupation, family and 
medical history, personal smoking habits, and smoking habits of all 
cohabitants and coworkers was elicited. ETS exposure was quanti- 
fied in hours and years according to who (i.e., husband, parents, in- 
laws, children, others) smoked in the subject’s presence and where 
(i.e., at home, at work) the exposure occurred. The analysis was based 
on a cumulative smoke exposure index (in total hours and total 
years) specific to place of exposure. 
The investigators concluded that there was no association between 
involuntary smoking and lung cancer in nonsmoking Chinese 
women, regard&s of the index of smoke exposure used. A small, but 
statistically nonsignificant, increased risk (RR 1.24) was associated 
with any exposure to tobacco smoke. There were no significant 
differences between the cases and the controls in total hours or total 
years of exposure. The results remained unchanged when exposure 
hours were categorized into three levels of exposure. Odds ratios of 
1.09, 1.28, and 1.02 were associated with no, low ( 5 35,900 hours), 
and high (> 35,000 hours) exposure levels, respectively. There was no 
apparent trend of lung cancer risk with the age when exposure to 
tobacco smoke began. The ORs for never exposed and first exposed at 
ages 0 to 19,20 to 39, and 40 or older were 1.09,0.96,1.53, and 0.91, 
respectively (Koo et al. 1984). AnaIysis by cell type suggested that 
the effects of involuntary smoking may be more pronounced for 
Kreyberg I tumors (squamous, smallcell, and largeceIl carcinomas) 
(OR 1.47, 95 percent C.I. 0.34, 3.33) than for adenocarcinoma (OR 
1.11, 95 percent C.I. O-49,2.59) (ILoo et al. 1985), but these numbers 
were amaR. 
The design of this study addressed the criticisms of other studies 
that an index of involuntary smoking exposure based only on 
spouses’ smoking habits is inadequate, and broadened the exposure 
assessment to include alI locations of tobacco smoke exposure. 
However, the cumulative exposure index created in this study may 
have Iimited validity. Unlike personal smoking, where there is 
essentiaIIy one source (personal smoking), one dose (usual or 
maximum amount smoked), and one duration of exposure (age at 
start and age at stop), EYES exposure derives from diverse sources at 
different doses and durations of exposure. The accuracy of the 
information on exposure to EIS will depend on the amount of detail 
requested, the age of the respondent, the temporal course of the 
exposure, and the source of the exposure. Weighing each type of 
exposure equally in a cumulative index (in total hours) may be 
incorrect because it assumes that all sources of exposure should be 
quantified in the same way and that each source of tobacco smoke 
contributes equally, disregardiug intimacy of contact and proximity 
to smokers and conditions of exposure (e.g., room size, ventilatory 
factors). Thus, random misclassification of the expoeure variable by 
inclusion of data from less relevant exposures than spousai smoking 
may obscure an association of involuntary smoking exposure with 
lung cancer risk. In this study, interviewer and respondent bias 
should also be considered because a structured questionnaire was not 
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An Ongoing Study of Tobacco-Related Cancers 
All of the cases of primary lung cancer in nonsmokers were 
selected (Rabat and Wynder 1984) from an ongoing case-control 
study of tobacco-related cancer conducted in five U.S. cities between 
1971 and 1980 (Wynder and Bellman 1977). For each case, one 
control was individually matched by age (r+5 years), sex, race, 
hospit,& date of interview (+_2 years), and nonsmoking status. 
controls were selected from a large pool of hospitalized patients who 
were interviewed over the same time period as the cases and who 
had diseases not related to tobacco smoking. Information on demo- 
graphic factors, residence, height and weight, drinking habits, 
previous diseases, and occupational exposure were obtained. Ques- 
tions on tobacco smoke exposure at work, at home, and from current 
spouse were added in 1978, and revised in 1979. Information on EYl!S 
exposure was available for 25 of 37 nonsmoking male cases, 53 of 97 
nonsmoking female cases, and their respective matched controls. 
A higher percentage of female controls than of female cases 
reported exposure to E’I’S at home (32 percent), at work (59 percent), 
and from spouses (66 percent). ‘Ihe percentages of female cases who 
reported exposure at home, at work, and from spouses were 39,49, 
and 54 percent, respectively. None of the case-control differences in 
women were statistically significant. Male cases reported more 
frequent exposure at work (OR 3.27, p= 0.045) and at home (OR 1.26), 
but no difference in the smoking status of their spouses (OR 1.60). 
The process for selecting the nonsmoking controls from the larger 
pool of controls in the ongoing study and for selecting the non- 
smoking csses and controls who were questioned with regard to ETS 
exposure was not described adequately. It is not clear whether the 25 
of 37 male and 53 of 97 female nonsmoking cases and controls who 
provided information on involuntary smoking were all interviewed 
during or after 1978 when the questions on involuntary smoking 
were introduced. ‘I’he proportion seemed high, since it represented 68 
percent of male and 55 percent of female nonsmoking cases 
interviewed during the 10 years of data collection. The study was not 
designed to specifically address the effect of involuntary smoking, 
and a variable subset of questions on involuntary smoking was 
asked, depending on when the subjects were interviewed. Misclassifi- 
cation of the exposure is possible because it is not clear whether the 
cases and controls answered the same set of questions and whether a 
comparable amount of information was obtained. The researchers 
acknowledged the limitations of this study and presented its results 
as prebinary findings. 
82 
The Los Angeles County Study 
In the case-control study by Wu and colleagues (1985), 220 white 
female lung cancer patients (149 with adenocarcinoma and 71 with 
squamous cell carcinoma) and 220 population controls were individu- 
ally matched on sex, race, age (f5 years), and neighborhood of 
residence. Cases were identified from the population-based tumor 
registry of Los Angeles County. All cases were histologically 
confirm& the histological type was based on the pathology report 
from the hospital of diagnosis. 
Using a structured questionnaire, cases and controls were directly 
interviewed by telephone and were asked about their own personal 
smoking habits and the smoking habits (amount and years of 
smoking) of current and former husbands, parents, and other 
household members during childhood and adult life. Exposure to 
tobacco smoke at work (in hours per day) was obtained for each job of 
at least 6 months’ duration. Information on medical and reproduo 
tive history, heating and cooking sources, and dietary intake of 
vitamin A were obtained. 
Of 149 patients with adenocarcinoma of the lung, 29 had never 
smoked, nor had 2 of 71 patients with squamous cell carcinoma. The 
analysis of involuntary smoking was based on the 29 nonsmokers 
among the adenocarcinoma cases and 62 nonsmokers among the 
controls. 
A subject was classified as married to a smoker if any of her 
husbands had ever smoked. Similarly, a subject was considered 
exposed at work if she was exposed to tobacco smoke for at least 1 
hour per day at any of her jobs. There were small, but nonsign& 
cantly increased risks associated with ETS exposure from spouse or 
spouses (OR 1.2; 95 percent C.I. 0.2,1.7), and from coworkers (OR 1.3; 
95 percent C.I. 0.5,3.3). Increased risk was not associated with smoke 
exposure from either parent (OR 0.6; 95 percent C.I. 0.2, 1.7). 
Exposure to tobacco smoke from spouses and from coworkers was 
combined in an index representing smoke exposure during adult life. 
There was an increasing trend in risk with increasing years of 
exposure. The ORs were 1.0,1.2, and 2.0 for 0,l to 30, and 31 or more 
years of involuntary smoking exposure during adult life, respective 
ly, but the results were not statistically significant. Because the 
exposures may have occurred concurrently, the years of exposure 
represented units of exposure rather than calendar years of expo 
sure. 
This study is limited by the small number of nonsmoking cases 
and controls. Unlike the two case-control studies that excluded 
adenocarcinoma or bronchioalveolar cell carcinoma (Trichopoulos et 
al. 1981; Correa et al. 1983), cases in this analysis were of these cell 
types (17 adenocarcinoma, 12 bronchioalveolar); this case mix may 
explain the weak association observed. 
The Four Hospitals Study 
A Mntrol study by Garfinkel and colleagues (1985) included 
134 nOnsmOking female lung cancer cases selected from three 
hospitals in New Jersey and one in Ohio over an 11-year period, 
1971-1981. Medical records served as the initial source of informa- 
tion on smoking status of the subject, and the nonsmoking status of 
each case and control was verified at interview. Three controls, 
color&al cancer patients matched to cases by age (f5 years) and 
hospital, were interviewed for each case, giving a total of 402 
controls. All diagnoses of cases and controls were pathologically 
confirmed. Interviewers, blinded to the diagnosis of the subjects and 
to the study hypothesis, administered a standard questionnaire to 
subjects or their next of kin. Information on the smoking habits of 
current spouse (total and amount smoked at home), tobacco smoke 
from other sources (in hours per day at home, at work, and in other 
settings), and exposure to tobacco smoke during childhood were 
obtained. 
Subjects were classified according to the smoking habits of current 
husbands. Smoking habits of a cohabitant in the same household was 
used for single women or those who no longer lived with their 
spouses. Of the cases, 57 percent were classified according to the 
smoking habits of husbands; the corresponding percentage in 
controls was not provided. Nonsmoking women living with a smoker 
showed an elevated risk for lung cancer (OR 1.31). The ORs for lung 
cancer in nonsmoking women were 1.09, 1.15, 1.03, and 2.11 when 
the husbands were nonsmokers, daily smokers of less than 10,lO to 
19, and 20 or more cigarettes at home, respectively (one-sided p for 
trend, <0.025). Similarly, a significant positive linear trend (one- 
sided p < 0.025) was shown when the husbands’ total amount smoked 
was categorized into four levels. However, there was no apparent 
dose-related trend by years of exposure to the husbands’ smoking (0, 
<20,20-29,30-39,40+ years). 
There was no apparent association between lung cancer and 
tobacco smoke exposure from other sources. Cases and controls did 
not differ in their reported exposure to tobacco smoke during 
childhood or in their average hours of exposure per day to other’s 
t&m0 smoke during the last 5 years and 25 yeam before diagnosis. 
The results remained unchanged when exposures at home, at work, 
and in other settings were e xamined separately. The odds ratios 
were highest for exposure in other settings, but they were based on a 
small number of positive responses. There was no consistent pattern 
by ~tologic type. Squamous cell carcinoma showed the strongest 
relationship with involuntary smoking, based on the husbands’ 
smoking habits at home (RR 5.0,95 percent C.I. 1.4,20.1), but failed 
to show any relationship when involuntary smoking exposure was 
classifkd by hours of daily exposure. 
This caswzontrol study has the largest number of nonsmoking 
lung cancer cases to date and provides estimates of the mis&s&ica- 
tion of disease and of the smoking status of the subjects. Among the 
published studies on involuntary smoking, this is the only one 
involving independent verification of the diagnoses of all cases. This 
verification showed that 13 percent of the cases classified as lung 
cancer were not primary cancers of the lung. This study showed that 
40 percent of the women with lung cancer who had been classified as 
nonsmokers (or smoking not stated) on hospital records had actually 
smoked, compared with 9 percent of the controls. The inclusion of 
lung cancer patients who had actually smoked would have substan- 
tially increased the odds ratios with involuntary smoking, because 81 
percent of the potentially misclassified cases had husbands who 
smoked compared with 68 percent of the %ue” nonsmoking patients 
with lung cancer. It should be noted that none of the other studies on 
involuntary smoking and lung cancer based classification of smoking 
status solely on data from medical records. The measure of involun- 
tary smoking based on smoking habits of husbands attempted to 
differentiate between current total smoking habits and current 
smoking habits at home. The interview also included RTS exposure 
not only at home but at work and in other settings. 
The exposure information presented in this study is potentially 
limited by its extensive reliance on surrogate interviews. Owing to 
the need to assemble sufficient nonsmoking cases, diagnoses as early 
as 1971 were included, so proxies were interviewed for a high 
percentage of the deceased cases. Among the cases, 12 percent of the 
interviews were conducted with the subject, 25 percent with the 
husband, 36 percent with offspring, and 27 percent with an 
informant who had known the subject for at least 25 years. The 
corresponding distribution of informants in the control series was 
not presented. Although the ORs did not. vary consistently by 
respondent group, the OR for smoke exposure based on the hus- 
bands’ smoking tended to be lower when husbands were the 
respondents. Presumably, the husbands reported their own smoking 
habits, and it cannot be determined whether bias resulted. The 
information provided by surrogates may be particularly inaccurate 
for exposures outside the home. Systematic bias between personal 
and surrogate interviews and systematic bias by informant status 
must also be considered. Given that the topic of involuntary smoking 
is potentially sensitive for the family of a lung cancer patient, it is 
possible that some surrogates may not have provided accurate 
histories, particularly with regard to their own smoking habits. 
Surrogate respondents for cases might have been more likely to 
underreport exposure than those for controls, such differential 
reporting would have led to an underestimation of the true effect. 
The multiple regression analysis performed in this study did take 
respondent status into consideration, and it was determined that this 
factor could not account for the relationship with husband’s smoking 
status (Garfinkel et al. 1965). It is not clear if the colorectal cancer 
controls were diagnosed in the same years as the lung cancer cases. 
Because the response patterns of relatives who are interviewed after 
the recent death of a subject may differ from responses obtained long 
after the subject has died, another source of bias may have been 
introduced. 
A United Kingdom Study 
In an ongoing hospital-based cas+control study of lung cancer, 
chronic bronchitis, ischemic heart disease, and stroke, Lee and 
dIeagues (1986) examined the role of involuntary smoking in a 
group of inpatients interviewed after 1979, when, to cover involun- 
tary smoking, the questionnaire was extended to married patients. 
An attempt was also made to interview the spouses of the married 
nonsmoking lung cancer patients and the spouses of the comparison 
group. 
The interview on involuntary smoking administered to hospital 
inpatients included questions on the smoking habits of their first 
spouse and on FXS exposure at home, at work, during travel, and 
during leisure, based on a subjective four-point scale. Spouses of 
nonsmokers were asked about their own smoking habits at the time 
of interview, during the year of admission of the subject, and during 
the course of their marriage. 
A total of 56 lung cancer cases among married lifelong nonsmok- 
ers was identified, 2 controls were selected for each case and 
individually matched on nonsmoking status, sex, marital status, age, 
and hospital. Among the 56 cases and 112 controls, information on 
spouses’ smoking habits was available for 29 (52 percent) cases and 
59 (56 percent) controls from an interview conducted while the 
patient was still in the hospital. Interviews with spouses were 
obtained for 34 (61 percent) of the cases and 80 (71 percent) of the 
controls. Using both of these sources of information, the smoking 
habits of spouses were available for 47 (84 percent) of the cases and 
96 (86 percent) of the controls. Nine risk estimates were presented 
for 8pouses’ smoking, for each of the three sources of information 
(subject, spouse, and both), for men and women separately and for 
both sexes combined. The researchers concluded that spousal 
smoking was not associated with lung cancer, because risks were not 
consistently elevated. When their spouses reported about their own 
smoking, a RR of 1.60 (95 percent C.I. 0.44, 5.78) was found for lung 
cancer in the women. In contrast, a RR of 0.75 (95 percent C.I. 0.24, 
2.40) was found when the female subjects reported about the 
smoking habits of their spouses. On the other hand, a RR of l.Ol(96 
percent C-1.0.23,4.41) was found for male lung cancer patients when 
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their spouses reported about their own smoking, whereas the risk 
was 1.53 (95 percent CL 0.37,6.34) when the male patients e~aluat& 
their spouses’ smoking habits. As might be expect&, the combined 
risk in relation to spouses’ smoking for both sexes and both sources 
of information was near unity, at 1.11 (95 percent C.I. 0.59, 2.39). 
Using a second group of controls, presumably all of the nonsmokers 
who had responded to the hospital inpatient interview on involun- 
tary smoking, the researchers reported no significant case and 
control differences in exposure to EXS at home, at work, during 
travel or leisure, from spouses, or for all sources combined. 
This study has several limitations that must be considered in 
interpreting its results. Although the study attempted tc verify 
involuntary smoking from spouses by using two sources of informa- 
tion, dual reports were obtained for only 16 (29 percent) of the cases 
and 43 (33 percent) of the controls. The questions on involuntary 
smoking included exposure from other sources, but they were based 
on a subjective scale, and different groups of controls were used for 
the analyses. Information was not presented on the accuracy of the 
diagnosis of lung cancer or on the histological types included in the 
study. Moreover, the investigators did not verity the smoking status 
of the subjects during the interviews with spouses. 
The study’s inconsistent fmdings by source of information and by 
sex may reflect the absence of an association between involuntary 
smoking and lung cancer in this population, or may reflect method- 
ological problems in the design or conduct of the study. The main 
study was not originally designed to investigate the effects of 
involuntary smoking. However, because of interest in this issue, the 
investigators decided to “increase the number of interviews of 
married lung cancer cases and controls.” The representativeness of 
the cases and the controls cannot be determined because there may 
have been differential selection factors in enrolling nonsmoking lung 
cancer cases and controls into the study; thus, selection bias cannot 
be ruled out. The method for selecting the 112 nonsmoking controls 
was not adequately described in the report; it is not clear whether 
they were selected from the pool of all controls for lung cancer or 
from the pool of controls for the four diseases under study. There is 
also an apparent discrepancy in the number of nonsmoking cases 
cited in the text and presented in the results. The report cited 44 
never smokers among a total of 792 lung cancer patients who 
completed the involuntary smoking questionnaires when they were 
in the hospital. However, the analysis for an involuntary smoking 
effect based on interviews with subjects in the hospital showed only 
29 lung cancer patients. This discrepancy was not explained. 
The risks in relation to smoking by spouses varied with the source 
of information. The risk estimates tended to be higher when the 
respondents were men, either reporting about their own smoking 
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habita or the smoking habits of their spouses. This pattern could 
result if the male respondents overestimated exposure to environ- 
ment& tobacco smoke or if the female respondents underestimated 
exposure. An analysis of the patients (16 cases and 43 controls) for 
whom data were provided by the spouses and by the subjects 
themselves showed a 97 percent concordance for spouses’ smoking 
during the year of the interview and 85 percent concordance for 
spouses’ smoking some time during the marriage. Lack of specificity 
in the question asked regarding spouses’ smoking any time during 
the marriage may partly explain the discrepancy in response. To the 
extent that there is no consistent pattern in the direction of this 
discrepancy, it can be assumed that a spouse was a smoker sometime 
during the marriage if either respondent answered positively. On the 
basis of this assumption, RRs of 1.47 (spouses of 4 of 7 cases and 7 of 
18 male controls smoked) and 1.39 (spouses of 8 of 9 female cases and 
16 of 25 female controls) were found for the men and the women, 
respectively, in relation to their spouses’ smoking. The risk estimates 
were not statistically sign&ant, but the number of subjects was 
Sldl. 
The Japanese CaseControl Study 
The study by Akiba and colleagues (1986) included 426 (264 men, 
164 women) incident primary lung cancer cases diagnosed between 
1971 and 1980 in a cohort of 110,090 Hiroshima and Nagasaki atomic 
bomb survivors. Controls were selected among cohort members who 
did not have cancer. For deceased cases, corresponding controls were 
selected from among cohort members who died of causes other than 
cancer or chronic respiratory disease. The controls were individually 
matched to cases on a number of factors, including age, sex, birth 
year (f2 years), city of residence, and vital status; a variable number 
of controls was interviewed, depending on the place of residence. Of 
the lung cancers, 29 percent were pathologically confirmed, 43 
percent were radiologically or clinically diagnosed, and the remain- 
der were found at autopsy. 
Subjects or their next of kin were interviewed regarding the 
subjects’ personal smoking, smoking habits of current spouses and 
parents, and occupation. Less than 10 percent of the interviews with 
the men and about 20 percent of the interviews with the women 
were conducted with the subjects themselves. The distributions of 
the next of kin interviewed were similar for the cases and the 
controls. 
Among the cases, 103 (19 men, 64 women) had never smoked, 
compared with 380 controls (110 men, 270 women). An elevated lung 
cancer risk associated with smoking habits of spouses was observed 
for men and women. An OR of 1.8 (95 percent C.I. 0.5,5.6) was found 
for nonsmoking men married to&ves who smoked and an OR of 1.5 
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(95 percent C.I. 1.0,2.5) for nonsmoking women married to husbands 
who smoked. Lung cancer risk increased with the amount smoked 
per day by the husband, with an OR of 2.1 for women whose 
husbands smoked 30 or more cigarettes per day. The OR was higher 
(1.8) among women who had been exposed within the past 10 years 
compared with those who had been exposed before that time (OR 
1.3). However, an increasing duration of exposure to husbands 
smoking was not associated with a monotonic trend of increasing 
risk. The relation between lung cancer and husbands’ smoking was 
observed regardless of the occupation of wives (housewife, white- 
collar, blue-collar), but the highest odds ratio was for women who 
worked in bluecollar jobs and whose husbands were heavy smokers 
(OR 3.2). 
Despite a high proportion of proxy interviews, the distribution of 
informant type was comparable for cases and controls, this compara- 
bility minimizes the possibility of recall bias. The high concordance 
between the subjects’ reported smoking status in a previous survey 
and the information from the next of kin is reassuring. Although a 
high proportion of cases had no histological confirmation, an 
increased risk was observed regardless of the method of diagnosis. 
This study also provided an opportunity to test for potential 
confounding factors, including radiation exposure and occupation, 
but none were identified. 
The Swedish Study 
The study by Pershagen and associates (in press) included 67 
incidents of primary lung cancer cases from a cohort of 27,409 
nonsmoking Swedish women who were participants in a national 
census survey or in a twin registry. Two controls were selected from 
each source and were matched to cases on year of birth, and on vital 
status if they were selected from the twin registry. 
Subjects or their next of kin (excluding husbands) were mailed a 
questionnaire that assessed their exposure to tobacco smoke from 
parents and the husband with whom the subject had lived the 
longest time. Information on residential and occupational history 
was also obtained. 
Elevated lung cancer risk associated with the smoking habits of 
spouses was observed. For all lung cancers, ORs of 1.0, 1.0, and 3.2 
were observed for women who had no, low ( 5 15 cigarettes/day or 
< 1 pack of pipe tobacco/week or < 30 years of marriage), and high 
exposure to their husbands’ smoking, respectively. The increased 
risk was found primarily for squamous and small cell carcinomas 
(OR 3.3); consistent effects could not be detected for other histologic 
types. On the basis of the approximately 75 percent of respondents 
who provided information on parental smoking, there was no effect 
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of parental smoking on risk for all lung cancers, after controlling for 
the husbands’ smoking. 
The study is similar in design to the Japanese c88e-control study 
(Akiba et al. 1986), except that the Swedish investigators obtained 
histologic confirmation for all of the cases under study. Moreover, 
this study excluded husbands as informants, so a potential bias 
associated with husbands’ reporting their own smoking habits could 
be eliminated. The investigators contended that the fmding of an 
association only for squamous cell and small cell carcinomas argues 
against a spurious finding because it is unlikely that the next-of-kin 
informers would have been aware of the histologic types diagnosed in 
the cases. 
The German Study 
The last in this description of studies to date based on the cask+ 
control design is a German study (Knoth et al. 1983), interpreted by 
the investigators as showing a role for involuntary smoking in the 
etiology of lung cancer. Of 39 nonsmoking women with lung cancer, 
24 (62 percent) had lived with smokers. Although a comparison 
group was not interviewed, the investigators surmised that this 
frequency of smokers in the household was about three times higher 
than expected from census-based smoking statistics for men in the 
age group 50 to 69. The limitations of this study are evident; the 
researchers assumed that smoking prevalences for men were indica- 
tive of smoking prevalences for members of the cases’ households 
and a specific control series was not enrolled. 
Other Sources of Tobacco Smoke &posure 
Parental Smoking 
Recently evaluated as a risk factor for lung cancer, parental 
smoking is of interest because of the large number of exposed 
children, the age at which it begins, and its duration. Results of this 
association are variable, demonstrating no association, association 
with just mothers’ smoking, or association with both mothers’ and 
fathers’ smoking. Cmea and colleagues (1983) reported an associa- 
tion between lung cancer risk and the mothers’ smoking in the men, 
which persisted after adjusting for personal smoking habits (OR 1.5, 
P <O.Ol). This association was not observed in the women, and 
increased risk was not related to fathers’ smoking in either the men 
or the women. A positive association between the mother’s smoking 
and lung cancer risk was reported in a study of female lung cancer, 
but the result was not statistically significant after adjusting for 
personal smoking habits (OR 1.7, 95 percent C-1. 0.8, 3.5) (Wu et al. 
1985). Another study suggested that the father’s smoking (OR 2.5) 
and the mother’s smoking (OR 1.8) were each related to increased 
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lung cancer risk after a@sting for age and individual smoking 
habits (Sandier, Wilcox, Everson 1985b). These results were based on 
small numbers, however, particularly for the mother’s smoking (in 2 
of 15 cases, the mother smoked). Significant associations with 
maternal or paternal smoking were not found in two other studies 
(Akiba et al. 1986; Pershagen et al. in press); however, information 
was lacking for about one-third of the subjects. Since smoking habits 
of children are highly correlated with smoking habits of parents, it is 
difficult, even at&x adjusting for personal smoking habits, to be 
certain that an independent effect of parental smoking has been 
Observed. 
None of the studies with data on parental smoking had sufficient 
numbers to examine the effects of parental smoking on nonsmokers. 
In Louisiana, one nonsmoking case had a mother who smoked 
(Correa et al. 1983). In Hong Kong, 6 percent (5/88) of the 
nonsmoking cases reported that their parents smoked compared 
with 2 percent (3/137) of the nonsmoking controls (Koo et al. 1984). 
In Los Angeles, the frequencies of smoking by mothers and fathers 
were lower for nonsmoking cases (4 percent mothers, 28 percent 
fathers) than for nonsmoking controls (11 percent mothers, 35 
percent fathers) (Wu et al. 1985). Exposure to tobacco products 
during childhood was not significantly different between cases and 
controls (OR 0.91, 95 percent C.I. 0.74, 1.12) in another study 
(Garfmkel et al. 1985). 
It is difficult to obtain accurate information regarding remote 
childhood events, so data on parental smoking tend to be crude or 
unavailable. Information on maternal smoking during pregnancy 
would not be available unless the parents could be interviewed. 
Because lung cancer occurs most often among older persons, an 
interview with a parent will generally be impossible. Moreover, 
information on parental smoking will most likely be unavailable or 
meaningless if surrogate interviews are conducted. 
Coworker’s Smoking 
The workplace, an important source of tobacco smoke exposure, 
was ,not considered in the early studies on involuntary smoking. 
hater case-control studies provided some information on tobacco 
exposure at work, but the data were limited and inconclusive. Kabat 
and Wynder (1984) reported a statistically significant positive 
association between tobacco smoke exposure at work for men but not 
for women. In comparison with controls, patients with cancer in 
Hong Kong reported more hours and years of exposure at the 
workplace, but only two cases and four controls had exposure to 
tobacco smoke at work (Koo et al. 1984). Data in the Los Angeles 
study suggested that the workplace may be an important source of 
exposure to tobacco smoke. A small increased risk was observed for 
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any exposure at work, and an index combining exposure from 
coworkers and spouse or spouses indicated a trend of increasing risk 
with inc x-easing exposure (Wu et al. 1985). Garfinkel and colleagues 
(1985) found no differences between cases and controls in their 
exposure to tobacco smoke at work during either the 5 years or the 
25 years before diagnosis, and a simiIar lack of an association wm 
also reported by Lee and colleagues (1986). 
Lkw+Response Relationship 
An important factor in the appraisal of the relationship between 
~~oluntary smoking and lung cancer ia the assessment of dose- 
response relationships. However, this analysis hinges on the defini- 
tion of exposure. Data on active smoking and lung cancer suggest 
that exposure measures considering amount, duration, and recency 
of exposure should be employed in examining dose-response rela- 
tionships in active smokers (DoIl and Pet0 1978; Pathak et al. 1986). 
Misclassification of exposure to EYTS may be expected when exposure 
categorization is based on the amount or the duration of smoking by 
the current spouse or cohabitant, as current exposure from one 
source may not adequately measure past exposure or cumulative 
exposure. Moreover, these exposure variables may not be indicative 
of the exposure dose to the respiratory tract because dose deter& 
nants such as ventilation rates, breathing pattern, and deposition 
factors are unaccounted for. 
Research is now being directed toward the integration of informa- 
tion from questionnaire responses, biochemical studies, and environ- 
mental sampling to determine the most accurate measures of 
exposure to the respiratory tract. However, exposure assessments for 
epidemiological studies of lung cancer and involuntary smoking will 
remain limited by the inaccurate recall of exposures that occurred as 
much as 40 to 50 years earlier. Nevertheless, research on exposure 
should resolve several points of uncertainty. The comparability 
between exposure dose measured by amount smoked and by hours or 
years of smoking should be assessed. The relative importance of 
sources of ETS should also be clarified, so there will be some 
agreement on whether cumulative dose should differentiate between 
sources of exposure. 
In the absence of data showing a particular exposure measure to 
be optimal, an index of involuntary smoking based on the amount 
smoked by spouses shows the most consistent do-response relation- 
ihip with lung cancer risk (Hirayama 1981a; Trichopoulos et al. 
1981; Correa et al. 1983; Garfiiel et al. 1985; Akiba et al. 1986). 
Other indices of involuntary smoking exposure have not been as well 
studied and have not shown a consistent dose-response relationship 
with lung cancer risk. These exposure variables included total years 
of exposure to spouses’ smoking, average daily hours of exposure 
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from all sources, and cumulative lifetime hours and years of 
exposure. 
Among the studies that have found a dose-response relationship 
with amount smoked by a spouse, three have also examined the 
relationship by duration of spouse’s smoking (Correa et al. 1966; 
Garfinkel et al. 1985; Akiba et al. 1966), but only one study showed 
similarly increased risk using a dose and duration variable (&nrea 
et al. 1963). In the study by Garfinkel and coworkers (1965), only 
years of smoking by the current husband or cohabitant was asked; 
therefore, differences in the duration of living with current husband 
or cohabitant may account for the less consistent dose-response 
relationship. In their Japanese case-control study, Akiba and 
colleagues (1966) suggest that intensity (amount smoked per day and 
recency of exposure) may be the key index of E?S in studies of lung 
cancer risk. 
Two studies have assessed total involuntary smoking exposure to 
ETS. The method used by Koo and coworkers (1964) relied on 
respondents to describe the exposures from each source separately, 
and a summary measure of exposure was derived by the investiga- 
tors. The method used by Ga&nkel and coworkers (1985) relied on 
the respondents to average their exposures from all sources for 
specific time periods. The method of Koo and coworkers (1964) may 
not have adequately considered intensity of exposure; therefore, an 
association may have been obscured by combining low and bigh 
intensity exposures as if they were equally important. In the study 
by Garfinkel and coworkers (196!5), a high percentage of case 
interviews and, presumably, control interviews was conducted with 
surrogates. Although information provided by surrogates regarding 
demographic variables is generally valid, as are responses on 
cigarette smoking status (current, prior, never), more detailed 
information on the cigarette smoking of a deceased spouse has more 
limited validity (Lerchen and Samet 1966). Surrogate interviews 
may provide adequate information about tobacco smoke exposure at 
home, but may be inaccurate for describing gradients of total tobacco 
smoke exposure from all sources. 
Expect& Lung Cancer Risk 
An extensive data base describes the relationship between active 
smoking and lung cancer (US DHEW 1979, US DHHS 1982; IARC 
1966). This information has been utilized to construct mathematical 
models to describe the relationship of dose, duration, initiation, and 
cessation of active smoking for risk of lung cancer. For several 
reasons, comparable models have not yet been developed for 
involuntary smoking and lung cancer. First, research on involuntary 
smoking and lung cancer is recent. Second, involuntary smoking is 
not as read.ily quantified as active smoking; tobacco smoke is 
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ubiq~~~ in the environment and, present in variable but generally 
low concentrations in comparison with MS, and inhaled dose varies 
with ventilation and other physiological factors @filler 1984; Hoegg 
1972; Hoffmann et al. 1984; Schmeltz et al. 1975; St&er 1984; US 
DHHS 1984). 
Nevertheless, theoretical models, originally developed to describe 
the relationship of active smoking and lung cancer, have been used 
to predict lung cancer risk from involuntary smoking. Using Doll 
and Peto’s (1978) model [(OX3 x 1012) (cigarette/day + 6)2 (age 
22.5)4.5] for active smoking and lung cancer, Vutuc (1984) cahlbted 
expe&d lung cancer risks for various exposure levels, ranging from 
0.1 to 5.0 cigarettes per day. For exposure levels of 0.1, 1.0, 2.0, and 
5.0 cigarettes per day, the corresponding risk estimates were 1.03, 
1.38,1.78, and 3.36, respectively. These lowdoae active smoking risk 
estimates are comparisons of active smokers ‘with all nonsmokers 
(those with high ETS exposure and those with low ETS exposure). 
The risk estimates in involuntary smoking studies are a comparison 
of nonsmokers with higher levels of involuntary smoking exposure 
with nonsmokers who have lower levels of involuntary smoking 
exposure. As a result, the numerical values of the risk estimates in 
active smoking studies are not directly comparable to those in the 
involuntary smoking studies. 
The appropriateness of extrapolating from the active smoking 
model hinges on the actual exposure of a nonsmoker. Estimates of 
exposure have been derived from various sources. Experimental 
conditions have been used to quantify the involuntary smoker’s 
exposure to ETS. Hugod and colleagues (1978) reported that under 
conditions heavily polluted with sidestream smoke (to maintain a 
carbon monoxide concentration of 20 ppm), the particulates of 
tohco smoke inhaled by involuntary smokers was small, the 
equivalent of one-half to one cigarette per day. Exposures may also 
be estimated from biochemical measurements. Studies comparing 
cotmine levels in nonsmokers and smokers show cotinine levels in 
nonsmokers that correspond to about one-sixth to one-third of a 
cigarette per day (Jarvis et al. 1984; Wald et al. 1984). Higher 
cothhe levels in nonsmokers, comparable to about two cigarettes 
per day, have been reported (Matsukura et al. 1964, 19&j), but the 
results were questioned (Acllkofer et al. 1985; Pittenger 1985) and 
await Confirmation. 
The epidemiologic evidence on the lung cancer risk associated with 
marriage of a nonsmoker to a smoker has been criticized as 
implausible on the basis of predictions from Doll and Peto’s model 
(Lee 1982a,b; Vutuc 1984. It has been argued that relative risks of 2 
or 3 from involuntary smoking correspond to active smoking of two 
to five cigarettes per day and that this equivalent level of active 
smoking is too large to be realistic. This argument fails to consider 
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the difference in the comparison groups used to generate the risk 
estimates in studies of active smoking and involuntary smoking. The 
risk estimates for studies of active smoking use as a comparison 
group all nonsmokers, which includes those with and without high 
levels of exposure to ETS. Studies of involuntary smoking use risk 
estimates that are derived by comparing nonsmokers with higher 
levels of exposure to ETS with nonsmokers with lower levels of 
exposure to ETS. Decause the risk estimates in active and involun- 
tary smoking studies use different comparison groupe, the numerical 
values are not directly comparable. 
In order to make them comparable, the risk estimates in involun- 
tary smoking and active smoking studies would have to be calculated 
using the same reference group. If the reference population used is 
all nonsmokers, then the risk estimates for nonsmokers married to 
nonsmokers are reduced to below 1 (i.e., their lung cancer risk would 
be lower than the risk for all nonsmokers as a group). The risk 
estimates for nonsmokers married to smokers would be above 1 (i.e., 
would be greater than the risk for all nonsmokers as a group), but 
the numerical value of the risk estimate w.ould be reduced from th 
value obtained by comparison with nonexposed nonsmokers. 
If the data from the Japanese cohort study (Hirayama 1981a) ar 
recalculated to use all nonsmokers as the reference population, the 
risk estimate for lung cancer in nonsmoking wives of nonsmoking 
husbands would be 0.63 and the risk estimate for nonsmoking 
women married to smokers (current or former) would be 1.12. The 
value of 1.12 compares the risk for nonsmoking wives of smoking 
husbands with the risk for all nonsmokers in the studies of active 
smoking. This magnitude of risk is within the range of risk that 
would be predicted using the Doll and Peto (1978) model for 
calculating active smoking risk for smokers of 0.1 (risk estimate 1.03) 
and 1 (risk estimate 1.38) cigarette per day. The evidence for 
exposure to environmental tobacco smoke based on biologic markers 
of tobacco smoke exposure indicate that i.n~~l~ntary smoking 
exposure results in levels of biologic markers (e.g., cotinine) that are 
similar to levels expected in smokers of 0.1 to 1 cigarette per day. 
Thus, estimates derived using similar comparison groups suggest 
that the lung cancer mortality experience due to involuntary 
smoking is similar to that which would have been expected from an 
extension of the dose-response data for active smoking to involun- 
tary smoking exposures. 
An alternative method of estimating expected lung cancer rates 
has been proposed by Repace and Lowrey (1986). They compared the 
age-standard&d lung cancer mortality rates of Seventh-Day Ad- 
ventists (SDAs) who had never smoked with a demographically 
comparable group of nonsmoking nonSDAs and attributed the 
difference in lung cancer deaths solely to involuntary smoking. This 
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analysis was based on the following ~SSUI&O~: (1) that SDAs had 
no expoeure to passive smoking, whereas alI of the non-SDAa were 
exposed, (2) that men and women had equal lung cancer death rates, 
and (3) that there were no other d.ifYerences between the two groups. 
previous reports of the Surgeon General have reviewed the data 
establishing dve cigarette smoking as the major cause of lung 
mmr. me &me of a tbreshold for respiratory carcinogenesis in 
active ~&hg, the presence of the same carcinogens in mainstream 
smoke ad &htream smoke, the demonstrated Uptake Of fxhacco 
smoke constituents by invohmtary smokers, and the demonstration 
of m b& lung cancer risk in some populations with exposures 
to ETs leads to the conclusion that involuntary smoking is a cause of 
lung cancer. 
me quantification of the risk associated with i.nvolun~ smoking 
for the U.S. population -is dependent on a number of factors for which 
only a limited amount of data are currently available. The fimt of 
these factors is the absolute magnitude of the lung cancer risk 
associated with invohmtary smoking. As was previously described, 
the studies that have been performed to assess the lung cancer risk 
of involuntary smoking do not contain a xero-exposure group. Some 
expomre to tobacco smoke is essentially a universal experience; 
therefore, studies of involuntary smoking compare a Iowexposure 
group with a high-exposure group. The magnitude of the risk 
estimate obtained is a function of the increase in risk produced by 
the difference in tobacco smoke exposure between the two groups 
examined, rather than an absolute measure of the risk of exposure in 
comparison wit& no exposure. The magnitude of the difference in 
tobacco smoke exposure between groups identified by spousal 
smoking habits may vary from study to study; this variation may 
padially explain the differences in risk estimates among the studies. 
The extrapolation of the risk estimate data to the U.S. population 
would therefore require a better understanding of the magnitude of 
the exposure to environmental tobacco smoke that occurs in the 
popdations examined in the studies of involuntary smoking and 
lung cancer. Of particular interest is the magnitude of the difference 
in exposure between the high-exposure group and the low-exposure 
group- 
A second set of data that would be needed to estimate the risk for 
the U.S. population is the dose and distribution of exposure to ETS iu 
the population. The studies that have been performed have attempt 
ed to identify groups with different exposures, but little is known 
about the magnitude of the exposures that occur in different 
segments of the U.S. population or about the variability of exposure 
with time of day or season of the year. !l%e changing norms about 
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smoking in public and the changing prevalence of a&ve smoking 
during this century suggest that ETS exposure may have varied 
substantially over this century. A better understanding of the 
exposures that are actually occurring in the United &atq and of 
past exposures, would be needed to accurately assess the risk for the 
U.S. population. 
The epidemiological evidence that involuntary smoking can signif- 
icantly increase the risk of lung cancer in nonsmokers is compelling 
when considered as an examina tion of lowdose exposure to a known 
carcinogen (i.e., tobacco smoke). Eleven of the thirteen epidemiologi- 
cal studies to date show a modest (10 to 300 percent) elevation of the 
risk of lung cancer among nonsmokers exposed to involuntary 
smoking, in six studies positive associations were statisticahy 
significant. The studies showing no or non&nificantly positive 
findings were generally the weakest in terms of sample size (Gillia et 
al. 1984; Ghan and F’ung 1982; Koo et al. 1984; Kabat and Wynder 
19&i; Wu et al. 1985; Lee et al. 1986), study design (Kabat and 
Wynder 1984; Lee et al. 1986), or quality of data (Ghan and F’ung 
1982). 
In Table 10 are shown the sources and types of bias, and in Table 
11, the statistical power, of the various case-control studies (Schles- 
selman 1982). On the basis of the observed relative risks reported in 
the studies, the respective exposure fraction in the control popula- 
tions, and an a=0.05 for a two-sided significance test, only the 
studies by Trichopoulos and colleagues (1983) and Gorrea and 
colleagues (1983) have a probability of above 80 percent of f%xling a 
statistically sign&ant result, whereas the majority of the caae- 
control studies show a study power of about 0.10 to 0.20. The power 
of the study, as expected, improves when a one-sided significance test 
is considered. Among the studies in which information on involun- 
tary smoking was available to conduct a trend test for dose, the 
power for detecting the observed trend was above 50 percent for five 
of the studies. However, the power for a twesided test and a one- 
sided test, baaed on observed relative risk, and the power for a one- 
sided trend test, based on observed results, are difficult to interpret 
because the power is a function both of design aspects (sample size, 
case-control ratio, exposure prevalence) and of the observed relative 
risk. To focus on comparisons of the design differences between 
studies, the power estimates for a fixed relative risk of 2 show that 
five of the studies would have a power of 0.75 or greater to detect a 
statistically significant result. Thus, it is not surprising that some 
studies failed to achieve statistical significance, but the lack of 
statistical significance in all studies should not invalidate the 
positive significant associations for involuntary smoking that have 
been observed. 
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Sii epidemiological studies found statistically significant in- 
creased risks 888ociated with spouse’s smoking; all demonstrated a 
dose-response relationship, and several suggested a stronger asso&- 
tion with squamous cell and small cell carcinoma than with other 
cell types. Three of these studies (Hirayama 1984a, Correa et al. 
1983; Akiba et al. 1986) included nonsmoking male lung cancer 
patients, and the complementary fmdings in nonsmoking husbands 
married to smoking wives strengthen the evidence on involuntary 
smoking. The four studies with sign&ant positive findings pub- 
lished since 1981 (Correa et al. 1983; Garfiikel et al. 1985; Akiba et 
al. 1986; Pershagen et al., in press) not only corroborated the 
fmdings of Hirayama (1981a) and Trichopoulos and colleagues 
(19811, but answered the many criticisms directed at these two 
StUdieS. 
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0.79 0.87 0.88 0.89 
0.33 0.83 0.97 0.56 
0.17 0.26 NA’ 0.90 
0.10 0.17 0.10 0.64 
0.06 0.10 NA’ 0.39 
0.10 0.17 0.16 0.37 
0.24 0.36 0.71 0.94 
0.04 0.w) NA’ 0.62 




of cases case ratio 
Observed relative Power for Power for Power for Power for 
Proportion of risk for ever ~8. twc-Gded test one-sided test onesided trend one-sided test 
controls’ BpouaeB never exposed to based on. bawd on test baeed on bad on RR=2 for 
who smoked SpoueBB’ Bmoking obeerved RR obeerved RR observed resulta’ ever vs. never expceed 
Per&age” et al. 67 6.18 0.44 1.23 0.12 0.19 0.46’ 0.83 
(in press) 
Pooled* 676 2.96 0.62 153 0.99 LOO NA 1.00 
Pooled a 509 3.40 0.62 1.66 1.M) 1.00 1.M) 1.00 
’ Based on three levels of passive smoke exposure as defined in respective stud&. 
‘Data not available for trend test. 
‘Includes spouses, cohabitanta, and coworkers who smoked. 
‘Based on nonsmoking caeea and mntrols with information on spouses’ smoking. 
‘Based on cases and controllr who were ever married. 
“Based on female casea and controls with information on husbands’ smoking (number of cigarettes smoked per day). 
‘Estimate based on 26 cases and 161 controls in the low exposure category, 7 cases and 12 controla in the hiih exposure category. 
‘Based on combined results of the 10 we-control studies. 
*Based on combined results of the doyen caee-contml studies with data available for trend test. 
The most serious criticism is the misclas&cation of the a&ve 
smoking status of the subjects, which can produce an apparent 
increased risk with involuntary smoking. Moreover, it is likely to 
result in differential misclassification because spouses tend to have 
similar smoking habits (Burch 1981; Sutton 1981; Higgins et al. 
1937). Speculation that the positive results reported in Japan and 
Greece were due to cultural bias against the admission of smoking by 
women in these more traditional societies may be discounted because 
positive significant findings have now been observed in the United 
States (Correa et al. 1983; Garfinkel et al. 1985) and in Sweden 
(Pershagen et al., in press), where no comparable social stigma 
exists. Moreover, in the studies by Garfinkel and coworkers (1985) 
and Pershagen and coworkers (in press), the personal smoking status 
of each subject was validated and verified at interview, usually by 
next of km, who presumably would have no reason to misrepresent 
the true smoking status of the subject. 
Misclassification of the lung as the primary site and the lack of 
pathological confirmation are repeated concerns, but it must be 
stressed that this bias would tend to dilute a true effect. Correa 
(1983), Garfiiel (198!5), and Pershagen (in press) and their respec- 
tive colleagues addressed this issue by including only pathologically 
confirmed lung cancers and considering histological cell type in their 
analyses. In the study by Garfmkel and associates (1985), after & 
independent pathological review was conducted, a significant associ- 
ation of excess risk with involuntary smoking remained. Misclassifi- 
cation of exposure to RTS cannot be dismissed, since an index based 
solely on the smoking habits of a current spouse may not be 
indicative of past exposure, cumulative exposure, or the relevant 
dose to the respiratory tract. 
The magnitude of risk associated with involuntary smoking 
exposure is uncertain. Relative risks ranging from 2 to 3 were 
generally reported for the highest level of exposure based on the 
spouses’ smoking habits, but since sample sixes in most studies are 
not large, the point estimates of effect are unstable, and confidence 
limits are broad and generally overlap from one study tc another. An 
index of involuntary smoking based on the smoking habits of the 
spouse is a simplistic and convenient measure. There is no reason to 
believe, however, that the excess risk associated with involuntary 
smoking is restricted to exposure from spouses. Nonsmokers married 
to smokers are likely to be more tolerant of EZS exposure and to 
experience more exposure to environmental tobacco smoke (Wald 
and Ritchie 1984). Higher risk estimates for involuntary smoking 
have been obtained in studies restricted to squamous cell and small 
cell carcinomas of the lung. 
Although involuntary smoking can be established as a cause of 
lung cancer, important questions related to this exposure require 
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further research. More accurate estimates for the assessment of 
exposure in the home, workplace, and other environments are 
needed. Studies of sufficiently large populations should also be 
performed. New data from such studies should yield more certain 
risk estimates and describe the magnitude of the lung cancer risk in 
nonsmokers. 
other Cancef8 
several recent studies provide data on the relationship of RTS 
exposure to cancer at sites other than the lung. Two published 
reports address the risk of other cancers in adults from exposure to 
tobacco smoke from spouses. Using the same Japanese cohort 
described previously, Hirayama (1984a) reported excess mortality for 
cancers of the paranasal sinus (N=28) and brain (N=34) among 
nonsmoking women who were married to smokers. The standardized 
mortality ratios (SMRs) for nasal sinus cancer were 1.00,1.67,2.02, 
and 2.65 for women whose husbands never smoked, or had smoked 
10 to 14,15 to 19, or 20 or more cigarettes per day, respectively (one- 
sided p for trend, 0.03). The corresponding SMRs for brain tumors 
were 1.00, 3.03, 6.25, and 4.32, respectively (on+sided p for trend, 
0.004). The total number of deaths due to nasa.l cancer and brain 
tumors was small, and the numerators in the risk calculations were 
unstable, based on five nasal cancers and three brain cancers in 
women whose husbands were nonsmokers. In one study (I3rinton et 
al. 19&Q, active tobacco smoking was associated with an increased 
risk of sinus cancer, particularly squamous cell tumors. Sidestream 
smoke has also been suggested to be of etiological importance in 
brain tumors in children (Preston-Martin et al. 1982). 
In a -ntrol study of adult cancers in relation to childhood 
and adult exposure to involuntary smoking, Sandier and coworkers 
(1965a, 1986) reported an overall cancer risk of 1.6 (95 percent C.I. 
1.2, 2.1) associated with exposure to spouses’ smoking, which was 
more marked in nonsmokers than smokers. Significant increases 
were observed for cancer of the breast (OR 1.8), cervix (OR 1.8), and 
endocrine organs (OR 3.2). This study has been criticized in its choice 
of controls and in the exclusion of certain cancers by the design of 
the study. The biological plausibility of the study’s findings was also 
questioned because the highest risk estimates were observed for 
cancers that have not been consistently related to active smoking 
and because higher risks were observed for nonsmokers than for 
smkers. Failure to control for potential confounding factors and 
kmnvn risk factors for the individual cancer sites under study may 
have produced artifact& results QYiedman 1986; Mantel 1986; 
Rurch 1966). In a subsequent analysis of the same study population, 
Samher, Wilcox, and Everson (1985a,b) reported increasing cancer 
risks with incmahg exposure to involuntary smoking as measured 
by the number of smokers in the household and by the time periods 
of exposure. The biologic plausibility of these findings was aIso 
questioned (Burch 1985; Higgins 1985; Lee 1985). 
The effect of parental smoking on the development of cancers both 
during ~hildhd and in adult life is also of in&eat. The relationship 
of parental smoking to overall cancer risk in children or in adults 
has been assessed in three studies. A prospective survey (Neubl and 
Buck 1971) of about 90,060 infants in Canada and the United 
Kingdom followed for a maximum of 10 years found an overa.II 
cancer risk of 1.3 (95 percent C.I. 0.8, 2.2) associated with maternal 
smoking during pregnancy. No dose-response relationship was 
observed, but there were few heavy smokers (>l pack/day) in this 
study. A Swedish case-control study (Stjemfeldt et al. 1986) of aII 
cancers found a risk of 1.4 (95 percent CL 1.0, 1.9) for maternal 
smoking during pregnancy. A do-response relationship was dem- 
onstrated; the risk was highest in the most exposed group, those 
smoking 10 or more cigarettes per day (RR 1.6, p < 0.01). On the basis 
of the smoking habits of the parents of subjects up to 10 years of age, 
Samher, Everson, W&ox, and Browder (1985) reported no significant 
difference between all cancer cases and controls with respect to the 
mother’s smoking (RR 1.1, 95 percent CL 0.7, 1.6), but the father’s 
smoking was related to an overall increased risk (RR 1.5,95 percent 
CL 1.1, 2.0). In these three studies, analysis by specific cancer site 
revealed an increased risk of leukemia associated with parental 
smoking. 
Neutel and Buck (1971) found an almost twofold increased risk of 
leukemia in &i&en of mothers who smoked during pregnancy, but 
the association was not statisticahy significant. Stjernfeldt and 
colleagues (1986) reported a sign&ant positive association between 
maternal smoking and acute lymphoblastic leukemia. The relative 
risks were 1.0, 1.3, and 2.1 (p for trend, <O.Ol) for mothers who 
smoked 0, 1 to 9, and 10 or more cigarettes per day, respectively. 
Similar significant positive associations with maternal smoking were 
not observed for other cancer sites, but the risk assessments were 
based on a smalI number of cases. This study suggests that the 
relationship between maternal smoking and leukemia was strongest 
for smoking during the 5-year period before pregnancy, intermediate 
for smoking during pregnancy, and lowest for smoking after 
pregnancy. In the study by Sandier, Everson, Wilcox, and Browder 
(1985), the mother’s smoking and the father’s smoking were sepa- 
rately and jointly associated with an increased risk for leukemia and 
lymphoma. The relative risk was 1.7 when one parent smoked and 
4.6 when both parents smoked (p for trend, <O.OOl). The increased 
risk with parental smoking was observed regardless of the personal 
smoking status of the subject. No other cancer site was associated 
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with the mother’s smoking, although the father’s smoking was 
associated with increased risks for other cancer sites, including the 
brain and the cervix. Two studies of leukemia in children found no 
relatio&ip with parental smoking (Manning and Carroll 1957; Van 
Steensel-Moll et al. 1965). In the study by Manning and Carroll 
(1957), the mothers’ general smoking habits were assessed, whereas 
van Steensel-Mall and colleagues (1985) obtained information on the 
smoking habits of both parents in the year before the pregnancy. 
Stewart and colleagues (1958) reported a statistically significant risk 
of 1.1 (p=O.O4) for leukemia in association with the mothers’ 
smoking, but cautioned that the smoking information on the 
mothers pertained to their habita at the time of interview, which 
took place a&r the deaths of the patients and may have been 
affected by bereavement. 
The effect of parental smoking habits has been examined in 
epidemiological studies of brain tumors, rhabdomyosarcoma, and 
teeticular cancer in children. Gold and colleagues (1979) reported an 
association between maternal smoking prior to and during pregnan- 
cy and brain tumors in children. A relative risk of 5.0 (p=O.22) ~88 
found, but the result was based on a small number of patients and 
was not statistically significant. No relationship between maternal 
smoking during pregnancy (RR 1.1, onegided p=O.42) and brain 
tumors in children was found in another study Preston-Martin et al. 
1982), but a significantly increased risk (RR 1.5, one-sided p=O.W 
associated with mothers living with a smoker (usually the child’s 
father) during pregnancy was observed. A significantly increased 
risk with the father’s smoking, but not the mother’s smoking ~88 
also reported in a study of rhabdomyosarcoma (Grufferman et al. 
1982). The father’s smoking conferred a signScant increase in risk 
@R 3.9, 95 percent C.I. 1.3, 9.6), but the mother’s smoking during 
and after the pregnancy was not significantly different between 
Cases and controls (RR 0.8, 95 percent C.I. 0.3, 2.0). A history of 
m&d smoking during pregnancy did not differ for testicular 
cancer cases and controls (RR 1.0, p=O.57) in one study (Henderson 
et al. 1979). 
There are at present insufficient data to adequately evaluate the 
role of ~voluntary smoking in adult camera other than primary 
carcinoma of the lung. In addition, active smokers n&y 
receive greater exposure to ETS than nonsmokers. Thus, effects 
would not be anticipated in involuntary smokers that do not occur in 
active smokers (IARC 1986), and the biological plausibility of 
associations between E’l!s exposure and cancer of sites not associated 
with active smoking must be questioned. The fmdings of Hirayama 
(19%) and Sandier, Everson, and Wilcox (1985) need confirmation 
in &xl& that take into account the potential confounding factors 
ad *he known risk factors for these individual sites. The evidence 
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for parental smoking and childhood cancer is also not clear, and 
evaluation of this association is made difficult by the various 
definitions of exposure that have been used, including maternal and 
paternal smoking before, during, and after the pregnancy. Mothers 
and fathers who smoke during a pregnancy generally smoked before 
the conception and continue to smoke after the pregnancy. Thus, an 
effect of involuntary smoking after birth cannot readily be distin- 
guished from genetic or transplacentally mediated effects. 
Cardiovascular Diseases 
A causal association between active cigarette smoking and cardio- 
vascular disease is well established (VS DHHS 1983). The relation- 
ship between cardiovascular disease and involuntary smoking has 
been examined in one wntrol study and three prospective 
studies. In the case-control study by Lee and colleagues (1986), 
described previously, ischemic heart disease cases and controls did 
not show a statistically significant difference in their exposure to 
involuntary smoking, based on the smoking habits of spouses or on 
an index accounting for exposure at home, at work, and during 
travel and leisure. In the Japanese cohort study, Hirayama (1984b, 
1985) reported an elevated risk for ischemic heart disease (N =494) 
in nonsmoking women married to smokers. The standardized 
mortality ratios when the husbands were nonsmokers, ex-smokers or 
smokers of 19 or more cigarettes per day, and smokers of 20 or more 
cigarettes per day were 1.0, 1.10, and 1.31, respectively (one-sided p 
for trend, 0.019). 
In the Scottish followup study (Gillis et al. 1984), nonsmokers not 
exposed to tobacco smoke were compared with nonsmokers exposed 
to tobacco smoke with respect to the prevalence of cardiovascular 
symptoms at entry and mortality due to coronary heart disease. 
There was no consistent pattern of differences in coronary heart 
disease or symptoms between nonsmoking men exposed to tobacco 
smoke and their nonexposed counterparts. Nonsmoking women 
exposed to tobacco smoke exhibited a higher prevalence of angina 
and major FCG abnormality at entry, and also a higher mortality 
rate for all coronary diseases. However, rates of myocardial infarc- 
tion mortality were higher for exposed nonsmoking men and women 
compared with the nonexposed nonsmokers. The rates were 31 and 4 
per 10,990, respectively, for the nonexposed nonsmoking men and 
women, and 45 and 12 per 10,000, respectively, for the exposed 
nonsmoking men and women. None of the differences were tested for 
statistical signif%ance. 
In the Japanese and the Scottish studies, other known risk factors 
for cardiovascular diseases, i.e., systolic blood pressure, plasma 
cholesterol, were not accounted for in the analysis. 
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ID a study of heart disease, Garland and coworkers (1985) enrolled 
82 percent of adults aged 50 to 79 between 1972 and 1974 in a 
predominantly white, upper-middle-class community in San Diego, 
California Blood pressure and plasma cholesterol were measured at 
entry, and all participants responded to a standard interview that 
asked about smoking habits, history of heart disease, and other 
health-related variables. Excluding women who had a previous 
history of heart disease or stroke or who had ever smoked, 695 
currently married nonsmoking women were classified by their 
husbands’ self-reported smoking status at enrollment. After 10 years 
of followup, there were 19 deaths due to ischemic heart disease; the 
age-standardized mortality rates for nonsmoking wives whose hus- 
bands were nonsmokers, ex-smokers, and current smokers were 1.2, 
3.6, and 2.7, respectively (one-sided p for trend, <O.lO). After 
adjustment for age, systolic blood pressure, total plasma cholesterol, 
obesity index, and years of marriage, the relative risk for death due 
to ischemic heart disease for women married to current or former 
smokers at entry compared with women married to never smokers 
was 2.7 (one-sided p 5 0.10). 
The study’s findings are not convincing from the point of view of 
sample stability. The total number of deaths due to ischemic heart 
disease was small, and the denominator in the relative risk 
calculation is unstable, based on the deaths of two women whose 
husbands had never smoked. Moreover, it is well established that the 
risk of coronary heart disease is substantially lower among those 
who have stopped smoking (US DHHS 1983), although the amount of 
time required for this change after cessation of smoking is not clear 
(Kennel 1981). In this study, 15 of 19 deaths occurred in nonsmoking 
women married to husbands who had stopped smoking at entry, and 
the age-standardized rate for ischemic heart disease was highest in 
this group. The high proportion of deaths in nonsmoking women 
married to men who became ex-smokers implies that the excess 
resulted from a sustained effect of involuntary smoking. More 
d&&d characterizations of exposure to EI’S and specific types of 
~di0~a8cu1ar disease associated with this exposure are needed 
before an effect of involuntary smoking on the etiology of cardiovas- 
cular disease can be established. 
one study (Aronow 1978a,b) suggested that involuntary smoking 
aggravates angina pectoris. This study was criticized because the end 
point, angina, was based on subjective evaluation, and because other 
factors such as stress were not controlled for (Coodley 1978; Robinson 
1978; Waite 1978; Wakehan 1978). More important, the validity of 
Aronow’s work has been questioned (Budiansky 1983). 
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Conclusions 
1. Involuntary smoking can cause lung cancer in nonsmokers. 
2. Although a substantial number of the lung cancers that occur 
in nonsmokers can be attributed to involuntary smoking, more 
data on the dose and distribution of ElTS exposure in the 
population are needed in order to accurately estimate the 
magnitude of risk in the U.S. population. 
3. The children of parents who smoke have an increased frequen- 
cy of hospitalization for bronchitis and pneumonia during the 
first year of life when compared with the children of nonsmok- 
ers. 
4. The children of parents who smoke have an increased frequen- 
cy of a variety of acute respiratory illnesses and infections, 
including chest illnesses before 2 years of age and physician- 
diagnosed bronchitis, tracheitis, and laryngitis, when com- 
pared with the children of nonsmokers. 
5. Chronic cough and phlegm are more frequent in children 
whose parents smoke compared with children of nonsmokers. 
The implications of chronic respiratory symptoms for respira 4 
tory health as an adult are unknown and deserve further 
study. 
6. The children of parents who smoke have small differences in 
tests of pulmonary function when compared with the children 
of nonsmokers. Although this decrement is insufficient to 
cause symptoms, the possibility that it may increase suscepti- 
bility to chronic obstructive pulmonary disease with exposure 
to other agents in adult life, e.g., active smoking or occupation- 
al exposures, needs investigation. 
7. Healthy adults exposed to environmental tobacco smoke may 
have small changes on pulmonary function testing, but are 
unlikely to experience clinically significant deficits in pulm* 
nary function as a result of exposure to environmental tobacco 
smoke alone. 
8. A number of studies report that chronic middle ear effusions 
are more common in young children whose parents smoke than 
in children of nonsmoking parents, 
9. Validated questionnaires are needed for the assessment of 
recent and remote exposure to environmental tobacco smoke in 
the home, workplace, and other environments. 
10. The associations between cancers, other than cancer of the 
lung, and involuntary smoking require further investigation 
before a determination can be made about the relationship of 
involuntary smoking to these cancers. 
11. Further studies on the relationship between involuntary 
smoking and cardiovascular disease are needed iu order to 
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The physicochemical nature of environmental tobacco smoke 
(ETS) is governed by the type and form of the tobacco product or 
products burned, by the prevailing environmental conditions, and by 
secondary reactions. Mainstream smoke (MS) is the complex mixture 
that exits from the mouthpiece of a burning cigarette, cigar, or pipe 
when a puff is inhaled by the smoker. Sidestream smoke (SS) is 
formed between puff-drawings and is freely emitted into the air 
surrounding a smoldering tobacco product. Sidestream smoke repre- 
sents the major source for ETS. The exhaled portions of MS and the 
vapor phase components that diffuse through the wrapper into the 
surrounding air constitute minor contributors to ETS. 
In the scientific literature, the terms “passive smoking,” “involun- 
tary smoking,” and “inhalation of ETS” are frequently used inter- 
changeably (US DHEW 1979; US DHHS 19821964). 
Laboratory Smoking 
Data on the composition of MS and SS originate from laboratory 
studies. For such studies, cigarettes, cigars, or pipes are smoked by 
machines under standardized reproducible conditions. It is a major 
goal of these measurements to compare the yields of the specific 
components in the MS or SS or both of a variety of experimental or 
commercial tobacco products and to simulate, though not to repro- 
duce, human smoking habits. The most widely used standard 
conditions for machine smoking cigarettes and little cigars (5 1.5 g) 
are one 35 mL puff of 2-second duration drawn once a minute to a 
butt length of 23 mm, or the length of the filter tip plus the over-wrap 
plus 3 mm (Brunnemann et al. 1976). The annual reports of the U.S. 
Federal Trade Commission on the tar, nicotine, and carbon monox- 
ide content of the smoke of U.S. commercial cigarettes are based on 
these laboratory smoking conditions. For cigars, the standard 
smoking conditions are a 20 mL puff of l&second duration taken 
once every 40 seconds, and a butt length of 33 mm CInternational 
Committee for Cigar Smoke Study 1974). The most frequently used 
pipe-smoking conditions call for the bowl to be filed with 1 g of 
tobacco and a 50 mL puff of l-second duration to be taken every 12 
seconds (Miller 1964). 
A number of devices for collecting sidestream smoke have been 
developed (Dube and Green 1982). The most widely used device is a 
collection apparatus made of glass and cooled by water circulating 
through an outer jacket. The air entering the chamber through a 
distributor has a flow rats of 25 mL per second (1.5 L/min) 
(Brurmemann and Hoffmann 1974). Under these conditions, the 
yields of mainstream smoke components from a cigarette approxi- 
mate those obtained from the same cigarette when it is being smoked 
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in the open air. However, the velocity of the airstream through the 
chamber has considerable influence on the yields of individual 
compounds in SS (Klus and Kuhn 1982). 
To collect the particulate phase of MS and SS, the smoke aerosols 
are passed through a glass fiber filter (a Cambridge filter with a 
diameter of 45 mm) that traps more than 99 percent of all particles 
with a diameter of at least 0.1 pm (Wartman et al. 1959). The portion 
of the smoke that passes through the glass fiber filter is arbitrarily 
designated as vapor phase, although it is realized that this separa- 
tion does not fully reflect the actual physicochemical conditions 
prevailing in MS and SS. For the analysis of individual components 
or a group of components, specific trapping devices and methods 
have been developed (Dube and Green 1982). 
Human Smoking 
The standardized machine-smoking conditions used in the tobacco 
laboratory were set up to simulate the parameters of human 
smoking as practiced 30 years ago. The examination of current 
smoking practices suggests that machinesmoking conditions no 
longer reflect current practices. Human smoking patterns depend on 
a number of factors, one of which is the delivery of nicotine. 
Do&retry of smoke constituents has shown that low nicotine 
delivery (~0.6 to 1.0 m&cigarette) generally induces the smoker to 
draw larger puff volumes (up to 55 mL per puff), to puff more 
frequently (three to five times a minute), and to inhale more deeply 
(Heming et al. 1981). Furthermore, many smokers of cigarettes with 
perforated filter tips tend to obstruct the holes in these tips by 
pressing their lips around them; thus, they inhale more smoke than 
would he expected according to the machine-smoking data (Kozlow- 
ski et al. 1960). Smokers of cigarettes with a longitudinal air channel 
in the filter tip compress the tip in a similar manner so that the 
mainstream smoke delivery is increased over that measured with the 
laboratory methodology (Hoffmann et al. 1983). 
These deviations from machin~moking patterns cause a greater 
ammt of tobacco to be consumed during MS generation. Conse 
quently, the quantity of tobacco burned between puffs is diminished, 
and lower amounts of combustion products are released as SS. 
Because of the proximity to the burning tobacco product, the active 
smoker usually inhales more of the SS and ETS than a nonsmoker. 
It is not known to what extent the different constituents of inhaled 
ETS aerosols can be retained in the respiratory tract of nonsmokers. 
Studies with MS have shown that more than 90 percent of the 
volatile, hydrophilic components are retained by the smoker @al- 
hamn et al. 1968a) and that less than 50 percent of the volatile, 
hydrophobic MS components are retained by the smoker (Dalhamn 
et al. 196813). On the basis of these data, it may be assumed that the 
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passive smoker retains a high percentage of the vapor phase 
components of ETS and significantly less of its hydrophobic volatiles. 
Sidestream Smoke 
Formation7 and Physicochemical Nature 
When nonfilter cigarettes are being smoked under standardized 
conditions, approximately 45 percent of the tobacco column is 
consumed during the generation of MS (puff-drawing), whereas the 
remainder is burned between puffs and under conditions of a 
strongly reducing atmosphere. In addition, MS and SS is generated 
at distinctly higher temperatures than SS (Wynder and Hoffmann 
1967). Thus, undiluted SS contains more tobaccoderived combustion 
products than does MS, and contains especially greater quantities of 
those combustion products that are formed by nitrosation or 
amination. Consequently, the composition of SS differs from that of 
MS. 
The SS of a smoldering cigarette enters the surrounding atmo- 
sphere about 3 mm in front of the paper burn line, at about 350” C 
(Baker 1984). In Table 1, the MS and the SS from nonfilter cigarettes 
are compared. Under standardized conditions, the formation of the 
MS of a nonfilter cigarette (80 mm, 1,230 mg) is completed during 10 
puffs, requires 20 seconds, and consumes 347 mg of tobacco. The 
formation of SS from the same cigarette during smoldering requires 
550 seconds and consumes 411 mg of tobacco (Neurath and Horst- 
mann 1963). 
The pH of the MS of a blended U.S. cigarette ranges from 6.0 to 6.2 
and the pH of SS, from 6.7 to 7.5. Above pH 6, the proportion of 
unprotonated nicotine in undiluted smoke rises; at pH 7.9, about 50 
percent is unprotonated. Therefore, SS contains more free nicotine 
in the vapor phase than MS. The reported measurements of the pH 
of cigars were 6.5 to 8.5 for MS and 7.5 to 8.7 for SS; measurements 
for the pH of SS from pipes have not been published (Brunnemann 
and Hoffmann 1974). 
Chemical Analysis 
In order to establish reproducible chemical-analytical data, ciga- 
rette SS is generated in a special chamber. This assures that the 
cigarettes burn evenly during puff intervals when an air-stream at a 
velocity of 25 mL per second is drawn through the chamber. At this 
flow rate in the chamber, MS generation is quantitatively similar to 
that measured without the SS chamber (Neurath and Ehmke 1964; 
Brunnemann and Hoffmann 1974; Dube and Green 1982). Through- 
out this chapter the data refer primarily to MS, SS, and ETS 
deriving from cigarettes and not from cigars or pipes, because 
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TAEJLE l.-Comparison of mainstream smoke (MS) and 
sidestream smoke (SS) of a nonfilter cigarette: 
Some physicochemical data 
Study Parameter3 MS ss 
Neurnth and Horstmarm Duration of emoke production (see) 20 660 
‘1963) Tobaccn burned (m& 347 411 




pHoft&alaemi3ol a-6.2 6.7-75 
sceSaellati-SfOlZOlhli 
and Savino WE6) 
Number of partiolen per ckareW1 10.6 x 10” 36 x 10” 
Carter and Haqawa 
(1975); Hiller et al. 
m82) 
Particle s&a cnm)’ 
Particle meau diameter (rut91 
0.1-1.0 0.01-0.8 
0.4 0.32 
Wynder and Hoffinann Smoke dilution (~01 %I’ 
(I967); K&b and 
Derrick wo); carbon momxide 3-S 2-3 
B&or (1964); 
Hoffmann, Bnmnemann carbon dioxide 6-11 4-6 
et al. w34) 
1!&16 1.6-2 
cigarette smoke is the major source of EYE3 in public places. Few data 
are available on the SS and ETS from cigars and pipes. 
About 300 to 400 of the several thousand individual compounds 
identified in tobacco smoke have been quantitatively determined in 
both mainstream and, sidestream smoke. A listing of selected agents 
iu the MS of nonfilter cigarettes with their reported range of 
concentration and their relative ratio of distribution in SS compared 
&ith MS is presented in Table 2. Values greater than 1.0 reflect the 
greater release of a given compound into SS than intO MS. The 
grouping of the compounds in Table 2 into vapor phase components 
and particulate phase constituents refers to the makeup of MS, but 
does not represent the physicochemical distribution of these corn- 
pounds in SS. Some of the volatile compounds in MS and SS are 
compared. On the basis of the amount of tobacco burned in the MS 
and SS of a nonfilter cigarette (see Table 11, the ratio of SS to MS 
should be 1.2 to 1.5 if the combustion conditions during both phases 
of smoke generation were comparable. However, this is not the case, 
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as is indicated by the higher SS to MS ratios for carbon monoxide 
(2.5-4.7), carbon dioxide W-11), acrolein (3-15), benzene (IO), and 
other smoke constituents. 
The high yield of carbon monoxide and carbon dioxide in SS 
indicates that more carbon monoxide is generated during smoldering 
than during puff-drawing. After passing very briefly through the hot 
cone, most of the carbon monoxide gas in both MS and SS is oxidised 
to carbon dioxide, most likely owing to the high temperature 
gradient and the sudden exposure to environmental oxygen upon 
emission., 
The higher yields of volatile pyridines in SS compared with MS are 
probably caused by the preferred formation of these compounds from 
the alkaloids during smoldering (S&melts et al. 1979). In contrast, 
hydrogen cyanide (HO is primarily formed from protein at 
temperatures above 700” C (Johnson and Kang 1971), and the 
smoldering of tobacco at about 690” C does not yield the pyrosynthe- 
sis of HCN to the extent that it occurs at the higher temperature 
present during MS generation. The very high levels of ammonia, 
nitrogen oxide, and the volatile N-nitrosamines in SS compared with 
the levels in MS is striking. Studies with ‘6N-nitrate have under- 
scored that the burning of tobacco results in the reduction of nitrate 
to ammonia, and that the latter is released to a greater extent during 
SS formation than during puff-drawing (Johnson et al. 1973). In a 
blended cigarette, this higher level of ammonia in SS causes its 
elevated pH to reach levels of 6.7 to 7.5, while the pH of MS is about 
6 (Brunnemann and Hoffmann 1974). 
The increased release of the highly carcinogenic volatile N-nitrosa- 
mines into SS (20 to 100 times greater than into MS) has been well 
established (Brunnemann et al. 1977). The carcinogenic potential of 
SS may also be affected by the levels of the oxides of nitrogen (NO=). 
Four to ten times more nitrogen oxide (NO) is released into the 
environment in sidestream smoke than is inhaled with the main- 
stream smoke. The smoker inhales more than 95 percent of the NO, 
in the form of NO, and only a small portion is oxidized to the 
powerful nitrosating agent nitrogen dioxide (NOa). Only a fraction of 
NO is expected to be retained in the respiratory system of smokers 
by being bound to hemoglobin. The NO, gases released into the 
environment are partially oxidized to NO, (Vilcins and Lephardt 
1975). Therefore, sidestream smoke-polluted environments are ex- 
pected to contain the hydrophilic nitrosating agent NO,. 
Data for particulate matter and some of its constituents in MS and 
SS are also listed in Table 2. The release of tobacco-specific N- 
nitrosamines into SS is up to four times higher than that into MS. 
Whether the distribution of these agents in the vapor phase and the 
particulate phase of SS is of major consequence with respect to the 
carcinogenic potential of SS needs to be determined. It is equally 
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0 TABLE ‘lo-Distribution of constituents in mainstream smoke (MS) and the ratio of sidestream smoke 
@X3) to MS of noufilter cigarettes 
Vapor phase constituents ’ 
MS SS/MS 






















10-23 mg 2.5-4.7 
20-40 mg a11 
16-42 pg 0.03-0.13 
12-46 pg 10 
160 PET 6 
70-100 Ilg o.k&O 
6&m I% 8-16 
1w250 pg 2-6 
16-40 PB 6.5-20 
12-36 p.g 3-13 
11-30 w CD-40 
4-w 0.1-0.25 
32 ng 3 
50-130 pg 40-170 
11.5-28.7 pg 4.2-6.4 
7.610 pg 3.7-5.1 
1-W 4-10 

















15-4a mg 1.3-1.9 
l-Z.5 mg 2.6-3.3 
2-%l% <0.1-0.6 
60-140 pg 1.6-3.0 
1-w 0.60.9 
110-300 pg 0.749 
3130 w 30 
160 ng 19 
1.7 ng 30 
4.6 ng 31 
2C-70 ng 2-i 
20-W 2.5-3.6 
22 w 0.9 
10-22 pg 3.k5.0 
0.5-2 pg a11 
1.7-3.1 w 0.7-1.7 
200-3,~ ng 0.6-3 
TABLE 2.-Continued 
MS -&SIMS MS 
Vapor phase constituents’ 
SSIMS 
range ratio Particulate phase constituents’ range ratio 
N-Nitrusodimethylamine’ 1040 ng 20-1cQ NNK’ 100-1,006 ng 14 
N-Nitrosopyrrolidine’ 630 ng 6-30 N-Nitrosudienthanolamine’ 20-70 ng 1.2 
Formic acid 216-490 ug 1.4-1.6 Cadmium 100 ng 7.2 
Acetic acid 33O-SlO l(g 1.9-3.6 Nickel a 20-80 ni3 13-30 
ZiiC 624 w 6.7 
Polonium-210’ 0.64-0.1 pCi 1.0-4.0 
Hensoic acid 14-28 pg 0.67-0.95 
Lactic acid 63-174 Iig 0.3-0.7 
Glycolic acid 37-126 pg 0.6-0.96 
Succinic acid 110-140 pg 0.43-0.62 
’ Values are given far fresh and undiluted MS and SS. 
*Human carcinogen (IARC 1936). 
3Suspxted human carcinogen (IARC 19%). 
‘Animal carcinogen (IARC 1966). 
SOURCE: Elliott and Rowe (1975); Hoffmann et al. (1983); Klw and Kuhn (1982); Sakuma et al. Nfl3); Sakuma, Kusama, Ysmaguchi. Mabuki et al. (1984); Sakuma. K-ma, Yamaguchi, 
Sugawara (1994); Schmeltz et al. (1976). 
important to examine the significance of the abundant release of 
amines into SS (levels are up to 30 times higher than in MS), 
indicated by the data for aniline, Ztoluidine, and the alkaloids. This 
is of concern because certain amines are readily nitrosated to N- 
nitrosamines. However, analytical data on secondary reactions of 
amines in polluted environments are lacking. 
For a meaningful interpretation of the data on the distribution of 
the compounds in cigarette smoke presented in Table 2, certain 
aspects of the methodology should be emphasized. First, the data are 
baaed on analyses of nonfilter cigarettes that were smoked under 
standardized laboratory conditions. Second, the standardized ma- 
chine-smoking conditions were established according to human 
smoking patterns observed three decades ago and do not reflect the 
smoking behavior of contemporary smokers. This caveat applies 
particularly to smoking patterns observed with filter cigarettes 
designed for low smoke yields. Most consumers of these cigarettes 
inhale the smoke more intensely than smokers of nonftiter cigarettes 
(Herning et al. 1981; Hill et al. 1983). This change in smoking 
intensity affects the delivery of the side&ream smoke. The conven- 
tional filter tips of cigarettes influence primarily the yield of MS and 
have little impact on SS yield. However, in the case of cigarettes with 
specially designed filter tips such as perforations, the yield of SS is 
also affected (Table 3) (Adams et al. 1985). 
Radioactlvity of Tobacco Smoke 
Naturally occurring decay products of radon are found in tobacco 
and, therefore, also in tobacco smoke. These include the isotopes of 
lead (Pb-2101, bismuth (Bi-210), polonium (Po210), and radon, which 
originates from the decay of uranium through radium (Radford and 
Hunt 1984; Max-tell 1975). Radon and its short-lived daughters (Po- 
218, Pb214, Bi-214, Po214), which precede long-lived daughters in 
the decay chain, are ubiquitous in indoor air and are largely derived 
from sources other than tobacco smoke. Most of the radon daughters 
are attached to particles in the air, but a small proportion, referred 
to as the unattached fraction, is not (Raabe 1989; Kruger and 
Nijthling 1979; Bergman and Axelson 1983). 
It has been suggested that the presence of Pb-210 and subsequent 
decay products in tobacco is dependent upon an absorption of short- 
lived radon daughters on the leaves of the tobacco plant, especially 
where phosphate fertilizers that are rich in radium have been used 
and have caused increased leakage of radon from the ground. These 
attached short-lived radon daughters then decay to long-lived Pb-210 
and subsequent nuclides found in the tobacco (Fleischer and Parungo 
1974; Martell 1975). However, the origin of these decay products may 
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TABLE 3.-Distribution of selected components in the sidestream smoke (SS) and the ratio of SS to 
mainstream smoke (MS) of four U.S. commercial cigarettes 
components 
Cigarette A Cigarette B Cigarette ( Cigarette D 
85 mm NF 85 mm F 85 mm F 85 mm PF 
ss SWMS ss SSiMS ss SS/MS ss SSIMS 
Tar imglgl 22.6 1.1 24.4 1.6 20.0 2.9 14.1 15.6 
Nicotine lmgigl 4.6 2.2 4.0 2.7 3.4 4.2 3.0 20.0 
C’arbon monoxide cmg/g) 28.3 2.1 36.6 2.7 33.2 3.5 26.8 14.9 
Ammonia ImyJgl 524 7.0 8Y3 46 213.1 6.3 236 5.8 
(‘atecho (pgtgl 58.2 1.4 89.8 1.9 69.5 2.6 117 12.9 
Benzolalpyrenv Ingig 67 2.6 45.7 2.6 51.7 42 448 20.4 
N~N~trosodlmethyumine tng/gl 735 236 597 139 611 50.4 685 167 
N-Nitrosopyrrolidtne cng/g~ 177 2.7 13Y 13.6 233 71 234 11.7 
N -Niirosonornlcotme (ng/yi 857 0.85 307 0.63 1x5 0.68 338 5.1 
also depend on the general occurrence of radon in the atmosphere 
and not on the local emanation of radon (Hill 1982). 
In recent years, it has been shown that relatively high levels of 
radon and short-lived radon daughters may occur in indoor air, and 
consistent observations in this regard have been made in several 
countries (Nero et al. 1985). In the air with a very low concentration 
of particles, the proportion of unattached radon daughters is 
increased beyond that found with a higher concentration of particles. 
The unattached daughters are removed more rapidly than those that 
are attached by plating out on walls and fixtures. The addition of an 
aerosol, such as tobacco smoke, increases the attached fraction, 
elevates the concentration of radon daughters, and reduces the rate 
of removal of radon daughters (Bergman and Axelson 1983). The 
dose of a radiation received by the airway epithelium depends not 
only on the concentration of radon daughters but also on the 
unattached fraction and on the size distribution of the inhaled 
particles. The interpIay among these factors as they are modified by 
KTS has not yet been fully examined. 
Environmental Tobacco Smoke 
The air dilution of side&ream smoke, and of other contributors to 
ETS, causes several physicochemical changes in the aerosol. The 
concentration of particles in ET’S depends on the degree of air 
dilution and may range from 300 to 500 mg/mg to a few p&ma. At 
the same time, the median diameter of particles may decrease as 
undiluted SS is diluted to form ETS (Keith and Derrick 1960, 
Wynder and Hoffmann 1967; Ingebrethsen and Sears 1936). Further- 
more, nicotine volatilizes during air dilution of SS, so that in ET’S it 
occurs almost exclusively in the vapor phase (Eudy et al. 1985). This 
is reflected in the fairly rapid occurrence of relatively high concen- 
trations of nicotine in the saliva of people entering a smokepolluted 
room (Hoffmann, Haley et al. 1984). Most likely there are also 
redistributions between the vapor phase and the particulate phase of 
other constituents in SS due to air dilution, which may account for 
the presence of other semivolatiles in the vapor phase of KTS. 
However, evidence of such effects needs to be established. 
Comparison of Toxic and Carcinogenic Agents in Mainstream 
Smoke and in Environmental Tobacco Smoke 
The combustion products of cigarettes are the source of both 
environmental tobacco smoke and mainstream smoke. Therefore, 
comparisons of the levels of specific toxins and carcinogens in KTS 
with the corresponding levels in the mainstream smoke are relevant 
to an estimation of the risk of E’I’S exposure. Although KTS is a far 
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less concentrated aerosol than undiluted MS, both inhalants contain 
the same volatile and nonvolatile toxic agents and carcinogens. This 
fact and the current knowledge about the quantitative relationships 
between dose and effect that are commonly observed from exposure 
to carcinogens have led to the conclusion that the inhalation of ET’S 
gives rise to some risk of cancer (IARC 1986). 
However, comparisons of MS and ETS should include the consider- 
ation of the differences between the two aerosols with regard to their 
chemical composition, including pH levels, and their physicochemi- 
cal nature (particle size, air dilution factors, and distribution of 
agents between vapor phase and particulate phase). Another impor- 
tant consideration pertains to the differences between inhaling 
ambient air and inhaling a concentrated smoke aerosol during puff- 
drawing. Finally, chemical and physicochemical data established by 
the analysis of smoke generated by machine-smoking are certainly 
not fully comparable to the levels and characteristics of compounds 
generated when a smoker inhales cigarette smoke. This caveat 
applies particularly to the smoking of low-yield cigarettes, for which 
the yields of smoke constituents in machine-generated smoking and 
human smoking activities may be most divergent (Heming et al. 
1981). 
The levels of certain smoke constituents in the mainstream smoke 
of one cigarette compared with the amounts of such compounds 
inhaled as constituents of ETS in 1 hour at a respiratory rate of 10 L 
per minute are presented in Table 4. Unaged MS does not contain 
nitrogen dioxide (NO* < 5 &cigarette) because the nitrogen oxides 
generated during tobacco combustion in the reducing atmosphere of 
the burning cone are transported in the smoke stream (a10 vol % 
0,) to the exit of the cigarette mouthpiece in less than 0.2 seconds, 
and it takes 500 seconds for half of the nitrogen oxide in MS to 
oxidize to nitrogen dioxide (Neurath 1972). The relatively low values 
for nicotine reported in ETS may be explained, in part, by the 
inefficiency of the trapping devices for collecting all of the available 
nicotine; the alkaloid is predominantly in the vapor phase, which 
escapes retention by the filters of such devices. 
The assignment of benzene as a “human carcinogen,” benzo- 
[alpyrene as a “suspected human carcinogen,” and N-nitrosodi- 
methylamine and N-nitrosodiethylamine as “animal carcinogens” is 
based on definitions by the International Agency for Research on 
Cancer (1986). Accordingly, a human carcinogen is an agent for 
which “sufficient evidence of carcinogenicity indicates that there is a 
causal relationship between exposure and human cancer.” A SUS- 
petted human carcinogen is an agent for which “limited evidence of 
carcinogenicity indicates that a causal interpretation is credible, but 
that alternate explanations, such as chance, bias, or confounding, 
could not adequately be excluded.” An animal carcinogen is an agent 
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E TAFHJZ 4-Concentrations of toxic and carcinogetic agents in notilbr cigarette mainstream smoke 
and in environmental tobacco smoke (EiTS) in indoor environments 
Agent 
. Inhaled ae ETS constituents during 1 hour 
Mainstream Smoke Range Episodic high values’ 
Weight Concentration Weight Concentration Weight Concentration 
Carbon monoxide lo-23 mg 
Nitrogen oxide 100-600M 
Nitrogen dioxide <5 w 
Acrolein 60-100 pg 
Acetone KNJ-260 pg 
Benzene 1248 pg 
N-Nitrosodimethylamine’ 10-40 ng 
N-NitrosodiethylemineJ 4-25 ng 
Nicotine v.3=2,500 Pl? 



















































NOTE: Values for inhaled mainstream smoke components were calculated from values in Table 2 and on a respiratory rate of 10 L per minute. Valuea for carbon monoxide and nicotine represent 
the range in mainstream smoke of U.S. nonfilter cigarettes 88 reported by the U.S. Federal Trade Commission (19%). Data under EIS are derived from Tables 8 through 16, with data fmm the 
unventilated interior compartmenta of automobiles excluded (Badre et al. 1978). 
‘The designation “episodic high values” was chosen to classify those data in the literature that require confirmation. 
*Human carcinogen according to the IARC (Vainio et al. 1986) and suspected carcinogen according to the ACGIH (198%. 
‘Animal carcinogen according to the IARC (V&do et al. 1995). 
4 Suep&.ed human carcinogen, according to the IARC (Vainio et al. 1985) snd according to the ACGIH (1986). 
“for which there is sufficient evidence of carcinogenicity in animals 
but for which no data on humans are available.” 
Polonium-210 is not listed in Table 4 because there are no data on 
the concentration of this isotope in ETS, although it is a component 
of both MS and SS. Whereas in clean air the short-lived radon 
daughters tend to plate out on room surfaces, in the presence of an 
aerosol such as El’s, some of the short&& radon daughters become 
attached to particles and consequently remain available for inhala- 
tion. Radon daughter background concentration may more than 
double in the presence of EYI’S (Bergman and Axelson 1989). 
Number and Size Distribution of Particles in EnvIronmentsI 
Tobacco Smoke 
Environmental tobacco smoke consists of the combined products of 
both fresh and aged sidestream smoke and exhaled Ilaainstream 
smoke. Coagulation, evaporation, and particle removal on surfaces 
occur simultaneously to modify the physical characteristica of the 
ETS particles; as a result, the “typical” particle size and chemical 
composition of ETS may vary with the age of the smoke and the 
characteristics of the environment. Other factors such as relative 
humidity, particle concentration, and temperature may also tiect 
the characteristics of EYE. 
The rapid dilution of SS smoke as it is emitted into a room leads to 
a number of physical and chemical changes. For example, the 
evaporation of volatile species as the ETS ages reduces the median 
diameter of the smoke particles. Several studies have measured the 
particle distribution of SS under controlled conditions (Table 5), and 
indicate that the mass median diameter (MMD) of ETS is between 
approximately 0.2 w and 0.4 v. The differences among the studies 
reflect the varying analytical methods. EYE3 particles are in the 
diffusioncontrolled regime for particle removal and therefore will 
tend to follow stream lines, remain airborne for long periods of time, 
and rapidly disperse through open volumes. 
As indicated, a number of factors can produce variation in the 
mean size of the particles in EYl’S, however, in considering transport, 
deposition, and removal in the human lung, it is useful to assume 
that the particle sizes of aged ETS will generally be between 0.1 and 
0.4 pm. Although the results presented in Table 5 do not permit the 
assignment of a single value for the diameter of side&ream smoke 
particles, the difference in deposition efficiency in the human 
respiratory tract of 0.2 pm particles and 0.4 w particles is negligible 
(C&an and Lippmann 1980). Particles in this size range are not 
efficiently removed by sedimentation or impaction. Although diffu- 
sion is the major removal mechanism for particles of this size, it is . . mmnnally efficient in the 0.2 to 0.4 v range. The relatively low 
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iii TABLE li.-Summary of sidestream smoke size distribution studies 
Study Cigarette Method 
Chamber 












Keith and Derrick 
IlW-ll 
Blended “Conifuge” Not reported 0.15 Not reported Not reported 38 x 10” 
PorstendGrfer and 
Schraub (19721 
Not reported CNUdiffusion tube Not reported 0.24 Not reported Not reported 3.3 x 10” 
Hiller et al. 
(1982J 
Not reported SPART analyzer 5@100 0.32 0.41 1.5 Not reported 
Leaderer et al. 
(1984) 
Commercial EAA mcl Not reported 0.225 21 Not reported 
lngebrethsen and 
sears (1986) 
MCICNC 0.2 1.5 
particle deposition efficiency for SS particles in human volunteers 
observed by Hiller and colleagues (1982) is consistent with particles 
in this size range. 
Several investigators have measured the size distribution of MS 
smoke (Table 6). As is the case with SS smoke, the different 
instruments and methodologies employed yielded differing results. 
For purposes of comparison, only two sets of studies utilizing 
similar instruments are discussed. McCusker and colleagues (19831, 
using a single particle aerodynamic relaxation time @PART) analyz- 
er to study highly diluted MS smoke particles, found a mass median 
diameter of 0.42 pm with a geometric standard deviation (GSD) of 
1.38. Hiller and colleagues (1982) used the SPART analyzer on SS 
smoke particles and found a mass median diameter of 0.41 pm and 
GSD of 1.5. Chang and colleagues (1985) used an electrical aerosol 
analyzer (EAA) to measure MS for various dilution ratios and 
reported a MMD of 0.27 pm (GSD 1.26) for the highest dilution. 
Leaderer and colleagues (1984) used an EAA to determine the size 
distribution for SS smoke particles in an environmental chamber 
and determined an MMD of 0.23 urn (GSD 2.08). These results also 
show that studies utilizing similar instruments provide similar 
results for the size distribution of both SS and MS particles. As 
discussed in an earlier section, however, the chemical composition of 
the MS and ETS particles can be quite different because of the very 
different conditions of their generation and the subsequent dilution 
and aging ETS undergoes before inhalation. 
Estimating Human Exposure to Environmental Tobacco Smoke 
Human exposure to ETS can be estimated using approaches 
similar to those used for other airborne pollutants. The concentra- 
tion of ETS to which an individual is exposed depends on factors such 
as the type and number of cigarettes burned, the volume of the room, 
the ventilation rate, and the proximity to the source. These factors, 
along with the duration of exposure and individual characteristics 
such as ventilatory rate and breathing pattern, dictate the dosage 
received by an individual. 
Ideally, the health effects of exposures to ETS might be assessed by 
quantifying the timedependent exposure dose for each of the several 
thousand compounds in cigarette smoke and defining the dose- 
response relationships for these compounds in producing disease, 
both as isolated compounds and in various combinations. The 
magnitude of this task, given the number of compounds in smoke, 
and the limited knowledge of the precise mechanisms by which these 
compounds cause disease have led to a simpler approach, one that 
attempts to use measures of exposure to individual smoke constitu- 
ents as estimates of whole smoke exposure. The accuracy with which 
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8’ TABLE 6.-s ummary of niainstream smoke size distribution studies 
count MaSa 
median median Geometric 
Dilution diameter diameter etadad concentration 
Study cigarem Method rati0 k-1 (run) deviation (number/cm’) 
Keith and Derrick 
ma3 
Blended “ConIf~” 298 0.23 Not reported 1.6 6.9 I 10 
Pomtmdllrfer and 
Sehraub (1972) 




Blended Light e&t.ering 















Not reported 0.62 
Not reported 0.44 
Not reported 0.39 
Not reported 0.38 
Not reported 0.98 
Not reported 0.36 
Not reported 0.37 
0.29 1.5 
1.36 Not reported 
1.44 Not reportad 
1.43 Not reported 
1.33 Not reported 
1.37 Not mported 
1.35 Not rqmrted 
1.31 Not revorkd 
3 a 10’” 
Mdxlsker et al. 2Rl SPAm analmr 1.2611~ 0.36 0.42 1.38 4.2 x t 
cbang et al. 2Rl EAA 6 0.25 0.30 127 4.2 I 10’ 
mm 10 0.24 0.26 1.18 3.6 x 10’ 
18 0.22 0.96 1.26 7 a 1w 
measurements of a single compound reflect exposure to whole smoke 
is limited by the changes in the composition of M‘s with time and 
the conditions of exposure. For this reason, exposures to E’l’S are 
often afessed using several measures as markers, including mark- 
ers of the vapor phase and the particulate phase as well as reactive 
and nonreactive constituents. Although biological markers show 
promise as measures of exposure because they measure the absorp 
tion of smoke constituents, they too have limitations (diecussed ’ 
Chapter 4). An individual’s exposure is a dynamic integration of &: 
concentration in various environments and the time that the 
individual spends in those environments. 
In specifying an individual’s exposure to specific components of 
EITS, consideration must be given tc the time scale of exposure 
appropriate for the response of interest. Immediate exposures of 
seconds or hours would be most relevant for irritant and acute 
allergic responses. Time-averaged exposures, of hours or days, may 
be important for acute contemporary effects such as upper and lowe 
respiratory tract symptoms or infections; chronic exposures occur 
ring over a year or a lifetime might be associated with increases 
prevalence of chronic diseases and risk of cancer. 
The spatial dimensions or the proximity of the individual to the 
source of smoke is important in assessing that individual’s exposure 
to ETS. E!lTS is a complex, dynamic system that changes rapidly once 
emitted from a cigarette. Physical processes such as evaporation and 
dilution of the particles, scavenging of vapors on surfaces, and 
chemical reactions of reactive compounds are continuously occurring 
and modify the mixture referred to as ETS. An individual located a 
few centimeters or a meter from a burning cigarette may be exposed 
to a high concentration of ETS, ranging from 200 to 300 mg/m*, and 
may inhale components of the mostly undiluted smoke plume and of 
the exhaled mainstream smoke. Ayer and Yeager (1982) reported 
cigarette plume concentrations of formaldehyde and acrolein in the 
core smoke stream emitted from the cigarette of up to 190 times 
higher than known irritation levels. Hirayama, as reported by 
Lehnert (1984), cites the importance of this “proximity effect” in 
assewing exposure. llist.anw on the order of a meter tc tens of 
meters from a burning cigarette are relevant for exposures in offices, 
restaurants, a room in a how, a car, or the cabin of a commercial 
aircraft. At these distances, the mixing of ETS throughout the 
airspace and the factors that affect concentration are of importance 
in determinin g exposure for people in the space. In many rooms, 
mixing is not completely uniform throughout the volume, and 
significant concentration gradients can be demonstrated Wizu 
1930). These concentration gradients wilI affect an individual’s 
exposure by modifying the effectiveness of ventilation in diluting or 
removing pollutants. The airborne mass concentration may vary by 
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a fa&r of 10 or more within a room. Short-term measurements in 
rooms with smokers can yield respirable particulate concentrations 
of 100 to 1,000 CLg/mS (Repace and Lowrey 1980). Multihour 
measurements average out variations in smoking, mixing, and 
ventilation and yield concentrations in the range of 20 to 200 CLg/mS 
(Spengler et al. 1981,1985,1986). Finally, on a systems scale, as in a 
house or building, concentrations are influenced by dispersion and 
dilution through the volume. Most timeintegrated samples are 
taken on tbis larger scale. 
Using a piexobalance, Lebret (1985) found significant variation in 
respirable suspended particulate (R.SP) levels between the living 
room, kitchen, and bedroom in homes in the Netherlands during 
smoking or within onehalf hour of smoking. Ju and Spengler (1981) 
studied the room-toroom variation in 24-hour average concentra- 
tions of respirable particles in various residences. Although differ- 
ences between some rooms were statistically sign&ant, absolute 
differences were relatively small, with a maximum difference of a 
factor of 2. 
Moscbandreas and colleagues (1978) released sulfur hexafluoride, 
a tracer gas, in the living rooms of several residences and observed 
uniform concentrations in adjacent rooms within 30 to 90 minutes, 
RSP, which is slightly reactive, and nonreactive gases would be 
expected to rapidly migrate through adjacent rooms. Therefore, in a 
setting such as the work environment, where the duration of 
exposure is several hours or more, HTS would be expected to 
disseminate throughout the airspace in which smoking is occurring. 
Smoke dissemination may be reduced when air exchange rates are 
low, as may occur when internal doors are closed. 
Time-Activity Patterns 
Individual time-activity patterns are a major determinant of 
exposure to ETS. The population of the United States is mobile, 
spending variable amounts of time in different microenvironments. 
Individual activity patterns depend on age, occupation, season, social 
class, and sex. For example, Letz and colleagues (1984) surveyed the 
time-activity patterns of 332 residents of Roane County, Tennessee, 
and found that 75 percent of the person-hours were spent at home, 
10.8 percent at work, 8.5 percent in public places, 2.9 percent in 
travel, and 2.8 percent in various other places. As expected, 
occupation and age were strong determinants of time-activity 
patterns. Housewives and unemployed or retired individuals spent 
84.9 percent of their time at home, and occupational groups worked 
21 to 24 percent of the hours. Students tended to spend the largest 
percentage of their time in public places, presumably schools, 
ranging from 14.7 percent for the youngest group to 19.17 percent for 
the oldest group of students. 
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TABLJZ ‘I.-Mean percent and standard deviation of time 
allocation iu various locations by work or 
school classification subgroup 
outdoor ofiice/ Indwtrial/ Thl,aU 
Location HOlIlemaLer student worker ssrvice c4luhuction perticipant.9 
Home 84.34 60.91 49.97 63.74 57.23 64.21 
(2.02l’ (13.92) (12.24) (8.72) c7.05) (13.99) 
outside 5.52 8.62 19.81 2.47 -10.69 
(3-m 6.53 K4.55) (2491 (10.74) (Fi 
Motor vehicle 4.28 5.11 8.67 
(3.19) (3.74) (6.15) 0 (7% 
5.51 
(4.m 
other incLmn 6.01 23.61 21.56 24.99 24.80 21.68 
(3.27) (10.61) (5.32) (10.241 a28a (11.37) 
cooking 4.69 0.52 1.24 
u.fm (lit (iii (:: @.W cw 
Near mnokem 2.34 5.!20 275 11.73 
(4.32) c1.88) (3.38) (15.19) (12: (!z: 
Number 8 32 4 12 8 66’ 
‘Numbershparentheemarethe~darddeviation. 
’ ‘ho unemployed partioipanta - inchded in the total. but not given a mparate catqmy. 
SOURCE: Data f-mm Quaokerlb et al. (1982). 
The time allocations for various population subgroups in Portage, 
Wisconsin, are summarized in Table 7 (Quackenboss et al. 1982). The 
data are consistent with the findings of Letz and colleagues (1984) 
and show that the variability of individual nonsmokers’ exposure to 
smokers can be quite marked between the various occupational 
subgroups. 
Infants have unique time-activity patterns; their mobility is 
limited and the locations where they spend their time depend 
primarily on their caretakers. The time-location patterns for 46 
infants is illustrated in half-hour segments in E’igure 1 (Harlos et al. 
in press). Although infants spend most of their time in their 
bedrooms, they are in contact with a caretaker while traveling or in 
the living room or the kitchen for approximately half of the day. 
These infant time-activity patterns presumably correspond to the 
family patterns and may significantly influence the infants’ poten- 
tial exposure. 
Although most people spend approximately 90 percent of their 
time in just two microenvironments (home and work) (&alai 1972), 
important exposures can be encountered in other environments. For 
instance, commuting or being Yn transit” accounts for about 0.5 to 










FIGURE I.-Time location patterns for 46 infants 
SOURCE: HarIm et al. (in prem). 
on the time spent and the EZS concentration in various microenvi- 
ronments may be useful in defining exposure. This exposure 
information can be obtained by questionnaire and validated by 
personal monitoring programs. The characterization of concentra- 
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tions or exposures or both in microenvironments should use time 
scales appropriate for the health effect of interest. These variations 
in location -and time-activity patterns can make the reconstruction of 
detailed ETS exposure difficult in studies of long-term health effects. 
The limitations in utilizing this timeactivity approach in charac- 
terizing exposures to other environmental pollutants also apply for 
ETS exposures. They include the following: the extent to which 
overall population estimates can be generalized to individual pat 
terns is poorly understood; concentrations in various microenviron- 
ments are only partially characterized, the variation in time and 
activity patterns and their effects on concentration levels are not 
established; extrapolation to longer time scales either prospectively 
or retrospectively has not been validated; the differences within 
structures, i.e., room to room ~variations, are not well established. 
Temporal and Spatial Distribution of Smokers 
Exposure to ETS can occur in a wide variety of public and private 
locations. Approximately 30 percent of the U.S. adult population 
currently are cigarette smokers. Nationwide, 46 percent of homes 
have one or more smokers (Bureau of the Census 1985). In a survey 
of more than 10,000 children in six U.S. cities, the percentage of 
children living with one or more smoking adults varied from a low of 
60 percent to a high of 75 percent (Ferris et al. 1979). Lebowitx and 
Burrows (1976) reported that 54 percent of children in a study in 
Tucson had at least one smoker in the home; Schilling and colleagues 
(1977) reported that 63 percent of homes in a Connecticut study had 
a smoker in the home. These data indicate that the population 
potentially exposed to ETS in the home is greater than might be 
inferred from aggregated national statistics on the prevalence of 
smoking. A variation in the percentage of homes with smokers may 
be observed among different regions. Furthermore, within house 
holds, smoking does not take place uniformly in time or space. 
Smoking patterns may change with activity, location, and time of 
day. These variables all serve to modify a nonsmoker’s exposure to 
ETS. 
Exposure to ETS at home may also correlate with ETS exposures 
outside the home, possibly because nonsmokers married to smokers 
may have a greater tolerance for ETS-polluted environments or may 
be in the company of more smokers because of the spouses’ tendency 
to associate with other smokers. Wald and Ritchie (1984) used a 
biological marker and questionnaires to show that nonsmokers 
married to smokers reported a duration of exposure to ETS greater 
outside the home than was reported by nonsmokers married to 
nonsmokers (10.7 hours and 6.0 hours, respectively). 
Smoking prevalence varies widely among different groups (e.g., 
teenage girls, nonworking adults, and adults employed in VICIOUS 
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occupations); this variation modifies the exposure of nonsmokers to 
EEL Smokers are present in nearly all environments, including 
most workplaces, restaurants, and transit vehicles, making it almost 
impossible for a nonsmoker to avoid some exposure to ETS. The 
number of cigarettes consumed per hour by the smoker may vary at 
different times in the day, and the rate and density of smoking will 
also differ by the type of indoor environment and activity in such 
hales as schools, autos, planes, offices, shops, and bars. 
Although there have been numerous measurements of ETS 
concentrations in various indoor settings, these data do not repre- 
sent a comprehensive description of the actual distribution of ETS 
exposures in the U.S. population. Spengler and colleagues (1995) and 
Sexton and colleagues (1984) demonstrated by the personal monitor- 
ing of respirable particles and the use of time-activity questionnaires 
that exposures to EZS both at home and at work are significant 
contributors to personal exposures. However, additional data on the 
distribution of smokers in the nonsmokers’ environment, as well as 
the distribution of ETS levels in that environment, are needed in 
order to characterize the actual E!CS exposure of the U.S. population. 
Determinations of Concentration of Environmental Tobacco 
Smoke 
Environmental tobacco smoke is a complex mixture of chemical 
compmmds that individually may be in the particulate phase, the 
vapor phase, or both. ETS concentration varies with the generation 
rate of its tobacco-derived constituents, usually given as micrometer 
per hour. The generation rate for ETS has been approximated by the 
number of cigarettes smoked or the number of people present in a 
room who are actively smoking. Room-specific characteristics such 
as ventilation rate, decay rate, mixing rate, and room volume also 
modify the concentration. Because ETS particles have MMDs in the 
0.2 to 0.4 Frn range, convective flows dominate their movement in 
air, they remain airborne for long periods of time, and they are 
rapidly distributed through a room by advection and a variety of 
mixing forces. Under many conditions, the ventilation rate of a space 
will dominate chemical or physical removal mechanisms in deter- 
mining the levels of ETS particles. 
Nonreactive ETS components distribute rapidly through an air- 
space volume, and their elimination depends almost solely on the 
ventilation rate. For example, Wade and colleagues (1976) simulta- 
neously measured carbon monoxide, a nonreactive gas, and nitrogen 
&oxide, a reactive gas, in a house and determined their half-lives to 
be 2.1 and 0.6 hours, respectively. This study demonstrates the need 
for caution in extrapolating from one vapor phase compound to 
another. Reactive gases and vapors may be rapidly lost to surfaces or 
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may react with other chemical species. Their removal may be 
dotted by their reactiOn Or absorption rates. Furthermore, the 
decay of ETsderived Substances can be a function of the chemical as 
well as the physical characteristics of room surfaces. For example, 
Walsh and colleagues (1977) found that sulfur dioxide removal was 
greater for rooms with neutral and alkaline carpets than for rooms 
bving carpets with acidic PH. Reactions with furnishings and other 
materials may occur for some M‘s components as well. 
~tx-c-tenvjronmental Measurementa of Conce&r&ion 
As was discussed earlier, the complex chemical tieup of ETS 
makes the measurements of individual levels for each compound 
present in JWS impossible with existing resources; thus, some 
individual constituents have been measured as markers of overall 
smoke exposure. Because many of these constituents are also 
emitted from other sources in the environment, the contribution of 
El% to the levels of these constituents is quantified by determining 
&e enrichment of specific compounds found in smoke-polluted 
environments relative to the concentration measured in nonsmoking 
areas. Various ETS components have been measured for this 
purpose, including acrolein, aldehydes, aromatic hydrocarbm, 
carbon monoxide, nicotine, nitrogen oxides, nitrosamines, phenols, 
and respirable particulate matter. A summary of the levels found 
and the conditions of measurement are presented in Tables 8 
through 15. The major limitation of using most of these gases, 
vapors, and particles is their lack of specificity for ETS. The presence 
of sources, other than tobacco smoke, of these compounds may limit 
their utility for determining the absolute contribution made by EITS 
to room concentrations. Levels of nicotine and tobacco-specific 
nitrosamines, however, are specific for ETS exposure. 
Obviously, no single measurement can completely characterize the 
nonsmoker’s exposure to ETS, and many studies have measured 
several of these components in order to characterize the exposure. 
Markers should be chosen both because of their accuracy in 
estimating exposure and because of their relevance for the health 
outcome of interest. 
One widely reported marker of ETS is respirable suspended 
particulate (RSP) matter. Although lacking specificity for tobacco 
smoke, the prevalence and number of smokers correlates well with 
RSP levels in homes and other enclosed areas. 
A study of the RSP levels in 80 homes in six cities (Figure 2) 
(Spengler et al. 1981) showed that indoor concentrations were higher 
on average and had a greater range than the outdoor concentrations. 
From these data, it is evident that even one smoker can SigllifiCiUltig 
elevate indoor R+SP levels. 
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TABLE EL-Acrolein measured under realistic conditions 
Study 





2 train compartment9 
car 
F&her et al. 
(1978) and 






Varied Not &em 
18 smokers Not given 
12 to a0 amokem Not given 
2to3mokera Not given 
3 smokers Natural, open 
2 mnokem Natural, cloned 
F&80/470 m’ 
6@-m/440 m* 






loo n&L. sampled 
100 mL eamplen 
loo mL mmpla 
100 mL .mulplea 
loo mL m.mpled 
1OOmLsampla 
27 x 30 mic samplea 
29X3Odlumpla 
28 x 30 min analplea 










6 ppb (5 Ppb 
non8moking eecticad 




Levele Ncmemcha aatde 
Monitwing 
Ventilation mnditiona Mean Ranec-w 






cf&a Varied Not given loo mL sampled 
Room 18 amokem Not @en loo mL Eamplee 
Train wmpartmente 2 to 3 emokem Not &en loo mL namplw 
car 2 maokern Natural, clcued loo mL samples 






Varied Not given 100 mL Blrmplen 
18 smokera Not given loo mL Mmples 
2 ta 3 amokere Not given loo mL amnples 
3 nmokera Natural, open loo mL Bamph 






























Just et al. 
(1972) 
Coffee houses Not given Not given 6 hr wntinuoue 02610.1 4.0-9.3 (outdoola) 
Jhzde~yrone (ng/m”) 
3.3-23.4 3.0-5.1 (outdoola~ 
Benmkhihmrylene (ng/m*) 
W-10.6 6.9-13.6 (outdoors) 
Perylene bglm*) 
o-7-1.3 0.1-1.7 (outdoola) 
F%mne (s&m’) 
4.1-9.4 2%?.O (outdoom) 
Anthanthrene (&ma) 






Peny (1973) ’ 14 public placea Nat piven Not given samples, 6 outdoor 
IoCatiOllE 
< 20460 (20-43 
’ The correctn~ of the data ia doubtful (Grimmer et al. 1977). 






Nonsmoking contmle @Pm) 
Mean 
Eadre et al. 
(1978) 
Bcafea Varied Not given 20 mill sempleu 2-23 (outdoore) O-15 
Room 18 emokma Not given 20 mln snmplea 60 0 (0ukJoonl) 
Hospital lobby 12 to 90 amokem Not given 20 mln samples 5 
2train 2 to 3 smokers Not given 20 min namplea 44 
wmpartmenta 
car 3 amokera Natural, open 20 min aample 14 0 (0utdooIu) 
2 Bmokera Natural, cloeed 20 min samples !?a 0 (outdoore) 














































2.5 f 1.0 1.5-4.6 2.5 f 1.0 1.5-4.5 
butdoors) 
4.0 f 2.5 1.0-9.6 2.5 f 1.6 1.0-6.0 
(outdwm) 







RI TABLE 10.4ntinud 
Study 
Coburn et al. ~oorrm Not given Not given 
(lssa) 
Not &en 4.9-9.0 
N-oked roome 2.2 f 0.96 oA-4.6 




Tavern 2 Not given l-2 cbangen/br 8 hr amtiauoun 17 -CM?2 valua not given 
2brefterMokblg -12 valum not given 
U.S. Dept. of 18 military 165-219 people Mecbwlcal 6-7 hr contlnuoue <Z-6 
RansportetiOll Pbce 
(1971) ’ 8 domeutic 27-11s people Mechenical 1%2% br s-2 
Planes continuoue 
Elliott and Arena1 l l@X psople Mechanical Not &en 9.0 
Arena2 2,ooO people N&Ud 
9.0 bmwtlvity day) 
Not given 26.0 9.0 bloMctivity day) 
No-~ 9.0 
Fischer et al. 
(1978) and 
Weber et al. 
W9) 
arena 






80-X0/574 m ’ 
Bamplee 
Natural 29X30&l 2.6 1.43.4 1.5 (outdoore) 
aamplm 
Natural, open 28XWdIl 4.8 2.4-9.6 1.7 cddoonl) 
=Pl- 
11 changee/llr 24XXlmin 1.2 0.7-1.7 0.4 buuoom) 








Nonsmoking controls @pm) 
i&an 
Godin et al. Ferryboat Not given Not given 11 grab samples 18.4 f 8.7 3.0 f 2.4 (r~onsmoking room) 
0972) Theater foyer Not given Not given Grab samples 3.4 rt 0.8 1.4 f 0.8 (auditorium) 

















42 (pdd (Nonsmokln# mm) 
13.5 (peak) 





Train 1-18 smokers Natural Not &en O-40 




Rooms Not given Not given Not given 8-26 
(1971)’ 






















9.9 f 5.5 value8 not given 
8.2 f 2.2 7.1 f 1.7 (outdooln) 
10.0 -f 4.2 11.5 zt 6.9 (outdcarn) 
44 Values not @en 
E TABLE lO.-Chntinud 
Level8 bud Nonsmokina’ eon- bran) 
Type of MOdWillg 
study plWli!3H OccupanCY Ventilation conditions Mesn MSan 




















8 changeslhr Continuous, 8b-W l-2 CeePnrate 
morning nonwnoking day) 
6 changedhr Continuous, 10 @aaM 1-2 (separate 
morning nm &Y) 
Not given continuous 2.78 + 1.42 2.66f2.23 
blYua~ llomdiw 
ofiica) 
‘The Drager tube u.d ia accurate only within f 25 percmt. 
‘The MSA Molit&e sampler used iu accurate only withio f 26 percent. 
*The cigarettes and one cigar smoked in 90 minuted. 
‘About 40 cigarettes/day were !mloked. 
*About 7Ocigarattes/day were smoked. 
‘Four tiltar cigarettea were smoked. 
’ No experimentd demiption givsn. 







Leiels (p&m*) controls 
Mean Range Mean Ranee 
Badre et al. 
(1978) 
Gcafea Varied Not given 60 min sample 25-52 
Boom 18 smokers Not given 60 min sample 800 
Hospital lobby 12 to 30 smokers Not given 80 mm sample 37 
2 tram compartments 2 to 3 smokers Not given 80 min sample 36-50 
Car 3 smokers Natural, onen 60 min ssmule 68 
Natural; closed fi0 min sample 1010 
Can0 et al. Submarines 





YeS 32 pg/m’ 




T&l Not given Natural, closed 30-46min 
samples 
0.741 
Hinds end First 
(1975) ’




Bus waiting room 





















2% hr samples 
2’1, hr samples 
2’/, hr semplos 
2% hr samples 
2’1, hr samples 
2% hr samples 
2% hr samples 
14ox3hr 
samples 
4.9 valuea not given 
6.3 Values not given 
1.0 valuca not given 
3.1 Valuea not given 
5.2 Values not given 
10.3 valuw not given 
2.8 Values not given 
0.9 * 1.9 13.8 @AC) Values not given 
TABLE 11.4ntinued 
Levels t&m’) controls- 
Monitor 
ventilation amdltions Mean rbge Man m 
First 
asw 
1 public buildin. 





5.5 Not given 
Not given 132 27-30.0 





6 confemace rooms 
3 howea 
Hcspital lobby 
4 hotal lobbits 
5 lwtaurants 
3 cafeteriaa 





Not given Not &en 
Not given Not given 
Not given Not given 
Not given Not &en 
Not given Not given 
Not given Not glvsn 
Not given Not given 
Not given Not given 
Not given Not given 



























Not given 47.7 7.7-83.1 
Not given 16.4 8.6-98.1 
Not given 16.2 6.3-28.8 




Fischer et al. 
(1678) and 
































NO,: 76 5%105 62 b3a.dcorl5~ 
No: 120 26-218 115 (outdoom) 
NO,: 66 24-99 60 f~tdoom) 
No:80 14-21 11 Mdoom) 
NO,: 21 l-61 46 (outdwm) 
No: 195 66-414 44 (outdoom) 
NO,: 58 25-103 24 (0utdoorB~ 
No: 9 w6 4 butdoom~ 
NO,: 27 15-44 
No: 5 2-9 
NO,: 24 f 22 115 k-w vehlw not gibwl 
No: 62 f 60 =J(peall) value3 nbt given 
1 Contml valua (unoccupied rooms) have bean subtracted. 
+ 















Not given Mechanical 
Not given Natural 
Not given Not given 
Not given Not given 
Not given Not given 
Not given Not given 
Not given Not given 
Not given Not given 
Not given Not given 
90 mill continuoue 0.13 
90 min amtinuoua 0.11 
3 hr wntinuow 0.24 
3 lx wntinuow 0.09 
90 min wntinuouB 0.05 
2v, hr contiMouB 0.09 
5 hr amtinuouB 0.01 
4 hr amtinuoua <o.oos 
4 hr wntinuoua <0.003 








Monitoring Levels @g/m’) wntmls @g/m’) 
conditions 







Church bingo game 
Inn 
Bowling alley 
Hospital waiting Mom 
Shopping plara restaurant 
Sample 1 
Sample 2 
0.75 Natural 15 
1.26 MWhanical 50 
1.18 Mechanical 18 
2.17 Mechanical 16 
2.94 Mechanical 32 
3.24 Mechanical 28 
0.47 MeChanieal 42 
0.74 MdWliWl 12 
1.53 MWbdCd 20 
2.15 Mechaoical 12 
0.18 MeChanical 18 


























Manitorine Luvel~ Cpgtm’) f3e0l~ (W/m’) 
wnditionm 
Ventiletion 0 Mea0 8D Meanm 
Barbeque restaurant 












Repace and Dinner theater 
bmY Reception hall 

























Mechanical (9.6 a&‘) 18 












136 f 17 
110 f 36 
Mf 5 
109 f 38 
94 * 1s 






145 f 43 

















‘Sequential outdoor meaauem ent (5 minute avelnge~. 
‘Eatimclted. 
‘Air changes per hour. 









Nonsmoking controls @g/m’) 
MWO 





6 changedhr 4xahr 310 
continuous 
l-2 changealhr 8 hr continuous 986 
U.S. Dept. of 
Tmrqmtation 
(1971) 
18 military planes 165-219 people 
8 domestic planes 27-113 people 
Mechanical 
Mechanical 
72 x 6-7 hr 
eamplw 










Arena 1 11,606 people MWlWliCd During activities 323 42 (nonactivity day) 
Arena 2 %W people Natural During activities 620 92 bM3rativity day) 
Arena 3 (smoking 11,090 people MWhEUliWl During actlvitiw 148 71 (nonactivity day) 
prohibited) 
Harmsen and Traine 
Effenberger 
(1957) 
Just et al. 4 coffee houses 
(19721 
16120 people Natural 
Not given Not given 
Not given 
Nonsmokem’ cam 





1160 6@-1900 670 (outdoom) loo-19lxl 
Neal et al. Hospital unit Not given Mechanical 48 hr samples 21 f 14 a-58 73 * 25 
(1978) Hospital unit Not given MeChanical 48 hr samples 40 + 21 13-79 72 f 25 
TABLE Id.- Continued 
Study 
Type of 





Nowmokhg control@ (&ma) 
Mean 
Spender et al. Residences 2+ smokers Natural 24 hr samples 70 + 43 21 f 12 
(1981) 
(outdoom) 
1 smoker Natural 24 br earnplea 37 f 15 21 f 12 (outdoom~ 




Quad et al. Of&e No. 1 0.82* MWlLSlliWl Five l@hr workday 45 39.54 616 
(1982) office No. 2 0.68 = Mechanical averagea; continuous 45 37-50 15-2ll 
Of!& No. 3 1.46’ Mechanical monitoeg 63 4289 15-m 
Brunekreef and 26 houses 1 to 3 smokers Natural 2 mo average0 153’ 60-340 55 20-m 
Boleii (1982) 
1 public building Nonsmokers Mechanical 2min 20 
8 public buildings 1 to 6 smokem Natural end 2min 280 
mechaniwl 
Hawthorne et al. 11 residences Nonsmokem o.18-oo.96 5-15 mill 9-40 
(1984) 8 reaidencea Nonemokera 0261.98 5-16 min 12-M 
2 residences Smokem 0.27-1.47. 5-15 min 96-196 
Nitschke et al. Outdoor 166 hr 11 11-m 
(1985) 19 residences Nonsmokers Natural 168 hr 26 6-88 
11 residences Smokers Natural 168 hr 59 lo-144 
Spengler et al. Outdoor 24 hr 18 
(1986) 73 renidencea Nonsmokers Natural 24lu 28 
24 residences Smokers Natural 2dhr 74 
Sterling and 1 office Smokem Not given Not given 26 15-36 
sterliig 22 Offlws Smokers Not given Not given 32 
(1984) 
’ valua abwa background. 
*Habitual smokers per 100111’. 
‘Wekhtad mean. 







@=panCY Ventilation conditions Mean hfem R-m 












Fwzher et al. 
I19781 
Restaurant W-60/470 m’ Mechanical 
Restaurant 6&100/440 ms Natural 
Bar 30-4060 ml Natural. open 
Cafeteria tW150/574 m’ 11 ch/hr 
Just et al 4 coffee houses 
55 
119721 
Varied Not given 
16 smokers Not given 
12 to 30 smokers Not given 





Not given VUied 24 hr earnplea 4.61 
Not given Not given 6 hr continuous 12.0-15.3 
103 mL samples 
100 mL aample 
100 mL samples 
100 mL samples 
100 mL aample 
100 mL 8ample.e 
27 x 30 min samples 
29 x 30 min samples 
28 x 30 min samples 











Sulfur dioxide (ppb) 
20 9-32 12 Fe 
13 5-18 6 
30 13-75 I3 




’ See original paper for nine other residuals. 
SOURCE. Sterling et al. (1982). 
0’ , , , I, , , , , , , , , , , , , , 
NW. ~ec. &n. Fd Mar. Apr. May Jun. Jul. Aug. Sep. Ott Nov. Dec. Jan. Feb. Mar. ~pr. 
1978 1977 1978 
FIGURE 2.-Monthly mean mass respirable particulate 
concentrations &g/m”) across six cities 
fmJRcEI~etd.(lWl). 
TABLE 16.~Respirable particulate levels as a  function of 
number  of smokers 
Smoker status NumbeI 
No smokers 36 homes/l,186 samples 
1 em&r 15 homed494 samples 
2 amokera 5 homed153 samples 
2+ emokera 4 homed? samples 
souRcE:~etd.(1981). 





Spengler and colleagues (1981) collected respirable suspended 
particulate samples in 55  homes in six cities. The average concentra- 
tions observed between May 1977 and April 1978 are shown in Table 
16. The quantity of tobacco smoked was not reported, nor was the 
number of hours each smoker spent in the home. The researchers 
concluded that the mean WP levels increased by 20 pg/ms per 
smoker. 
Dockery and Spengler (1981) further analyzed these data and 
considered the number  of cigarettes smoked in the home. They 
concluded that the mean RSP concentration increased by 0.88 w/ma 
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for every cigarette smoked per day in the house. A one-pack-a+lay 
smoker in the home thus raises indoor respirable particulate leveE, 
by 17.6 w/ma. Air conditioning increased the contribution of each 
cigarette by 1.26 w/ma, to a total of 2.11 Clg/ms per cigarette in fully 
air-conditioned homes. These values are annual averages; a&ond& 
tioned homes, in which air is recirculated during the warmer 
months, have higher levels. 
Repace and Lowrey (1989) measured RSP concentration using a 
piexobalance in several public and private lo&ioris, imh&g 
restaurants, cocktail lounges, and halls, in both the presence and the 
absence of Bmoking. They then developed an empirical model 
utilizing the mass-balance equation. Using both measured and 
estimated parameters as input to the model, they validated the 
model for predicting an individual’s exposure to the RSP constituent 
of HIS. The model takes the form: C, = 666 D./n,; where C&equals 
the equilibrium concentration of the RSP component of ETS @g/m”), 
D. equals the density of active smokers (number of burning cigarettes 
per 100 ma), and nv equals the ventilation rate (in air changes per 
hour). The ventilation rate is a complex parameter that takes into 
account all the room-specific constants affecting the removal of HIS, 
such aa ventilation, decay, and mixing. 
Measurements in a large number of locations using measures of 
smoke generation such as the number of people smoking or the 
number of cigarettes being smoked have shown a definite relation- 
ship of smoke generation to particulate levels. First (1964) cautioned 
again& the use of RSP measurements a~ a measure of El% in public 
places because of its nonspecificity for ETS, and noted that other 
~ouroes may contribute enough to the levels to invalidate the 
determination of the ETS contribution. However, there are few other 
sources of RSP in most U.S. homes, and therefore, the relationships 
of RSP measurements to HIS levels are generally quite accurate in 
this setting. 
Nicotine appears to be a promising tracer for ETS because of its 
specificity for tobacco and its presence in relatively high concentra- 
tions in tobacco smoke. It can also be measured in biological fluids to 
provide an indication of acute exposure to tobacco smoke. Cotinine, 
nicotine’s major metabolite, can be used as an indicator of more 
chronic exposure. These biological markers are discussed in a 
separate chapter of this Report. Recent studies have indicated that 
nicotine may be p rimarily associated with the vapor phase of HI’S 
and therefore not a surrogate for the particulate phase as once 
thought (Eudy et al. 1986). However, the possible useftiess of this 
compound in estimating exposure to EXS warrants further evalu- 
ation. The nicotine content of side&ream smoke does not differ 
significantly from brand to brand when normalized on a per gram of 
tobacco basis (Rickert et al. 1984). The use of nicotine as a marker for 
ETS must also give consideration to its loss to surfaces and its 
subsequent revolatilization and readmission to the room volume. 
Carbon monoxide, a marker for gas phase components, has been 
measured extensively as a surrogate for FYI’S There are many 
sources of carbon monoxide other than cigarettes, indoors (e.g., 
stoves, grills) and outdoors (e.g., automobile). This nonspecificity for 
ETS seriously limits its usefulness for environmental measurements. 
In summary, no single compound definitively characterizes an 
individual’s exposure to ETS. Additional research is currently under 
way to quantify the relationships among various constituents and 
ETS levels. Because of the complex nature of RTS, investigators may 
need to measure several markers or to separately record source 
variables (such as number of cigarettes smoked) in order to estimate 
exposure to ETS. 
Monitoring Studies 
Personal monitors can measure the concentrations of ETS in an 
individual’s breathing zone. Personal monitoring is preferable to 
area monitoring because it integrates the temporal and spatial 
dimensions of an individual’s exposures. At the present time, all of 
the studies that have used personal monitors to measure RTS 
constituents have utilized active samplers that provide integrated 
exposures over differing time periods. 
The markers assessed in personal monitoring studies have the 
same lack of specificity found in area monitoring studies. However, 
in many of the personal monitoring studies, time-activity diaries 
were kept to permit greater resolution in attributing exposure to 
specific sources. 
In Topeka, Kansas, 45 nonsmoking adults carried personal RSP 
monitors for 18 days, and area monitors were placed inside and 
outside their homes (Spengler and To&son 1981). The indoor RSP 
levels were consistently higher than outdoor levels, and the personal 
exposures levels were higher than either. The group was divided into 
those who reported ETS exposure and those who did not (Figure 3). 
Reported exposure to ETS clearly shifts the distribution to the right. 
On the average, reported ETS exposure increased an individual’s 
personal concentration by 20 pg/m3. 
Personal RSP monitors were carried by 101 nonsmoking volun- 
teers for 3 days in Kingston-Harriman, Tennessee (Spengler et al. 
1985). The study population was divided into two groups: those who 
lived with a smoker and those who did not. ETS exposure was 
reported by 28 of the participants, with the remaining participants 
reporting none. The RSP distribution for the ambient samples is 
shown in Figure 4. Clearly, exposure to ETS significantly increases 














0 5 10 15 20 25 30 35 40 45 60 55 60 65 70 75 60 85 60 65 
FIGURE 3.-Percentage distribution of personal respirable 
particulate concentrations, non+moke+qwsed 
and smoke-exposed samples, Topeka, Kansas 
6OUROE Spqler and Tceteaon (1981). 
Sexton and col leagues (1984) mon itored personal RSP exposure for 
48  nonsmokers in W a terbury, V&mont, every other day for 2  weeks. 
The participanta kept activity logs and had simultaneous indoor and 
outdoor FC3P samples collected at their homes. The proportion of 
time individuals spent exposed to EX’S was the single most important 
determinant of their personal exposure. Volunteers who reported 
greater than 120 m inutes of exposure to ETS had a mean RSP 
exposure of 50.1 M /ma, whereas those volunteers who reported no 







FXXJRE 4Ahmulative frequency distributions of central 
site ambient and personal smoke-exposed and 
non-smokeaqosed respirable suspended 
ptulhulate concentrations 
sG~spannBier~t0@55). 
Ni&&, a tobacco-specific compound, should make an excellent 
tracer for ETS if its usage can be properly validated. Some 
considerations in its usage are detailed in the section on area 
sampling. Currently, no published reports are available that utihm 
this compound for the type of detailed personal monitoring studies 
carried out for PSP. However, a lightweight personal nicotine 
monitor has recently been developed (Muramatsu et al. 1994) that 
may aid this type of research. The researchers measured average 
nicotine concentrations ranging from 9.0 &ma in a hospital lobby to 
38.7 H/m3 in a conference room and 47.7 &ma in an automobile, 
No information on the duration of exposure or representativeness of 
these levels to the general population was given. However, this study 
does provide information as to the range of exposures an individual 
may encounter and demonstrates that high nicotine levels can be 
encountered in various settings. It will be necessary to quantify the 
relationship between nicotine, a vapor phase component of El!& and 
other components of interest such as RSP in order to fully utilize t&s 
tracer. 
Chtain organic gasa have been measured as possible indicators of 
EZ’S exposure or of specific effects such as irritation. These include 
formaldehyde and acrolem Weber and F’ischer 1980) and aromatic 
compounds such as benzene, toluene, xylene, and styrene (Higgins et 
al. 1983). The U.S. Environmental Protection Agency’s recent TEAM 
study utilized personal monitors, employing Tenax carkidges, to 
develop profiles of individual exposures to volatile organics (Wallace 
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st al. m press). The TEAM study has found significantly increased 
exposure to benzene for individuals exposed to E!lS. Again, the 
xoxspecificity of these materials for ‘ET’S limits their applicabi&. 
()tber materials such as carbon monoxide and nitrogen &oxide 
have heen measured in personal monitoring studies attempting to 
sss.sss individuals’ exposure to ETS. Their nonspecificity and lack of 
sensitivity for low-level ETS exposure make them inappropriate for 
pop~ation-based StUdies. 
persald monitoring techniques are currently available that will 
&cw the assessment of individual exposures to various components 
of E’l’S. Although not widely used in the past, they can provide 
&u&le input in developing exposure models and in vaM&ing 
other monitoring schemes. Their usefulness is primarily that they 
sample all of the microenvironments in which individuals find 
t&mselves and therefore automatically compensate for the nonurn- 
form temporal and spatial distributions of ETS that affect individual 
exposure profiles. 
Conclusions 
1. Undiluted sidestream smoke is characterized by significantly 
higher concentrations of many of the toxic and carcinogenic 
compounds found in mainstream smoke, including ammonia, 
volatile amines, volatile nitrosamines, certain nicotine decom- 
position products, and aromatic amines. 
2. Environmental tobacco smoke can be a substantial contributor 
to the level of indoor air pollution concentrations of respirahle 
particles, benzene, acrolein, N-nitrosamine, pyrene, and carbon 
monoxide. ETS is the only source of nicotine and some N- 
nitrosamine compounds in the general environment. 
3. Measured exposures to respirable suspended particulates are 
higher for nonsmokers who report exposure to environmental 
tobacco smoke. Exposures to JTI’S occur widely in the non- 
smoking population. 
4. The small particle size of environmental tobacco smoke places 
it in the diffusion-controlled regime of movement in air for 
deposition and removal mechanisms. Because these submicron 
particles will follow air streams, convective currents will 
dominate and the distribution of El% will occur rapidly 
through the volume of a room. As a result, the simple 
separation of smokers and nonsmokers within the same 
airspace may reduce, but will not eliminate, exposure to ETS. 
5. It has been demonstrated that El% has resulted in elevated 
respirable suspended particulate levels in enclosed places. 
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An understanding of the deposition of &arette smoke partick in 
the respiratory tract is important because many of the toxic 
cmstituents of cigarette smoke are conbined in the particles. me 
quantity retained, which c~nstitutea the dose, is some fraction of the 
quantity inhaled. Meas~reg of tobacco smoke constituents or their 
metabolites are also important because they reflect the absorption of 
tobacco smoke by the individual smoker or nonsmoker, and therefore 
may be more accurate markers of the actual exposure experienced 
by an individual. There is little experimental information describing 
the deposition of environmental tobacco smoke in the respiratory 
tract (Jarvis et al. 1983). However, cigarette smoke particles 
probably behave in a manner similar to other inhaled particles. I,n 
contrast, there are a number of observations of different markers in 
the biological fluids of smokers and nonsmokers. This review begins 
with a discussion of particle deposition in general and the factors 
that affect deposition. This understanding is then applied to the 
existing data on tobacco smoke deposition in the human respiratory 
tract. Subsequently, a variety of biologic markers of smoke absorp- 
tion are e namined, and the levels of these markers found in smokers 
and nonsmokers under a variety of circumstances are presented. 
~inal.ly, an attempt is made to qua&it& the exposure of nonsmok- 
ers relative to that of active smokers using levels of these biologic 
markers. 
Deposition 
The term “deposition” refers to the transfer of a particle from 
inhaled air to the surface of any portion of the respiratory tract, 
from nose to alveolus. “Retention” is the quantity of deposited 
material remaining in the respiratory tract at a specified time 
following deposition. Retention decreases as clearance mechanisms 
such as mucociliary action and absorption reduce the respiratory 
tract burden of inhaled particles. Retention is not discussed in this 
review. 
An aerosol is a suspension of particles in a gaseous or vapor 
medium; cigarette smoke is an aerosol. Aerosols are characterized by 
such terms as mass median diameter @MD), the diameter below 
which lies one-half of the particles by mass, and count median 
diameter (CMD), the diameter below which lies one-half of the 
particles by number. Most naturally occurring aerosols have a log- 
normal size distribution, and the magnitude of the spread of particle 
size is the geometric standard deviation @SD). Particle ma88 is a 
function of the cube of the diameter; a particle with a diameter of 0.5 
pm has one one-thousandth of the mass of a 5 pm particle. Thus, for 
au aerosol with a large geometric standard deviation, the mass 
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median heter may be considerably greater than the count 
median hemr. The smaller pdicle~ of an aerosol, despite tbeu 
relatively small mass, have a large total surface area because of their 
great number. A monodisperse aerosol has particles of one size, with 
C&ID equal to M&ID, and a G-SD of 1. For practical purposes, a GSD 
of 13 or less is accepted as monodisperse. Most naturally oawring 
mrmb EU-C? p~lydisperse, with GSDs in the 2 range. A lognormally 
&t&&cl aerosol with a GSD of 2 and a CMD of 0.1 will have an 
MMD of O.&-Z. In this discussion, when size is referred to, it is the 
JMI$D unless otherwise stated. Both the total deposition and the 
‘deposition site in the respiratory tract vary substantially with 
particle size. 
site wtributlon of Cigarette Smoke 
m Smoke 
The size distribution of cigarette smoke hes been of interest to 
investigators for many years. The important relationship between 
size and respiratory tract deposition is discussed below. Most studier 
have been performed using mainstream smoke. Mainstream smoke 
is the smoke exiting from the butt of the cigarette during puff- 
drawing, and sidestream smoke is the smoke plume that drifts into 
the environment from the burning tip of a cigarette between puffk. 
Environmental tobacco smoke @TS) is the ambient burden of 
side&ream smoke and the smoke exhaled by a smoker. Involuntary 
smoking is the consumption of ETS by people, either smokers or 
nonsmokers, from the environment. One purpose in discus&g the 
size distribution and respiratory tract deposition of particles is to 
illustrate the discrepancy between the measured particle size of 
mamstresm smoke and its measured deposition in the human 
respiratory tract. The deposition fraction of mainstream smoke is 
several times higher than would be predicted on the basis of its 
particulate size. The measured deposition of side&ream smoke is 
more in keeping with its measured size (Hiller, McCusker et al. 
1982). 
The standard laboratory smoke-generation technique is tc force 
air through the cigarette as would be done by a smoker, followed by 
the rapid dilution of the resulting mainstream smoke so that particle 
size can be measured. A standard 36 cma, 2-second puff is usdY 
used, although actual puff volume was shown to average 45 cm’ in 
one tidy (Mitchell 1962) and 56 cm3 in mother; for individuals, the 
Puff vohme can vary from 20 to 30 ems UP to 70 to 80 ems (Hinds et 
al. 1983). 
The sire distribution of the diluted mainstream smoke aerosol in 
then m-u& by one of a variety of techniques such as light 
scattering devices, microscopic measurement, or impactor collectipg 
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devices. using various diluting and sizing techniques, particle s& 
measurements of mainstream cigarette smoke have been repor-teo 
from many laboratories (Table 1). One potential cause of error in 
measuring the Sk%3 distribution of main&-e&m cigarette smoke & the 
relative insensitivity to ultrafine particles of some previously used 
measurement methods. More recent studies using newer measure- 
ment techniques support the suggestions by the earlier investigators 
(Sinclair 1950) that there is an ultrafine, (< 0.1 pm) component u-~ the 
cigarette smoke. Size characteristics have been measured by electron 
microscopic methods, following rapid fixation of undiluted fresh 
tobacco smoke, as CMD 0.2 pm and GSD 1.5 (Keith 1982). me sb 
distribution measured with an electrical aerosol analyzer has been 
reported as CMD 0.1 pm, GSD 2.0, suggesting more ultrafine 
particles than previously recognized (Anderson and HjJ,ler 19%). 
Smaller particles (< 0.4 pm) of tobacco smoke have been shown to 
have a chemical composition different from that of larger particles 
(St&x 19&I), possibly because of the large surface area of smaller 
particles. 
Laboratory methods, such as rapid dilution, commonly used to 
study mainstream smoke, are highly artificial and may not accurate- 
ly duplicate the generation, dilution, and inhalation of mainstream 
smoke by the smoker. Smoking technique and respiratory tract 
conditions may promote changes in particle size. Therefore, the 
particulate sizes in the respiratory tract may differ from the sizes 
measured when mainstream smoke is diluted for size analysis or 
when diluted sidestream smoke is inhaled by the involuntary 
smoker. The smoker’s puff is taken as a bolus in a relatively small 
volume of air into the humid upper respiratory tract. Smoking 
techniques vary widely (Griffrtbs and Henningfield 1982) and have 
been shown to vary significantly among groups classified as healthy 
smokers compared with those with emphysema and also between 
those with emphysema and those with bronchogenic carcinoma and 
bronchitis (Medici et al. 1985). Some smokers hold the puff in the 
mouth for several seconds prior to deep inhalation. The initial puff is 
highly concentrated, with approximately lo8 particles/ems. At this 
concentration, particle coagulation can occur rapidly, causing a 
tenfold to a hundredfold reduction in particle number and an 
increase in particle size (Hinds 1982). Also, the accumulation of 
water in or on the particles in the high humidity of the respiratory 
tract can increase particle diameter (Muir 1974), and may increase 
the diameter as much as 30 percent (Mitchell 1962). Some evidence 
suggests, however, that at least for dilute cigarette smoke, hygrc+ 
scopic growth occurs only under supersaturated conditions (Kousaka 
et al. 1982). Coagulation and water uptake by particles in the 
respiratory tract may considerably alter particle size distributions so 
that measurements under laboratory conditions probably do not 
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!i ‘l’ABLE L--Size distribution of mainstream tobacco smoke 
Study 
Size (pm). concentration 
[no. particles/cm’] Dilution Method Comment 




DallaValle et al. 
(1959) 
CMD 0.27 Not given Oscillation amplitude 
CMD 0.0-0.3 fresh 
CMD 0.4-0.5 aged 
0.1-025 Not given 
Light scattering 
Electrostatic separation 
Agedz size increase attributed to 
water accumulation 
Langer and Fisher 
m53 
CMD 0.5 filter 
CMD 0.6 plain 
12-6 x 1OY 
1431 Microscopic impinger 
collection 
Compared with electrostatic 
precipitation 
mm 1.75 








Porstendijrfer and ChlD 0.22 
Schraub (1972) [5-7 x 108] 
1OO,ocQ1 Related rate of deposition 
of radioactive decay 
products onto particles to 
particle 8ir.e 







Radon daughter attached 







1,50&l Liiht scattering GSD 1.46 
TABLE l.-Continued 
Size (pm), concentration 
Study [no. particleelcm’] Dilution Method Comment 
Hinds 
(1978) 
McCusker et al. 
(19821 











Laser doppler v&&o&y 
Size distribution decreases as 
dilution incrensee 
GSD 1.3-1.6 
Aerodynamic diameter OSD 1.4 
CMD 0.24-0.26 
[3.6 x lay 
MMD 5.5 secondary 
mode 
&l-18:1 Electrical aerosol aaaIyzer 
(EAA) 




l-8 I 100 
Primary mode @AA) CSD 1.18 
Secoad mode (CD Sk-3046 of 
total mass 
NOTE: CMD = count median diameter: MMD = mass medii diimeter; GSD = geometric standard deviation. 
TABLE 2.-&e distribution of sidestream tobacco smoke 




CMD 0.16 296zl AWSOl Nature of sideetxeam 
centrifuee centrifuge smoke generation 
pmcmamakeadif6cult 
exact detednation of 
wncentration at 











Mecusker et al. 
w32) 
CMD 0.31 Not &en Laser doppler 
veIwiIn* 
GED 1.6 
NUlECMD=axmtmediMdiamaa;~=geometric etamid deviation 
represent distributions found in actual mainstream smoking condi- 
tions. 
Side&ream Smoke 
Sidestream smoke is generated by cigarettes burning spontaneous- 
ly between puffs and is quantitatively the major contributor to ETS. 
Fit+five percent of the tobacco in a cigarette is burned between 
puffs, forming sidestream smoke (see Chapter 3). Dilution takes place 
as smoke rises in the ambient air currents. This dilution with air 
reduces, but probably does not eliminate entirely, the coagulation 
that causes the particulate to increase in size, as they may in the 
highly concentrated state that occurs when a smoker draws a puff of 
mainstream smoke into the mouth and holds it briefly before 
inhalation. The size distribution of sidestream smoke might be 
expected to resemble that of diluted mainstream smoke. The results 
of several reports of sidestream smoke size measurements (Table 2) 
support this impression. 
Particle Deposition in the Respiratory Tract 
Total Deposition 
Total deposition haa been studied both theoretically and experi- 
mentally. Mathematical equations can be used to predict deposition 
by combining mathematical models of lung anatomy with equations 
describing the behavior of particles in tubes. The major property to 
be considered is particle size and its influence on impaction, 
sedimentation, and diffusion. Inertial impaction is the mechanism 
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that causes Particles moving in an airstream to be tile, because of 
exceesive mass, to follow the airstream around a bend. Large 
particles impact at the bend in the aimtmam or m the lung on or 
near a site of airway branching. The Iarger the particle the greater 
its chance of depositing by impaction. Impaction ia a relatively 
unimportant form of deposition for particles smaller than 0.6 pm. 
The effect of gravily on suspended particles causes them to fall, a 
process called sedimentation, which also becomes relatively unim- 
portant for particles less than 0.6 I.Lm in size. Larger particles fall 
faster, end for all particles, the greater the residence time (in the 
lung) the greater the likelihood of deposition by sedimentation. 
Diffusion is the net transport of particles caused by Brownian 
motion. It becomes increasingly important for particles less than 0.5 
pm in size (Hinds 1982). The mass median diameter of aide&ream 
smoke is in the 0.3 to 0.5 w size range. Total deposition for inhaled 
particles is in the 10 to 30 percent range for 0.5 pm sixed particles. 
In Figure 1, Lippmann’s review (1977) of the measurements of 
total deposition of monodisperse aerosols in human subjecta is 
modified to include more recent data and data on ultrafine particle 
depcsition. 
The respiratory pattern clearly affects particle deposition. Most 
important for all particles, including environmental tobacco smoke, 
is the residence time in the lung. Deposition increases with slow deep 
inspiration (Altshuler et al. 1957) and with breath holding (Pahnes et 
al. 1966, Anderson and Hiller 1985). In hamsters, the deposition of 
0.38 pm particles rises in a nearly linear fashion with oxygen 
consumption (Harbison and Brain 1983). These data indicate that 
deposition of ETS during involuntary smoking increases with the 
increasing activity level of the exposed individual. 
The presence of an electrical charge on particles may increase 
deposition, Mainstream smoke is highly charged (Corn 1974). The 
addition of either a positive charge or a negative charge to inhaled 
particles increases deposition in animals (Fraser 19&l), and neutral- 
ization of the charge reduces deposition 21 percent in rats (Per-in et 
al. 1983). There is little information describing the effect of a charge 
on the deposition of either mainstream or side&ream smoke in 
human subjects. 
Particle growth by water absorption may affect deposition. Mathe- 
matical models that describe the effect of humidity on particle 
growth indicate the potential for a considerable change in size of 
some particles during transit in the humid rt -iratory tract (Perron 
1977; Cocks and Fernando 1982; Renninger et al. 1981; Martonen 
and Pate1 1981) and that these changes could ~igniikmtly alter 
deposition @‘err-on 1977). Growth of 0.4 to 0.5 p particles should 
increase their deposition fraction, but growth of a 0.07 pm particle to 
0.1 pm, for example, would reduce its deposition (see Figure 1). Such 
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an effect has been shown for laboratory-generated aerosols in human 
subjects (Blanchard and Willeke 1983; Tu and Knudson 1984). While 
hygroscopic growth has been postulated for tobacco smoke (Muir 
1974), it has been demonstrated in the laboratory to occur, at least 
for dilute smoke, only in supersaturated conditions (Kousaka et al. 
1982). 
Many reports describe measured deposition of mainstream ciga- 
rette smoke in the human respiratory tract CTable 3). Although few 
studies of total sidestream smoke deposition are available, those few 
(Table 3) suggest that sidestream smoke does indeed deposit in a 
manner similar to that found for laboratoryde&ned research 
aerosols. The deposition fraction of mainstream smoke diluted 1:30 
and inhaled by rata from chamber air containing 1.68 mg/L 
(assuming a rat tidal vo 1 ume of 1.5 mL and a respiratory rate of 85) is 
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8.1 percent @IUU et d. 1978). &positiop for the side&ream smoke 
has been measured in mouth-breathing human volunteers at 11 
pertint, similar to that for similarly sized polystyrene latex spheres 
(Hiller, Mazumder et al. 1982). Environmental tobacco smoke 
exposure frequently occurs with breathing through the nose rather 
than through the mouth, but inert particles in the size range of ETS 
(0.2 to 0.4 pm) are not substantially reduced in number by passage 
through the nose. The fraction of inert 0.2 pm particles deposited in 
the alveolar region of the lung is similar for mouth breathing and 
nasal breathing (Raabe 1984). It is possible that the charged or 
reactive particles of J3TS may behave somewhat differently than 
inert particles, but it seems unlikely that nasal breathing substan- 
tially alters the deposition of the small particles of EY.CS in 
comparison with mouth breathing. 
Ftegiomd Deposition 
Total deposition is subdivided into the fractions depositing in the 
upper respiratory tract (larynx and above), the tracheobronchial 
region (trachea to and including terminal bronchioles), and the 
pulmonary region (respiratory bronchioles and beyond) (Figure 2). 
Deposition in these areas is referred to as regional deposition. 
Particle size is a major dete rminant of both total and regional 
deposition. A mathematical model prediction of regional deposition 
of polydisperse aerosols is shown in Figure 2 (ICRP 1966). 
Experimental verification of mathematical models of regional 
deposition is limited. Using isotope-labeled particles, it is possible to 
quantitate the upper respiratory tract deposition as a fraction of 
total deposition. By assuming that the aerosol depositing in the 
tracheobronchial region will be cleared within 24 hours, it is possible 
to measure alveolar deposition as the fraction of the total initial 
deposition below the larynx that is remaining at 24 hours and 
tracheobronchial deposition as the difference between the initial 
deposition and what is remaining at 24 hours. Using this method, the 
deposition of 3.5 pm particles was this: total deposition, 0.79; upper 
respiratory tract, 0.10; tracheobronchial region, 0.24; and pulmonary 
region (alveolar), 0.45 (Emmett et al. 1982). These measurements are 
below the estimated regional deposition for upper respiratory tract 
deposition and higher for the pulmonary deposition than are the 
measurements calculated by using the Task Group on Lung Dynam- 
ics model (ICRP 1966). 
‘The regional deposition of mainstream cigarette smoke in smokers 
ha alSo been studied. Subjects inhaled smoke from cigarettes 
labeled with radioactive l-iodohexadecane (Black and Pritchard 
1984; Pritchard and Black 1984). The results indicate that less than 
40 percent of the particulate mass deposited in the pulmonary 
region, compared with an expected 90 percent deposition in the 
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Figure Z.-Regional deposition of particles inhaled during 
nasal breathing, as predicted using the 
deposition model proposed by the Tack Group 
on Lung Dynamics 
pulmonary region for 0.5 pm particles, the size reported for cigarette 
smoke (Table 1). This finding further supports the concept that 
mainstream smoke particles increase in size in the respiratory tract 
by coagulation, hygroscopic growth, or both, and that this growth 
affects total and regional deposition. The same group studied the 
effect of switching the tar content of cigarettes on regional deposi- 
tion. Using. cigarettes with between 16 and 17 mg tar, extrathoracic 
deposition was found to be 14 percent of the total deposition and 
intrathoracic deposition to be 86 percent, with 51 percent in the 
tracheobronchial area and 35 percent in the pulmonary region 
(Pritchard and Black 1984). After switching to cigarettes with 
between 8 and 9 mg tar, total deposition was 74 percent of that 
measured from cigarettes with the higher tar content, the extratho 
racic deposition was unchanged, the tracheobronchial deposition was 
from 34 to 42 percent, and the pulmonary deposition was 18 to 25 
percent of the total mass deposited with the higher tar cigarettes. 
With the use of mathematical deposition modeling, the observed 
deposition pattern was consistent with one predicted for an aerosol 
with an MMD of 6.5 pm, more than 10 times greater than the MMD 
described for cigarette smoke (Black and Pritchard 1984). 
The deposition of particles is probably not uniform within a lung 
region. The mass deposited in the airways, for instance, may vary 
191 
widely. -4 deposition at specific anatomic sites may ba 
eswy important for mme inhalants. For example, the concentra- 
tion of carcinogenic subetances at a site may favor that site for 
cancer development. This may be e@ecmhY hW”rtant for c*arett@ 
smoke, hm lung mcer my occur at sites of high deposition such 
88 my bifurcations. &p&ion of a 0.3 v laboratory-generated 
stable -1 has been shown to favor right upper lobe deposition, 
and on t-he ba& of surface density of deposition, the lobar bronchi 
(wesmger and Lippmann 1978). The deposition per airway genera- 
&n haa been d&~ for large particles, but has not received 
sufficient a-eon for p&idea in the size range of main&ream or 
Bidegtream smoke. A deposition peak has been Predicted, using a 
lung model for the fourth airway generation (trachea is 0) for 5 q 
particles, and a peak in airway surface concentration density was 
predicted for 8 w particles at the fourth generation (Gerrity et al. 
1979). Both of these deposition peaks are calculated for particles 
&&&ially larger than those of cigarette smoke. 
)3q0&ions may be quite nonuniform even within a single airway 
generation. An enhanced deposition at bifurcations with highly 
concentrated deposition on carina ridges within bifurcations has 
been demonstrated in a five airway generation model of the human 
respiratory tract for both cigarette smoke (l&u-tonen and Lowe 
1983a) and restxnch aerosols (Martonen and Lowe 1983153. 
Epidemiological studies of the pathophysiologic consequences of 
involuntary smoking have emphasized, among other things, an 
increase in the incidence of respiratory illness in children (see 
Chapter 2). The issue of the respiratory tract deposition of particles 
in children has been addressed only recently. Using morphometrm 
measurements from casts of the lungs of children and young adults 
aged 11 days to 21 years, a mathematical growth model was created. 
Using this model and conventional methods for predicting the 
behavior of particles in tubes, the deposition of particles at various 
ag- c-m be presided. On the basis of these calculations, tracheo- 
bronchial depositions per kilogram of body weight for 5 p particles 
Was &h&d b be six times higher in the resting newborn than m a 
resting adult @halen et al. 19851. Differences are predicted &o for 
particles the s&e of sidestream smoke, with tracheobroncm 
deposition m infancy beii twofold to threefold higher in adulthood. 
Total deposition has also been estimated using mathematical model- 
ing, with the total deposition estimated at approximately 15 percent 
at age 6 months and at 10 percent in adults (XU and YU 1936). 
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ResphtoW Tract Dose of EnvIronmental ~-cc0 smoke 
Cigarette Smoke Particulate lbht3 ~epoeited 
The dose of environmental tobacco smoke to the respiratory tract 
is the product of the mass in inhaled air and the deposition fraction. 
To this point, particle size and deposition fraction, which is related to 
both size and respiratory pattern as well as to other less understood 
factors such as particle charge and hygroscopicity have been 
addressed. To estimate dose, the content of smoke in inhaled air- 
must be known, as well as the respired minute volume. m content 
in inhaled air varies widely, as does minute volume, which depends 
considerably on activity level. Sidestream smoke concentrations 
have been raised as high as 16.5 mg/m5 in expetiental chambers 
(Hoegg 1972). High levels, 2 to 4 mg/ms, have also been estimated 
using measured carbon monoxide concentrations for rooms 146 m’ in 
size containing 50 to 70 persons @ridge and Corn 1972). Such levels 
far exceed the EPA air quality standards for total suspended 
particulate of 75 w/m* annual average and the 260 w/m* 24-hour 
average in the United States and the 250 w/ma 24-hour average for 
the United Kingdom. 
Measurement8 of environmental smoke concentrations vary wide- 
ly, depending upon the location and measurement technique (Tables 
4 and 5). Levels of total suspended particulates (TSP) measured 
under realistic circumstances have been found to be from 20 to 60 
w/m3 in no-smoking areas, and can range from 100 to 700 &ms in 
the presence of smokers (Repace and Lowrey 1980). These measure- 
ments include all suspended particulates, and so could include 
part&e other than tobacco smoke. However, in a smoky indoor 
setting where measurements as high as 600 w/m9 have been found, 
tobacco smoke is the major contributor to particulate mass, with the 
non-tobaccwmoke contribution being small and similar to that 
measured for nonsmoking areas, namely in the 20 to 60 @mS range. 
This concept is supported by studies in which tobacco smoke 
concentration in the environment was determined by measuring the 
Gcotme content of suspended particulates. Using this technique 
(Hinds and First 1975), EI’S levels have been ehimati to be 20 to 
4.80 p,g/ms in bus and airline waiting rooms and as bigh as 640 p&m” 
in cocktail lounges. These calculations of smoke concentrations were 
based on an average weighted nicotine fraction of 2.6 percent, an 
approach that may underestimate tobacco smoke particulate concen- 
tration. 
The mass deposition in the respiratory tract can be estimated if 
the atmospheric burden of cigarette smoke particulates, minute 
volume, and deposition fraction is known. Assuming a smoke 
concentration of 500 CLg/mS, a minute volume of 12 liters per minute, 
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TABLE 4.--Indoor concentration of total suspended p&cUlates (TSP) meamlred iu OIY%II~ living or 
work.ing situations 
Study 
Just et al. 
(1972) 




Conditions of location, 

























Not applicable Suspended paarticulates _ _ 
collected on filter; nicotine 
content measured for 
calculation; TSP = 
nicotine/O.026 
Elliott and Rowe 
(1975) 
Attendance 9,660 
Air conditioned (S) 
Attendance 14,300 
Air conditioned (S) 
Attendance 2,900 
Not air conditioned 9X 
Attendance 11,990 





High volume sampler for 
suspended particulates; also 
measured Co at all locations 
and benr4alpyrene in arena A 
Cuddeback et al. 
(1976) 
Tavern 6 air changes/hr 
Tavern None apparent 
0.31 f 0.05 
(0.23-0.34) 
0.99 
8hr air sample collected on 
filter (6 pm pore size); TSP 
measured gravimetrically 









Conditions of location, 
occupsncy, smoking 03, 
nonsmoking (NS) 
TSP 
pm/m” x &SD 
Sackground 
pm/m3 Comments 
Weber and Fischer 
(1930) 











32144 allowed unrestricted 
smoking 
Air conditioned 
5 locations, 6 measurements, 
10 * 8 persons/l00 m3, all 
NS 
9 locations; 10 f 10 
perwns/100 m’, all NS 
19 locations, 20 samples, 11 
+ 8 persons/100 ms, all S 
locations 
7 locations with >l 
smoker/ms (mean 2.2 
smokers/mJ) 
18 f 7 persons/lo0 ma, with 
1 smoker/l00 ma 
,202 
120 
38 f 16 
38 f 16 
242 f 176 
m-697) 






36 + 10’ 
(4 locations) 
47 f 13’ 
(13 locations) 
53 f 8' 
TSP measured with 
pieeoefectric balance (see 
above) 
All samples colfected using 
pieroelectric balance with very 
high collection efficiency at 3.6 
pm and 10% at 4 (cm; sample 
the l-60 min, outdoom 6-16 
min 
z TABLE 4.-Continued 
Study Location 
Conditions of location, 
occupancy, smoking 6% 
nonsmoking (NS) 
TSP 
pmhn’ I fsD 
Background 
pm/m’ Comments 









2 smokers, tightly sealed, 
central air conditioning 
24.4 f 11.6’ 
36.6 f. 14.6 
70.4 f 42.9 
144 
21.1 zlz 11.9 
all 55 homes 
Annual mean: respirable ma8s 
collected on filters after 
removal of nonrespirable 
fraction; ‘24-hr sample collected 
every 6 days 
’ Ambient prticulate concentration at site, but outdm~~. 
‘This home is one of the !ive homes above. 
TABLE &-Indoor concentration of total suspended particulates (TPM) generated by smoking 
cigarettes under laboratory conditions 
chamber Cigarette TPM 
Study Test conditions Ventiition Size consumption mg/m’ Comment.9 
Penkala and Well mixed None 9.2 ma 3 simultan~usly, 2 q 3.0 
de Oliveira (19’76) puffs 
Hoegg Sealed chamber; Portable fans 25 ma 24 simultaneously by 16.66 
(1972) experimenter and test circulated air 
TPM measured gravimetrically 
machine after collection of suspended 
equipment in chamber; particulatea on fdten; 
measured 18 min sidestream smoke mlIected in 
pcetamoking chamber; mainstream smoke 
dischaqp?d 
Same, 150 min Same 4 simultaneously by 1.61 
wetsmokina machine 
Hugod et al. 
(1978) 
Sealed room Unventilated 68 mJ 20 simultaneously by 
machine 
6.76 TPM measured gravimetrically 
from 3hr collection on filter; 
mainstream smoke in chamber 







11 ft3/min/oceupant 11 ma 4/hr (by occupants) 0.350 
66 ft’lminloccupant 11 mJ 4/hr fby occupants) 0.16 
11 ft’/min/occupant 11 ma 16/hr (by occupants) 1.26 
68 ft’/min/occupant 11 mJ 16/hr (by GCGU~MW 0.40 
16.4 air changes/hr 34 ms l/8 min to 60 min 0.19-0.26 
F5ezoelectric balance messwed 
total mass over 0.01-20 pm 
Pieaoelectric balance 
et al. (1963) chamber 
Climate-controlled 
chamber 
16.4 air changeslhr 30 ma 3 simultaneously, then 
2/8 min 
0.47-0.622 
and a deposition fraction of 11 percent (Hiller, McCusker et al. 1982), 
mass deposition over an &hour work shift would be 0.317 mg. 
The Concept of “Cigarette Equivalents” 
Many investigators have attempted to estimate the potential 
toxicity of involuntary smoking for the nonsmoker by calculating 
“cigarette equivalents” (C.E.). To inhale one C.E. by involuntary 
smoking, the involuntary smoker would inhale the same mass 
quantity of ETS as is inhaled from one cigarette by a mainstream 
smoker. This approach has led to estimates from as low as 0.001 C.E. 
per hour to as high as 27 C.E. per day (Hoegg 1972; Hinds and First 
1975; Hugod et al. 1978; Repace and Lowrey 1980). These differences 
of up to three orders of magnitude seem illogical when most reports 
of measurements of environmental concentrations of smoke, from 
the most clean to the most polluted with environmental tobacco 
smoke, are within tenfold to fiftyfold of each other. The following 
discussion demonstrates why the C.E. can vary so greatly as a 
measure of exposure. 
The calculation of C.E. is as follows: PMIw = TSP (mg/m’) x Ox; 
where PM&,) equals the particulate mass inhaled by passive smoking, 
TSP equals the total suspended particulate, and VE equals the 
inhaled volume. C.E. = PMI&PML); where C.E. equals cigarette 
equivalent and PML) equals the mass inhaled by (mainstream) 
smoking one cigarette. (This is taken to be the tar content of a 
cigarette as reported by the U.S. Federal Trade Commission.) 
Cigarette equivalents can be calculated for any time interval 
chosen, i.e., per hour, per day. Although the example given is for 
particulate mass, C.E. can be calculated for any component of 
cigarette smoke, such as carbon monoxide and benzo[a]pyrene. The 
following calculations illustrate the different results from two 
different approaches to the calculation of C.E. 
Example 1 Example 2 
SIB 0.36 mg/hr 20 ma/day 
PMIw 16.1 mg tar/@ 0.55 mg tar/cig 
TSP 40 CLg/mS 700 pg/m9 
Example 1 
PMIcp, = TSP x Ox 
= 40 
P 
/m9 x 0.36 ms/hr 
= 14. CLg/hr 
C.E. = PMI&PM&ms, 
= (0.0144 mg/hr)/(l6.1 mg/cig) 




= 700 w/ma x 20 ma/&y 
= 14,990 p&day 
C.E. = PMldwIk4 
= (14 mgklay)/(O.65 mghig) 
= 245 &g/day 
These caktitiOn8 of C-E. approximate the approach- d h ho 
~~rts-Exanw~e 1 by Kinds and Pi.& (1975) and Example 2 by 
Repace and Lowrey (198O)-and the results are similar. The exam- 
ples are the extremes used in the two studies, and are at the 
extremes Of CommOmy cited rep&a of C.E. Even if the Tsp 
concentration used in the two examples were the me, the multx 
would differ 24-fold because Example 1 is calculated per hour and 
Example 2 is calculated per day; 2%fold because of the aerence in 
inhaled minute volume; and 29-fold because of the difference in what 
is considered to be a ‘Wandard” cigarette. Even using the same TSP 
concentration, the results would be 1.6 x 10” different. If C.E. is to be 
calculated, all of the factors used in the calculation should be 
Standardized. 
The calculation of C.E. is deficient in several other ways. The 
deposition fraction of the total inhaled particulate mass in the 
respiratory tract from mainstream smoke is higher than from 
involuntary smoking. The deposition fraction for involuntary smok- 
ing is approximately 11 percent for mouth breathing (Hiller, 
Mazumder et al. 1982). The deposition from mainstream smoke has 
been reported to vary from 47 to 90 percent (Table 3). The cigarette 
equivalent calculation considers only the quantity inhaled, and if 
mm dose depoeited is considered, one C.E. from passive smoking 
will cause several times less mass to be deposited than the 
mainstream smoke of one cigarette. 
The differences in the chemical composition between sidestream 
smoke and mainstream smoke make the C.E. concept misleading 
unless C.E. is calculated for each smoke constituent. This has been 
accomplished (Hugod et al. 1973) using measured levels of various 
smoke co&ituente in a chamber filled with sidestream smoke. The 
redts indicate that one C.E. for carbon monoxide could b i&&j 
5.5 times faster, and for aldehyde, 2.9 times faster, than for 
particulate mass. Measurements of total particulate matter and 
benxc(a]pyrene taken in an arena with active smoking revealed a 
fivefold rise in TSP above background and an eighteenfold increase 
in benzo[ajpyrene over background. Using the measured ben- 
zo[alpyrene concentration of 21.7 ng/ms, an inhaled volume of 2.4 
ma, and 3.2 ng benxo[ajpyrene per cigarette, the occupant of such an 
environment would consume 6.4 C.E. for benzo[ajpyrene (IARC 1986, 
p. 87). The C.E. TSP would be 1.7. Therefore, a C.E. for the 
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carcinogen bedabyrene would be inhaled 3.6 times more rapidly 
w a C.E. for ‘JSP moth and Rowe 1975). 
me *de latitude h the results of C.E. calc~ations demonstrates 
the &pen&n= of the C.E. c.ahhtiOn On the numerical VahleS of the 
variables chosen, and correspondingly demonstrates the marked 
lotion of &e use of C.E. as an atmospheric measure of exposure 
b the wnb h en&m&d MOROCCO smoke. When the quantifica- 
con of an w ia needed, it is far more precise to use terms that 
defiae &e a of exposUre t0 the agent Of interest per unit 
he. However, the term cigarette equivalent is frequently used, not 
&ply 88 a mwure of exposure, but 88 a unit of disease risk that 
~~them~ured~uresintoatikofdiseaseusingthe 
known daeresponse relationships between the number of ciga- 
re#es~~perdayandtheriskofdiseaee.IfC~.istobeusedasa 
tit of risk, the variables used to convert atmospheric measures into 
levels of rid for the active smoker need to be determined on the 
basis of the depcsition and smoke exposure measures for the average 
smoker. The deposition fraction of individual smoke constituents in 
t&e population of active smokers is needed rather than the range 
ob~rved in a few individuals. In addition, the actual average yield of 
the cigarettes smoked by the subjects in the prospective mortality 
studies would be needed to compare the dose-reeponse relationships 
accurately. The yield using the Federal Trade &nmission (Fl’c 
method may dramatically underestimate the actual yield of a 
cigarette when the puff volume, rate of draw, or number of puffs is 
increeeed; therefore, calculations using the Fl’C numbers may be 
inaccurate, particularly for the low-yield cigarettes. These limita- 
tions make exlxapolation from atmospheric measurea to c&are* 
equivalent units of disease risk a complex and potentially meanin- 
BleseP~. 
lAaiwa of Absorption 
In contrast, measuma of absorption of environmental tobacco 
smoke, particularly cotinine levels, can potentially overcome some of 
the limitations in translating environmental tobacco smoke expc+ 
sure3 into expected d&ease risk. Urinary cotinine levels are a 
reLatively accurate dosage measure of exposure to smoke; they have 
been measured in populations of smokers and nonsmokers, and are 
not subject to emrs in estimates of the minute ventilation or yield of 
the average cigarette. Potential differences in the half-life of cotinine 
in smokers and nonsmokers, differences in the absorption of nicotine 
relative to other toxic agents in the smoke, and differences in the 
ratio of nicotine to other toxic agents in mainstream smoke and 
sidestream smoke remain sources of error, but the accuracy with 
which active smoking and involuntary smoking exposure can be 
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compared is almost certainly substantially greater with measures of 
absorption than with atmospheric measures. 
Tobacco smoke contains many substances, but only a few have 
been measured in human biological fluids. of the g-w compo- 
nents, markers include carbon monoxide and thiocyanate. The latter 
is not a gas but a metabolite of gaseous hydrogen cyanide. Concentra- 
tions of nicotine and its metabolite cotinine are markers of nicotine 
uptake. In mainstream smoke, nicotine uptake reflects exposure to 
particulates. In environmental tobaccc smoke, nicotine becomes 
vaporized and therefore reflects gas phase expcsure @udy et al. 
1985). Quantitating tar consumption is more difficult urinary 
mutagenic activity has been used as an indirect marker. 
The relative exposures of nonsmokers to various tobacco smoke 
constituents differs from that of smokers. Assuming that exposure to 
a single tobacco smoke constituent accurately quantifies the expo- 
sure of both smokers and nonsmokers to other constituents is 
inaccurate because mainstream smoke and environmental tobacco 
smoke differ in composition (see Chapter 3). 
To understand the usefulness and limitations of various biochemi- 
cal markers, it is important to appreciate the factors that influence 
their absorption by the body and their disposition kinetics within it. 
Carbon Monoxide 
Carbon monoxide is absorbed in the lungs, where it dZfuses across 
the alveolar membrane (Lawther 1975; Stewart 1975). It is not 
appreciably absorbed across mucous membranes or bronchioles. 
Within the body, carbon monoxide binds, as does oxygen, to 
hemoglobin, where it can be measured as carboxyhemoglobin. 
Carbon monoxide may also be bound to myoglobin and to the 
cytochrome enzyme system, although quantitative details of binding 
to the latter sites are not available. Carbon monoxide is eliminated 
primarily by respiration. The amount of ventilation influences the 
rate of elimination. Thus, the half-life of carbon monoxide during 
exercise may be less than 1 hour, whereas during sleep it may be 
greater than 8 hours (Castleden and Cole 1974). At rest, the half-life 
is3to4hour-s. 
The disposition kinetics of carbon monoxide explain the temporal 
variation of carbon monoxide concentration in active smokers during 
a day of regular smoking. With a half-life averaging 3 hours and a 
reasonably constant dosing (that is, a regular smoking rate), carbon 
monoxide levels will plateau after 9 tc 12 hours of cigarette smoking. 
This has been observed in studies of circadian variation of carbon 
monoxide concentrations in cigarette smokers (Benowitx, Kuyt et al. 
1982). Smoking is not a constant exposure source, but results in 
pulsed dosing. There is a smsll increment in carboxyhemoglobin 
level immediately after smoking a single cigarette, which then 
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declines mta tie next, cig~tt.e is smoked. But after several hours of 
smou, the m @ t&e of rise and faR is small compared with the 
trough vahres. For this reason, carboxyhemoglobm levels at the end 
of a day of smoking are satisfactory indicators of carbon monoxide 
exposure during that day. 
&bn monoi& e-m may be more’constant during environ- 
mental ~~CCCB m&e exposure than during active smoking. The 
major lim itation m  using carbon monoxide as a means of measuring 
hrvohmtary smoke exposure is its lack of specificity. Endogenous 
carbcn monoxide generation from the metabolism of hemoglobin 
results in a low level of carbo~hemoglobin (up to 1 percent) 
(Lawther 1975; Stewart 1975). Carbon monoxide is generated by any 
source of combustion, including gas stoves, machinery, and automo 
bile exhaust. Thus, nonsmokers in a community with moderate home 
and industrial carbon monoxide sources may have carboxyhemogb 
bin levels of 2 or 3 percent (Woebkenberg et al. 1981). A carbon 
monoxide level of 10 in room air results in an increment of 0.4 and 
1.4 percent carboxyhemoglobin at 1 and 8 hours of exposure time, 
respectively (Lawther 1975; Stewart 1975). Thus, small increments of 
carhcn monoxide due to environmental tobacco smoke may be 
indistinguishable from that due to endogenous and non-tobacco 
related sources. 
Measurement of carbon monoxide is straightforward and i,nexpen- 
sive. &dar carbon monoxide pressures are proportional to the 
concentration of carhoxyhemoglobin in blood, therefore, end&~ 
carbon monoxide tension accurately reflects blood carboxyhemoglo 
bin (Jti and Russell 1980). Expired carbon monofide - & 
measured Using an instrument (Ecolyzer) that measures the rate of 
conversion of carbon monoxide to carbon &&de 88 it pm over a 
catalytically active electrode. Blood carboxyhemoglobin - b 
xm~~ured ~~1~ ad quickly wing a differential spectropho~m~ 
ter. 
Hydrogen cyanide is metabolized by the liver to thiooyanate. In 
addition to tobacco smoke, certain foods, particularly leafy vegeta- 
bles and some nuts, are sources of cyanide. Cyanide is also present in 
beer. 
Thiocyanatc is distributed in extracellular fluid and is eliminated 
slowly by the kidneys. The half-life of thiocyanate is long, about 7 to 
14 days. Thiocyanate is also secreted into saliva, with salivary levels 
about 10 times that of plasma levels (Haley et al. 1983). The long 
half-life of thiocyanate means that there is little flu&ration in 
plasma thiocyanate concentrations during a day or from day to day. 
Thus, the time of sampling is not critical. On the other hand, a given 
level of thiocyanate reflects exposure to hydrogen cyanide over 
several we&~ ~mceding the time of sampling. When a smoker stops 
smoking, it takes an estimated 3 to 6 weeks for thiocyanate levels to 
reach that individual’s nonsmoking level. 
Because of the presence of cyanide in foods, chiocyanate is not 
specific for exposure to cigarette smoke. Although active smokers 
have plasma levels of thiocyanate two to four times those of 
nonsmokers (vogt et al. 1979, Jacob et al. 1981), light smokers or 
involuntary smokers may have little or no elevation of thiocyanate. 
When thousands of subjects are studied, involuntary smokers have 
been found to have slightly higher thiooyanate levels than those 
without exposure (Friedman et al. 1983). Other studies of smaller 
numbers of subjects have shown no difference in thiocyanate level 
between exposed or nonexposed nonsmokers (Jarvis et al. 1984). 
Serum or plasma thiocyanate levels can be measured using 
spedrophotometric methods or, alternatively, gas chromatography. 
Nicotine 
Nicotine ia absorbed through the mucous membranes of the mouth 
and bronchial tree as well as across the alveolar capillary mem- 
brane. The extent of mucosal absorption varies with the pH of the 
smoke, such that nicotine is absorbed in the mouth from alkaline 
(cigar) smoke or buffered chewing gum, but very little is absorbed 
from acidic (cigarette) mainstream smoke (Armitage and Turner 
1970). With aging, environmental tobacco smoke becomes less acidic; 
pH may rise to 7.5, and buccal or nasal absorption of nicotine by the 
nonsmoker could occur (see Chapter 3). 
Nicotine is distributed rapidly to body tissues and is rapidly and 
extensively metabolized by the liver. Urinary excretion of unmetabo- 
lized nicotine is responsible for from 2 to 25 percent of total nicotine 
ehnrination in alkaline and acid urine, respectively; nicotine excre- 
tion also varies with urine flow (Rosenberg et al. 1980). Exposure to 
environmental tobacco smoke, active smoking, and use of smokeless 
tobacco markedly elevate salivary nicotine transiently out of propor- 
tion to serum and urinary levels (Hoffiann et al. 1984). Nicotine is 
present in breast milk (Luck and Nau 1985), and the concentration 
in the milk is almost three times the serum concentration in the 
mother (Luck and Nau 1984). 
The rate of nicotine metabolism varies considerably, as much as 
fourfold among smokers (Benowitz, Jacob et al. 1982). There is 
evidence that nicotine is metabolized less rapidly by nonsmokers 
than by smokers (Kyerematen et al. 1982). A given level of nicotine 
in the body reflects the balance between nicotine absorption and the 
metabolism and excretion rates. Thus, in comparing two persons 
with the same average blood concentration of nicotine, a rapid 
metabolizer may be absorbing up to four times as much nicotine as a 
slow metabolizer. To determine daily uptake of nicotine directly, 
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both the nicotine blood concentrations and the rates of metabolism 
and excretion must be known. These variables can he measured in 
experimental studies (Renowitz and Jacob 1984; Feyerabend et al. 
1985), but are not feasible for large-scale epidemiologic studies. 
The time course of the decline of blood concentrations of nicotine is 
multiexponential. Following the smoking of a. single cigarette or an 
intravenous injection of nicotine, blood concentrations of nicotine 
decline rapidly owing to tissue uptake, with a half-life of 5 to 10 
minutes. If concentrations are followed over a longer period of time 
or if multiple doses are consumed so that the tissues are saturated, a 
longer elimination half-life of about 2 hours becomes apparent 
(Renowitz, Jacob et al. 1982; Feyerabend et al. 1985). Because of the 
rapid and extensive distribution in the tissues, there is considerable 
fluctuation in nicotine levels in cigarette smokers during and after 
smoking. As predicted by the Z-hour half-life, nicotine blood concen- 
trations increase progressively and plateau after 6 to 8 hours of 
regular smoking (Renowitz, Kuyt et al. 1982). Nicotine concentra- 
tions have been sampled in the afternoon in studies of nicotine 
uptake during active cigarette smoking (Renowitz and Jacob 1964, 
and similar timing might be appropriate in assessing the plateau 
levels that result from continuous ETS exposure, such as during a 
workday. 
Russell and colleagues (1965) quantitated nicotine exposure by 
comparing blood nicotine concentrations during intravenous infu- 
sions (0.5 to 1.0 mg over 60 minutes) in nonsmokers to the blood 
nicotine concentrations in nonsmokers exposed to environmental 
tobacco smoke. The data suggest that nicotine uptake in a smoky bar 
in 2 hours averaged 0.20 mg per hour. .. 
The presence of nicotine in biologic fluids is highly specific for. 
tobacco or tobacco smoke exposure. Nicotine concentration is sensi- 
tive to recent exposure because of nicotine’s relatively rapid and 
extensive tissue distribution and its rapid metabolism. Urinary 
nicotine concentration has been examined in a number of studies of 
environmental tobacco smoke exposure. Although influenced by 
urine pH and flow rate, the excretion rate of nicotine in the urine 
reflects the concentration of nicotine in the blood -over the time 
period of urine sampling. In other words, nicotine excretion in a 
timed urine collection is an integrated measure of the body’s 
exposure to nicotine during that time. When timed urine collections 
are not available, nicotine excretion is commonly expressed as a 
ratio of urinary nicotine to urinary creatinine, which is excreted at a 
relatively constant rate throughout the day. Urinary nicotine 
excretion is highly sensitive to environmental tobacco smoke expo 
-sure (Hoffmann et al. 1984; Russell and Feyerabend 1975). Saliva 
levels of nicotine rise rapidly during exposure to sidestream smoke 
and fall rapidly after exposure has ended (Hoffmann et al. 1984). 
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Presumably, this the course reflects local mouth contamination, 
followed by absorption or the swallowing of dcotine. 
Blood, urine, or saliva concentrations of nicotine can be measured 
by gas chromatography, radioimmunoaaeay, or high pressure liquid 
chromatography- sample preparation is problematic in that contam- 
ination of samples with even small amounts of tobacco smoke c8n 
substantially elevate the normally low concentrations of nicotine in 
the blood. Thus, careful Precautions against contamination during 
sample collection and processing for analysis are essential. &cause 
the concentrations are so low, the measurement of nicotine in blood 
has been difficult for many laboratories in the past, but with 
currently available assays, it is feasible for largescale epidemiologic 
StUdiM. 
C&nine 
Cotinine, the major metabolite of nicotine, is distributed to body 
tissues to a much lesser extent than nicotine, Cotmine is eljmmated 
primarily by metabolism, with 15 to 20 percent excreted unchanged 
in the urine (Benowitz et al. 1983). Urinary pH does affect the r-end 
elimination of cotinine, but the effect is not as great as for nicotine. 
Since renal clearance of cotinine is much less variable than that of 
nicotine, urinary cotinine levels reflect blood coti.&e levels better 
than urinary nicotine levels reflect blood nicotine levels. Plasma, 
urine, and saliva cotinine concentrations correlate strongly with one 
another (Haley et al. 1983; Jarvis et al. 1984). 
The elimination half-life for cotinine averagea 20 hours (range, 10 
to 37 hours) (Benowitz et al. 1983). Because of the relatively long 
half-life of cotinine, blood concentrations are relatively stable 
throughout the day for the active smoker, reaching a maximum near 
the end of the day. Because each cigarette adds relatively little to the 
overall cotinine level, sampling time with respect to smoking is not 
critical. Assuming that smoke exposure occurs throughout the day, a 
midafterrmcm or late afternoon level reflect8 the average wtinine 
concentration. 
The specificity of cotinine as a marker for cigarette smoking ie 
excellent. Because of its long -half-life and its high specificity, 
cotinine measurements have become the most widely accepted 
m&hod for assessing the uptake of nicotine from tobacco, for both 
active and involuntary smoking. 
Gotinine levels can be used to generate quantitative estimates of 
nicotine absorption. Galeazzi and colleagues (1985) defined a linear 
relationship between nicotine uptake and plasma cotinine levels in 
six healthy volunteers who received several i.v. doses of nicotine 
( 5 480 &kg/day) for 4 days. The ability to extrapolate from this 
model to levels in nonsmokers is limited, however, because the 
elimination half-life of cotinine may be shorter in smokers than in 
nsmokers, as is the elimination ha&life of nicotine (Kyerematen 
1; al. 1982). 
Cotinine can be assayed by radioimmunoassay, gas chromatogra- 
phy, and high pressure liquid chromatography. 
Urinary Mutagenicity 
TO&~ smoke condensate is strongly mutagenic in bacterial test 
s-m (ties test) (Kier et al. 1974). A number of compourids, 
j&u&g polycyclic aromatic hydrocarbons, contribute to this 
mutagenicity. The urine of cigarette smokers has been found to he 
mutagenic, and the number of bacterial revertants per test plate is 
r&ted to the number of cigarettes smoked per day Wamasaki and 
Ames 1977). Urinary mutagenicity disappears within 24 hours after 
smoking the last cigarette &do et al. 1986). 
For several reasons, the measurement of mutagenic activity of the 
urine is not a good quantitative measure of tar absorption. Individu- 
als metabolize polycyclic aromatic hydrocarbons and other mutagen- 
ic substances differently. Only a small percentage of what is 
absorbed is excreted in the urine as mutagenic chemicals. The 
bacterial system is differentially sensitive to different mutagenic 
compounds. The urine of smokers presumably contains a mixture of 
many mutagenic compounds. In addition, the test lacks speciEcity, in 
that other environmental exposures result in urinary mutagenicity. 
The test may also be insensitive to very low exposures such as 
mvobmtary smoking. However, one study, by Bos and colleagues 
(1983), indicated slightly increased mutagenic activity in the urine of 
nonsmokers following tobacco smoke exposure. 
The presence of bedalpyrene and 4-amino biphenyi covalently 
bound to DNA and hemoglobin in smokers (Tannenbaum et al., in 
press) suggests other potential measures of carcinogenic exposure. 
Whether such measures will be sensitive to HIS exposure is 
unknown. The development of specific chemical assays for human 
exposure to componenta of cigarette tar remains an important 
researchgoal. 
Populations in Which Exposure Has Been Demonstrated 
Absorption of tobacco smoke components by nonsmokers has been 
demonstrated in experimental and natural exposure conditions. 
Experimental Studies 
Nonsmokers have been studied after exposures in tobaccosmoke- 
Clled rooms. The smoke may be generated by a cigarette smoking 
machine or by active smokers placed in the room by the investigator, 
or the location may be a predictably smoke-filled environment such 
as a bar. The level of environmental smoke has most often been 
quantitated by measuring ambient carbon monoxide concentrations. 
In nonsmokers exposed for 1 hour in a test room with a carbon 
monoxide level of 33 ppm, carboxyhemoglobin levels increased by 1 
percent and urinary nicotine increased about eightfold (Russell and 
Feyerabend 1975). Seven subjects in a similar study sat for 2 hours in 
a public house (bar) with a carbon monoxide level of 13 ppm; their 
expired carbon monoxide increased twofold and their urinary 
nicotine excretion increased ninefold (Jarvis et al. 1983). In a study 
exposing eight nonsmokers to a smoke-filled room for 6 hours, a 
small increase in urinary mutagenic activity was measured (Bos et 
al. 1983). 
Nonexperimental Exposures 
Exposure studies performed in real-life situations have compared 
biochemical markers of tobacco smoke exposure in different imiivid- 
uals with different self-reported exposures to tobacco smoke. Absorp 
tion of nicotine (indicated by urinary cotinine levels) was found to be 
increased in adult nonsmokers if the spouse was a smoker (Wald and 
Ritchie 1934). In another study (Matsukura et al. I984), urinary 
cotinine levels in nonsmokers were increased in proportion to the 
presence of smokers and the number of cigarettes smoked at home 
and the presence and number of smokers at work. Blood and urinary 
nicotine levels were increased after occupational exposure to ETS 
such as a transoceanic flight by commercial airline flight attendants 
(Foliart et al. 1983). Nicotine absorption, documented by increased 
salivary cotinine concentration, has been shown in schoolchildren in 
relationship to the smoking habits of the parents (Jarvis et al. 1985), 
and using plasma, urinary, and saliva measures, in infants in 
relation to the smoking habits of the mother (Greenberg et al. 1934; 
Luck and Nau 1985; Pattishall et al. 1935). 
Quantification of Absorption 
Evidence of Absorption in Different Populations 
One questionnaire survey indicated that 63 percent of individuals 
report exposure to some tobacco smoke (Friedman et al. 1983). 
Thirty-four percent were exposed for 10 hours and 16 percent for 40 
or more hours per week. The distribution of cotinine levels in a few 
populations has been reported. In men attending a medical screening 
examination, there was a tenfold difference in mean urinary 
cotinine in nonsmokers with heavy exposure (20 to 80 hours per 
week) compared with those who reported no ETS exposure (wald et 
al. 1984). The median and 90th percentile urinary cotinine concen- 
trations for all nonsmokers who reported exposure to other people’s 
smoke were 6.0 and 22.0 ng/mL, respectively, compared with a 
median of 1645 ng/mL for active smokers, In 569 nonsmoking 
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schoolchildren, salivary cotinine concentrations were widely distrib- 
uted. Values were strongly influenced by parental smoking habits 
(Jarvis et al. 1985). The median and 25 to 75 percent ranges (in 
ng/mL) were 0.20 (O-0.5), 1.0 (O&1.8), 1.35 (0.7-2.71, and 2.7 (l.M.4) 
for children whose parents did not smoke or whose father only, 
mother only, or both parents smoked, respectively. 
Quantification of Exposure 
Expired carbon monoxide, carboxyhemoglobin, plasma thiocya- 
nate, plasma or urinary nicotine, and plasma, urinary, or salivary 
cotinine have been used to evaluate exposure to ETS. However, 
successful attempts to quantify the degree of exposure have been 
limited largely to measurements of nicotine and cotinine. Expired 
carbon monoxide and carboxyhemoglobin have been found to be 
increased up to twofold after experimental or natural exposures 
(Russell et al. 19731, ‘but not in more casually exposed subjecta. 
Thiocyanate was slightly increased in one very large study of heavily 
exposed individuals (Friedman et al. 1983), but most studies report 
no differences as a function of involuntary smoking exposure. The 
most useful measures appear to be nicotine and cotinine. The data on 
nicotine and cotinine measurements are presented in Tables 6 and 7 
and suggest the following: 
(1) Both nicotine and cotinine are sensitive measures of environ- 
mental tobacco smoke exposure. Levels in body fluids may be 
elevated 10 or more times in the most heavily exposed groups 
compared with the least exposed groups. 
(2) The tune course of change in the levels of biochemical markers 
depends on which marker is selected and which fluid is sampled. 
There ia a lag between peak blood levels of nicotine and peak blood 
levels of cotinine, owing to the time required for metabolism 
(Hoffmann et al. 1984). Salivary levels of nicotine, because of the 
local deposition of smoke in the nose and mouth, peak early and 
decline rapidly. 
(3) With nicotine, salivary levels increase considerably after 
environmental tobacco smoke exposure, but decline rapidly follow- 
ing the end of exposure. Blood nicotine levels are too low to be very 
useful in quantitating environmental nicotine exposure. Urinary 
nicotine is a sensitive indicator of passive smoke exposure, but 
because of its relatively short half-life, urinary nicotine levels 
decline within several hours of the time of exposure. 
(4) Cotinine levels are less susceptible than nicotine to transient 
fluctuations in smoke exposure. Blood or plasma, urine, and saliva 
concentrations correlate strongly with one another. Because of the 
stability of cotinine levels measured at different times during an 
exposure and the availability of noninvasive (i.e., urine or saliva) 
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TABLE 6,Nicotine measurea in nonsmokers with environmental tobacco smoke (EIB) sxponve and 
comparisons with active smoking 
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12.4 (O&64.3) - - 
8.9 (o-26) - - 
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lb.2 (8.Sr.4) - - 
. 
JAetal. 7 NS s&m, 1Mo can. 0.8 2.6 10.6. 92.6 1.9 49.6 
After, public houm x 
2hr 
HolTmann et al. 10 NS Rxpimental chamber 
(1980 2cigaburned 1.1 1.1 24’ Sl’ 0 427 
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Hospital clinic patients 
NS No expmure - 1.0 - 3.9 - 3.8 
NS Little expceure - 0.8 12.2 4.8 
NS Some expcmm - 0.7 - 11.9 4.4 
NS Lot of exposure - 0.9 - 12.2 12.1 
S - 14.8 1760 - 872 
NS Infanta, mother S - - as’ (O-370) 12.7 (O-188) 
NS infant, mother NS - - 0 o-89) - 0 (O-17) 
NS, neonates No exposure - - 0’ @14) - - 
NS, neonates Nuraad by S mother: - 14 (&llO) - - 
no Em expomre 
NS, infants S mother, not nursed - - 36 (4-218) - - 
NS, infants Nureed by S mother; - - 12 (s-42) - - 
Em exposure 
1 nglmg creatinins. 
TABLE V.-Cotini.ne measures in nonsmokers with environmental smoke exposure and comparisons 
with active smoking 
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Children aged 11-16 
NS Neither parent SM - 0.4 
(median 0.2) 
NS SM father 1.9 (1.0) 
NS SM mother 2.0 (1.7) 
NS Both parents SM - 3.4 (2.4) 
NS, neonates No exposure - - - 0’ @-w - 
NS, neonates Nursed by S mother; - - loo Qo-666) - 
no Fps exposure 
NS, infants S mother, not nursed - - 327 (117-780) 




et al. 18 
NS, children Smokers in home 4.1 - - 
NS, children No smokers in home 1.0 - 
E TABLE CI.-Continued 






statue Expoeure level 
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b&W 




coulta8 88 NSaBed (6 No emokera in home 
et al. 41 NS aged (6 1 smoker in home 
w66) 21 NS aged <6 2 or more smokera in home 
200 NS aged Cl7 No smokers in home 
98 NS aged 6-17 1 smoker in home 
26 NS aged 617 2 or more mnokem in home 
316 NSaged >17 No smokers in home 
80 NSaged >17 1 emoker in home 
12 NSaged >17 2 or more smokers in home 
- - - - 0, 1.7’ 
- - 7 - 3.8, 4.1 
- - - - 6.4, 6.6 
- - 0, 1.3 
- - - 1.6, 2.4 
- - - - 6.3, 6.8 
- - - 0, 1.6 
- - - - - 0.6. 2.8 
- - - - - 0, 3.7 
‘rag/me creatinine. 
*median. mean. 
meats-men% &i&e appears to be the short-term marker of 
choice for epidemiological studies. 
(6) Mean levels of urinary nicotiue and of cotinine in body fluids 
increase with an increasing seKreported E!l’S exposure and with an 
increasing number of cigarettes smoked per day. There is consider- 
able variability in levels among individuals at any given level of self- 
reported exposure. 
Comparison Of Abeorption From Environmental Tobacco 
Smoke and From Active Smoking 
&idemiologic studies show a dose-responss r&tiomGp between 
number of cigarettes smoked and lung cancer, coronary artery 
disease, and other smoking-related d&eases. Aseuming that dose- 
response relationships hold at the lower dose end of the expoeure- 
respome curve, risks for nonsmokers can be estimated by using 
measures of absorption of tobacco smoke constituenta to compare the 
relative exposures of active smokers and involuntary smokers. 
As diSCUSStd PreviOuSly, measures Of nicotine uptake (i.e., r&&&e 
or cotinine) are the most specific markers for El% exposure a& 
provide the best quantitative estimates of the dose of expoeum. 
Although the ratio of nicotine to other tobacco smoke constituents 
differs in mainstream smoke and sidestream smoke, nicotine uptake 
may still be a valid marker of total ETS exposure. Nic@ne uptake in 
nonsmokers can be estimated in several ways. 
Russell and colleagues (1965) infused nicotine intravenously to 
nonsmokers and compared resultant plasma and urine nicotine 
levels with those observed iu nonsmokers with E’l’S exposure. An 
infusion of 1 mg nicotine over 60 minutes resulted in an average 
plasma nicotine concentration of 6.6 ng/mL and an average urinary 
mcotine concentration of 224 ng/mL. Using these data in combina- 
tion with measured plasma and urinary nicotine levels in nonsmok- 
ers after 2 hours in a smoky bar, nicotine uptake was estimated as 
0.22 mg per hour. Since the average nicotine uptake per cigarette is 
1.0 mg (Renowitz and Jacob 19&i, Feyerabend et al. 1965), 0.22 mg of 
nicotine is equivalent to smoking about onefifth of a cigarette per 
hour. In m&.ng these calculations, it is assumed that the disposition 
~etics of inhaled and intravenous nicotine are similar and that the 
rate of nicotine expowre from ETS ifs constant. 
Steady state blood cotinine concentrations can also be used to 
estimate nicotine uptake. Galeazzi and colleagues (1985) measured 
c(ginj.ne levels in smokers receiving various doses of intravenous 
nicotine, simulating cigarette smoking, for 4 days. They described 
the relationship: [steady state plasma cotinine concentration] 
(ng/mL) = (0.783) x [daily nicotine uptake] (w/kg/day). With such 
data, a 70 kg nonsmoker with a plasma cotinine concentration of 2.5 
ng/mL would have an estimated uptake of 3.2 )~g nicotine/kg/day, or 
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0.22 mg nicotine/day, equivalent to one-f* of a cigarette. This 
approach assumes that the half-life for cotinine and nicotine 
ewt,iom is similar in smokers and nonsmokers, an assumption 
that may not be correct Wyerematen et al. 1982). 
A third approach is to compare cotinine levels in nonsmokers with 
those in smokers. Jarvis and colleagues (1984) measured plasma, 
saliva, and urine nicotine and cotinine levels in 100 nonsmokers 
selected from outpatient medical clinics and in 94 smokers. Ratios of 
average values for nonsmokers compared with smokers were as 
follows: plasma cotinine, 0.6 percent; saliva cotinine, 0.6 percent; 
urine &nine, 0.4 percent; urine nicotine, 0.6 percent; and saliva 
nicotine, 0.7 percent. These data suggest that, on average, nonsmok- 
em absorb 0.5 percent of the amount of nicotine absorbed by 
smokers. Assuming that the average smoker consumes 30 mg 
nicotine per day (Benowitx and Jacob 1984), this ratio predicts an 
exposure of 0.15 mg nicotine, or onesixth of a cigarette per day. The 
most heavily exposed group of nonsmokers had levels almost twice 
the overall mean for nonsmokers, indicating that their exposure was 
quivslent to one-fourth of a cigarette per day. Most studies (see 
l’ables 6 and ‘7) report similar ratios when comparing nonsmokers 
with smokers. The exception is Matsukura and colleagues (1984), 
who reported urine cotinine ratios of. nonsmokers to smokers of 6 
percent. The reason for such high values in this one study is 
UllhOWIl. 
Personal air monitoring data for nicotine exposure can also be 
used to estimate nicotine uptake. For example, Muramatsu and 
colleagues (1984) used a pocketable personal air monitor to study 
environmental nicotine exposures in various living environments. 
They reported air levels of from 2 to 48 cog nicotine/ma. Assuming 
that respiration is 0.48 ms per hour and exposure is for 8 hours per 
day, nicotine uptake is estimated to range from 8 to 320 w per day. 
The average values are consistent with other estimates of onegixth 
to onethird cigarette equivalents per day in general populations of 
nonsmokers exposed to ETS. 
Aa noted before, these estimates must be interpreted with caution. 
Rddh absorption of nicotine in smokers and nonsmokers may 
substantially underestimate exposure to other components of ETS. 
Conclusions 
1. Absorption of tobacco-specific smoke constituents (i.e., nicotine) 
from environmental tobacco smoke exposures has been docu- 
mented in a number of samples of the general population of 
developed countries, suggesting that measurable exposure to 
environmental tobacco smoke is common. 
216 
2. Mean levels of nicotine and c&nine in body fluids increase 
with self+ep0rted EXS exposure. 
3. Because Of the stability of cotinine levels measured at different 
times during exposure and the availability of noninvasive 
sampling techniques, cotinine appears to be the short-term 
marker of choice in epidemiological studies, 
4.Both mathematical modeling techniques and experimental 
data suggest that 10 to ZO percent of the particulate fraction of 
sidestream smoke would be deposited in the airway. 
5. The development of specific chemical assays for human ew 
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Irritation: Acute Expoeure 
Irritants in Emirogmental Tobacco Smoke 
Tobacco smoke is a complex aerosol that contams several thousand 
different constituents (Hoffmann, Haley, Brunnemann 1983). Little 
is known about the health effects of most of these compounds 
individually and even less is known about their interactions. Tobacco 
smoke contains compounds established as irritants, toxins, muta- 
germ, and carcinogens. The main irritanta identified in environmen- 
tal tobacco smoke @Z’S) to date are respirable particulates, certain 
aldehydes, phenol, ammonia, nitrogen oxides, sulfur dioxide, and 
toluene. The range of concentrations of these irritants measured m 
mainstream smoke, in side&ream smoke, and in smoky air under 
“realistic” and “natural” conditions or as results of field studies is 
summarized in Table 1. 
The levels of irritants in air contaminated with ETS vary 
considerably (Table 1). Some of this variation is due to differences ir 
the number of cigarettes smoked, the amount of ventilation, the 
adsorptive properties of the surroundings, and measurement me& 
odology. Triebig and Zober (1984) compared the measured concentra- 
tions of these irritants with the maximum permissible concentration 
(MAK) values for working areas and the maximum emission 
concentration (MIK) values for outdoor air pollution in the Federal 
Republic of Germany. They concluded that concentrations approxi- 
mating or in excess of the MIK values can be found for respirable 
particulates, nitrogen dioxide, and acrolein. The other irritants 
generally do not reach the existing threshold limit values under 
realistic conditions. For phenol there is no MIK value. An evaluation 
of the hygienic and medical importance of the compounds in EC’S 
based on threshold limit values is problematic for two reasons: first, 
MAK values for industries are established for healthy adults with an 
Shour exposure per day; MYIK values are for the outdoor environ- 
ment, and no indoor limit values exist for “everyday life.” Second, 
the threshold limit values are valid only for single compounds; E’l’S 
contains many different irritants, which might interact to produce 
more toxicity than anticipated from the concentrations of individual 
compounds. 
Many of the constituents of tobacco smoke are also produced by 
other sources that contribute contaminants to the indoor or outdoor 
environment. For example, sources unrelated to smoking such as 
urea formaldehyde foam insulation or certain wood materials can 
emit formaldehyde and may give rise to mean air concentrations as 
high as 100 to 400 ppb (Triebig and Zober 1984). In measuring the 
contribution of tobacco smoke to the levels of these constituents, 
some researchers (Weber et al. 1979a; Weber and Fischer 1980) have 
subtracted the measured indoor concentrations from the levels 
TABLE l.-Major irritants in environmental tobacco smoke 
(ETS), their concentrations in mainstream 
smoke (MS), sidestream smoke (SS) to 
mainstream smoke (MS) ratios, and levels in 
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* Meeaured under experimental conditions only. 
b Fischer (1979). 
c Difference: indoor concentration minus control value (unoccupied mom or outdoon). 
d NA = not available. 
SOURCE: Date from Cdlishaw et al. MFA). Remmer W&5). Triebig and zober WM), US DIUB WW, except 
where noted. 
measured either in the unoccupied room or in the outdoor environ- 
ment near the room. 
The measured concentrations of irritants listed in Table 1 are 
primarily the mean values in air samples collected over intervals of 
onehalf hour to several hours. Substantial variation in levels can 
occur, depending on the proximity to a smoker and the air-mixing 
conditions in the room. Weber and Fischer (1983) measured peak 
concentrations of 3,330 to 99,680 ng/ms for the particulates and 41 to 
750 ppb for nitrogen oxide in the “blowing cloud” 1 meter from the 
smoker immediately after smoke exhalation. These high concentra- 
tions decreased very rapidly with time (half-life between 2 and 20 
seconds) and distance from the smoker. Ayer and Yeager (1982) 
measured formaldehyde and acrolein concentrations in the side 
stream smoke plume rising from a cigarette between puffs and 
obtained concentrations of some constituents up to three orders of 
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Irritating and Annoying Effecta of Environmental Tobacco 
Smoke 
The main effects of the irritants pr&ent in El’s occur in the 
conjunctiva of the eyes and in the mucous membranes of the nose, 
throat, and lower respiratory tract. The main ocular symptoms are 
reddening, itching, and increased lachrymation; the main respira- 
tory tract symptoms are itching, cough, and sore throat. The 
relationship of the site of the effect of some irritanta in the eyes and 
in the respiratory tract to their water solubility is illustrated in 
Figure 1. The penetration of the particulatea into the lung depends 
on their size; because most of the particulates in tobacco smoke are 
smaller than 1 pm, they can penetrate to the smallest airways. 
Studies of Healthy Individuals 
Field Studies 
Several studies have shown that annoyance and irritation are the 
most common acute effects of EZ’S exposure. Shephard and Labarre 
(1978) surveyed more than 1,000 Canadian citizens aged 10 to 80 
years. The interviewed population was representative of southern 
231 
ontio with respect to both income and profession but underrepre- 
sentative of the elderly. Seventy-three percent of the nonsmokers 
were disturbed by tobacco smoke in restaurants and 53 percent by 
tobacco smoke in offices. The  most frequently reported symptom was 
eye irritation. Complaints of nausea, dizziues~, and wheezing as well 
as rhinorrhea were also reported, al though much less frequently 
than stinging eyes. 
Similar results were obtained in a  survey conducted in three 
restaurants in Switzerland (Weber et al. 1979a).  A mu ltiplechoice 
questionnaire was administered to 220 guests. One-third to two- 
thirds of the respondents complained about air quality, and up  to 12  
percent reported eye irritation. In another survey of more than 2,100 
white-collar emp loyees, Barad (1979) found that nearly one-fourth of 
the nonsmokers reacted to smoke exposure with frustration and 
hostility. 
Weber  and F ischer (1930) surveyed emp loyees in 44  worksite 
workrooms, located in seven different companies, that included 
offkes, rooms for design and technical and clerical work, and 
conference rooms. The choice of companies and worksites was based 
on availability and therefore was not a  random sample. In all 
workrooms, the concentrations of carbon monoxide (CO), nitrogen 
oxide (NO), acrolein, particulate matter (PM), and nicotine were 
measured in the air. The  contribution of tobacco smoke to these 
levels was obtained by subtracting background levels obtained before 
working hours from the concentrations during working hours. These 
differences from the background levels were called SCO, 5N0, and so 
on. Measurements were conducted in each room on 2  successive days 
(12 l-hour mean values per workroom), and 472 emp loyees were 
quest ioned about irritation and annoyance as well as about their 
opinions on  involuntary smoking. 
Some of the exposure results are summarized in Table 2. The  
comparison of these 6  values with the measured absolute indoor 
concentrations revealed that 30  to 70  percent of the measured indoor 
concentrations of carbon monoxide, .nitrogen oxide, and particulate 
matter were due to tobacco smoke. The correlations between the gas 
phase components 5CO and &NO were relatively high (Pearson 
correlation coefficient r=0.73). However, the correlations of SC0 
with Gn icotine and 5PM were low. Nicotine values were generally in 
the range of the lower detection lim it of the method of measurement 
used (gas chromatography). The low correlation of the gaseous 
components with the particulate matter is probably due to the 
different physical properties (sedimentation, adsorption, and desorp- 
tion of the particulates) and to the fact that the &PM values include 
particulates from sources other than tobacco smoke. 
Approximately one-third of the emp loyees described the quality of 
air at work as %ad” with regard to tobacco smoke. Forty percent 
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TABLE %--Air pollution due to tobacco m&e in 44 
workrooms 
NumberOf Mean 
component s-d- veluea deviation Maximum 
6&rbon monoxide @pm) 363 1.1 1.3 6.5 
SNitrc@n oxide @pb) 348 32 60 280 
6Pa1ticulat.e matter @g/m’) 429 133 130 962 
were disturbed by smoke. One-fourth reported eye irritation at work 
Seventy-two percent of the interviewed nonsmokers and 67 percent 
of the smokers were in favor of a separation of the workrooms mt,o 
smoking and nonsmoking sections; 49 percent supported a partial or 
total prohibition of smoking at work, 
Contradictory results were reported by Sterling and Sterling 
(1964), who found no relationship between smoking conditions in 
ofices and comfort complaints. A self-administered work environ- 
ment questionnaire was given to approximately 1,100 employees 
working in nine buildings. Data were analyzed according to the 
smoking habits of the respondents and the office rules regulating 
smoking. The distribution of the responses to questions assessing the 
presence of symptoms (headache; fatigue; nose, throat, and eye 
irritations; sore throat and cold symptoms) were similar in environ- 
ments +ith and without smoking. The researchers concluded that 
“smoking is not a pivotal source of indoor pollution of health-related 
building complaints.” No objective measurements of air pollution 
were carried out, however, and there were no descriptions of building 
ventilation. The researchers used a “building illness index” that 
included several different symptoms in addition to irritation (e.g., 
headache, fatigue), and the irritating effects on the most sensitive 
organ-the eyes-may have been masked by this use of an overall 
symptom index. 
Experimental Studies 
Harke and Bleichert (1972) examined the acute physiological 
response to ETS in a 170 m3 room. The electrocardiogram, blood 
pressure, heart rate, and skin temperature showed no change with 
expcsure to ETS, even at extremely high exposure levels (150 
cigarettes smoked in 30 minutes, corresponding to a carbon monox- 
ide concentration of 60 ppm at the end of the exposure). 
The infhrence of the temperature and humidity of room air on odor 
perception and irritation was investigated by Kerka and Humphrey 
(1956). They found that odor intensity was somewhat reduced by 
increasing the temperature at a constant humidity. Both odor and 
bfit.ation intensity were reduced by increasing the humidity. 
Johansson and Ronge (1966) also observed that acute irritation is 
increased in warm and dry air. Johansson (1976) exposed 12 subjects 
in a 6.7 m3 climatic chamber for 29 minutes to the El% produced by 
the smoking of 10 cigarettes. The air in the chamber was cold (18“ or 
19” C) or warm (25” or 26” C), and at each temperature, the relative 
humidity was evaluated at three levels from 30 to 80 percent. Under 
all conditions, subjective irritation, asses& by a questionnaire, 
increased during exposure; eye irritation increased more than nose 
irritation. No marked effect of temperature on the degree of 
irritation was observed, probably owing to the limited temperature 
range studied (1P to 26” C). Kerka and Humphrey (1956) demon- 
strated a thermal effect when the temperature range was greater 
than 8O C. The low relative humidity (7 to 20 percent) in aircraft may 
be responsible for the substantial level of perceived irritation due to 
TS among passengers, despite the low levels of pollutants measured 
n aircraft (WHO 1984). 
Basu and colleagues (1978) studied the effects of ETS on human 
tear fihu and observed a reduction in the stability of the preccmeal 
tear film in subjects exposed to a smoke concentration corresponding 
to approximately 20 ppm CO. In the presence of EYE!, the tear fti 
breakup time was significantly reduced by 35 to 40 percent com- 
pared with baseline measurements without smoke. The researchers 
suggested that this reflects an alteration in the relative proportions 
of the constituents of tear film. 
In these studies, the quantitative exposures to JITS either were not 
measured or were determined in a relatively imprecise way. More 
systematic studies, including measurements of several compounds of 
ETS, were carried out by Weber and collaborators (Weber et al. 1976, 
1979a,b; Weber, Fischer, Grandjean 1977; Weber, Fischer, Gierer et 
al. 1977; Weber and Fischer 1983) and Muramatsu, Weber, and 
colleagues (1983). These experiments were carried out in a climatic 
chamber of 30 m3, with an air temperature of 20” to 24” C and a 
relative humidity between 40 and 60 percent. The ventilation rate 
could be varied between 0.1 and 16 air changes per hour. The smoke 
was produced by a Borgwald smoking machine under standardixed 
conditions, and only the side&ream smoke of cigarettes was used. 
Healthy students were exposed to the sidestream smoke of cigarettes 
in groups of two or three in the climatic chamber. They all also 
participated in a control exposure with identical conditions, but 
without sidestream smoke in the air. The concentrations of the 
following compounds were continuously recorded: carbon monoxide, 
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nitrogen oxide, formaldehyde, acrolein, and partictite matter. me 
background levels before smoke production were subtracted from the 
measured concentrations during smoking; the resultmg values were 
called SCO, 5N0, and so forth. The degree of irritating and annoymg 
effects of the ~rcposed subjects was determined every 10 minutes by 
means of queetion.mires and by measuring the eye bh& rate, 
considered an objective measure for eye irritation. 
In the first study, 33 subjects were exposed to continuously 
increasing smoke concentrations (Weber et al. 1976). ‘&e majn 
re~uh are Summarized in &Ure 2. The concentrations of CC, NO, 
formaldehyde (HCHO), and acrolem increased with the number of 
cigarettes smoked. Both mean subjective eye irritation and mean eye 
blink rate increased with increasing smoke concentration. S&j&ve 
nose and throat irritation was also evaluated. Nasal symptoms were 
less pronounced than eye symptoms, and the throat was the least 
ElffWti?d. 
h a second series of studies, acute effects were analyzed in 
relation to smoke concentration and duration of exposure (Weber et 
al. 1979; Muramatsu, Weber et al. 1983). The tobacco smoke 
concentrations corresponded to 1.3, 2.5, 5, and 10 ppm CO @CO). 
Subjects were exposed to these smoke concentrations for 1 hour, each 
smoke concentration increasing linearly during the first 5 to 10 
minutes and then remaining constant at the desired level for the rest 
of the hour. Because very high correlations (r > 0.9) were obtained in 
the first experimental series between 6CO and each of the other 
~m~unds, only 500 was used tc quantify the level of exposure to 
E3.S. 
The results obtained for subjective eye irritation and eye blink 
rati me shown in Figures 3 and 4. The mean reported level of eye 
irritation as well as the eye blink rate increased with increasing 
smoke concentration. Both irritation parameters E&O increased with 
the duration of exposure under conditions of constant smoke 
concentration. The same, but less pronounced, results were observed 
for nose and throat irritation. 
Annoyance increased rapidly as soon as smoke production began 
and increased with increasing smoke concentration, but after 10 to 
15 minutes the level of annoyance remained approximately constant 
during the rest of the exposure. Thus, the intensity of exposure was 
important in determining the degree of annoyance and the duration 
of exposure was less importam. 
mese experiments demonstrated an objective irritant response in 
h&thy adult subjects at levels of smoke exposure substantially 
lower than the levels at which an airway response has been 
demonstrated. Whether this difference represents a difference in 
threshold for irritation in the eye and airway or a limitation in the 
&l&y to measure subtle changes in the airway is uncertain. 
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FIGURE 2.Mean subjective eye irritation, mean eye bliuk 
rate, and concentrations of some pollutants 
during continuous smoke protection in an 
unventilated climatic chamber 
NOTE:33eubjectqOmin: mdesnrement before smoke procluction. 
SOURCE: WabsretaL(1976). 
Hugod and colleagues (1978) and Weber and colleagues (Weber, 
Fischer, Grandjean 1977; Weber, Fischer, G ierer et al. 1977; Weber 
et al. 1979b) canid out several experiments in order to determine 
which compounds in ETS are responsible for irritation and annoy- 
ance. The resulta of the two studies were somewhat conflicting. 
Hugod and colleagues exposed 10 subjects in an unventilated 68 ma 
room to high concentrations of sidestream smoke (concentrations 
corresponding to 20 ppm Co), to the gas phase of sidestream smoke 
alone, and to acrolein alone at concentrations three times those 
found in sidestream smoke alone. Irritation was assessed via a 
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FIGURE 3.-Mean subjective eye irritation related t,o 
smoke concentrations (ppm delta CO) and 
duration of exposure 
questionnaire. Both annoyance and irritation were reported at 
similar levels in the subjects exposed to the whole sidestream smoke 
or to the gas phase only. Exposure to acrolein caused only slight 
discomfort. 
Weber and colleagues (Weber, Fischer, Grandjean 1977; Weber, 
Fischer, G ierer et al. 1977; Weber et al. 1979b) exposed students in 
groups of two or three in a 30 mS climatic chamber to whole 
sidestream smoke, to acrolein alone, to formaldehyde alone, or to the 
gas phase of smoke. Subjective irritation and annoyance as well as 
eye blink rate were measured. The results indicated that acrolein 
and formaldehyde did not produce substantial irritation or annoy- 
ance at the levels used. The gas phase exposure resulted in high 
levels of reported annoyance, but was less important as a determi- 
nant of irritation. The objectively measured eye blink rate, as well as 
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FIGURE 4.-Mean effecta of environmental tobacco smoke 
on eye blink rate 
NOTE: 32 to 43 subjecta; 0 min: measurement before smoke production; 0 to 5 min: increasing smoke 
conantrntion; 6 ta 60 min: co&ant smoke production. 
SOURCE: Muramatau. Weber et al. (199%. 
than with the total sidestream smoke, suggesting that the particu- 
late phase is the major determinant of irritation. The researchers 
postulated that the irritating effects of the particulate phase are due 
to the semivolatile irritant compounds. These compounds, which 
volatilize rapidly during the process of combustion, recondense on 
the particulates with cooling and may deposit irritants in relatively 
high concentrations on the mucous membranes. 
Studies of Sensitive Individu& 
Children 
Several investigators have used questionnaires to examine the 
subjective symptoms of children and young people with ElTS 
exposure Gameron 1972; Muramatsu 1977; Muramatsu, Muramatsu 
et al. 1983). The last group found that 81 percent of B-year-old 
children disliked involuntary smoking and 82 percent complained of 
one or more kinds of irritation, the most common being eye 
irritation. Several epidemiological studies have shown that children 
with parents who smoke have an increased risk for respiratory 
illness (see Chapter 2). 
Allergic Individuals 
A few studies have asses& the effects of ETS on allergic 
individuals. Speer (1968) found that allergic individuals report 
irritation more frequently than healthy individuals. Weber and 
Fischer (1980) observed that employees suffering from hay fever 
reported significantly more eye irritation at work than those without 
hay fever. 
Effects on the Lung 
Cigarette smoking is associated with prominent changes in the 
numbers, types, and functions of respiratory epithelial and i&Jam- 
matory cells. These alterations have been implicated in the develop- 
ment of pulmonary emphysema, chronic bronchitis, and respiratory 
tract cancers and in an increased susceptibility to infections. Chronic 
exposure to environmental tobacco smoke might cause similar 
changes. Because studies that directly address the effect of chronic 
exposure to environmental tobacco smoke on lung structure and 
biochemistry have not been conducted, this section reviews those 
studies in humans and animals that provide evidence on smoke 
exposures that may be relevant to ETS exposure. 
Effects of Cigarette Smoking on Respiratory Epithelium: 
Studies in Humans 
Extensive evidence shows that exposure to cigarette smoke has 
adverse effects on respiratory epithelial cells, and dose-respon~ 
relationships have been established from these changes (Auerbach et 
al. 1961; Auerbach, Hammond, Garfinkel 1970). Studies involving 
the systematic examination of the bronchial mucosa from large 
numbers of human smokers have recorded three principal types of 
epithelial changes: epithelial hyperplasia, loss of cilia, and nuclear 
atypia. In an autopsy study of 402 adult male subjects (Auerbach et 
al. 1961), 98 percent of the sections of the tracheal and bronchial 
TABLE 3.Cections with one or more epithelial changes, 
by packs of cigarettes per day 
Group 
Subjects without lung cancer 
Never smoked regularly 
Smoked <l/2 pack/day 
Smoked 112-l pack/day 
Smoked l-2 pack/day 
Smoked 22 pack/day 







Total with one 







Subjects with lung cancer 63 2.764 2,778 99.8 
Totals 
Average 
SOURCE: Auerbach et al (1961). 
402 19,797 16,759 
84.7 
epithelium of the men who had smoked had epithelial changes. The 
most common abnormality observed was atypical nuclei, and a large 
proportion of sections had hyperplasia. Denudation of the ciliated 
epithelium was also present in most of those who had smoked. Other 
studies have observed that goblet cells were frequently increased in 
the airways of cigarette smokers (Regland et al. 1976; Jones 1981). 
The extent and severity of the abnormalities have been closely 
related to the intensity of smoking. A similar relationship of 
smoking habits to laryngeal lesions has been observed (Auerbach, 
Hammond, Garfinkel1970), although the laryngeal lesions were less 
frequent and less advanced than those in the bronchi for a given 
smoking history. 
The frequency and severity of epithelial lesions observed in 
smokers contrasts sharply with those in individuals who do not 
smoke regularly. In the study by Auerbach and colleagues (1961) 
(Table 3), 98 percent of the sections from the tracheobronchial tree 
from smokers contained abnormal epithelial changes; however, 
similar changes were observed in only 16.8 percent of the sections 
from nonsmokers. The most common lesion in nonsmokers was 
epithelial hyperplasia (9.4 percent); atypical cells were seen in only 
4.8 percent of the sections from nonsmokers. 
If it is assumed that the nonsmoking group included a subgroup of 
individuals who were chronically exposed to environmental tobacco 
smoke, an assumption that seems reasonable in light of the largely 
U.S. veteran population under consideration in the Auerbach 
group’s study, then some information on the effect of chronic 
exposure to environmental tobacco smoke on the respiratory epithe- 
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lium can be inferred. Epithelial hml&acn; w atypia due to 
chronic exposure to environmental~farnabseW.ocau in some 
nonsmokers, but these findings a,re not eorrrmDp in the majority of 
nonsmokers. 
c\igarette smoking also has adverse e&&c&+= @ w w& 
‘, 
beneath the epithelium. Submucosal gagnd hi has been 
observed frequently (Auerbach et al. 196l; ‘&&n&&t& me, Jo- 
1981). The prevalence is related to the intensity of- a. 
Mucous gland hypertrophy is seen in B, ,w js,. nd 
prevalent and is usually not extensive (Au-& & w& ., : .,. ,
The loss of ciliary epithelium, the increased, n~~d!.w 
cells, and the mucous gland hypertrophy -t&y qw ti 
cigarette smokers would predict muco&ary de w 
available evidence indicates that long-term cigarette 6 & 
pairs mucociliary transport Wanner 1977). Once a cigarette * 
develops chronic bronchitis, mucus transport appears to be w 
ibly damaged. Impairment persists even in patients who have 
abstained from cigarette smoking for many years (Santa w et +, 
1974). Prior to the development of chronic broncwis, howevq 
partial recovery of function has been observed (Cam& et al. +?7% 
Studies examining mucociliary dysfunction in humaq ,due, s&Q t,o 
chronic environmental smoke exposure have not been rqorted. 
Effect of Cigarette Smoking on Lung Infhm&bti C& 
Studies in Humans 
One of the earliest pathologic lesions found in the lungs of young 
smokers is a respiratory bronchiolitis (Anderson and Foraker 196l; 
&Laughlin and ‘Tueller 1971; Niewoehner et aL 1974). Clusters of 
pigment-laden phagocytes, predominantly alveolar macrophages 
(AM), lodge in the respiratory bronchioles of cigarette smokers 
precisely at the sites of the earliest lung injury. The infiltration’ by 
AM precedes the development of emphysema and focal fibrosis 
(&sio et al. 1978). Analyses of cells harvested by bronchoalveolar 
lavage complement the morphologic studies. Lavage fluid yields five 
to seven times more AM from the lungs of cigarette smokers than 
from nonsmokers’ lungs (Harris et al. 1970; Reynolds and Newball 
1974; Warr et al. 1976; Hunningbake et al. 1979; Hoidal et al. 1981). 
The alveolar macrophages from smokers appear to be activated 
morphologically and metabolically. The AM from smokers have 
increased size, endoplasmic reticulum, G-olgi apparatus, glucose 
metabolism, hydrolytic and proteolytic enzyme activities Pratt et al. 
1971; Cohen and Cline 1971; Harris et al. 1970; Rodriguez et al. 1977; 
Hinman et al. 1980; Martin 1973; Cantrell et al. 1973), and increased 
rates of oxidative metabolism resulting in increased producti& of 
reactive oxygen species (superoxide radical, hydrogen peroxide, and 
hydroxyl radical) (Hoidal et al. 1981; Hoidal and Niewoehner 1982). 
The strategic location of the alveolar macrophages and their 
altered function have led to the hypothesis that they may contribute 
to the alteration of the protease-antiprotease balance of the lower 
respiratory tract and thus foster the development of emphysema in 
smokers. Two plausible mechanisms have been identified by which 
AM may influence the protease-antiprotease balance in cigarette 
smokers. The first is by directly increasing the lung protease burden. 
Human AM release enzymes with elastolytic activity in vitro, 
whereas those from nonsmokers do not (Rodriguez et al. 1977). The 
activity may originate from endogenous or exogenous sources. A 
metalloenzyme with activity against synthetic amide substrates, 
which have specificity for elastase, was detected in the bronchoalveo 
lar washings of cigarette smokers (Janoff et al. 1983; Niederman et 
al. 1984) and was also found in the cell culture fluid of smokers’ AM 
(Hinman et al. 1989). Alveolar macrophages can synthesize a 
metalloprotease capable of solubilizing elastin; they also contain a 
thiolprotease with such activity (Chapman and Stone 1984). The 
metalloprotease, if analogous to that of murine macrophage elastase, 
would be resistant to inactivation by alpha,-protease inhibitor (a,PI) 
(Banda et al. 1989). These enzymes have not been demonstrated to 
csuse emphysema. The content of elastolytic activity in AM at a 
given time is less than that of equal numbers of polymorphonuclear 
leukocytes (PMN); thus, AM may be only a minor source of enzymes 
capable of lung parenchymal destruction. However, their potential 
importance must be considered in light of their demonstrated ability 
to degrade elastin in the presence of serum protease inhibitors 
(Chapman and Stone 1984) and their capability of ongoing synthesis 
of elastolytic enzymes. Cell matrix contact may be critical for their 
matrix-degrading action, since the AMderived enzymes are likely to 
be membrane bound. 
Human AM also acquire elastolytic activity from exogenous 
sources. AM can bind and internalize neutrophil elastase by virtue of 
possessing a specific membrane receptor for this and other neutro- 
phi1 glycoproteins (Campbell et al. 1979; Campbell 1982; McGowan et 
al. 1983). Studies to date suggest that the scavenged elastase 
accounts for much of the elastolytic activity in AM lysates. Seques- 
tered PMN elastase may subsequently be released by AM over an 
extended period of time. 
The second mechanism by which AM may influence the proteas+ 
antiprotease balance in cigarette smokers is by inactivating a,PI, a 
major antiprotease of the lower respiratory tract in humans (Gadek 
et al. 1981). Smokers’ AM can inactivate a,PI through oxidant 
mechanisms in vitro (Carp and Janoff 1989). Studies on bronchoal- 
veolar lavage fluids have identified oxidatively inactivated a,PI in 
some human smokers (Gadek et al. 1979; Carp et al. 1982), but this 
has not been a consistent finding (Stone et al. 1986; Boudier et al. 
1983). Studies that directly assess t& a of a,PI activity in the 
alveoli space and interstitium of cjsaretts smokers are needed to 
clarify this issue. 
The phagO@iC Capabilities Of~from~smogerS 4 
nonsmokers are similar in most studies m et al. 1970; &hen 
and Cline 1971; %ynolck et al. 1975; ‘&r&o :md @I& lg‘&b), 
although a few studies (Martin and WAR 1~; ~ et d 1982) 
have suggested a modest decrease in the m. -ties of m 
from smokers. The experimental desii of these- has differed 
considerably, and technical factors may be responsible for the 
variable results. In particular, there are merenccs m cehw 
culture conditions. In view of the increased number af m in 
cigarette smokers, it seems unlikely that a primary m defect 
of AM would account for the bacterial colonization observed b some 
cigarette smokers. 
The possibility that increased numbers of PMN may be present in 
the lungs of cigarette smokers has been examined primarily because 
of the attention given these cells in the study of the pathogen&sof 
emphysema. PMN elastase is the only purified human enzyme +th 
ready access to the lung psrenchyma that has been demon&rated to 
cause emphysema when admmistered to animals. The ,nu.mber of 
PMN is increased in the distal airways and lung parenchyma of 
cigarette smokers. Bronchoalveolar lavsge from some smokers yields 
increased PMN (Reynolds and Newbsll 1974; Hunninghake &al. 
1979). More compelling evidence for incressed PMN in the lungs of 
smokers comes from the morphologic evaluation and direct cell* 
analysis of the lung parenchyma A fourfold increase in PMN 
infiltration has been observed in the lungs of cigarette smokers 
compared with the lungs of nonsmokers, using morphometric 
techniques (Ludwig et al. 1985). Analysis of cell suspensions from: 
lung biopsies has also demonstrated increased PMN in the lung 
parenchyma of smokers (H unninghake and Crystal 1983). The 
alveolar septa are the primary site of the PMN accumulation. 
Increased PMN are present in the alveolar walls of smokers both 
with and without emphysema, which suggests that other factors 
must also be involved in the development of the destructive lesion. 
Factors that might influence the destruction of lung parenchyma 
by PMN elastase include the intensity of PMN Mux, the amount of 
ela&sse per cell, the quantity and site of elastase released, and local 
factors that enhance or inhibit the elsstolytic activity. Investigations 
of the relation of PMN elastase levels and the development of 
emphysema have provided discrepant results. Some studies have 
shown elevated levels of PMN elastase in patients with chronic 
obstructive pulmonary disease (Gal&on et al. 1977; Rodriques et al. 
1979; Kramps et al. 1980), but others have not CTayJor and Keuppem 
1977; Abboud et al. 1979). Other alterations in the PMN function of 
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cigarette smokers include the enhanced generation of reactive 
oxygen species in certain smokers (Ludwig and Hoidal 1982). After 
stimulation, the release of superoxide anion by PMN was 50 percent 
greater from smokers with peripheral white blood counts (WBC) 
greater than 9,000 per mm3 than from nonsmokers with similar 
WBC or from smokers or nonsmokers with WBC less than 9,000 per 
mm’. (Cigarette smokers have increased peripheral WBC counts 
compared with nonsmokers.) 
The influence of cigarette smoking on many aspects of the immune 
system has been examined. Immunoglobulin (Ig) levels in the 
peripheral blood of smokers have been reported to be decreased 
(Gerrard et al. 1980; Ferson et al. 19791, but similar results have not 
been observed in all studies (Bell et al. 1981; Merrill et al. 1985). In 
contrast to the decrease of IgG in peripheral blood, cigarette smokers 
appear to have increased IgG levels in bronchoalveolar lavage fluid 
(Bell et al. 19811, primarily owing to an increase in IgG, (Merrill et 
al. 1985). Cell-mediated immunity may also be affected by cigarette. 
smoking, but again, the results are somewhat conflicting. Peripheral 
blood T-lymphocytes and mitogen responsiveness have been reported 
to be increased (Silverman et al. 19751, unchanged (Daniele et al. 
19771, or decreased (Petersen et al. 1983). Natural killer-cell activity 
in the peripheral blood of cigarette smokers appears decreased 
(Ginns et al. 1985; Ferson et al. 1979). Analysis of peripheral blood 
lymphocyte populations by monoclonal antibodies has demonstrated 
increased T-lymphocytes (OKT3+), with a decreased proportion of 
OKT4+ (helper/inducer), and an increased proportion of OKT8+ 
(suppressor/cytotoxic) subsets in smokers with greater than 50 pack- 
years of smoking (Miller et al. 1982). Analysis of bronchoalveolar 
lavage fluid from cigarette smokers with a mean smoking history of 
14 -- 9 pack-years demonstrated a decreased proportion of 
OKT4 + lymphocytes and an increased proportion of OKT8+ 
lymphocytes (Costabel et al. 1988). In the latter study, the alterations 
in T-lymphocyte subsets observed in bronchoalveolar lavage were 
not present in peripheral blood. This finding and the increase in IgG 
in bronchoalveolar lavage fluid, but not in serum, raise the 
possibility of regional effects of cigarette smoking on the immune 
system. 
The extent to which the alterations of inflammatory cell numbers 
and functions observed in smokers are also present in individuals 
who are chronically exposed to environmental tobacco smoke 
remains unknown. Studies in humans have not directly addressed 
this issue. Studies of dose-response relationships are absent, except 
for those cited that document a relationship of peripheral white 
blood cell count and lymphocyte T-cell subsets. If it is assumed that a 
subgroup of nonsmokers is composed of individuals who are chroni- 
cally exposed to environmental tobacco smoke, then some inferences 
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are possible. As has been stated, the most common pathologic feature 
in the lungs of young cigarette smokers is an accumulation of 
pigment-laden macrophages in the respiratory bronchioles. In the 
study by Niewoehner and colleagues (1974), all 19 male cigarette 
smokers who died suddenly else-where than in a hospital had such 
lesions, which were present in all sections studied in 16 of the 19 
subjects. In contrast, only 5 of 20 nonsmokers had similar lesions, 
and they were minimal in all but 2. One of the two individuals was a 
stoker in a foundry and the other was undergoing desensitization for 
severe hay fever. Although the inflammatory cell accumulation 
cannot be absolutely attributed to these extenuating circumstances, 
it is clear that the respiratory bronchiolitis is not common in young, 
healthy individuals who do not smoke regularly. In contrast, autopsy 
studies have observed focal inflammatory changes quite frequentl: 
in older subjects who had not smoked, but the lesions were of much 
less severity than in age-matched subjects who had smoked (C&o et 
al. 1978). Similar changes have not been observed in studies on 
bronchoalveolar lavage fluids. The metabolic activation of the AM 
from younger and older nonsmokers is similar (Hoidal and Niewoeh- 
ner 1982). These findings suggest that the characteristic inflammato- 
ry lesions seen in the lungs of smokers are usually absent or are 
modest in those individuals who do not smoke cigarettes and who are 
not exposed to an alternative inciting agent. 
Experimental Models 
The effect of cigarette smoke inhalation on lung inflammation and 
inflammatory cell function has been extensively studied in experi- 
mental animal models; however, studies have not investigated 
inflammatory cell alterations in models intended to simulate chronic 
environmental tobacco smoke exposure. Several studies have demon- 
strated that chronic cigarette smoke exposure produces an accumu- 
lation of AM within the respiratory bronchioles of many animal 
species, including dogs (Hernandez et al. 1966; Frasca et al. 1971, 
1983; Park et al. 1977), rats (Hendrick et al. 1976; Coggins et al. 1980; 
Huber et al. 1981), hamsters (Bernfeld et al. 1979; Hoidal and 
Niewoehner 1982), and mice (Matulionis and Traurig 1977), that is 
strikingly similar to that seen in human smokers. In most studies, 
the accumulation of AM has been dependent on the duration and 
intensity of the smoke exposure (Hoidal and Niewoehner 1982; 
Huber et al. 1981). Increases in lysosomal enzyme activities have 
been observed in rats (Etherton et al. 1979) and mice (Matulionis and 
Traurig 1977) following tobacco smoke exposure. Increased elastase 
secretion by alveolar macrophages from mice chronically exposed to 
cigarette smoke has also been observed (White et al. 1979). Oxygen 
consumption, superoxide anion release, hydrogen peroxide produc- 
tion, and hexose monophosphate shunt activity were reported to be 
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increased in AM harvested by bronchoalveolar lavage from hamsters 
(Hoidal and Niewoehner 1982) and rats (Drath et al. 1978; Huber et 
al. 1981) chronically exposed to tobacco smoke. Accumulation of 
PMN in the alveolar septa of cigarette smoke-exposed hamsters, 
strikingly similar to that observed in human smokers, has also been 
reported (Ludwig et al. 1985). In contrast to the focal nature of the 
AM accumulation, the accumulation of PMN was diffuse. Studies of 
PMN function have not been systematically evaluated in smoke- 
exposed animals. One distinctive feature in rats has been a lymph+ 
cytic periairway infiltration (Innes et al. 1956; Huber et al. 1981). 
Similar alterations are not seen in humans. The lymphocytic 
infiltration may be due to complicating respiratory infections with 
mycoplasma or a respiratory virus, which have been common in rata. 
Effects of Cigarette Smoking on Lung Parenchyma: Studies 
in Humans 
The most striking alteration of the lung parenchyma associated 
with cigarette smoking is centrilobular emphysema. The relation- 
ships between smoking history, age, and the degree of emphysema 
have been examined. The effect of smoking on the development of 
emphysema is believed to be cumulative (Anderson et al. 1972; 
Auerbach et al. 1974). In a study of 1,824 autopsies from individuals 
who had died in the hospital, Auerbach and associates, using a 
semiquantitative scoring system, detected emphysematous lesions in 
all individuals who had smoked two or more packs of cigarettes per 
day, including 111 who had been under 66 years of age at the time of 
death. The extent of emphysema strongly correlated with the 
number of cigarettes smoked per day. However, some emphysema- 
tous changes, usually of a mild degree, were noted in 94 percent of 
the individuals who had regularly smoked less than one-half pack 
per day. In contrast, no emphysema was detected in 95 percent of the 
175 individuals who had not smoked regularly, and only one case of 
emphysema of moderate severity had occurred in a person who had 
not smoked. These findings suggest that emphysema is rare in 
individuals who do not smoke regularly and do not have a genetic 
predisposition for the disease. 
Summary of Lung Effects 
Substantial evidence documents that active cigarette smoking 
produces adverse effects on respiratory epithelial cells and causes 
lung inflammation and alveolar septal disruption. Whether these 
effects occur following chronic exposure to environmental tobacco 
smoke cannot be definitively answered by the fragmentary data now 
available. It is possible that clinically significant pulmonary conse 
quences of chronic exposure to environmental tobacco smoke in 
adults might occur only when this exposure interacts with other 
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factors in pad hdarl~ susceptible individuals. In this regard, future 
studies directed at W&cted h@-risk populations or animal models 
immporating exposure to emi~~xu~~~~tal ~&XCCO SIIIO~B along with 
other exposures might be the most fruit&l areas of investigation into 
the effects of chronic exposure to environmental tobacco smoke. 
Carcinogenicity of Environmental Tobacco Smoke 
This section reviews some of the more widely employed m&o& of 
evaluation of the carcinogenicity of mains&am smoke that may also 
be extended to the evaluation of ETS. The &I&&&J, diffemnces, 
and technical difficulties in employing these various bioassays with 
MS, smoke condensate, and ETS are discussed. 
Inhalation Experiments 
Because inhalation is the primary mode of exposure for w he 
and in~01~ntav smoking, animal inhalational assays dd appear 
to be the ideal approach to developing an animal s&em for 
carcinogenicity testing. However, the acute toxicity (mainly due b 
carbon monoxide and nicotine) have limited the expos- to wh& 
smoke that can be tolerated by laboratory animals. 
Two types of passive exposure systems offer the primary ap 
proaches to inhalation studies with small laboratory animals. These 
systems provide either the forced exposure of the whole body to 
tobacco smoke or exposure of the head only. The amount of smoke 
that is retained in the lower respiratory tract of the animals is the 
dosage variable of interest in assessing these studies. The particulate 
matter content of whole smoke is probably of greater importance 
than the vapor phase content (Wynder and HoRmann 1967; Davis et 
al. 1975) for studies of carcinogenesis. Labeled particulate phase 
components have been used for determining the deposition of the 
particulate phase in the respiratory tract in smoke inhalation 
studies (Mohr and Rexnik 1978). However, since such markers are 
applied to the tobacco column, they may be partiahy volatilized 
during smoking. Thus, some of the values reported in deposition 
studies of inhaled smoke aerosols in mice, rats, and hamsters reflect 
the deposition of the trapped particulate phase plus the gas phase of 
cigarette smoke in the respiratory tract. A less ambfguow tracer is 
decachlorobiphenyl (DCBP). It is added to the tobacco column of 
cigarettes, and after exposure of the animals to the smoke of the 
treated cigarettes, this tracer can be determined in extra&J of 
various segments of the respiratory tract by gas chromatography 
with an electron capture detector (GGECD). The detection limit of 
DCBP is < 5 x 1011 g (Lewis et al. 1973; Hoffmann et al. 1979). using 
these techniques, only a small percentage of the smoke particulates 
of cigarette mainstream smoke can be shown to reach regions in the 
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lower respiratory tract of small laboratory animals. This may 
explain, at least in part, why the lifetime inhalation exposures of 
small animals to tobacco smoke have led only to limited numbers of 
lung tumors. 
In mice, inhalation assays with cigarette smoke have generally led 
to hyperplasia and metaplasia in the trachea and bronchi of the 
animals (Wynder and Hoffmann 1967; Mohr and Reznik 1978). In 
one of the most extensive studies, the Leuchtenbergers (1970) 
induced pulmonary adenoma and adenocarcinoma in Snell’s mice. 
However, only the gas phase, not the total smoke, induced a 
statistically significant number of lung tumors. 
In another inhalation bioassay, male and female C57Bl mice (100 
in each group) were exposed, nose only, to fresh mainstream smoke 
diluted with air (1:39) for 12 minutes every other day for the 
duration of their lives. Four lung tumors were detected in both the 
treated male mice and the treated female mice. No lung tumors were 
found among controls. A similar experimental design was used to 
examine the possible differences between the smoke of flu-cured 
Bright tobacco cigarettes and the smoke of air-cured Bright tobacco 
cigarettes (Harris et al. 1974). Female Wistar rata (408 animals) were 
exposed, nose only, to a 1:5 smoketo-air mixture for 15 seconds of 
every minute during an 11-minute exposure twice a day, 5 days per 
week, for the lifespan of the animals. Three of the rata exposed to 
cigarette smoke developed pulmonary squamous neoplasms of uncer- 
tain malignancy and one animal had an invasive squamous-cell 
carcinoma of the lung. No tumors were found in the 104 sham- 
control animals or in the 104 untreated female rats (Davis et al. 
1975). 
Fischer-344 rats (80 animals) were exposed, nose only, to a 1:lO 
smoke-toair mixture for approximately 30 seconds of every minute 
that a cigarette was being smoked (Dalbey et al. 1980). In this 
manner, the animals were exposed to the smoke of one cigarette per 
hour, 7 hours per day, 5 days per week, for 128 weeks. The mean 
pulmonary particulate deposition during the smoke-aerosol exposure 
was 0.25 mg per cigarette, or 1.75 mg per rat per day. Ten 
respiratory tumors were observed in seven smoke-exposed rats. One 
alveologenic carcinoma and two adenomatoid lesions were observed 
in 3 of the 93 control rats employed in this study. A similar protocol 
was used to evaluate the effects of the inhalation of the smoke of 
cigarettes with varying tar deliveries. In this study (Wehner et al. 
1981), squamous metaplasia of the laryngeal and tracheal epitheli- 
urn was significantly increased in the smoke-exposed Fischer-344 
rats. 
Syrian golden hamsters (80 males and 80 females) were exposed, 
nose only, to a 1:7 smoke-toair mixture for 10 to 30 minutes, 5 days 
per week, for a period no longer than 52 weeks. The incidence of 
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laryngeal leukoplakias ranged from 11.3 percent for the animal 
receiving the low dose to 30.6 percent for those animals receiving the 
highest dose of cigarette smoke. Such changes were not observed in 
the controls or in the hamsters exposed to the gas phase only 
(Dontenwill 1974). Exposing 102 male BIO 87.20 and BIO 15.16 
hamsters, nose only, twice a day, 5 days a week, for up to 100 weeks, 
resulted in almost 90 percent of the animals having hyperplastic or 
neoplastic changes in the larynx (Bernfeld et al. 1974). Laryngeal 
cancer was five times more frequent in the BIO 15.16 strain. Two 
animals in this strain also developed nasopharyngeal tumors. 
Another study using nose-only exposures and similar extents of 
exposure reported similar changes in the larynx of the smoke- 
exposed animals (Wehner et al. 1974). Increasing the exposure 
duration to the lifespan of the animals resulted in the development 
of squamous papilloma of the larynx. 
Thirty rabbits in an inhalation chamber were exposed to the 
smoke generated from 20 cigarettes for up to 5 l/2 years. Thirty-one 
animals were used as controls. No tumors were found among the 
treated animals that could be related to the exposure to cigarette 
smoke (Holland et al. 1963). 
Eighty-six beagle dogs, trained to inhale cigarette smoke through 
tracheostomata, were actively exposed to smoke from either filter or 
nonfilter cigarettes (Auerbach, Hammond, Kirman et al. 1970). 
Tumors of the lung were reported in 23 of the 62 dogs exposed to 
smoke from the nonfilter cigarettes. Two of the dogs in this group 
had small bronchial carcinomas. Noninvasive bronchioalveolar 
tumors were reported in 4 of the 12 dogs exposed to the smoke of 
filter cigarettes and in 2 of the 8 control dogs. The bronchioalveolar 
tumors tended to be multiple, with as many as 20 per lung, and were 
reported in 40 of the 203 lung lobes in the 29 dogs with such tumors. 
Inhalation studies with SS or ETS have not been reported thus far 
with any of the laboratory animal inhalational assays. This lack of 
experiments has in large part been due to the absence of exposure 
devices that allow the appropriate delivery of the inhalant without 
incurring the loss of the test animals due to the toxicity of carbon 
monoxide and nicotine. 
Other In Vivo Bioassays 
Among alternative methods used to assess the relative carcinoge- 
nicity of mainstream cigarette smoke, the most widely utilized test is 
to collect the cigarette smoke condensate (CSC) and to bioassay this 
material for carcinogenicity. In the process of preparing CSC, many 
of the volatile and semivolatile components are lost. Furthermore, 
there are serious concerns regarding the influence of aging of the 
CSC, which can affect both the chemical composition and the 
biological activity. Despite these shortcomings, bioassays using CSC 
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have provided insight into mechanisms by which tumor induction in 
animal tissues is likely to occur. The application of CSC to mouse 
skin haa helped to identify those agents that are active as tumor 
initiators and has shown that within the CSC subfractions are 
components that can act as tumor promoters or cocarcinogens, 
respectively. Thus, this approach allows the comparison of various 
condensates, especially when large groups of animals are used (>50 
per group). 
The application of CSC to mouse skin is the most widely employed 
assay for the evaluation of its carcinogenic potential. The mouse skin 
bioassays in tobacco carcinogenesis have been reviewed (Hoffmann, 
Wynder et al. 1983). A typical experiment uses two to three dose 
levels of condensate, generally 25, 50, and 75 mg of CSC, which are 
administered topically to the shaved backs of mice three to six times 
weekly for approximately 78 weeks. The CSC is most frequently 
applied as an acetone suspension (25, 33, or 50 percent). At the 
conclusion of such a study, skin tumors, some of which are 
malignant, generally are observed among the treated animals in a 
dose-related fashion. Such studies have shown that the carcinogenic 
activity of CSC! is also a function of tobacco variety, is influenced by 
replacement materials such as tobacco sheet or semisynthetics, and 
may be influenced by the use of additives. Although such bioassays 
have been extensively performed for the tars from mainstream 
cigarette smoke, only one study has examined the carcinogenic 
potential of the condensate of sidestream cigarette smoke. 
Cigarette tar from the sidestream smoke of nonfilter cigarettes 
that had settled on the funnel covering a multiple-unit smoking 
machine was suspended in acetone and applied to mouse skin for 15 
months (Wynder and Hoffmann 1967). Out of a group of 30 Swiss- 
ICR mice, 14 animals developed benign skin tumors and 3 animals 
had carcinomas. In a parallel assay of MS from the same cigarettes, 
a 50 percent CSCacetone suspension applied to deliver a comparable 
dose of CSC to 100 Swiss-ICR female mice led to benign skin tumors 
in 24 mice and to malignant skin tumors in 6 mice. This indicates 
that this smoke condensate of SS had greater tumorigenicity on 
mouse skin than MS tar (p > 0.05). 
In Vitro Assays 
Several short-term bioassays have been performed to evaluate the 
genotoxicity of the MS of cigarettes. These studies have been the 
subject of two reviews (DeMarini 1983; Obe et al. 1984). Although 
most of these studies have evaluated the effects of CSC, some 
investigations were focused on either the gas phase or the whole 
smoke. In recent years, there has been increased use of short-term 
assays to attempt to evaluate the relative genotoxic potential of 
environmental tobacco smoke. 
The most c=monly employd my for mu~ ectivity is done 
with various strains of &l~~~~ e whole irmdta 8% 
well as CSC from four types of bh - fauad ;O be mutageaic in 
S. typhrimurium TA1533 (Basrur et d 1~8). - gmo)reWarr also found to be mutagenic in a w hy- wLLB - 
directly on the bacterial plates (w et d 193~. b etudies lend 
support to the extensive assays performed a a w eehaMiah 
that tobacco smoke has significant mutagepic *w 
Several of the studies with Csc fm em haW besu 
aimed at comparing the effects of &ous tobaocas, w - 
strains, and various systems selected far m w lost 
of the mutagenic activity was m &tb & bagic fnrtion a 
CSC (DeMarini 1983). For the CSC! from w e mpta 
genie activity was primarily detected with &e m T- and 
TA98, thus indicating the presence of &e u - tJped 
mutagens. Except for studies on the e&&s af m 
cigarettes, metabolic activation was required t.4) demoaastra&e m* 
genie activity for most of the CZC studied. 
Several short-term tests have been performed in s 
systems. A solution of the gas phase of e mm 
dissolved in a phosphate buffer induced reciprocal u&c& e 
nation in Swcharcmzpc?s ~e~~isiae D3 snd petite mm io m 
i&ate of strain D3 (Izard et al. 1980). Whole mainetwam c&are&e 
smoke induced mitotic gene conversion, reverse mu&&m, and 
reciprocal mitotic recombination in strain M ofS. cenx&& @air&a 
1982). 
Transformation of mammalian cells was also induced in several 
cell systems using the CSC from mainstream 
. 
&g&t&i 1968; Inui and Takayama 1971; Rhim auE?m 
&n&ct et al. 1975; Takayama et al. 1978; Ridal and ti 
1980). Transplacental exposure t0 n CSC was WJorted b 
trasfom Syrian hamster foeti cells (Raamuseen et ~ ml). 
Transforming activity was reported in the acidic and basic fra&~~ I 
as well as the neutral fractions of C&L S~dies on v of 
csc have shown that the basic fraction and some of the a&c& 
fractions are the most active in Cd tran%formation (Bened& ~4 d 
1975). The neutral fraction OfCSCwaS*~ported~~*DNA 
repair h normal human lymphocytes (Gadin et al- 197% Transfer 
mation of mammalian cells with SS or m has not been repOti 
Summary of Carcinogenicity 
At present, the scientific literature offers some information on the 
physicochernical nature of the sidestream smoke from tobacco 
products and of environmental tobacco smoke. Chemical analytical 
studies have already demonstrated that SS and FYI’S contain a wfde 
spectrum of carcinogens such as polynuclear aromatic hydrocarbons, 
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volatile and tobacco-specific N-nitrosamines, and polonium-210. To 
date, only one study has demonstrated the carcinogenic activity of 
the particulate matter of sidestream smoke and a few isolated 
reports have dealt with the genotoxicity of SS and EX’S. Therefore, 
bioassay studies with the mainstream smoke and the environmental 
tobacco smoke of cigarettes are needed. Although the resulting 
bioassay data will derive from tests of concentrations of environmen- 
tal smoke that do not realistically occur in the human setting, these 
results will provide information about the relative carcinogenic 
potential of sidestream smoke in comparison with the mainstream 
smoke of the same cigarettes. In a comprehensive analytical 
approach, data should be generated to systematically determine the 
concentrations of toxic and tumorigenic agents in the ETS samples 
and to simultaneously measure the uptake of tobacco-specific agents 
by the body fluids of nonsmokers exposed to ETS. 
Conclusions 
1. The main effects of the irritants present in EZS occur in the 
conjunctiva of the eyes and the mucous membranes of the nose, 
throat, and lower respiratory tract. These irritant effects are a 
frequent cause of complaints about poor air quality due to 
environmental tobacco smoke. 
2. Active cigarette smoking is associated with prominent changes 
in the number, type, and function of respiratory epithelial and 
inflammatory cells; the potential for environmental tobacco 
smoke exposure to produce similar changes should be investi- 
gated. 
3. Animal models have demonstrated the carcinogencity of ciga- 
rette smoke, and the limited data that exist suggest that more 
carcinogenic activity per milligram of cigarette smoke concen- 
trate may be contained in sidestream smoke than in main- 
stream cigarette smoke. 
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Since the 197% the accumulating evidence on the health risks of 
involuntary smoking has been accompanied by a wave of social 
action regulating tobacco smoking in public places. hntiatives in the 
public sector and in the private sector have aimed at protecting 
individuals from exposure tc side&ream smoke by regulating the 
circumstances in which smoking is permitted. Smoking h public 
places has been regulated ~rhmily by government action at the 
local level and at the Federal level. Legislation has been the most 
common vehicle at the local and State level; agency regulations have 
predominated in the Federal Government. There has been relatively 
little judicial action to restrict smoking in public places; most cases 
have focused on nonsmoking employees’ right to a smokefree 
workplace (Feldman et al. 1978; Eriksen, in press; Walsh and Gordon 
1986). Private sector initiatives have gained momentum in the 1980s. 
Businesses in a ,wide variety of industries have adopted smoking 
policies to protect employee health. Other private initiatives include 
no-smoking sections in restaurants, no-smoking rooms in hotels and 
motels, and smoking restrictions in hospitals. 
Though this trend was fueled by growing evidence about the 
health effects of involuntary smoking, it also reflects the changing 
public attitudes about smoking since 1964, when public attention 
was focused on the health hazards of cigarette smoking by the 
Report of the Advisory Committee to the Surgeon General (US PEIS 
1964). The acceptability and desirability of tobacco smoking in public 
places has fallen dramatically over time, as reflected in public 
opinion surveys. A majority now support the right of nonsmokers to 
breathe smoke-free air and favor policies that ensure that right 
(ALA 198!jb; Hanauer et al. 1986; BNA 1966; US DHEW 1969). 
This chapter addresses the scope and impact of these diverse 
pohcies. It begins with a review of the current status of policies 
restficting smoking. Issues specific to smoking regulation in trans- 
portation vehicles and motels, restaurants, stores, schools, health 
care facilities, and the workplace are addressed. The effects of 
smoking policies on air quality, attitudes, and smoking behavior are 
considered. 
Current Status of Restrictions on Smoking in Public Places 
Smoking regulations in public places represent a mix of public and 
private actions. A public place may be defined as any enclosed area 
in which the public is permitted or to which the public is invited. 
Smoking restrictions are generally limited to indoor enclosed spaces 
(Hanauer et al. 1986). This broad definition of a public place 
encompasses a diverse group of facilities that differ in the degree to 
which smoking is restricted, the ease of introducing new regulations, 
and the methods by which new smoking restrictions have been 
proposed and adopted. 
Smoking in Federal, State, and local government facilities has 
been addressed by legislative and regulatory action. These facilities 
include government offices, public schools and libraries, and publicly 
owned transport&ion, health care, cultural, and sports facilities. In 
public facili&s under private ownership, smoking restrictions are a 
mixture of government-sponsored regulation and private initiative. 
These facilities include retail stores, restaurants and bars, hotels and 
motels, and privately owned transportation, health care, cultural, 
and sports facilities. 
The extent and ac&ptability of smoking restrictions in public 
places is influenced by (1) whether ownership is public or private; (2) 
the historical acceptance of smoking in the facility; (3) the degree to 
which nonsmokers are exposed to involuntary smoking, determined 
by the facility’s size, degree of ventilation, and ease of separating 
smokers and nonsmokers; and (4) the degree of inconvenience that 
smoking restrictions pose to smokers. Smoking restrictions are still 
most widespread and least controversial in facilities where smoking 
has traditionally been prohibited by fire codes, such as theaters or 
libraries, or where smoking is negatively associated with the activity 
taking play, such as gyms or health care facilities (Feldman et al. 
1978). Small crowded areas with poor ventilation, such as elevators 
and public transit vehicles, are also frequently regulated. On the 
other hand, the strong association of smoking with eating and 
drinking contributes to the controversial nature of smoking re&ic- 
Cons in restaurants and bars. 
Legislative Approaches 
Fe&r-d Legislation 
Congress has enacted no Federal legislation restricting smoking in 
public places, although bills have been introduced in Congress 
several times since 1973 (Feldman et al. 1978). 
State Legislation 
Most legislation restricting smoking has been enacted at the State 
level. Although legislation regulating smoking for health reasons is 
largely a phenomenon of the past decade, cigarette smoking has been 
the subject of restrictive legislation for nearly a century. Early 
legislation had two different rationales. The first, a relatively 
noncontroversial rationale, was the protection of the public from fire 
or other safety hazards, largely in the workplace (Warner 1981b). 
The second, more controversial motivation for early legislative 
action was a moral crusade against cigarettes similar in tone and 
coincident with the moral crusade against alcohol that emerged at 
the tux-n ofthe century Wlow 1981; Nobel 1978). INS goal w~ a total 
ban On Cigarettes, which were blamed for social e* and physical 
% based 1arge~Y on unfounded claims. By 1887, three States (North 
Dakota, Iowa, and Te==ee) had completely banned the de and 
use of cig=ett-. At the peak of the movement, cigarettes were 
b-cd h a dozen Stat.e~ RJuhing and Markle 1974; sobe 1978). 
Most were in the Midwest where cigarette consumption was low and 
a~~ticigarette feeling high. The movement lost momentum when 
enforcing the regulations proved controversial. AS part of the strong 
reaction to alcohol prohibition, ah State laws banmng smoking were 
repealed by 1927. 
During the 196Os, as the health risks of smoking became widely 
‘recogn&d, public POLICY on smoking began tc focus on encow 
the smoker to quit. However, the few existing State laws regulating 
smoking in public places were old and limited in scope. Even newly 
enacted laws-in Delaware (1960) and in Michigan (1967, 1968& 
restricted smoking in limited areas: public buses and trolleys, 
elevators, and retail food establishments (VS DHHS 1985b). Protec- 
ting the health or comfort of nonsmokers was not cited as a rationale 
of these laws. As Of 1970,~tatuteS restricting smoking were in force 
in 14 states (US DHHS 1985b). 
In the early 19709, a new wave of smoking legislation emerged. It 
covered smoking in a larger number of places and extended for the 
first time to privately owned facilities. The language became more 
restrictive, moving from permitting a no-smoking section to requir- 
ing one and making nonsmoking the principal or assumed condition. 
me language also changed to make it clear that the specific intent 
was the safety and comfort of nonsmokers. 
me pace of new legislation increased in the mid-1970s. Between 
1976 and 1974, 9 laws were enacted in 8 States, between 1975 and 
1979, 29 new laws were passed and 15 additional States adopted 
smoking regulations. Minnesota passed its landmark Clean Indoor 
fi Act in 1975 “to protect the public health, comfort, and 
environment by prohibiting smoking in public places and at public 
meet-s except in designated smoking areas” (M~IUESO~~ Stthte~ 
Annual 1985). It covered restaurants, private worksites, and a large 
number of public places, and soon became the model for other State 
legislation. Within the next 5 years, Utah, Montana, and Nebraska 
enacted similar comprehensive legislation (US DHHS 1985b). The 
language of statutes passed by 11 States during the 1970s made it 
clear that the specific purpose was to protect nonsmokers from 
involuntary smoking (US DHHS 198523). Model legislation and 
advice about the successful enactment of State laws can be found in 
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FIGURE l.-Prevalence and restrictiveness of State laws 
regulating smoking in public places, 19604986 
NOTE See appendix for definitions of mtrictivenem of laws. 
S4WRCE: ASH (1SW; OTA (1986); Tri-Agency Tobacco Free Project MSSk US DHHS WS6b). 
The rate of enactment of State legislation increased throughout 
the seventies (Figure 1, Table 1). The pace of new legislation 
continues in the 1980s with 23 new laws enacted by 16 States 
between 1980 and 1985 (Table 1). As of 1986, 41  States and the 
District of Columbia have enacted laws regulating smoking in at 
least one public place (Figure 1). Eighty percent of the U.S. 
population currently resides in States with some smoking restric- 
tion, compared with 8  percent in 1971 Warner 1981b).  Most of the 
nine States with no smoking legislation are concentrated in the 
southeast United States and include three of the six ma jor tobacco- 
producing States (North Carolina, Virginia, and Tennessee) (Figure 
a. 
Current State legislation varies in comprehensiveness and lan- 
guage. The number  of public places in which smoking is regulated by 
State law ranges from 1  (Delaware, M ississippi, and South Carolina 
regulate smoking on public transportation only) to 16  (Minnesota 
and F lorida) (US DHHS 198513,  Tri-Agency Tobacco Free Project 
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1986). State laws most often restrict smoking in public transporta- 
tion (35 States), hospitals (33 States), elevator (31 States), indoor 
cultural or recreational facilities (29 States), schools (27 Stat.@, 
public meeting rooms (21 States), and libraries (19 States) (Table 2). 
Other public places specifically mentioned in State smoking legisla- 
tion are public restrooms and waiting rooms, jury rooms, polling 
places, prisons, hallways, stairwells, and stables. Most laws restriqt 
smoking in these places to designated areas, thereby making 
nonsmoking the norm; in a few States smoking is banned entirely in 
these places. For example, smoking on pqblic transportation is 
banned entirely in four States (Florida, Georgia, Massachusetts, and 
W&&t& ad one (Washington) bans smoking in theaters, 




FIGURE 2.-Geographic variability of State laws regulating 
smoking in public places, 1996 
tions extend to restaurants and retail stores, which are largely 
privately owned, in 18 States. 
Smoking at the workplace is restricted for public sector employees 
in 22 States and for private sector employees in 9 States. The 
provisions of worksite smoking legislation vary widely, making 
direct comparisons of their comprehensiveness difficult. 
Currently enacted workplace smoking laws contain provisions to 
(1) require a written policy (5 States); (2) limit smoking to designated 
areas (8 States); (3) require the posting of signs (10 States); and (4) 
give preference to nonsmokers in resolving conflicts over the 
designation of a work area (2 States) (OTA 1986). Public or private 
worksites are included in the definition of public places in some 
States where worksites are subject to the general provisions for 
public places. O ther States have written separate guidelines for the 
worksite, which are usually more stringent. Laws in four States 
apply only to State and local government employees; restrictions 
apply to the private worksite in an additional nine States. 
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state AL AK AZ AR CA CO (;T DE DC FL GA HI ID IL IN IA KS KY 
1971.76 1973 1925 
Year(s) legislation 1975 1973 1977 1960.61 1977 1974 1963 1975 
enacted - 1964 1981 1963 1962 1985’ 1963 1960 1979 1965 1975 1976 1965 - 1978 1975 1972 
PUBLIC PLACES WHERE SMOKING IS PROHIBITED (EXCEPT IN DESIGNATED AREAS) 
Public transportation x x (X)’ X3.4 X X8 x X x3.5 X’ X X X X 
Elevators X’ x X X’ X x1 X’ x X X X 
Indoor recreational or 
cultural facilities’ x x X X X X X X X 
Retail stores (X)’ (X)’ x X X X X 
Restaurants X’ X0 X X’O X’ X 
Schools X X X X X X X X X 
Health care facilities 
Hospitals X X X X X X x x X X X X 
Nursing homes X X X X X X X X X 
Public meeting rooms X X X X X X X X X 
Libraries X X X X X 
Restrmns X’ x X X X 
Waiting rooms X X X X X X 
Other p.27 xn X262-7.30 
WORKSITE SMOKING RESTRICITONS ” 
Public worksites D” B D’ B B B,D I11 B’ B D 
Private worksites A B BD 
IMPLEMENTATION PROVISIONS 
Nonsmokers prevail 




Penalties for violations X X X X X X X X X X X X x x 
Smoking Xm pa x23. XS xm X” x= X21’ x23. X” X2&i x- 2P x- 
Y Failure to post signs X@h XUh 
c 
Overall State law 
restrictiveness:” 0 3 2 1 3 3 4 1 2 4 1 2 3 0 0 2 2 1 
ii TABLE 2.-Cantinued 
St& LAME MDMAMIMN IbiB MO MT NE NV NH NJ Nbf NY NC ND OH 
1954 1924 1967 1955 1921 
Year@) legislation 1961,63 1957 1947 1966 1971 1911 1979 1975 1961 
enacted 1965 1975 1975 1976 1975 1942 - 1979 1979 1976 1961 1965 16% 1976 - 1977 lsec 
PUBLIC PLACES WHERE SMOKING I8 PROHIBITED (EXCEPT IN DEslGNATBD AREAS) 
Public transportation X X X’ 00’ x x X x x x x x x x x 
ElW&XI X X’ x x x x x x x x x x 
Indoor recreational or 
cultural facilities* X X x x x x x x x x x 
Retail stores X cm’ x x x x X X 
Restaurants X X” x x X” X” X 
Schools X x x x x x x x x 
Health care facilities 
Hospitals X x x x x x x x x x x x x 
Nursing homea X x x x x x x x x x x x x 
Public meeting rooms X x x x x x x x x 
Libra+ X X x x x x x X 
Rentmoms x X X x x 
waiting rooms X X x x x X X 
Other X’” X” Xmm X” X” X” 
WORKSITE SMOKING RE!i%‘RICl’IONS” 
Public worksites BP D” D ” D” D’O B,C” B$F C C 
Private worksites 4D Dl7.21 D” D17P A” B,C ” Aal 
IMPLEMENTATION PROVISIONS 
Nonsmokers prevail 
in disputes X X 
No discrimination 
against nonsmokers X 
ENFURCEMENT 
state OK OR PA I.. SC SD TN TX UT VT VA WA WV WI WY 
1973.76 1927 1913 w 
Year(s) legislation 1977 1947 1976 1976 1919 N CC) 
enacted 1975 1961 1977 1977 1937 1974 - 1975 1979 1692 - 1963 1965 1964 - 51 wo) 
PUBLIC PLACES WHER?- SMOKING IS PROHIBITED (EXCEPT IN DESIGNATED AREAS) 
Public transportation X X (x)* x X 
Elevators X X X X X 
Indoor recreational or 
cultural facilities0 X X x x X X 
Retail stores X X X 
Restaurants X X 
Schools X X X X 
Health care facilities 
Hospitals X X X X X 
Nursing homes X X X X 
Public meeting rooms X 
Libraries X X X X 
Restrooms 
Waiting rooms X 








































WORKSITE SMOKING RESTRICI’IONS” 
Public worksites D 
Private worksites 
D” D D” 22 (43.1) 






X 4 (7.6) 
X 2 (3.9) 
ENFORCEMENT 
Penalties for violations X X X X X X X X x x X 40 (78.4) 
Smoking XW XWb X2” x= X2.% X2” x= X23. XZJ’ psa X= 39 (76.5) 
Failure to post signs X2& XW pe 9 (17.6) 
Overall State law 
restrictivenewzS 2 3 2 3 1 2 0 2 4 1 0 4 1 3 0 
Y TABLE 2.-C!ontinued (Footnotes) 
’ Executive order. 
‘School buses only. 
a Including school buses. 
‘California stipulates that at least 50 percent of all passenger seats must be in nonsmoking areas on trains, airplanes. and street railroad cam departing from the State. 
‘Smoking never permitted in this area. 
‘Indoor recreational and cultural facilities: museums, auditoriums, theaters, and sports arenas. 
‘Grocery storea only. 
’ Beatauranta seating 50 or more persons must have a no-smoking section. 
eBestauranta seating 50 or more persons must have e no+moking eection if the restaurant ia in a publicly owned building. 
‘OBestauranta seating 15 or more persons must have a nwmoking section. 
” Restaurants must designate at least 30 percent of their mata aa a no+moking area. 
” Reatauranta are encouraged to establish noamoking areas. 
‘I Ftentauranta must designate at least 50 percent of their seats 88 a no.emoking area. 
“Kkleted). 
I’ No place other than a bar may be designated B smoking area in its entirety. 
‘* Worksite (only 8, C. and D munt aa having a worksite policy in maculation of totals): A - Employer must post a sign prohibiting smoking at the work&q B - Employer mu& have a (wit&n) 
smoking policy; C - Employer must have policy that provides a nonsmoking area; D - No smoking except in designated .wcas. 
” Employer must post signs designating smoking and nwmoking arena. 
‘*Employer mu& vt signs in smoking area.% 
‘*Employer must post either smoking or nwemoking sign& depending upon their policy. 
‘“Employer must post Ggna in no-smoking areas. 
” State doea not restrict smoking in factories. warehouses. and similar placea of work not usually frequented by the general public. 
” Prohibita smoking in any mill or factory in which a no-emoking sign is pasted. 
“Pereons who smoke in a prohibited area are subject to a tine or a penalty. Maximum fina or penalties, where applicable, are listed below: a = $5; b = $10, c = 1%; d = $& e = $100, f = 
$loO/day; g = $200; h = *urn; i = $5CO; j = $50 or up to 10 days in jail or both; k = $60 or SO daya imprisonment; 1 = civil action; m = minor misdemeanor; n = petty mi&mwnor; o = 
misdemefmor; p = petty offense. 
” Persona who are required to and fail to pcet smoking and/or no+moking sigma are subjected b a penalty. Maximum finea. where applicable. are listed in footnote 23. 
I6 Restrictivenea key: 0 = None, no statewide restrictions; 1 = Nominal, State ragul&en smoking in one to three public placm, excluding restaurants and private vorknita; 2 = B&c, State 
regulatea smoking in four or more public places, excluding restaurants and private workaita; 3 = Moderate. State regulatea smoking in restaurants but not private workaitcs; 1 = ENnaive. 
State regulates smoking in private work&es. 
*‘Jury moms. 
” Halb and stain. 
‘*stables. 
“Polling plaan. 
*‘Prisons, at ptin offL%& diiretion. 
The least restrictive workplace laws simply empower the employer 
to restrict smoking in factories by posting signs. These statutes were 
enacted in the early 1900s. The weakest recent laws simply require 
an employer to issue a written smoking policy and to post signs. 
More restrictive laws require that employers designate no-smoking 
areas at work, implying that smoking is the norm. The most 
comprehensive laws prohibit smoking except in designated areas, 
making nonsmoking the norm. Seven States (Florida, Maine, Minne- 
sota, Montana, Nebraska, Utah, and Washington) have this type of 
law. In several States, some worksites or some parts of a worksite 
(usually private offices) are exempted from the regulations. To 
prevent employers from complying with the letter but not the intent 
of the law, some States prohibit a workplace from being designated 
as entirely smoking. 
State laws vary in their provisions for implementation and 
enforcement. In most States, the State health department is 
responsible for policy enforcement. Nearly all (39 of 42) States with 
laws provide penalties for smokers who violate restrictions; the 
maximum penalty is $500. In two States violators can be jailed. 
Employers or others who fail to designate smoking areas can be fined 
in nine States. 
The comprehensiveness of State laws, as defined by the number 
and nature of places where smoking is restricted or prohibited, has 
increased since 1970. In 1981, Warner (1981b) classified State laws 
according to their comprehensiveness (restrictiveness) and docu- 
mented an increase in the average restrictiveness from 1971 to 1978. 
An updated and modified index of the comprehensiveness of State 
laws (described in the appendix) demonstrates that the phenomenon 
reported by Warner has continued into the mid-eighties. The 
comprehensiveness of newly enacted laws increased markedly dur- 
ing the mid-seventies, and the average restrictiveness of State laws 
in effect has increased more than twofold between 1972 and 1985 
(Table 1, Figure 3). As shown in Figure 1 and Table 1, the increase in 
comprehensiveness of State laws occurred in two ways. The average 
comprehensiveness of first laws in additional States increased, and 
existing State smoking laws were replaced with more comprehensive 
legislation. 
Warner also documented that both the prevalence and comprehen- 
siveness of State laws enacted through 1978 varied by geographic 
region (Warner 1982). This has not changed (Table 3, Figure 2). Over 
90 percent of the States in the Northeast and West have enacted at 
least one law regulating smoking, as have three-fourths of the North 
Central States. Southern States have fewer laws than other regions, 
and the laws they have are less comprehensive than laws in other 
regions. The six major tobacco-producing States, all located in the 




















T  -L I I I I I I 1  I 
1960 1965 1970 1975 1960 1965 
Year 
FIGURE 3.-Average restrictiveness of State laws in effect, 
1990-1985 
NWlW Coding of restrictiveness of law; Extensive = 1.00; Moderate = 0.75; Rasic = 0.50; Nominal = 0.25 ISee 
appendix for definitions of ratrictivenw of laws.) 
SOURCE: ASH ,1966); WI-A (1966); Tri-Agency Tobacco Free F’mject W366); US DHH6 W35b). 
States. Compared with other States, ma jor tobacco States are less 
likely to have enacted smoking legislation and  more likely to have 
enacted less stringent laws. 
TABLE 3.-Regional variation in State laws restricting 
smoking 
Total Stetes Average 
Statea with laws’ Average restrictiveness 
effective date of laws in effect 
Region N N CC) of first law in 19852.3 
Northeast 11 11 (loo) 1944 614 
North Central 12 9 (75) 1976 694 
west 15 14 (93) 1968 ,714 
South 12 7 (58) 1955 357 
Major t&am 
producing states* 6 3 60) 1961 2.50 
Other southern 
states 6 4 (67) 1951 438 
‘Differences in pl’~dence Of laws among four regions: chi .q-; (3 dfj = 6.67, p = 0.03, difference m 
~revdence of law, 6011th vs.. all others: chi square (1 dfJ = 5.66, p = 0.04. 
’ Includes only States with lavm in effect bee Table 1 for Index of Resttictivenea). 
’ Difference in restrictiveness. South vs. all others: t = 2.76, p = 0.03. 
’ North Caroline, South Carolina, Virginia, Kentucky, Tennessee, Georgia. 
Local L.egislation 
In the 198Os, the momentum of nonsmokers’ rights legislation 
spread from the State to the local level, spearheaded by actions in 
California (Warner et al. 1986). Although not the first local action, 
the successful passage of San Francisco’s Proposition P in 1983 in 
spite of heavily subsidized tobacco industry opposition attracted 
widespread publicity and was followed by the passage of comprehen- 
sive legislation in a number of other local communities (Doyle 1984). 
Many local ordinances extend existing State policies to restau- 
rants and worksites. According to a March 1986 survey, 74 Califor- 
nia cities and counties have passed smoking ordinances, including 62 
requiring no-smoking sections in restaurants and 54 restricting 
smoking in retail stores (Americans for Nonsmokers’ Rights Founda- 
tion 1986). In the survey, 66 of these cities and counties rewire 
private employers to have a smoking policy or to identify ncwnoking 
areas. As a result, 44 percent of California’s population lives in 
communities that have enacted workplace smoking ordinances even 
though California has no State legislation covering the private 
workplace. 
According to the Tobacco Institute, by the end of 198% 89 cities 
and counties nationwide had restricted smoking in the Viva* 
workplace. As stated above, three-fourths of these were in California 
(BNA 1986). Workplace smoking ordinances have also been passed in 
Cincinnati (Ohio), Kansas City (Missouri), Tucson (Arizona), Aspen 
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(Colorado), San Antonio, Austin, and Fort Worth (Texas), Newton 
(Massachusetts), and Suffolk County (New York). In New York City, 
a bill to prohibit smoking in all enclosed public places has been 
proposed by the mayor (New York Times 7/6/86). 
Regulatory Approaches 
Administrative agencies have become involved in smoking regula- 
tion in two ways: (1) the enforcement of smoking legislation enacted 
by State and local government is commonly delegated to a specific 
agency, usually the public health department; or (2) an agency may 
initiate smoking regulation as part of the activities it has been 
authorized to supervise (Feldman et al. 1978). Agency regulations 
have been the major mode of regulation at the Federal level, where 
smoking by Government employees and by passengers in interstate 
transportation vehicles have been addressed. Smoking by State and 
local employees has also been addressed by the actions of administra- 
tors; e.g., smoking by municipal employees and in public areas of 
municipal buildings was banned by a recent mayoral order in New 
York City (New York Times 6/26/E%). 
Smoking Regulation in Specific Public Places 
Public Transportation 
Because high concentrations of environmental tobacco smoke can 
accumulate inside public transport vehicles, smoking is often 
restricted or banned in public transportation. Smoking is likely to be 
banned entirely in vehicles where smokers spend relatively little 
time (e.g., city buses), and confined to designated areas in situations 
where smokers spend several hours (e.g., intercity buses, trains, and 
airplanes). Such restrictions are relatively well accepted. 
Smoking on interstate transportation vehicles is regulated by 
Federal agencies. The Civil Aeronautics Board, under its jurisdiction 
to “ensure safe and adequate service, equipment, and facilities,” 
initially regulated smoking on airplanes, requiring, since 1972, that 
every commercial air flight provide a no-smoking section for all 
passengers requesting such seating (Feldman et al. 1978; Walsh and 
Gordon 1986). Airline control is currently part of the authority of the 
U.S. Department of Transportation. Likewise, the Interstate Com- 
merce Commission has restricted smoking on buses and trains to 
designated areas since the early 1970s (Feldman et al. 1978; Walsh 
1984). 
Additionally, States and local governments have regulated smok- 
ing in public transportation vehicles. Thirty-one States have enacted 
legislation to restrict smoking to designated areas in public transit 
vehicles; an additional four (Florida, Georgia, Massachusetts, and 
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Washington) ban smoking entirely on these vehicles (Table 2). Local 
ordinances also frequently address public transportation. 
Retail Stores 
In general, State and local legislation prohibiting smoking in retail 
stores is well accepted. Eighteen States currently prohibit smoking 
in retail stores (Table 2). Proprietors and their trade associations 
have generally supported smoking restrictions out of concern for the 
costs of cigarette burns to merchandise and facilities and for the 
image presented to customers by employees. Furthermore, their 
business is less likely to be affected than, for instance, the restaurant 
trade because smoking is not as closely associated with shopping as it 
is with eating and drinking. 
Restaurants 
The average American, who according to National Restaurant 
Association (NRA) statistics eats out 3.7 times per week, has the 
potential for repeated environmental tobacco smoke (ETS) exposure 
(NRA 1986). This is a problem particularly in small restaurants, 
where ventilation may not be able to remove smoke and room size 
precludes a meaningful separation of smokers and nonsmokers. 
Public opinion polls document support for restaurant smoking 
restrictions among nonsmokers and smokers. Ninety-one percent of 
nonsmokers and 86 percent of smokers responding to a 1983 Gallup 
poll favored either restricting or banning restaurant smoking, with 
most preferring restriction (Gallup 1983). Similar results were 
reported by two regional polls in 1984 (UC SRC 1964, Hollander- 
Cohen Associates 1984). Roper polls in 1976 and 1978 demonstrated 
the growth in this sentiment during the mid-seventies; the propor- 
tion of respondents supporting restrictions grew from 57 percent to 
73 percent in 2 years (Roper 1978). Yet little is known about how 
restrictions affect decisions to dine out or the choice of restaurant. A 
1981 telephone survey of 949 individuals conducted by the NRA 
(1982) found that the existence of a no-smoking section was near the 
bottom of a list of 13 attributes influencing an individual’s choice of 
restaurant. On the other hand, 47 percent of 1,038 adults answering 
a 1984 Gallup Monthly Report on Eating Out stated that one reason 
they did not eat out more was that they were bothered by smoke 
(Gallup 1984). 
As in other privately owned facilities, smoking regulations in 
restaurants have come about through private initiative and public 
mandate. Private initiatives have sometimes occurred in anticipa- 
tion of a local ordinance, but the number of restaurants that have 
voluntarily established no-smoking sections is not known. The 
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Ontario Restaurant and Food Services Association (1985) published a 
handbook of guidelines for establishing no-smoking sections. 
In 1974, Connecticut became the first State to require restaurants 
to have no-smoking sections. By 1980, eight other States also 
regulated restaurant smoking. At present, laws in 18 States and an 
unknown number of localities regulate smoking in restaurants. 
Although a nationwide accounting of local regulations is not 
available, data are available for several States (Table 2). Most State 
and local ordinances specify (1) the minimum number of seats that 
must be included in a no-smoking section, (2) the smallest restaurant 
for which rules apply, and (3) the manner in which customers are to 
be informed about not-smoking sections. Bars that do not serve meals 
are uniformly excluded from restrictions. Most current State legisla- 
tion specifies that a minimum of 30 percent of seats be designated as 
no-smoking and exempts facilities with fewer than 50 seats. Local 
ordinances are generally more restrictive, specifying that a higher 
percentage of seats be designated no-smoking and extending cover- 
age to smaller establishments. Model ordinances (Hanauer et al. 
1986) suggest that a minimum of 50 percent of seats be designated as 
no-smoking, require the posting of signs inside and outside the 
facility, and specify that owners ask patrons about smoking prefer- 
ence rather than respond only to customer requests. 
There has been more opposition to smoking restrictions in 
restaurants than in other privately owned public places (Hanauer et 
al. 1986). Opposition has come primarily from restaurant associa- 
tions and centers on three concerns: (1) government intrusion into 
business practice, (2) practical problems in coordinating seating of 
smokers and nonsmokers, and (3) losing the business of smokers who 
chose to leave a facility rather than to dine in a no-smoking section 
or wait for an available table in a smoking section. These concerns 
assume that the supply of no-smoking tables will exceed demand. 
While the proportion of tables allocated by most laws to no-smoking 
sections greatly underrepresents the proportion of nonsmokers, 
mixed parties of smokers and nonsmokers would have to decide 
which section to sit in. Restaurant owners appear to perceive little 
customer demand for no-smoking areas, or are unaware of the very 
high percentage of smokers and nonsmokers responding to public 
opinion polls who support smoking restrictions. 
In anecdotal reports, the experience of restaurant owners who 
have implemented restrictions is that they are well accepted by 
customers and less difficult to implement than expected (Lehman 
1984). There is little information on the extent of restaurant 
compliance with State and local laws. In Park City, Utah, the 
Chamber of Commerce polled its 32 member restaurants, and only 
25 percent had complied with State law to set up no-smoking areas 
(Park Record 6/13/85). However, a random survey of Minneapolis 
restaurants in 1976, 1 year after enactment of the comprehensive 
Minnesota Clean Indoor Air Act, found near-total compliance with 
the State’s smoking regulations (Sandell 1984). In a 1978 Minnesota 
survey, 66 percent of nonsmokers and 81 percent of smokers felt that 
there were adequate no-smoking areas in that State’s restaurants 
(Minneapolis Tribune 1978). 
Hotels and Motels 
Over the past decade, hotel and motel operators have begun to 
offer guest rooms in which smoking is prohibited. In some facilities, 
no-smoking areas in lobbies and restaurants are also provided. 
Hotels are unique among public places in the manner and ease with 
which smoking has been addressed. Unlike the situation in restau- 
rants, among hotels the no-smoking room policy is uniformly a 
private initiative, introduced by management in response to per- 
ceived customer demand (Linnell 1986). Hotel and motel rooms are 
not covered by State and local regulations and have not been 
addressed by nonsmokers’ rights advocates. 
Designating guestrooms as no-smoking began in the early 1970s in 
smaller hotel and motel chains. In the 1980s the concept has spread 
to larger chains, including Hyatt Hotels in 1984 and Hilton Hotels in 
1986 (Los Angeles Times 1986). According to a 1985 survey of 98 
hotel and motel chains, 37 of 41 respondents provided no-smoking 
rooms, 23 by chainwide policy. The four respondents who did not 
offer no-smoking rooms were considering doing so (Linnell1986). The 
percentage of rooms allocated as no-smoking varied from 5 to 30 
percent, far less than the prevalence of nonsmokers in the adult 
population (70 percent). As a result, demand often exceeds supply, 
leading several chains to increase the percentage of no-smoking 
rooms (Linnell 1986; Vettel 1986). The only entirely no-smoking 
facility is the Non-Smokers Inn, a 134-room motel in Dallas, Texas, 
which has been open since 1982 and reports a 96 percent occupancy 
rate (Vettel 1986). Although there are anecdotal reports of problems 
with compliance, hotels do not have penalties for violators. The 
exception is the Non-Smokers Inn, where at check-in guests sign an 
agreement to abide by the rule; if the management detects smoking 
by occupants, $250 is charged to cover the costs of cleaning. 
Whether no-smoking guestrooms offer significant protection from 
sidestream smoke exposure is not clear. It is not known whether 
nonsmokers are exposed to significant. quantities of ETS by staying 
in hotel rooms previously, but not currently, occupied by smokers. 
Rooms designated as no-smoking may primarily allow nonsmokers to 
avoid stale tobacco odors. 
The regulation of smoking in hotels and motels is supported by 
public opinion. Fifty to sixty percent of respondents to recent opinion 
polls favor restrictions on smoking in hotel rooms, and an additional 
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7 to 18 percent favor outright bans on smoking (Gallup 1983, UC 
SRC 1984, Hollander-Cohen Associates 1984). In the 1983 Gallup 
poll, 60 percent of nonsmokers and 49 percent of smokers supported 
smoking restrictions in hotels, with an additional 15 percent of 
smokers and 7 percent of nonsmokers favoring outright smoking 
bans. 
Hotel management regards such policy as a marketing tool. Cost 
savings do not appear to be a motivating force in the trend, in spite 
of anecdotal reports of reduced cleaning and maintenance costs in 
no-smoking rooms (Linnell 1986). Preparing no-smoking rooms 
requires an up-front cost for the thorough cleaning of furnishings 
and often the repainting of walls. For instance, Quality Inns 
estimated that it spent $138 per room when it allocated 10 percent of 
its rooms as no-smoking in 1984 (Vettell986). 
Schools 
Smoking by students in schools has been the subject of State 
legislation, State and local school board regulations, and individual 
school policies. Colleges and universities are not discussed in this 
section. In 27 States, schools are among the public places where 
smoking is restricted to designated areas (Table 2). School board 
policies often combine restrictions on tobacco use in schools with 
educational programs about the hazards of tobacco use. Smoking by 
teachers, for whom school is the workplace, is also regulated by 
many school boards. 
Smoking has traditionally been regulated in schools for reasons 
other than concern about sidestream smoke exposure. The two 
rationales have been to comply with State law and to prevent the 
initiation of smoking by adolescents. The sale or use of tobacco by 
minors is prohibited in 35 States (Breslow 1982). Many of these laws 
are rendered ineffective by the availability of cigarettes in vending 
machines and by cultural norms that discourage the laws’ enforce- 
ment (US DHEW 1969). Nonetheless, the laws do provide a legal 
incentive for schools to regulate student smoking. The second reason 
for restricting smoking in schools is that adolescents are making 
decisions about whether to begin smoking and the influence of peers 
as well as of adult role models who smoke is recognized to be 
important (US DHHS 1980,1982). 
Recognition of the health effects of involuntary smoking provides 
an additional reason to address smoking in schools and a reason to 
expand attention from students to faculty. For teachers and staff, 
the school is the worksite, a location with the potential for 
substantial ETS exposure (Repace and Lowrey 1985). For students, 
school is the site where they spend the most time outside of the 
home. 
A total prohibition of smoking on school grounds provides the 
greatest protection from sidestream smoke exposure and unwanted 
role modeling effects. In practice, however, this policy has often 
proved difficult to enforce effectively (Rashak et al. 1986). In some 
cases it has created major discipline problems and required substan- 
tial time and personnel for enforcement. School officials, faced with 
the management of other social problems, may not wish to devote 
much of their resources to enforcement of a strict smoking ban. 
Consequently, many schools have established student smoking areas 
inside or outside the school building. Use of these areas often 
requires parental permission. Smoking areas for students are not 
popular with parents or teachers, according to survey data. Over 
three-fourths of 603 adults responding to a 1977 Minnesota poll 
opposed allowing school boards to establish smoking areas for 
students. Only 13 percent of 1,577 public school teachers responding 
to a 1976 nationwide survey thought students should be able to 
smoke on school grounds. 
The nature and extent of school smoking policies nationwide is not 
known. Results of the few statewide surveys vary considerably. A 
Connecticut survey reported that 75 percent of the State’s public 
high schools permitted smoking (Bailey 1983). In contrast, in 
Arizona, where State law requires schools to restrict smoking on 
school grounds, 92 percent of the State’s 169 public and private 
secondary schools surveyed had written smoking policies for stu- 
dents, and most policies prohibited all tobacco use by students 
(Rashak et al. 1986). 
Smoking by teachers at schools is generally prohibited in the 
classroom, but is often permitted in a lounge where students are not 
allowed. Ninety percent of Arizona schools permit smoking in 
teachers’ lounges, 40 percent in private offices, and 19 percent in 
meetings (Rashak et al. 1986). Such policies attempt to avoid 
negative role modeling effects; however, they create a double 
standard that may be a barrier to student compliance with smoking 
bans. There has been little concern for protecting teachers from 
involuntary smoke exposure at the worksite. Since smoking is 
prohibited in the classroom, their exposure is limited to offices and 
lounges. 
Health Care Facilities 
There are strong reasons for health care facilities to have 
particularly stringent restrictions on smoking. Many patients treat- 
ed in these facilities suffer from illnesses whose symptoms can be 
worsened by acute exposure to tobacco smoke. Hospitals also convey 
messages about health to patients and visitors; permitting smoking 
on the premises may undermine the messages delivered to many 
patients about the importance of not smoking (Kottke et al. 1986). 
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Stringent restrictions on smoking in hospitals have been endorsed by 
the American Academy of Pediatrics (1986), the American Medical 
Association (19&i), and the American College of Physicians (1986). 
Hospital smoking policies have been opposed by some who are 
concerned about inconveniencing smokers at times of illness and 
stress. Proponents of hospital no-smoking policies, on the other hand, 
are concerned about inconveniencing the nonsmoking patient or 
visitor at these stressful times. 
Public opinion supports smoking restrictions in health care 
facilities. In the 1978 Roper survey, 69 percent of respondents 
favored a ban on smoking in doctors’ and dentists’ offices and 
waiting rooms (AMA 1984). Of the more than 3,000 individuals 
interviewed in hospitals and restaurants, 66 percent favored restric- 
ting or banning smoking in these areas (Barr and Lambert 1982). 
Over 80 percent of patients and faculty and 68 percent of employees 
agreed that “a smoke-free hospital would be an improvement in 
patient care” at the University of I Minnesota hospital (Kottke et al. 
1986). 
Smoking in health care facilities has been addressed through State 
and local legislation, Federal regulation, and private initiative. In 
most States, hospitals and nursing homes are included among public 
places where smoking is restricted to designated areas (Table 2). In 
many cases, these legislative efforts have not led to strong protection 
of patients from involuntary smoke exposure because patient care 
areas may be included among the designated areas where smoking is 
permitted. Federally run hospitals have adopted increasingly strin- 
gent restrictions on smoking. For instance, Veterans’ Administra- 
tion hospitals and clinics adopted a new smoking policy in 1986, and 
a large number of Indian Health Service hospitals are now entirely 
smoke free (OTA 1986; Rhoades and Fairbanks 1985). Health care 
facilities run by some States, such as Massachusetts, have also 
adopted no-smoking policies (Naimark 1986). In nongovernment 
hospitals, most smoking restriction has been the result of private 
initiative, often spearheaded by the medical staff. Much of this 
action has taken place in the 1980s. 
Hospital smoking policies can be complex. Within a single 
institution, smoking may be handled differently in inpatient, outpa- 
tient, and administrative areas. Patients, visitors, and employees 
may be subject to different sets of restrictions. Consequently, 
smoking policies vary widely among hospitals (Ernster and Wilner 
1985). The least stringent policy prohibits smoking only where it is a 
safety hazard, such as near oxygen, and may permit the sale of 
cigarettes on the premises. Mild policies often assign patients to beds 
by smoking status, prohibit staff from smoking in patient care areas, 
and provide areas in cafeterias and waiting rooms for nonsmokers. 
Moderately stringent policies prohibit smoking in shared patient 
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rooms or in all patient rooms. Some hospitals permit patients to 
smoke with a doctor’s written order. The most stringent policies,- the 
so-called smoke-free hospitals, prohibit smoking throughout the 
facility or limit smoking to a single room away from patient care 
areas (Kottke et al. 1986). Enforcement of a smoking policy is usually 
the responsibility of the nursing staff. Guidelines for implementing 
hospital smoking policies have been formulated (Kottke et al. 1986; 
Emster and Wilner 1985; AHA 1982). 
In spite of anecdotal reports of the adoption of stringent smoking 
policies in individual hospitals (Andrews 19831, survey data indicate 
that smoking is still widely permitted in patient care areas. A survey 
of 360 randomly selected U.S. hospitals published in 1979 found few 
restrictions on smoking; fewer than half elicited the patients’ 
smoking preference on admission or had nosmoking areas in 
cafeterias, waiting rczms, or lobbies, and smoking was permitted on 
76 percent of the wards (Kelly and Cohen 1979). A 1981 survey of 
1,168 community hospitals (Jones 1981) documented some change in 
policy prevalence. More than 90 percent of the hospitals had a 
written smoking policy, which restricted smoking to designated 
areas in 97 percent of cases. Over 85 percent of the hospitals offered 
no-smoking patient rooms, subject to availability (Jones 1981). A 
recent survey of 185 hospital administrators in Georgia reported 
that 70 percent continue to allow smoking in patient rooms, 
although only 6 percent permit it at nurses’ stations (Berman et al. 
1985). The proportion of hospitals allowing cigarette sales on the 
premises has declined from 56 to 58 percent in the late seventies 
(Kelly and Cohen 1979; Seffrin et al. 1978) to less than 30 percent in 
the eighties (Em&x and Wilner 1985; Jones 1981; Berman et al. 
1985; Bert&en and Stolberg 1981). While there are little data on the 
prevalence of smoking policies in private physicians’ offices, guide- 
lines for physicians wanting to provide assistance in smoking 
cessation are well developed (Lichtenstein and Danaher 1978; 
Shipley and Orleans 1982; US DHHS 1984). 
Current Status of Smoking Regulations in the Workplace 
Policies regulating smoking at the workplace for the protection of 
employees’ health are a trend of the 1980s. As of 1986, smoking is 
restricted or banned in 35 to 40 percent of private sector businesses 
(HBPC 1985; BNA 1986; US DHHS 1986) and in an increasing 
number of Federal, State, and local government offices (OTA 1986). 
Private sector workplace smoking is regulated by law in 9 States and 
over 70 communities (OTA 1986; US DHHS 1985b; ASH 1986). 
Actions to restrict or ban smoking at the workplace are supported by 
a large majority of both smokers and nonsmokers (Gallup 1985). 
The workplace has become the focus of particular attention as 
evidence about the health hazards of involuntary smoking has 
accumulated. Urban adults spend more time at work than at any 
other location except home (Repace and Lowrey 1985). For adults 
living in a household where no one smokes (Ha+ 19851, the 
workplace is the greatest source of FTS exposure. Consequently, an 
individual’s workplace FTS exposure can be substantial in duration 
and intensity. This is of particular concern for individuals also 
exposed to industrial toxins whose effects may be synergistic with 
tobacco smoke (US DHHS 19854. Furthermore, individuals have less 
choice about their ETS exposure at work than they do in other 
places, such as restaurants or auditoriums. 
The nonsmoker’s right to clean air on the job has been supported 
by common law precedent (US DHHS 1985a; Walsh and Gordon 
1986). Assuring clean air at work has received the growing attention 
of policymakers and nonsmokers’ rights advocates. The worksite has 
also received attention because of its naturally occurring interper- 
sonal networks and intrinsic social norms. Behavioral scientists have 
attempted to take advantage of the social milieu of the workplace to 
increase the success of smoking cessation programs (US DHHS 
198%). Smoking policies have the potential to alter worksite norms 
about smoking and thereby to contribute to reductions in employee 
smoking rates or the prevention of smoking onset. A substantial 
fraction of blue-collar workers who smoke report the initiation of 
smoking at ages coincident with their entry into the workforce (US 
DHHS 1985c). 
Smoking Policies 
Legislation mandating smoking policies in the private sector 
workplace has been more controversial and less widespread than 
legislation covering public places. Because a worker’s behavior off 
the job has traditionally been viewed as beyond the employer’s 
legitimate concern, private employers have been reluctant to impose 
rules on behavior not directly related to employment (Walsh 1984; 
Fielding 1986). The concept of workplace smoking restriction has 
become more acceptable to employers and legislators as the hazards 
of involuntary smoking have become better known and as public 
attitudes about smoking have shifted. The rationale for policies has 
been reframed as guaranteeing an employee’s right to a healthy 
work environment. 
Prevalence of Smoking Policies 
Notwithstanding the recent attention, regulating smoking at work 
is not a new idea. There is a long and noncontroversial tradition of 
smoking restrictions to insure the safety of the worker, workplace, 
and product (OTA 1986). Employers have restricted smoking to 
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prevent fires or explosions around flammable materials or to prevent 
product contamination. The policies were supported by State legisla- 
tion dating back to 1892, when Vermont authorized employers to 
ban smoking in factories so long as a sign was posted (Warner 1982; 
US DHHS 198513). New York, Nevada, and West Virginia had 
enacted similar legislation by 1921, and in 1924 Massachusetts 
banned smoking in stables because of the fire hazard (US DHHS 
1985b). 
Smoking restrictions remained uncommon throughout the 1960s. 
During the 1970s workplace smoking regulations were included in 
the comprehensive clean indoor air legislation being proposed at the 
State level. In 1975, Minnesota became the first State to enact 
regulations for private work&es for the purpose of protecting 
employee health. Since then, eight other States have passed laws 
covering private sector workplace smoking (T&Agency Tobacco Free 
Project 1986; 0T.A 1986; ASH 1986; US DHHS 1985b). Fifteen 
percent of the U.S. population lives in these nine States. The scope of 
this legislative effort widened in the 1980s to include local govern- 
ment. It has been strongest in California, where ordinances in 66 
communities cover 44 percent of the State’s population (Americans 
for Nonsmokers’ Rights Foundation 1986). 
In spite of this legislative activity, surveys of employers through 
the 1970s reveal that worksite smoking regulations remained limited 
overall (Table 4). Those in place applied primarily to blue-collar 
areas and were motivated by safety concerns (NICSH 198Oa,b, 
Bennett and Levy 1980). Policies were more common in industries 
with product safety concerns (food, pharmaceuticals) or explosion 
hazards (chemicals) (HRPC 1985). Safety was the prime reason for 
smoking policies in a survey of 128 large Massachusetts employers in 
1978-1979. The potential for an adverse impact on clients, especially 
in service industries, was also cited (Bennett and Levy 1980). 
Concerns about the impact of smoking on the health of employees or 
costs to employers-the focus of the current workplace smoking 
action-were not mentioned. Fewer than 1 percent of 855 employers 
answering a nationwide survey in 1979 had calculated the costs of 
employee smoking (NICSH 1980a,b). 
Five surveys of employers conducted between 1977 and 1980 
document the situation just prior to the proliferation of workplace 
smoking policies. Estimates of the prevalence of smoking policies 
ranged from 14 to 64 percent, reflecting differences in types of 
businesses sampled and response rates (Table 4). A survey conducted 
by the National Interagency Council on Smoking and Health in 1979 
had the largest sample size and the only random sample, but had a 
low response rate (29 percent) (NICSH 198Oa). Their estimate of a 50 
percent prevalence of smoking policies is probably biased upward by 
the likelihood that companies with policies were more likely to 
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TABLE I.-Surveys of worksite smoking policies 
Survey name Survey 
(pub. date) year Number 
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19801 chapters 











Survey name SUI-WY 
(pub. date) yeat NUIdXT 
Business surveyed 






Restrict cessation for 
Response rate smoking program nonsmoking 
N (%) (%I (%I (%) 
U.S. Depart- 
ment of Health 
and Human 
Services (19@4? 
1965 1600 Two strata: small (5G U.S. Random sample Phone 1358 (65) 36 19 








1966 1967 Predominantly small- U.S. Random Mail Personnel 662 (34) 36 41 4 
medium 60%-c 1000 sample, selected executives 






1966 1100 Predominantly small- U.S.. ? Mail ? 577 (53) 56 50 5 
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Correlates of having a smoking policy 
Survey name Workplace 
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(pub. date) aim Location Businees type Other 
Type of smoking policy 
(B = ban, R = restrict Reason for policy 
Duration 





Large >small West 52%. Nonbusiness or Located Open work areas 19%R/41%B; Comply with laws 85% <5 2%toadopt 
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only nonsmokers, 5% prefer mandate by penalties set; 







only 33% of 
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Health care Located Designated areas only 38%, Employee pressure 43% ~3 6% made 
(93%), retailing where client-contact area 13%B, l%B (21%), comply ye**, 53% structural 
(83%). finance workplace entirely, 2% hire only with laws (19%). <6 years changes; 2790 
(61%), smoking law nonsmokers protect employee use barriers 
manufacturing in effect health (19%). or air 
(57%), reduce insurance purifiers; 45% 
transportation Costa (9%) discipline 
GO%), service violators 
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insurance (18%) 
respond. An even higher prevalence of smoking policies (64 percent) 
reported in a ‘survey of large Massachusetts businesses may reflect 
similar biases or regional variation or both. Smoking policies were 
reported in only 14 percent of white-collar offices in a nonrandom 
survey (Thomas 1980) and in 23 to 30 percent of large corporations 
responding to two nonrandom surveys by the same group (Petersen 
and Massengilll986). 
These surveys found that smoking restrictions were moderate, 
worksite smoking cessation programs uncommon (9 to 15 percent), 
and incentives for nonsmoking rare (< 3 percent). Outright smoking 
bans and preferential employment of nonsmokers were not men- 
tioned. However, employee complaints about smoking were reported 
by one-third of the businesses in two surveys (Petersen and Massen- 
gill 1986; Thomas 1980), suggesting a growing pressure on employers 
for change. Smoking policies were stricter for bluecollar workers 
and larger worksites (NICSH 1980b; Bennett and Levy 1980). 
A second set of business surveys, conducted only 5 years later 
(1984-1986), shows a different picture (Table 4). Three large surveys, 
two based on random samples, reported a remarkably similar 
prevalence of workplace smoking restrictions, ranging from 32 to 38 
percent (HRPC 1985; US DHHS 1986; BNA 1986). A fourth study 
reported that 56 percent of small and medium sixed businesses had 
smoking policies, but only 38 percent of businesses restricted 
smoking to designated areas (Petersen and Masaengilll986). 
Because of uncertainty in the earlier (1977-1980) estimates, it is 
difficult to conclude that the most recent estimates of policy 
prevalence represent an increase. However, there is suggestive 
evidence on this point: half or more of policies reported in the 1984- 
1986 surveys were adopted within 5 years, indicating that the 
policies are largely products of the 1980s; a sizable number of 
companies without policies are considering them; in addition to the 
36 percent of companies reporting policies in one 1986 report, 2 
percent were planning to implement a smoking policy in 1986 and 
another 21 percent were considering adopting a policy (BNA 1986). 
Finally, companies that adopt policies rarely reverse them: in the 
BNA 1986 survey, only 1 percent of companies without policies had 
ever had one and rescinded it. These data support a contention that 
workplace smoking policies are a growing trend. 
The nature and scope of smoking restrictions also changed during 
the 1980s. The most common policy still restricted smoking to 
designated areas, but those areas appeared to be shrinking. Despite 
several well-publicized examples (Pacific Northwest Bell, Group 
Health Cooperative of Puget Sound), total workplace smoking bans 
were still rare (1 to 3 percent). An even more stringent smoking 
policy now being adopted, giving preference to nonsmokers in hiring 
or refusing to hire smokers, was not even considered less than a 
294 
decade before (BNA 1986, HRPC 1965; Petersen and Massengill 
1966). Fewer than 5 percent of businesses have curr&tly adopted 
such a policy. Workplace smoking cessation programs were more 
common, but incentives for nonsmoking remained rare. 
The 1964-1966 surveys suggest that the diffusion of workplace 
smoking policies throughout the private sector is occurring in a 
nonuniform fashion. Companies with policies differ from those 
without policies in workforce size, geographic location, and type of 
industry. Smoking policies are slightly more prevalent in large 
companies than in small businesses (45 versus 33 percent) (Petersen 
and Massengill 1966; BNA 1966). Policies also differ by company 
location, being more common in the West and Northeast than in the 
North Central region or the South (BNA 1986, HRPC 1935). This 
geographic disparity is similar to the pattern of State smoking 
legislation, and may in part be explained by it. Businesses in States 
with workplace smoking laws are more likely to have adopted 
smoking policies than are companies located elsewhere (HRPC 1965; 
BNA 1966). Industries are adopting smoking policies at different 
rates, with more policies and more recent policies in nonmanufactur- 
ing industries (finance, insurance, health care, pharmaceuticals) 
(HRPC 1965; Petersen and Massengill 1986; BNA 1996). This 
represents a shift from the earlier blue-collar predominance of 
smoking restrictions and reflects the change in policy orientation 
from workplace safety to employee health. 
Two factors may explain the growth of workplace smoking policies 
in the 1960s. Recently enacted State and local workplace smoking 
legislation is one factor influencing the private sector. Legal 
mandates are cited as a major reason for adopting policies, and as 
noted above, the prevalence of private sector smoking policies is 
higher in regions with legislation in place. Laws may encourage 
more rapid private action by putting smoking on the corporate 
agenda. A second factor is public support. Support for an employer’s 
right to restrict smoking to a designated area at work grew from 52 
percent to 61 percent during the 1970s (Roper 1978) and continued to 
increase in the 1980s (Gallup 1983,1985). In 1985,79 percent of U.S. 
adults, including 76 percent of smokers, favored restricting smoking 
at work to designated areas. Only 8 percent favored a total 
workplace smoking ban (Gallup 1935). These attitudes may also be 
manifest as employee pressures to restrict smoking (Petersen and 
Massengill1986; BNA 1966; HRPC 1965). 
Reasons for Adopting Smoking Policies 
It is not always easy to identify the motivations and goals for a 
specific workplace policy (OTA 1966). Explicit reasons for imple- 
menting policies, according to the most recent employer surveys, are 
(1) to protect the health of the employ ee-especially the nonsmok- 
er-and assure a safe working environment, (2) to comply with State 
and local statutes mandating worksite smoking policies, and (3) to 
anticipate or handle demands from nonsmoking employees for a 
smoke-free working environment. Other reasons may be the fear of 
possible legal liability for illnesses caused by sidestream smoke 
exposure in the workplace (Fielding 1982; Walsh 1984). an opportuni- 
ty to symbolize a company’s concern for employee welfare (Walsh 
1984; Eriksen, in press), as part of a general health promotion and 
wellness program, and the goal of saving the company money. 
Although it is generally agreed that employees who smoke cost 
their employers more than do nonsmoking employees, there is as yet 
little evidence that implementing policies will reduce the extra 
smoking-related costs (OTA 1986; Fielding 1986; Eriksen, in press). 
Corporations are keenly interested in stemming the rapid rise in 
health insurance costs, but may not see smoking policies as a means 
to that end. The top management at Xerox, for example, rejected a 
proposed smoking policy because of concerns about the potentially 
adverse economic impact of excess smoking breaks on productivity 
(Walsh 1984). Actually, economic considerations do not appear to be 
a major reason why businesses adopt smoking policies, according to 
three recent surveys (HRPC 1985; BNA 1986; Petersen and Massen- 
gill 1986). 
Barriers to Adopting Smoking Policies 
Roth survey data and case reports give insights into reasons why 
employers have elected not to implement worksite smoking policies. 
According to a Tobacco Institute-sponsored survey, the 24 percent of 
large employers who had considered and rejected a smoking policy 
gave these reasons: policy not acceptable to employees (59 percent), 
employees can handle the problem on their own (58 percent), 
implementation too difficult (39 percent) or too costly (5 percent), 
policy not acceptable to clients (10 percent), and no employee 
complaints about smoking (29 percent) (HRPC 1985). 
Fear of worker discontent or union opposition is the major reason 
cited by employers who have considered and rejected a workplace 
smoking policy. Surveys consistently indicate that smoking policies 
are initiated by management, and are often adopted with little or no 
employee or union input (HRPC! 1985; BNA 1986; NICSH 198Oa,b). 
Although most businesses that have surveyed their employees have 
found strong support for smoking restrictions (Pacific Telephone 
1983; Robert Finnigan Associates 1985; Addison 1984; Ziady 1986; 
Marvit et al. 1980), some unions have actively opposed employer- 
mandated policies, both in individual cases and at the national level. 
In 1986 the AFL-CIO Executive Council stated its opposition to 
unilateral policies and called for the case-by-case handling of 
workplace disputes between smokers and nonsmokers (BNA 1986). 
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Roth employee organizations and employers find it difficult to 
simultaneously balance the wishes of all their constituents. 
Another reason for reluctance to adopt smoking policies is concern 
about implementation (HRPC 1985). In some cases, this means 
concerns about how to enforce the policy (BNA 1986) or whether it is 
enforceable (Eriksen, in press). Other reasons cited by companies 
were questions about the legality of limiting employee smoking 
(BNA 1986) and the nonsupport of top management who are smokers 
(BNA 1986). Some companies are dependent on business relation- 
ships with tobacco companies and businesses with tobacco-related 
interests, which they do not want to jeopardize (Kristein 1984; Walsh 
1984). 
Types of Smoking Policies 
Private sector businesses have addressed the issue of employee 
smoking in a variety of ways. In addition to smoking policies, the 
umbrella concept of “worksite smoking control” can include educa- 
tional campaigns to motivate workers to quit, self-help and organized 
smoking treatment programs, medical advice, and incentives to 
encourage nonsmoking (Orleans and Shipley 1982; Windsor and 
Bartlett 1984). Smoking programs are sometimes subsumed as part 
of broader corporate wellness programs. Worksite smoking cessation 
programs were reviewed in the 1985 Report on the Health Conse- 
quences of Smoking (US DHHS 1985c). 
Businesses have taken a variety of approaches to a worksite 
smoking policy. The chClces reflect the individual company’s motive 
in adopting a policy and assessment of the potential for implementa- 
tion and enforcement. When protection from fire or explosion was 
the primary motive, policies primarily applied to blue-collar areas; 
when the goal was to avoid antagonizing customers, smoking bans 
applied only to client-contact areas (Bennett and Levy 1980). A 
company’s solution also reflects its particular social environment. 
Recent study indicates considerable variability among individual 
worksites in attitudes and norms about smoking cessation (Sorensen 
et al. 1986). 
Because smoke travels, the desires of smokers and nonsmokers 
will inevitably come into conflict in common areas, and it is difficult 
to simultaneously maximize the goals of smoke-free air, minimum 
employee disruption, and minimum cost. A business adopting a 
policy primarily to avoid employee conflicts is likely to pay greater 
heed to smokers’ wishes at the expense of smoke-free air, and may 
consider solving the problem with increased ventilation (to avoid the 
necessity of behavioral change) or may separate smokers and 
nonsmokers. A business whose primary goal is to reduce involuntary 
smoking hazards will be more willing to sacrifice smokers’ conve- 
nience and may consider a total smoking ban. A business that aims 
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to reduce costs may choose a minimum of structural changes and a 
maximum likelihood that the policy will result in employee smoking 
cessation; a total ban on workplace smoking or the hiring of only 
nonsmokers would be more likely to achieve these goals. Altemative- 
ly, adopting no policy may also be ineqxmiue, so long as there are no 
employee conflicts over smoking. 
The myriad of current smoking policies have been categorized in 
several ways (US DHHS 1985a; BNA 1986; OTA 1986, ALA 1985a,b). 
The range, in ascending order of protection for the nonsmoker, 
includes these: 
(1) No explicit policy (the “individual solution” approach) 
(2) Environmental alterations (separating smokers with physical 
barriers, using air filters, or altering ventilation) 
(3) Restricting employee smoking, a range with these extremes: 
(a) smoking permitted except in designated no-smoking areas 
(b) smoking prohibited except in designated areas 
(4) Banning employee smoking at the worksite 
(5) Preferential hiring of nonsmokers. 
Options (1) through (3a) effectively state that smoking at work is 
acceptable behavior; options (3b) through (5) indicate to employees 
that nonsmoking is the company norm. Several groups have 
developed model policies of varying degrees of comprehensiveness to 
assist employers (ALA 1985a,b; GASP 1985; BNA 1986; Hanauer et 
al. 1986). 
The “individual Solution” Approach 
According to surveys, having no explicit policy is still the most 
prevalent approach to smoking in the workplace (HRPC 1985; BNA 
1986; US DHHS 1986). Smokers and nonsmokers work out differ- 
ences on their own, using so-called common courtesy or finding an 
individual solution. According to a 1984 Tobacco Institute-sponsored 
survey, ‘70 percent of large employers encourage employees to work 
out differences on their own (HRPC 1985). When there is no explicit 
policy, there is the implicit message that environmental tobacco 
smoke does not represent a hazard. So long as there are few disputes 
and they are easily settled, this approach is expedient. However, it is 
not likely to be a successful long-term policy. Nonsmokers in the late 
1970s may have been reticent to assert their rights and perceived a 
burden of confrontation (Roper 1978; Shor and Williams 1978), but 
there is a growing consensus, even among smokers, that supports 
abstention in the presence of nonsmokers and smoking restrictions 
at worksites (Gallup 1983,1985). 
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Environmental Alterations 
Environmental alterations range from simply separating smokers 
and nonsmokers to different areas of a room to installing improved 
ventilation systems to remove environmental tobacco smoke. The 
advantage of this approach is that it requires no behavioral change 
of smokers and satisfies some of the wishes of nonsmokers. However, 
because tobacco smoke easily diffuses beyond physical boundaries, 
simple barriers provide at best a slight reduction in involuntary 
smoke exposure (see chapters 3 and 4) (Olshansky 1982). More 
sophisticated ventilation systems can be prohibitively expensive, and 
even the best may not be able to clean the air adequately (Bepace 
and Lowrey 1985; Lefcoe et al. 1983). Workplace modification has 
sometimes been utilized as a company’s first step in the development 
of a more restrictive policy, as happened at the Control Data 
Corporation in Minneapolis (OTA 1986). 
Restrictions on Employee Smoking 
The most common workplace smoking policy is to restrict where 
employees may smoke (BNA 1986). This policy has broad public 
support; in a 1985 Gallup poll it was the approach favored by 79 
percent of U.S. adults, including 76 percent of smokers (Gallup 1985). 
Policies differ in (1) the proportion of the workplace in which 
smoking is permitted, (2) whether the default condition is smoking, 
nonsmoking, or unspecified, (3) who has the authority to designate 
the smoking status of an area, and (4) whose wishes prevail when 
smokers and nonsmokers disagree. Policies often categorize the 
worksite into four areas that are subject to different rules: (1) private 
offices, (2) shared offices or work areas, (3) small common use areas 
(elevators, bathrooms), and (4) large common use areas (conference 
and meeting rooms, auditoriums, cafeterias). 
The least restrictive policies permit smoking except in designated 
no-smoking areas, indicating that smoking is the company norm. 
Who has the authority to designate an area’s smoking status and 
whether smokers’ or nonsmokers’ wishes prevail may not be explicit. 
The usual pattern is for common use areas to be designated either 
totally no-smoking (elevators, bathrooms, conference rooms) or 
partly no-smoking (cafeterias, auditoriums). Private offices are left to 
the discretion of the occupant, who is often given the authority to 
declare it no-smoking. In shared office areas, where the wishes of 
smokers and nonsmokers may conflict, each individual may be given 
the authority to designate his or her own immediate work area, or 
the policy may stipulate that a compromise be reached. However, 
this cannot ensure that an employee’s self-designated no-smoking 
area is free of side&ream smoke. Because the majority of an 
employee’s time is spent in the immediate work area rather than in 
the no-smoking common use areas, a policy that does not specify no- 
smoking in shared work areas may not substantially reduce an 
employee’s environmental tobacco smoke exposure. However, these 
policies may satisfy some nonsmokers’ wishes with minimal disrup 
tion to smokers. In some cases, companies seeking to limit smoking 
have adopted this type of policy as a first step to more stringent 
restrictions or a total ban (e.g., Boeing, cited in OTA 1986). 
The most restrictive policies specify that “smoking is prohibited 
except in designated areas,” establishing nonsmoking as the work- 
place norm. In the strictest policies, smoking is prohibited in shared 
work areas (unless all occupants agree to designate an area 
“smoking permitted”) and in most common use areas. Policies may 
limit the areas that can be designated “smoking permitted” and 
predetermine that the wishes of nonsmokers prevail when conflict 
occurs. Even stricter regulations stipulate not only the location in 
which but also the time when smoking is allowed (e.g., work breaks 
only). So long as the smoking areas do not contaminate the air of 
work areas, these policies provide greater protection of employees 
from sidestream smoke at the cost of greater inconvenience to 
smokers, who may perceive the restrictions as coercive. The produc- 
tivity of smokers may suffer if they are permitted to take extra 
smoking breaks or if smoking areas are ~uraI%d too far from the work 
station. 
The variability of smoking restrictions in common work areas was 
demonstrated in a 1985 survey conducted by the Bureau of National 
Affairs, Inc. (BNA). Of the 239 companies with smoking policies, 41 
percent banned smoking in open work areas, and an additional 20 
percent banned it if employees or supervisors wished. Only 8 percent 
permitted smoking in all open work areas, and 19 percent divided 
areas into smoking and no-smoking sections. There was more 
uniformity in treatment of common use areas. Over 50 percent of the 
companies banned smoking in hallways, conference rooms, rest- 
rooms, and customer contact areas, and smoking was partially 
banned in 58 percent of cafeterias (BNA 1986). 
In contrast to shared work areas, smoking was permitted in 56 
percent of the private offices in that survey, with occupants often 
given the authority to designate the office as smoking or no-smoking. 
This has the potential for charges of unequal treatment and 
problems with employee morale (BNA 1986). 
Banning Smoking at the Workplace 
Some businesses-including large corporations, among them Pacif- 
ic Northwest Bell and the Group Health Cooperative of Seattle- 
have recently opted for total bans on smoking at work (US DHHS 
1985a; Ziady 1986). Bans may be preceded over several years by 
progressively stricter smoking regulations. Notwithstanding these 
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well-publicized successful examples, smoking bans are rare and not 
widely supported by public opinion. Only 6 percent of companies 
with smoking policies (2 percent of all respondents) in a 1986 survey 
totally banned smoking (BNA 1986). Only 12 percent of adults (4 
percent of smokers) agreed that “companies should totally ban 
smoking at work” in a 1985 Gallup poll. In spite of this hesitancy, 
smoking bans are gaining momentum among large employers such 
as Boeing, who recently announced an upcoming ban that will cover 
its 90,000 employees (Iglehart 1986). 
Smoking bans provide the maximum protection for nonsmokers, at 
the cost of greater inconvenience for smokers. They send a clear 
message that nonsmoking is the company norm. They can reduce 
ventilation needs and maintenance costs due to smoking, but pose 
potential problems with enforcement and loss of employees who 
smoke. Thus, how a ban is planned, prefaced and introduced, and 
implemented and enforced is very important. Through a concern for 
employee well-being, assistance for smokers who wish to quit should 
be implemented along with bans (Orleans and Pinney 1984). 
Preferential Hiring of Nonsmokers 
The most restrictive workplace smoking policy, preferential hiring 
of nonsmokers, was not even discussed several years ago. Explicit 
policies favoring nonsmokers are still uncommon. According to the 
1986 report of the Bureau of National Affairs, Inc., 1 percent of 
businesses hire only nonsmokers, 5 percent give nonsmokers prefer- 
ence, and 10 percent permit supervisors to exercise a nonsmoking 
preference (BNA 1986). The majority either have no policy (43 
percent) or do not permit such a preference (39 percent). On the 
other hand, data from small surveys indicate that personnel 
managers, the majority of whom are themselves nonsmokers, may 
preferentially hire nonsmokers (Weis 1981; Iglehart 1986). In a 
unionized setting, selective hiring of nonsmokers may need to be the 
subject of collective bargaining (Eriksen, in press). 
Hiring only nonsmokers ensures a smoke-free work environment 
without conflicts over smoking and makes it clear that nonsmoking 
is the company norm. Since the nonsmoking workforce should be 
healthier, lower health insurance premiums may also result. On the 
other hand, such a policy limits the potential pool of new employees, 
raises the issue of what to do about currently employed smokers, and 
may present problems with verification of smoking status. Employ- 
ers may be reluctant to adopt a policy in which off-the-job activity is 
a condition of employment (Walsh 1984). 
Assuring compliance with workplace smoking policies is complex. 
Model policies usually include three enforcement provisions: (1) 
identifying who is responsible for policy enforcement, (2) designating 
penalties for noncompliance, and (3) ensuring the protection of an 
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employee bringing a complaint. These provisions are often not 
included in practice. Only 23 percent of the policies stipulated 
penalties for noncompliance and only 32 percent specified proce- 
dures for resolving disputes in the 1986 BNA survey. Approximately 
half of the policies outlined in two other business surveys had 
provisions for disciplining violators (Petersen and Massengih 1986; 
NICSH 198Oa,b). 
Implementation of Smoking Policies 
Worksites that have adopted smoking policies have differed in the 
ease with which policy was implemented. To aid employers, the 
American Lung Association and the Office of Disease Prevention and 
Health Promotion of the U.S. Department of Health and Human 
Services have developed guides with specific recommendations on 
how to adopt and implement worksite smoking policies (ALA 1985b; 
US DHHS 1985a). These are based on the experience of companies 
and can be extremely helpful even though they are not based on 
research. 
The experiences of 12 corporations that considered smoking 
policies are described in a report of the Bureau of National Affairs, 
Inc. (1986). Case reports are also included in the guide from the 
Office of Disease Prevention and Health Promotion (US DHHS 
1985a). According to these case reports, strong support from top 
management and having an advisory committee composed of a wide 
variety of employees (including both smokers and nonsmokers, 
managers, and employee representatives) are common to successful 
policies. Surveys of employees can assess distress caused by involun- 
tary smoking and support for policy changes. As a rule, such surveys 
have generally documented widespread support for smoking restric- 
tions from employees, the majority of whom are nonsmokers. 
Another correlate of success is 1 well thought out and clearly 
articulated communication of the policy. A written document should 
give the rationale for the policy implementation, specify where 
smoking will be allowed or prohibited, and define responsibility and 
procedures for policy enforcement and penalties for violation. 
Successful policies avoid criticizing smokers or setting up an 
antagonistic situation between smokers and nonsmokers. They make 
it clear that the company is not requiring that employees quit 
smoking and will help smokers in adjusting to the new regulations. 
Giving smokers advance notice of the policy and providing help for 
those who want to quit smoking can help gain their support. 
Careful plans for implementation are recommended. Allowing 
several months between the announcement of the policy and its 
effective date gives smokers time to prepare for the change and to 
attend smoking cessation programs if they wish to quit. This also 
provides time for the posting of adequate numbers of signs and for 
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‘making any structural alterations that may be necessary. After 
policy implementation, an advisory committee should monitor its 
effectiveness and enforcement. A followup survey is helpful to 
determine what, if any, adjustments need to be made. 
Impact of Policies Restricting Smoking in Public Places and in 
the Workplace 
Policies that regulate where smoking is permitted may have a 
number of direct and indirect effects. In the short term, a policy that 
is adequately implemented and enforced will alter the behavior of 
smokers in areas where smoking is prohibited and should result in a 
reduced concentration of tobacco smoke in that area. Beyond these 
direct effects, there is the potential for smoking restrictions to have 
broader, indirect effects on smoking behavior and on public attitudes 
about tobacco use. This section outlines the possible impacts of 
smoking policies, addresses methodologic considerations, and re- 
views existing data that bear on these hypotheses. 
Potential Impacts of Smoking Policies 
Policy Implementation and Approval 
The degree to which a smoking policy or law has been implemen- 
ted as written is an essential consideration in evaluating its effects 
on attitudes, behavior, and air quality. Successful implementation 
involves public awareness of the policy, compliance with its regula- 
tions, and enforcement of violations. Compliance requires not only 
that smokers refrain from smoking where prohibited from doing so, 
but also that appropriate decisionmakers develop written policies, 
designate areas as no-smoking, and post signs as stipulated. Enforce 
ment requires that policy violations be dealt with, either by peer 
action or by penalties defined by the policy. Because smoking policies 
and laws are approved by the majority of individuals whose behavior 
they affect, they are generally held to be self-enforcing, obviating the 
need for active policing (Hanauer et al. 1986). When enforcement is 
needed, smoking policies and legislation rely primarily on peers, 
assuming that the nonsmoking majority of the population will 
enforce the policy or statute because it is in their best interest. 
Nonsmokers can be expected to favor smoking restrictions, which 
offer the benefits of cleaner air and reduced health risks and require 
no change in their behavior. The opinions of smokers are expected to 
be less favorable because they stand to be inconvenienced. Some 
smokers may support the policy to assure themselves of having a 
location where smoking is clearly permitted, because of a desire to 
quit smoking, or because of concerns about the health hazards of 
involuntary smoking. The degree of smokers’ support for a policy 
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may also depend on other factors, such as the degree of smoking 
restriction or the adequacy of policy implementation. 
Direct Effects: Air Quality and Smoking Behavior 
The evaluation of a specific policy or piece of legislation must 
address whether the policy achieved its stated goals and must also 
screen for other effects. The primary goal of policies regulating 
smoking in public places or in the workplace is the reduction of 
individuals’ exposure to environmental tobacco smoke. Measures of 
air quality directly assess how well a policy meets this goal. Air 
quality also indirectly reflects the behavior of smokers and the 
degree of policy compliance. 
Smoking policies may have both direct and indirect effects on 
smoking behavior. The direct effect of adequately implemented 
smoking restrictions is to limit where smoking is permitted, altering 
the behavior of smokers in those settings. Smoking policies may have 
indirect effects on smoking behavior if they influence the behavior of 
smokers outside these settings. 
Indirect Effects: Knowledge, Attitudes, Social Norms, and 
Smoking Behavior 
Policies that restrict or ban smoking in public places or the 
worksite convey potentially powerful messages about the role of 
cigarettes in society and help to reinforce nonsmoking as the 
normative behavior. Restricting smoking to protect nonsmokers may 
increase public knowledge of the health risks of smoking and of 
involuntary smoking. Smoking restrictions may also alter attitudes 
about the social desirability of smoking and the acceptability of 
smoking in public. Changes in the knowledge or acceptance of health 
risks combined with attitude shifts contribute to changing social 
norms about where smoking should and should not occur, as well as 
whether it is an acceptable social behavior. 
Changes in social norms may influence smoking behavior by 
reducing pressures to smoke and increasing social support for 
nonsmoking and cessation. The combination of altered social norms 
and reduced opportunities to smoke may encourage smokers to quit 
and discourage experimentation among nonsmoking youth. Chang- 
ing social norms may have their greatest impact on teenagers and 
young adults, who might be less inclined to experiment with a 
socially undesirable substance. Current smokers are likely to be 
prompted by changing social norms to move further through the 
stages of self-change that precede cessation (Prochaska et al. 1985). 
Smoking restrictions may influence smoking behavior apart from 
their influence on social norms. By reducing opportunities for 
smoking, restrictions may decrease a smoker’s daily cigarette 
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consumption. By reducing the range of settings where smoking 
occurs, they reduce the cues and alter the stimulus-response 
patterns that help to maintain smoking behavior and that contribute 
to relapse among ex-smokers (Orleans 1986). This could increase the 
success of quit attempts. Smoking restrictions, especially those at the 
workplace, may also help smokers to discover alternatives to 
smoking as a stress reduction tool. Likewise, new entrants into the 
workforce may not as easily learn to rely on cigarettes to cope with 
work-related stressors. This might blunt the increase in smoking 
prevalence that occurs at the time of workforce entry, especially 
among blue-collar workers (O’Malley et al. 1984; US DHHS 1985c). 
Thus, the widespread adoption of smoking restrictions may have a 
profound impact on smoking behavior at many points in its natural 
history. Hypothesized consequences include reduced cigarette con- 
sumption, increased motivation and progress through the stages of 
self-change, increased rates of smoking cessation, and decreased 
rates of smoking initiation. 
Smoking policies may have additional impacts beyond their effects 
on attitudes and smoking behavior, such as positive economic effects 
for employers by reversing the excess costs associated with employ- 
ees who smoke. It is generally agreed that employees who smoke cost 
their employers more than nonsmoking employees because of excess 
absenteeism, increased health care utilization, and reduced produc- 
tivity (OTA 1986; Fielding 1986; Eriksen, in press). This leads to 
greater use of sickness, disability, and health care benefits and 
ultimately, higher health insurance costs to business. Productivity 
losses to business are attributed not only to the individual smoker’s 
time lost owing to on-the-job smoking, but also to increased 
maintenance costs due to cigarette-related damage and refuse. 
Estimates of the excess annual cost per smoking employee vary by 
an order of magnitude, but even conservative estimates are substan- 
tial: $300 to $600 (Kristein 1983, 1984; Solomon 1983; Weis 1981). 
Reductions in health care costs are partly dependent on whether 
policies lead smokers to quit smoking. Even if smokers quit, the 
reduction in health care costs may not be. seen in the short term. 
Some employers have been concerned that strict smoking bans may 
unfavorably alter employee turnover patterns or productivity. 
Smokers’ productivity could decrease if, for example, they are 
permitted to take extra breaks away from their work stations in 
order to smoke (OTA 1986; Michigan Tobacco and Candy Distribu- 
tors and Vendor Association 1986). Ccsts involved in adopting a 
smoking policy should also be considered. Assessment of these 
endpoints is useful because employers may consider them in deciding 
whether to implement smoking policies. 
Methodologic Considerations in Policy Evaluation 
Study Design 
Evaluating a new smoking policy in a defined population is similar 
to evaluating a smoking cessation intervention, with the addition of 
nonsmokers. Impacts on beliefs and attitudes, as well as on behavior, 
can be assessed in the population at baseline and at intervals after 
implementation. Because smoking policies may influence smoking 
behavior gradually, designs must be able to measure delayed effects. 
Simultaneous assessment of outcomes in a control population 
strengthens confidence in the validity of conclusions. With uncon- 
trolled pretest/posttest designs, there is the possibility that changes 
in smoking behavior and attitudes are confounded by outside 
influences. Worksites, for example, may have concurrent smoking 
cessation programs that can affect attitudes and behavior. Popula- 
tionwide trends in smoking behavior are another source of confoun- 
ding. In practice, random assignment of whole populations will 
rarely be feasible, since researchers are rarely in a position to 
“assign” the intervention and must rely on natural experiments. 
Quasiexperimental designs, which include natural comparison 
groups, are the best alternative. Identifying and accessing such 
appropriate comparison populations may be difficult in practice. 
Either longitudinal or cross-sectional sampling can be employed. 
Longitudinal designs, in which the same individuals are interviewed 
at two or more points in time, provide the best measure of changes in 
outcome measures, but depend on high rates of followup, which may 
be practically difficult. Furthermore, individuals’ behavior or atti- 
tudes may be influenced by repeated assessments in such studies. On 
the other hand, when attitudes and behavior are evaluated by 
repeated assessments of independently chosen cross-sectional sam- 
ples, the possibility exists that smokers and nonsmokers will enter or 
leave the population at different rates as a consequence of smo!cing 
restrictions. Turnover needs to be followed to assure that changes in 
behavior or attitudes are a result of changes in individual behavior 
and not changes in the composition of the population. 
One-time comparisons of populations with and without policies 
can provide suggestive but not conclusive data about impact. The 
validity of differences detected in attitudes and behavior is depen- 
dent on the degree of similarity between the policy group and the 
control group. Uncontrolled one-time assessments done before or 
after policy adoption do not permit conclusions about the policy 
effects, although they may provide hypotheses for further work. 
Postimplementation surveys of a population can, however, provide 
useful information about the degree of policy approval, awareness, 
compliance, and enforcement. 
Assessment of the impact of legislation on smoking behavior is 
more difficult because the unit of study is larger and more diverse. 
306 
Consequently, detailed behavioral or attitudinal data and repeated 
assessments are more difficult to obtain. Evaluations are often 
limited to analyses of aggregate measures such as smoking preva- 
lence and tobacco consumption, which are collected for other 
purposes. This approach does not control for potentially confounding 
influences on tobacco use or smoking behavior, such as price 
fluctuations. Identifying and assessing control groups not subject to 
smoking legislation or regulation can strengthen the confidence in 
conclusions for the same reasons as above, but is often difficult to 
achieve in practice. 
Assessing the Effects of Smoking Policies 
Ideally, air quality should be measured objectively, but current 
technology for measuring the concentration of tobacco smoke in 
indoor air is expensive and cumbersome. There is also uncertainty 
about which constituent of smoke is best to measure (See chapters 3 
and 4 of this volume). Air quality can also be assessed subjectively. 
Ratings made by occupants of smoke-free areas can be compared 
with those of a control area or to ratings made prior to the ban. 
Measurement of an individual nonsmoker’s actual exposure to 
secondhand smoke, using biochemical measures, is not a specific 
measure of the concentration of this smoke in a single area because 
an individual may have other sources of smoke exposure. Such 
measures might be useful for assessing the concentration of smoke in 
areas, like the worksite, that represent a primary source of exposure. 
They cannot be used to measure air quality in other places, like an 
auditorium, where an individual spends only a few hours. 
Many markers of smoking behavior need to be examined in order 
to understand the multiple effects of smoking restrictions on 
behavior. In a defined population, a new policy may increase 
smokers’ motivation to quit, confidence in their ability to quit, or the 
number, duration, and success of quit attempts. It may also reduce 
cigarette consumption among continuing smokers. Workplace poli- 
cies may have different impacts on cigarette consumption at work 
and outside work. These variables should be separately assessed. As 
in other research in smoking behavior, biochemical verification of 
self-reported smoking status is desirable. 
Public knowledge about the health risks of involuntary smoking 
and attitudes about smoking can be assessed by surveys. Data on 
social norms can be construed from survey items such as those 
measuring the social acceptability of smoking in public places or in 
the presence of nonsmokers, the rights of nonsmokers to smoke-free 
air, the perceived prevalence of smoking in the environment, and the 
perceived social support for cessation or nonsmoking. 
The adequacy of a policy’s implementation can be assessed by 
surveys that measure individuals’ knowledge and compliance with a 
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policy. The degree of noncompliance and enforcement can also be 
assessed by observations of behavior in public places subject to 
smoking restrictions. 
Review of Current Evidence on Impact 
Workplace Smoking Policies 
In 1982, Orleans and Shipley concluded that the evaluation of 
worksite smoking policies was limited to a few public opinion polls. 
Since then, many policies have been adopted, but evaluation remains 
rare. Most common are baseline surveys done by companies consider- 
ing smoking policies. The best surveys utilize random or probability 
samples and achieve high rates of completion; they provide useful 
one-time data on attitudes and behavior prior to policy implementa- 
tion. Unfortunately, few companies adopting smoking policies have 
done postimplementation surveys to assess impact. To date, the best 
evaluations of worksite smoking policies have been done in the 
health care setting. There are two controlled and two uncontrolled 
studies assessing the effects on employees of adopting a smoking 
policy for a hospital (Rigotti et al. 1986; Biener et al. 1986; Andrews 
1983; Rosenstock et al. 1986). 
One uncontrolled study was reported by Andrews (1983). He 
described the process by which the New England Deaconness 
Hospital in Boston adopted a restrictive smoking policy in 1977. 
Patients and employees were surveyed prior to the policy. Employees 
were surveyed again 20 months after the policy took effect. The 
survey method and response rate were not specified; presumably it 
was not a random sample. Policy approval and smoking behavior 
were assessed. 
The second uncontrolled study (Rosenstock et al. 1986) evaluated 
the impact of a near-total smoking ban adopted in April 1984 by the 
Group Health Cooperative of Puget Sound, Washington, the fourth 
largest health maintenance organization in the Nation. Four months 
after the policy was adopted, they surveyed a systematic probability 
sample of 687 employees, assessing smoking behavior, attitudes 
toward the policy, and its effect on work performance. Employees 
were asked retrospectively about attitudes and behavior prior to the 
policy. The response rate was 65 percent. 
The two controlled studies of the impact of adopting a restrictive 
hospital smoking policy are similar in design. Both involve prepolicy 
and postpolicy measurements of intervention and control groups and 
assess similar outcomes. Rigotti and colleagues (1986) studied the 
impact of a total ban on smoking adopted in November 1984 by the 
pediatric service at Massachusetts General Hospital in Boston. All 
nurses employed by the service were surveyed at baseline and at 4 
and 12 months. Nurses working on the hospital’s medical service, 
where no policy change occurred, were surveyed concurrently as 
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controls. Response rates to the surveys ranged from 55 to 75 percent; 
the prevalence of smoking among respondents and nonrespondents 
did not differ. Surveys assessed smoking behavior, attitudes about 
smoking, and perceived air quality in both groups. The pediatric 
nurses answered additional questions about approval, compliance, 
and awareness of the policy. Employment records were reviewed to 
assess employee turnover before and after the policy. 
Biener and colleagues (19861 studied employees at two Providence, 
Rhode Island, hospitals where self-help smoking cessation programs 
were being introduced. At one, the Miriam Hospital, there was a 
concurrent change in smoking policy. Smoking was prohibited 
hospitalwide except in three locations as of August 1985. Separate 
random probability samples of 85 employees at each hospital were 
surveyed by telephone at baseline (2 to 4 weeks before the policy) and 
at 1, 6, and 12 months after the policy. Data were collected in both 
hospitals on smoking behavior, attitudes about smoking, and air 
quality. Information on policy awareness, compliance, and approval 
was obtained at the intervention hospital. 
Results of these studies are included in the subsequent sections, 
which address the outcomes of workplace smoking policies. 
Policy Implementation 
According to case reports, organizations that have adopted smok- 
ing control policies generally develop careful plans to introduce the 
policy, but rarely evaluate how effectively the policy has been 
implemented. The findings of Rosenstock and colleagues (1986) 
indicate that even careful implementation plans may fall short of 
their goals. In their survey of the Group Health Cooperative 
employees, only half of the respondents knew of the existence of the 
advisory group whose role was to provide information to employees. 
Only 36 percent of the smokers and 76 percent of the nonsmokers 
felt that they had had an adequate opportunity to express their 
views. Not all smokers knew that the decision to prohibit smoking 
was an irrevocable one. 
Rigotti and colleagues (1986) found that awareness of the smoking 
ban on the pediatric service was high; at 4- and 1Zmonth followups, 
over 90 percent of employees knew where smoking was not permit- 
ted. Employees noted smoky air or smoking in restricted areas on 
approximately 20 percent of days worked. Two-thirds of the employ- 
ees who smoked admitted at least one personal episode of noncompli- 
ance during the year after the policy took effect. Although nonsmok- 
ers perceived themselves to be more assertive in enforcing smoking 
rules after the smoking ban, many were reluctant to confront a 
smoker, especially if the smoker was a coworker. 
Biener and colleagues (1986) found a similar high level of policy 
awareness and better compliance among the employees of Miriam 
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Hospital in Providence. Six months after the adoption of a policy 
prohibiting smoking in all but three areas, 95 percent of the 
employees were aware of the policy and half had noted no evidence 
of noncompliance. There was no evidence that smokers perceived 
more pressure to abstain in the form of increased assertiveness by 
nonsmokers; the policy may have reduced the need for assertive 
behavior. Rigotti and colleagues (1986) reported that nurses in the 
control group described themselves as having to be more assertive 
about asking people not to smoke than nurses in the policy group. 
Dawley and colleagues (Dawley et al. 1980; Dawley, Carrol et al. 
1981; Dawley, Morrison et al. 1981; Dawley and Baldwin 1983; 
Dawley and Burton 1985) addressed the question of compliance with 
smoking restrictions at the New Orleans Veterans’ Administration 
Medical Center. Their technique was to unobtrusively observe the 
smoking behavior of individuals occupying areas designated as 
smoking or no-smoking. In a series of lO-minute periods, an observer 
noted the proportion of people smoking among all individuals 
occupying a no-smoking area, which sexed as the measure of 
noncompliance. Posting no-smoking signs in a hospital lobby reduced 
the prevalence of smoking to one-third of its previous level (from 29 
percent to 5 to 11 percent, p < 0.01). There was a nonsignificant trend 
for better compliance with positively worded signs (e.g., “Please do 
not smoke”) compared with negatively worded signs (e.g., “No 
smoking--Offenders subject to fine”) (Dawley, Morrison et al. 1981). 
Posting signs designating a no-smoking area in a cafeteria resulted 
in a similar decline in smoking prevalence in the area. The 
combination of signs and enforcement (polite reminders from staff to 
noncompliant patients) achieved greater reductions in smoking 
prevalence than were achieved with signs alone; however, the 
incremental value of enforcement was not directly assessed in the 
study (Dawley and Baldwin 1983). Following a change to a more 
restrictive smoking policy (smoking prohibited except in designated 
areas, with provisions for enforcement), the noncompliance rate 
dropped to under 2 percent (Dawley and Burton 1985). Another 
study demonstrated that smoking models reduce compliance with 
smoking restrictions. The noncompliance rate doubled when a 
smoker was experimentally introduced into the no-smoking area 
(Dawley, Carrol et al. 1981). 
These studies indicate that there has been good employee compli- 
ance with smoking policies in health care facilities, even though 
there may be some reluctance by employees to enforce restrictions. 
The implementation of smoking policies in other types of worksites 
has not been systematically evaluated. Descriptions of the adoption 
of policies in a number of worksites do not report major problems 
with compliance (BNA 1986). 
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Air Quality 
Three studies assessed air quality before and after hospitals 
adopted restrictive smoking policies. Both Rigotti and colleagues 
(1986) and Biener and colleagues (1986) used a subjective measure, 
the frequency that an employee was bothered by smoke at work. In 
the Rigotti group’s study, perceived air quality was similar in the 
intervention group and the control group at baseline. It improved 
significantly at 4- and l&month followup on floors where smoking 
was banned and did not change on control floors. At 12 months, 79 
percent of the nurses on floors with the smoking ban reported 
noticing less smoke, and none noted an increase; in contrast, 87 
percent of control nurses noted no change in air quality. Biener and 
colleagues found a similar pattern; there was a significant difference 
in employee assessments of perceived air quality between hospitals 
with and hospitals without a smoking policy. 
At the New England Baptist Hospital in Boston, the distribution of 
respiratory particulates (RSP) was measured before and 1 year after 
the adoption of a restrictive smoking policy (Bearg 1984). At 
followup, RSP were lower in many hospital areas where smoking 
was restricted, most notably in patient care areas and an employee 
lounge, but remained high in the cafeteria. Because same-day 
measurements of outside air revealed low ambient RSP levels, Bearg 
concluded that the high levels inside the building were attributable 
to smoking rather than air pollution. 
These studies suggest that hospital policies result in less smoking 
in work areas designated no-smoking, but that no-smoking areas in 
cafeterias may provide little protection from secondhand smoke 
exposure because of ventilation problems and the increased smoking 
in the few smoking-permitted areas. 
Policy Approval 
A number of private and public sector organizations considering a 
smoking policy have assessed employee attitudes prior to implemen- 
tation. Pacific Northwest Bell, Pacific Telephone, New England 
Telephone, Texas Instruments, and StrideRite are among businesses 
that have done employee surveys (R. Addison, personal communica- 
tion, July 21, 1986; Pacific Telephone 1983; Robert Finnegan 
Associates 1985; BNA 1986; Ziady 1986). Public sector employers 
include the Hawaii and Massachusetts Departments of Public 
Health (Marvit et al. 1980; Naimark 1986). The findings of these 
surveys are remarkably similar. Over 60 percent of employees report 
being at least occasionally bothered by smoke at work (Robert 
Finnegan Associates 1985; Pacific Telephone 1983; Ziady 1986; R. 
Addison, personal communication, July 21, 1986). There is broad 
support for adopting a smoking policy, even among smokers (Pacific 
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Telephone 1983; Robert Finnegan Associates 1985; Marvit et al. 
1980, Sorensen and Pechacek 1986). 
Assessment of employees’ approval of policies after implementa- 
tion have been done primarily in health care settings. High rates of 
approval are the uniform finding, with smoker-nonsmoker differ- 
ences. In the Rigotti group’s study (1986), the overall approval of a 
smoking ban increased from 72 percent at baseline to 85 percent at 4 
and 12 months. Most of the increase was a result of the improved 
opinions of the smokers. Only 35 percent of smokers supported the 
ban at baseline, but by 1 year this nearly doubled, to 67 percent. 
High rates of policy approval at followup by both smokers and 
nonsmokers were also reported by Biener and colleagues (1986) (69 
percent smokers, 89 percent nonsmokers) and Andrews (1983) (83 
percent smokers, 93 percent nonsmokers). Rosenstock and colleagues 
(1986) found high overall policy approval at 4 months (85 percent), 
but less support by smokers (36 percent). These data indicate that 
smoking policies in hospitals are well accepted by employees, and 
that smokers’ initial reluctance diminishes as they gain experience 
with the policy. Generalization from these studies is limited by the 
nature of the population studied-health care workers. Followup 
surveys in industrial setting would be valuable. 
Sorensen and Pechacek (1986) have examined correlates of smok- 
ers’ approval of smoking restrictions. They surveyed smokers in 
eight Minnesota businesses without smoking policies, sampling a 
broad cross-section of employees, from blue-collar workers to profes- 
sionals. Over three-fourths of the 378 respondents agreed that 
employers should establish separate smoking and no-smoking areas 
at work. Smokers who favored worksite smoking policies had greater 
interest in quitting and more concern for the health risks of smoking 
and saw their social environment as supportive of nonsmoking, as 
measured by a higher perceived coworker support for quitting and a 
greater perceived prevalence of nonsmokers. 
Smoking Behavior 
Many smokers anticipate that their smoking behavior will change 
after a smoking policy is adopted at their worksite. At Pacific 
Telephone, 51 percent of the smokers expected that the policy would 
lead them to alter their smoking habits, either by cutting down (38 
percent) or quitting (13 percent) (Pacific Telephone 1983). In the 
Rigotti group’s study (1986) of a hospital smoking ban, 72 percent of 
the smokers expected the policy to change their habits. All expected 
to smoke less at work and most to smoke less outside work. 
A successfully implemented smoking policy will provide a smoker 
fewer opportunities to smoke. Of course, the smoker may compen- 
sate for reduced smoking opportunities at work by more intense 
smoking (number of cigarettes, inhalation, puff topography) on 
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breaks or with increased smoking outside work to maintain a 
constant overall daily consumption. This is consistent with the 
addictive model of smoking behavior (Grit.2 1980; US DHEW 1979). 
But if compensation does not occur, the smoker’s lower rate at work 
would reduce overall daily smoking. Studies at present differ on 
which of these alternatives occurs. The results reported below are 
entirely self-reports; thus, they suffer from a lack of biochemical 
validation of smoking status as well as from an inability to detect 
compensation through altered smoking topography (US DHHS 
1985c). 
Compensation did not appear to occur in the Biener group’s 
hospital study (1986). Among smokers in the “policy” hospital, the 
number of cigarettes smoked daily while at work fell from a baseline 
of 8.1 to 4.5 at 1 month and 4.0 at 6 months. Over the same time 
period, the at-work cigarette consumption in the control hospital 
rose slightly (7.6 to 8.1 cigarettes). The difference in smoking rates 
between baseline and l-month followup in the “policy” group was 
significant (p=O.O2). At 6 months, the difference in smoking rates at 
work between hospitals (8.2 vs. 4.0) was also significant (p=O.Ol). 
There were no significant changes in the smoking rate outside work. 
Smokers in the hospital study by Rosenstock and colleagues (1986) 
reported smoking a mean of 15.6 cigarettes daily, 2 fewer than before 
the policy (p <0.003). These data suggest that smokers did not 
compensate for reduced smoking opportunities at work by increasing 
their smoking at home. 
Rigotti and colleagues (1986) found indirect evidence for compen- 
sation. The nurses’ self-reported cigarette consumption at work 
decreased in the policy group, but did not change in the control 
group. However, overall cigarette consumption in the policy group 
did not change. Both the degree of change and the number of 
smokers in the study were small. 
In an earlier study, Meade and Wald (1977) compared the smoking 
behavior of three British employee groups. Smoking was prohibited 
at work for two groups. Smokers who were allowed to smoke at work 
had a somewhat higher self-reported average daily cigarette COP 
sumption. The maximum rate of smoking occurred at work in the 
aft,ernoon, but for workers prohibited from smoking at work, the 
maximum rate occurred in the interval between leaving work and 
retiring at night. 
There has been much speculation that smoking policies will 
increase the smoker’s motivation and success in quitting. In the 
study by Biener and colleagues (1986), the percentage of smokers 
considering quitting in the next 6 months increased from 71 percent 
at baseline to 91 percent at followup, but there was no change in 
motivation in the control hospital group. Two-thirds of the smokers 
in Rosenstock and colleagues’ uncontrolled study (19861 had a 
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definite desire to quit. However, Rigotti and colleagues (1986) found 
no difference in the motivation of nurses between the control group 
and the policy group. 
Smokers’ use of worksite smoking cessation programs before and 
after policies go into effect have been used as an index of their 
motivation to quit smoking. The results are mixed. In the 6 months 
after Pacific Northwest Bell adopted a smoking ban in October 1985, 
1,944 employees, representing 25 percent of all smokers, enrolled in 
programs reimbursed by the company. This compared with 331 who 
attended free onsite programs in the previous 26 months. The cost to 
the company per smoker was $142 (Martin 1986; K. Rowland, 
memorandum for Len Beil, April 25,1986). At Texas Instruments (R. 
Addison, personal communication, July 21, 19861, 486 smokers 
enrolled in cessation classes within the first year after the announce- 
ment of a smoking policy; this compares with only 11 in 1982, the 
last year for which statistics were kept. In both cases, this enthusias- 
tic response may in part be due to the employers’ new willingness to 
pay for the classes, as well as to the incentive provided by a new 
policy. For example, only 8 of 148 smokers at the New England 
Deaconness Hospital who said they were interested in a smoking 
cessation program on their own time actually showed up (Andrew6 
1983). Even company sponsorship is not a guarantee of popularity. 
At the Group Health Cooperative, only two smokers aware of the 
company-sponsored cessation programs had participated within 4 
months of policy adoption (Rosenstock et al. 1986). The signup rate 
for work&e-based self-help smoking cessation programs was no 
greater at a Rhode Island hospital with a new smoking policy than at 
one without (Biener et al. 1986). 
It is not known whether the cessation rate of smokers who enroll 
in worksite programs is affected by the presence of a smoking policy 
at the worksite. Only uncontrolled studies with self-report measures 
are currently available. At Texas Instruments (R. Addison, personal 
communication, July 21, 1986),34 percent of 354 employees enrolled 
in the first round of company-sponsored cessation classes quit 
smoking by the end of the program; in the second round of classes, 17 
percent of 132 enrollees quit. At Pacific Northwest Bell, 44 percent 
of 639 respondents quit smoking in a survey of the 1,200 participants 
in a company-sponsored program. If nonrespondents are included as 
smokers, the cessation rate was 23 percent (Shannon 1986). 
There is as yet no conclusive evidence that smoking policies are 
associated with increases in smoking cessation attempts or reduc- 
tions in smoking prevalence. All reports are based on self-reported 
smoking behavior. There are anecdotal reports of smokers quitting 
in case reports of company policies (StrideRite, cited in BNA 1986) 
and in uncontrolled surveys (Rosenstock et al. 1986; Andrews 1983). 
Supporting evidence comes from the New England Deaconness 
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Hospital, where a two-part survey, before and 20 months after the 
adoption of a strict smoking policy, demonstrated a reduction in the 
prevalence of smoking among employees from 32 to 24 percent, along 
with an increase in the prevalence of ex-smokers (27 to 34 percent) 
(Andrew6 19831. However, methodologic problems prevent an un- 
equivocal conclusion. The first survey included both employees and 
patients, but the followup covered only employees; smoking rates for 
employees only are not provided. The survey method was not 
specified, but it did not appear to be a probability sample, thereby 
limiting generalizability of the finding to the entire group. Finally, 
because the same group of employees was not surveyed at followup, 
an alternate interpretation for the change in smoking prevalence is 
that the policy influenced employee turnover rates so that smokers 
left and were replaced by ex-smokers. The study did not assess 
employee turnover. 
Controlled studies by Biener and colleagues (1986) and Rigotti and 
colleagues (1986) did not detect an increase in smoking cessation by 
employees of hospitals that adopted smoking policies. In the study by 
Rigotti and colleagues, nurses in the policy group did not differ from 
controls in their motivation to quit, or their expectation of doing so, 
or in the number or success of quit attempts. The prevalence of 
smoking in the policy group and in the control group was similar at 
baseline and did not change in the year after policy adoption. 
Similarly, employees in a Rhode Island hospital with a smoking 
policy were no more likely to try to quit or to succeed in quitting 
than were employees in a control hospital (Biener et al. 1986). The 
number of smokers in these two studies was small, and it is possible 
that the studies lacked adequate power to detect changes in 
behavior. Followup periods of greater than 1 year may also be 
required. 
Attitudes About Smoking 
There has been little assessment of the impact of worksite smoking 
policies on attitudes about smoking. The two controlled studies of 
hospital smoking policies assessed attitudes about the health risks of 
smoking and about involuntary smoking (Biener et al. 1986; Rigotti 
et al. 1986). There was no significant change in the smokers’ beliefs 
about the health risks of smoking or about environmental tobacco 
smoke exposure. 
Management Issues 
There is only sketchy evidence about the impact of worksite 
smoking policies on absenteeism, health care costs, productivity, or 
employee turnover. No systematic analysis of economic impact has 
been done. There is an anecdotal report of cost saving by the Merle 
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Norman Cosmetics Company, which reported lower absenteeism and 
housekeeping costs and increased productivity in the year after it 
adopted a ban on smoking (ALA of San Diego 1984). In the 6 months 
after Pacific Northwest Bell adopted a total smoking ban, no 
employees left because of it (Martin 19861. Rigotti and colleagues 
(1986) reported no change in employee turnover in the year after the 
adoption of a hospital smoking ban. Rosenstock and colleagues (1986) 
found that self-reported work performance was unaffected in 75 
percent of employees and improved in 21 percent. Costs involved in 
implementing a smoking policy have not been systematically mea- 
sured, but appear from case reports to have been small (BNA 1986). 
Adverse impacts of worksite smoking policies have not been report- 
ed. 
Legislation Restricting Smoking in Public Places 
Legislation restricting smoking in public places has been less well 
evaluated than worksite smoking policies. Opinion polls in States 
and communities that have passed smoking control regulations 
provide some information on attitudes about smoking and smoking 
policies. There are no controlled studies of the impact of legislation 
on smoking behavior or attitudes. 
Policy Implementation and Enforcement 
Evaluation of the implementation of State or local smoking control 
statutes has been limited. In general, enforcement is delegated to a 
State or local agency, such as the department of public health. 
Enforcement is handled passively rather than actively; the responsi- 
ble agency responds to complaints, but does not actively monitor 
policy compliance by surveying worksites, restaurants, or public 
places. Nonsmokers rights groups and individual activists are a 
major force for informing the public and aiding enforcement by 
bringing complaints (Sandell1984). 
The experience of cities like San Francisco and States like 
Minnesota contradicts tobacco industry estimates of the expense and 
intrusiveness required to enforce a smoking law (Martin 1986, New 
York Times 4/13/86; Sandell 1984). In the first year after San 
Francisco implemented a strict workplace smoking law in March 
1984, only 124 complaints were processed and 1 citation was issued; 
there were no legal actions. No new employees were hired and no 
additional funds were required for enforcement. Policy enforcement 
required progressively less of a single employee’s time over a l-year 
period (Martin 1986). Minnesota enforces its 1975 State smoking law 
in a fashion similar to San Francisco’s. State public health depart- 
ment officials estimate that they handle 1,200 to 1,400 complaints 
per year, with costs of enforcement estimated to be under $5,000 per 
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year (Sandell 1984). A survey of 10 California cities with workplace 
smoking laws documented that complaint rates were low and 
enforcement of these laws was a low priority for all city govem- 
men& Officials indicated that they would spend any additional 
funds available for enforcement on a public education campaign to 
increase awareness of the law rather than initiate active surveil- 
lance (Linson 1986). 
Because active monitoring of policy compliance is not done, a low 
complaint rate is often taken as evidence of a high compliance rate. 
Data from Minnesota suggest that this is not always true. In 1976,l 
year after the comprehensive Clean Indoor Air Act was enacted, 43 
percent of respondents to a statewide poll felt that the law was not 
very effective in reducing smoking in public places; 38 percent found 
it somewhat effective and 12 percent, very effective (Minneapolis 
Tribune 1976). Six years after the law took effect, a survey of 
Minnesota businesses with 200 or more employees documented that 
only 46 percent of businesses had such a policy. Restaurants, 
however, had nearly uniformly conformed to the law within a year of 
implementation (Sandell 1984). A statewide opinion poll in 1978 
demonstrated that over 70 percent of both smokers and nonsmokers 
felt that the Clean Indoor Air Act should be strictly enforced 
(Minneapolis Tribune 1978). Two years later, Minnesotans were of 
mixed opinion about the law’s enforcement: fewer than half (43 
percent) considered it very well enforced, 42 percent felt it was not so 
well enforced, and 10 percent said it was not enforced at all 
(Minneapolis Tribune 1980). 
Randolph (1982) studied factors associated with compliance and 
enforcement of local ordinances regulating smoking. She asses& 
the implementation of a recently enacted San Rafael, California, 
smoking ordinance by interviewing proprietors of randomly selected 
businesses. Less than 1 year after the ordinance went into effect, 68 
percent of 25 proprietors were aware of the policy, but only 44 
percent of 30 businesses had complied with the requirement to post 
nesmoking signs. The major variable associated with compliance by 
businessmen was the type of business; restaurants, retail food stores, 
drug stores, banks, and movie theaters were generally posting signs 
as required, but department stores and small retail stores were not. 
City residents were less well informed. Fewer than half (45 percent) 
of 200 randomly selected residents surveyed by telephone were 
aware of the ordinance, and only 11 percent could describe its 
provisions. 
Randolph’s study (1982) of implementation also included a 1980 
telephone survey of 600 randomly selected residents of three 
northern California cities, two with smoking ordinances and one 
without. Smokers were classified as compliers or noncompliers 
according to whether they refrained from smoking in supermarkets, 
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which was required by State law. Characteristics of smokers who 
complied were (1) lower daily cigarette consumption, (2) less per- 
ceived need to smoke, (3) greater perception of others’ disapproval 
for tobacco smoking in public, (4) and greater support for policies 
restricting smoking in public places. Smokers’ perception of pres- 
sures to refrain from smoking in public, awareness of the presence of 
a local smoking law, and the duration of the ordinance were not 
associated with compliance. Enforcement of smoking laws was 
studied in nonsmokers. The best predictor of enforcement behavior 
was a nonsmoker’s degree of annoyance with tobacco smoke. Other 
characteristics associated with enforcement behavior were more 
negative attitudes about smoking in public places, greater intoler- 
ance of noncompliance, and higher educational level. 
Policy Approval 
National and regional polls have surveyed public opinion about 
where smoking should be restricted or banned. Regional polls have 
often been taken when legislation is being considered. There are 
little data about public opinion on legislation after its enactment. 
Nationwide public opinion about smoking in public places was 
assessed by Roper polls in 1976 and 1978 (19781, two Gallup polls 
(1978, 19831, and the Harris Prevention Index 85 (Harris 1985). The 
Roper polls asked separate questions about preferences for a 
smoking restriction or a total ban; the Gallup and Harris polls 
offered a choice between the two in the same question. In both Roper 
polls, a majority of respondents favored restricting smoking in all 
places mentioned: transportation vehicles (airplanes, buses, and 
trains), restaurants, workplaces, and indoor arenas. By 1978 three- 
fourths of the respondents favored restrictions in all places except 
the worksite. Total smoking bans were less popular but still the 
choice of at least one-fourth of the respondents. 
The 1983 Gallup poll documented increased public support for 
smoking restrictions, particularly in restaurants. More than 80 
percent of smokers and 90 percent of nonsmokers favored either 
banning or restricting smoking in airplanes, buses, and trains and 
restaurants. Over half of both smokers and nonsmokers favored 
restrictions in motels and at the worksite. Although bans were less 
popular than restrictions, they were twice as popular with nonsmok- 
ers as with smokers. In 1985, 80 percent of the respondents to the 
Harris poll supported restrictions or bans in public places in general. 
Regional polls generally support the conclusions of nationwide 
surveys. 
Minnesota is one State where public opinion of existing legislation 
has been measured. Five years after enactment, public opinion of 
Minnesota’s 1975 Clean Indoor Air Act remained high. Ninety-two 
percent of the 1,200 respondents to a statewide poll favored the act, 
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including 87 percent of heavy smokers (two packs per day) and a 
larger fraction of lighter smokers (Minneapolis Tribune 1980). 
During the first year of the San Rafael, California, smoking 
ordinance, nearly 70 percent of 200 randomly selected residents 
agreed that there should be laws about smoking in public places and 
77 percent said they would have voted for the ordinance had they 
had the opportunity Randolph 1982). The reaction of local busi- 
nesses was less favorable. Over half (52 percent) did not like the 
ordinance, but only 41 percent favored rescinding it. The most 
common reason for support was concern for smoking-related damage 
to property. Concerns about invading personal rights and fear of 
losing business were the major reasons for opposition. 
Attitudes and Social Norms 
It has been suggested that smoking restrictions will alter public 
attitudes and norms about smoking behavior. There are few data 
addressing this hypothesis. 
Randolph (1982) reported on attitudinal differences between 
residents of California communities with and without smoking 
ordinances. Smokers in two cities with laws had more negative 
attitudes about smoking in public places and were more likely to feel 
that there should be laws regarding tobacco smoking in public. 
However, there was no difference in smokers’ perceptions of social 
pressures to refrain from smoking. Nonsmokers in cities with laws 
were more likely to believe that tobacco smoke should be regulated 
in public, but they were no more annoyed by tobacco smoke, 
intolerant of noncompliance, or disapproving of smoking in public 
places than residents of the city without a law. Although residents of 
communities with and without smoking ordinances did not differ in 
their personal support of smoking laws, residents of communities 
with laws perceived greater support for these laws by other residents 
of their communities. This cross-sectional study cannot differentiate 
whether these attitudinal variations were a cause or consequence of 
differences in community smoking ordinances. 
Data from opinion polls demonstrate that negative attitudes about 
smoking generally preceded rather than followed legislation to 
restrict smoking in public places. The four Adult Use of Tobacco 
Surveys, a series of nationwide surveys conducted between 1964 and 
1975, measured attitudes in the decade after the health hazards of 
smoking were first widely appreciated (US DHEW 1969, 1973, 1976). 
As early as the first survey in 1964, a majority of nonsmokers agreed 
with these statements: “It is annoying to be near a person who is 
smoking cigarettes” and “Smoking should be allowed in fewer places 
than it is now.” By 1970, a majority of all respondents agreed with 
these statements. By 1975, a majority of smokers agreed with the 
idea of further restricting smoking, suggesting that there was wide 
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public support for restricting smoking well before the first compre 
hensive Clean Indoor Air Act was passed in Minnesota in 1975. As 
early as 1973,73 percent of the nonsmokers in a Minnesota poll felt 
that they had the right to a smoke-free environment, and 65 percent 
wanted to ask others not to smoke (Minneapolis Tribune 1973). More 
recent opinion polls document that negative attitudes about smoking 
in public continue to grow. In a 1985 Gallup poll, 75 percent of the 
respondents (including 62 percent of the smokers) felt that smokers 
should refrain from smoking in the presence of nonsmokers. 
However, nonsmokers’ attitudes do not translate directly into 
action. A smaller proportion of nonsmokers are willing to confront a 
smoker whose smoke is bothersome. In three successive Roper polls 
between 1974 and 1978, fewer than 10 percent of the nonsmokers 
indicated that they would ask an individual smoking indoors to stop 
(Roper 1978). Only 32 percent of the nonsmokers in a 1974 
Minnesota poll would complain when bothered by another person’s 
smoking, although an additional 31 percent would take nonconfron- 
tational action such as moving away or opening windows (Minneapo- 
lis Tribune 1974). These data suggest that in the mid-197Os, despite 
strong preferences, many nonsmokers did not perceive that asking a 
smoker to stop was socially sanctioned behavior. 
Smokers, on the other hand, report an awareness of nonsmokers’ 
concerns and a willingness to comply with restrictions. Over 90 
percent of the smokers in a 1981 Iowa poll (Des Moines Register 
1981) extinguished tobacco when they saw a no-smoking sign. Sixty 
percent of the smokers in a 1973 Minnesota poll (Minneapolis 
Tribune 1973) had at least some misgivings about smoking in the 
presence of nonsmokers, and 90 percent would not have been 
offended if asked not to smoke. Only 29 to 36 percent of smokers in 
three Roper polls (1974-1978) lit a cigarette without looking around, 
asking others, or refraining from smoking (Roper 1978). 
There may be, therefore, an interaction between attitudes and 
policy development. These survey data suggest that attitudes about 
smoking in public preceded and may have contributed to the 
development of a public policy (Breslow 1982). At the same time, 
publicity surrounding campaigns for legislation may increase public 
awareness of an issue such as the hazards of involuntary smoking 
and therefore contribute to further changing attitudes. 
Smoking Behavior 
The impact of legislation on smoking behavior has received little 
formal attention. There are no controlled studies in which smoking 
behavior has been tracked over time in the States or communities 
that have enacted smoking legislation. In Randolph’s one-time 
assessment (1982) of smoking behavior in California communities 
with and without smoking control ordinances, there was no differ- 
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ence in smoking prevalence or mean daily cigarette consumption 
between the residents of a city with a recent ordinance and one 
without. A lower prevalence of smoking in one community with a 
longstanding ordinance was probably explained by demographic 
differences between that community and the other areas. 
Uncontrolled reports of declining smoking prevalence or cigarette 
consumption in a State or community with a smoking law cannot 
establish a causal relationship. This was particularly the case during 
the 197Os, when both smoking prevalence and per capita cigarette 
consumption were declining nationally. Warner (1981a; Warner and 
Murt 1982) conducted a series of analyses of this decline. In separate 
analyses, he estimated the levels of smoking prevalence and ciga- 
rette consumption that would have been achieved if previous trends 
in these indicators had continued unabated through the 1960s and 
1970s. Cigarette consumption in 1978, for example, would have been 
36 to 41 percent higher had previous patterns continued. He ascribed 
the difference between observed and modeled values to the impact of 
the so-called antismoking campaign, defined as the combination of 
public events, legislative activity, and Federal regulations that 
affected cigarette price, counter-advertising, and the circumstances 
in which smoking was allowed. 
To assess the relative contributions of components of the anti- 
smoking campaign to the decline in adult per capita cigarette 
consumption, Warner (1981a) developed a multivariate analysis that 
included independent variables to account for price fluctuations, 
adverse publicity about smoking, antismoking activities, and the 
effectiveness of the nonsmokers’ rights movement. The percentage of 
adults residing in States restricting smoking in public places was 
used as an index of the strength of the nonsmokers’ rights 
movement. This variable was strongly associated (p <O.OOOl) with 
decreases in consumption from 1973 to 1978. 
In Warner’s view, the temporal relationship between the growth 
in legislation restricting smoking in public places and the decline in 
cigarette consumption is so close that a causal relationship is 
unlikely. He attributed the decline in consumption to the changes in 
attitudes and social norms about smoking that were an earlier 
consequence of the entire antismoking campaign. He regarded the 
legislation as another reflection of changing social norms rather 
than the creator of them (Warner 1981b). 
Recommendations for Research 
Policies restricting the circumstances in which smoking is permit- 
ted have been adopted by a broad range of institutions, mostly in the 
last decade. Smoking regulations affect the daily lives of a large and 
growing number of Americans. Consequently, these policies are of 
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interest to many individuals and groups. For instance, public health 
officials are concerned about the health effects of both active and 
involuntary smoking; they are most interested in whether these 
policies actually reduce a population’s exposure to environmental 
tobacco smoke and whether they will alter the prevalence of 
smoking. Behavioral scientists, primarily concerned with smoking 
behavior and attitudes, are chiefly interested in how smoking 
policies alter these variables and how this knowledge can increase 
our understanding of the dynamics of smoking behavior. Businesses, 
unions, and government policymakers have different perspectives. 
They are faced with deciding whether to adopt smoking restrictions 
and how to improve the implementation and acceptability of existing 
ones. Information about the determinants of policy approval and 
compliance will be of most interest to them. Businesses may also be 
concerned about the economic and managerial impacts of smoking 
restrictions. 
Understanding the effect of policies on smoking behavior is of 
widest interest and deserves attention. Policies may affect the 
natural history of smoking behavior at several points, and detailed 
behavioral information should be collected to distinguish among 
effects on rates of initiation, cessation, and relapse. Studying how 
smokers cope with enforced abstinence may provide additional 
insights into the maintenance of smoking behavior. Detailed studies 
of the influence of policy may advance the state of knowledge about 
the determinants of smoking behavior in general. The relationship 
between interventions at the social and individual levels is also of 
interest. Researchers should consider whether the effectiveness of 
individual treatment is enhanced by the presence of a smoking 
policy, and whether the impact of a policy is enhanced by the 
availability of individual treatment. Concurrent collection of infor- 
mation on attitudes about smoking may help to clarify the nature of 
the relationships among attitudes, smoking behavior, and smoking 
policies. 
In addition to considering a variety of outcome measures, re- 
searchers should address the determinants of these outcomes. 
Characteristics of the policy, the institution, and the population 
should be considered. The components of a smoking policy and its 
implementation (such as restrictiveness, degree of advance notice, 
degree of support for the policy by affected groups, access to smoking 
cessation programs) that contribute to its effect-be it on behavior, 
attitudes, air quality, acceptability, or compliance-have generally 
not been analyzed. Because smoking policies vary widely in their 
provisions and implementation, they cannot be evaluated as a 
unitary intervention; i.e., better operationalization of “policy” inter- 
ventions is needed. The relative strength of policy components on 
each outcome measure should be assessed in order to make informed 
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policy recommendations. For example, the degree of protection from 
involuntary smoke exposure afforded by policies of different degrees 
of stringency in not empirically known. To acquire this knowledge, 
researchers will need to develop and validate measures of such 
concepts as restrictiveness. The index described in the appendix to 
this chapter is a preliminary attempt to do that. The components of a 
policy that are most powerful in reducing cigarette consumption, 
inducing cessation attempts, preventing relapse, or reducing smok- 
ing initiation need to be identified. 
Similarly, the components of a policy associated with maximal 
acceptability and compliance have been addressed only cursorily. 
Dawley and colleagues (Dawley, Morrison et al. 1981; Dawley and 
Burton 19851, for example, have examined variables such as the 
wording of signs or the presence of active enforcement. Guidelines 
for the implementation of smoking policies have not been experi- 
mentally derived. Research could empirically support or refute 
recommendations on the basis of experience. Interventions such as 
the training of managers to handle implementation problems might 
then be developed to increase policy acceptability and compliance. 
Different types of organizations have presented different climates 
for the adoption of smoking regulations. In assessing policy impact, 
there may also be substantial interactions between the policy and 
type of facility in which it is adopted. Even within a single type of 
facility, there may be considerable variability in social norms, social 
supports, and characteristics of the population using it. Sorensen 
and colleagues (1986) have pointed out these differences among 
worksites. Policy evaluations should consider these variables. 
Because smoking policies represent a recent social phenomenon, 
there is at present relatively little information about their impact. 
New policies are being adopted at a growing rate, providing 
researchers with the opportunity to study natural experiments that, 
up to now, have largely gone unevaluated. The variety of potential 
outcomes, number of interested parties, and current lack of informa- 
tion make efforts to collect systematic data on new public and 
private sector smoking policies a high priority for research. Con- 
trolled studies are desirable and permit the firmest conclusions, but 
with the current knowledge base, even limited efforts may yield 
valuable information. Uncontrolled case studies, for example, can 
provide suggestive data and generate hypotheses for further testing. 
In some cases, data are already partially collected. For example, 
many businesses considering smoking policies survey employees at 
baseline, but few repeat the survey after policy adoption. At the 
aggregate level, it may be possible to estimate the impact of 
legislation on smoking prevalence or cigarette consumption by 
relating national survey data on smoking behavior to smoking 
restrictions in geographic areas. 
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Conclusions 
1. Beginning in the 1970s an increasing number of public and 
private sector institutions have adopted policies to protect 
individuals from environmental tobacco smoke exposure by 
restricting the circumstances under which smoking is permit- 
ted. 
2. Smoking in public places has been regulated primarily by 
government actions, which have occurred at Federal, State, 
and local levels. All but nine States have enacted laws 
regulating smoking in at least one public place. Since the mid- 
197Os, there has been an increase in the rate of enactment and 
in the comprehensiveness of State legislation. Local govern- 
ments have enacted smoking ordinances at an increasing rate 
since 1980; more than 80 cities and counties have smoking laws 
in effect. 
3. Smoking at the workplace is regulated by a combination of 
government action and private initiative. Legislation in 12 
States regulates smoking by government employees, and 9 
States and over 70 communities regulate smoking in the 
private sector workplace. Approximately 35 percent of busi- 
nesses have adopted smoking policies. The increase in work- 
place smoking policies has been a trend of the 1980s. 
4. Smoking policies may have multiple effects. In addition to 
reducing environmental tobacco smoke exposure, they may 
alter smoking behavior and public attitudes about tobacco use. 
Over time, this may contribute to a reduction of smoking in the 
United States. To the present, there has been relatively little 
systematic evaluation of policies restricting smoking in public 
places or at the workplace. 
5. On the basis of case reports and a small number of systematic 
studies, it appears that workplace smoking policies improve air 
quality, are met with good compliance, and are well accepted 
by both smokers and nonsmokers. Policies appear to be 
followed by a decrease in smokers’ cigarette consumption at 
work and an increase in enrollment in company-sponsored 
smoking cessation programs. 
6. Laws restricting smoking in public places have been imple- 
mented with few problems and at little cost to State and local 
government. Their impact on smoking behavior and attitudes 
has not yet been evaluated. 
7. Public opinion polls document strong and growing support for 
restricting or banning smoking in a wide range of public places. 
Changes in attitudes about smoking in public appear to have 
preceded legislation, but the interrelationship of smoking 




The Comprehensiveness Index of State Laws 
To permit comparisons over time, an index of the comprehen- 
siveness of each State’s smoking law was created. Laws were 
classified on the basis of the number and nature of places where 
smoking was restricted or prohibited. The overall principle was that 
stronger measures are those that reduce exposure to ETS to the 
greatest degree. More comprehensive laws were considered to be 
those that restrict smoking in a larger number of public places, 
extend to privately owned facilities, and cover places where individu- 
als spend a large amount of time. 
Laws regulating smoking in private worksites were considered to 
be the the most comprehensive, and States with such laws were 
assigned the extensive category. Because individuals spend more 
time at work than in any other place outside the home, worksite 
legislation has the potential for marked reductions in public 
exposure to involuntary smoking. Worksite laws also represent an 
extension of legislation to the private sector, considered a further 
evidence of their comprehensiveness. Nine States are categorized as 
having extensive restrictions; the average number of public places 
covered by their legislation was 11.0. 
The next most stringent category, moderate, was assigned to 
States that regulated smoking in restaurants. Restaurants were 
chosen because they represent privately owned public places and 
because laws covering them have been controversial to enact. It was 
felt that States regulating restaurants but not the private workplace 
had moderately comprehensive restrictions. The 10 States in this 
category also regulated smoking in a large number of public places 
(9.5). 
The last two categories, nominal and basic, were defined for States 
that did not regulate smoking in restaurants or in the private 
workplace. They differed in the number of public places covered. 
States restricting smoking in one to three public places were 
considered to have nominal restrictions. Those restricting smoking 
in four or more public places were classified as basic. 
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This number of public places covered by smoking restrictions 
increases with increasing comprehensiveness of categories. 




Extensive 9 11.0 
Moderate 
Basic :: E 
Nominal 1:4 
No policy i 0 
For the calculation of the comprehensiveness index, categories 






No policy .oo 
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particle size as factor in dispersion, 
169 
particle size distribution and 
breathing pattern effect on dose, 
25 
particle size facilitates rapid distri- 
bution, 14 
particles, number and size distribu- 
tion, 137, 139 
particulates, aldehydes, phenol, am- 
monia, and other irritants, 229 
personal monitors to measure con- 
centrations preferable to area 
monitoring, 166 
physiochemical nature, distribution, 
and estimation of human expo- 
sure, 125-169 
plasma and urine nicotine levels in 
nonsmokers vs. intravenous nic- 
otine injection, 215 
plasma, urine, saliva cotinine in 
exposed nonsmokers vs. active 
smokers (table), 211-214 
plasma, urine, saliva nicotine in 
exposed nonsmokers vs. active 
smokers (table), 209-210 
proximity to smoke source as expo 
sure factor, 141 
questionnaires for estimating expo- 
sure, uses and limitations, 34-35 
radioactivity, 134 
reduction of exposure as primary 
goal of smoking regulation in 
public places, 304 
respirable suspended particulates in 
exposed vs. nonexposed nonsmok- 
ers, 169 
respiratory disease risk relationship 
in infants, children, adults, 10 
respiratory infections in infants, 
risk relationship, 31 
respiratory symptoms in nonsmok- 
ers, possible relationship, 31 
school smoking regulations tradi- 






sidestream smoke as major contrib- 
utor, 186 
statistical significance testing of 
health risks, 36-37 
summary and conclusions of 1986 
report, 12-13 
temporal and spatial distribution of 
smokers in exposure determina- 
tion, 145-146 
thiocyanates as biological marker 
of exposure, 202-203 
time-activity patterns as determi- 
nant of exposure, 142-145 
time period most important deter- 
minant of personal exposure, 167 
total suspended particulates in in- 
door working and living areas 
(table), 194-196 
toxic and carcinogenic agents in- 
doors from nonfilter cigarettes 
(table), 136 
toxicity, acute irritant effects, and 
carcinogenicity, 15 
urinary cotinine levels in exposed 
vs. nonexposed men, 207 
vapor phase, retention by involun- 
tary smokers, 126-127 
workplace exposure, evidence of 
health hazards as factor in 
smoking regulations, 286 
workplace, lung cancer risk in non- 
smokers, 91-92 
ENZYME ACTIVITY 
lungs of smokers, alveolar macro- 
phages influence on protease-an- 
tiprotease balance, 242-243 
polymorphonuclear elastase in 
lungs of smokers, 243 
respiratory system of smoke-ex- 




(See also CASE-CONTROL STUD 
IlW 
confounding variables, 36 
lung cancer risk in spouses of 
smokers, 98, 101 




questionnaires for estimating ETS 
exposure, uses and limitations, 
34-35 
ETS See ENVIRONMENTAL TO- 
BACCO SMOKE 
EXSMOKERS 
(See also NONSMOKERS1 
misclassification of status and ETS 
exposure as factors in determin- 
ing risks, 66-67, 72-73 
EYES 
annoying and irritating effects of 
ETS exposure, 231-239 
irritation from ETS exposure, 11 
irritation in ETS-exposed children, 
239 
nonsmokers, irritant effect of invol- 
untary smoking in restaurants 
and offices, 232 
nonsmokers, sidestream smoke as 
irritant in laboratory, ventilation 
as factor, 234-235 
smoke concentration vs. exposure 
duration as factors in irritation, 
235 
tear film in ETS-exposed nonsmok- 
ers, experimental study, 234 
FETUS 
maternal smoking, effect of expo 
sure to tobacco smoke constitu- 
ents, 31-32 
GAS PHASE, CIGARETTE SMOKE 
activity in in vitro assays, 251 
irritation in nonsmokers vs. whole 
sidestream smoke, 236-238 
HOSPITALS 
(See akio PUBLIC PLACES) 
air quality, effect of smoking poli- 
cies, 311 
cessation of smoking programs, ef- 
fect, 314-315 
employee attitudes and approval of 
smoking policies, 311312, 315 
lung cancer cas+control study in 
four hospitals, 84-86 
smoking policies, positively worded 
signs and enforcement factors in 
compliance, 310 
smoking policies, review of current 
evidence on impact, 308-309 
INDEX 
HOSPITALS-Co&d. 
State legislation restricting smok- 
ing, 269 
IMMUNE SYSTEM 
cigarette smoking effects, 244 
INFANTS 
respiratory diseases, parental smok- 
ing as risk factor, 10 
respiratory system effects of invol- 
untary smoking, 38-59 
time-location patterns, 144 
tracheobronchial smoke particle de- 
position, mathematical model 
prediction, 192 
INVOLUNTARY SMOKING 
(See also ENVIRONMENTAL TO- 
BACCO SMOKE; NONSMOK- 
ERS) 
absorption vs. active smoking, 215 
216 
absorption of constituents under 
experimental and natural expo- 
sure, 206-207 
adult asthmatics, lung function ef- 
fects, 63, 65 
allergic persons, irritant effect, 239 
assessment of nonsmoker’s expo- 
sure, 307 
atmospheric vs. biological markers 
of ETS absorption in disease 
risk estimation, 200-201 
bronchoconstriction and asthma in 
children of parents who smoke, 
55-58 
bronchoconstriction in normal adult 
nonsmokers, 63 
cancers other than lung cancer, 
risk relationship, 102-104 
carbon monoxide as biological 
marker of ETS exposure, 201- 
202 
cardiovascular disease risk, prospec- 
tive and case-control studies, 
105-106 
children, brain cancer risk, 104 
children, lung function effects (ta- 
ble), 50-52 
children, nonuniform deposition of 
particles in respiratory disease 
risk, 192 
children, parental smoking as fac- 
tor in saliva cotinine concentra- 
tions, 207-208 
INVOLUNTARY SMOKING-Contd. 
children, reported eye irritation, 
239 
children, respiratory disease rela- 
tionship (table), 3941 
children, respiratory symptoms re- 
lationship (table), 45-46 
children, respiratory symptoms 
risk, 44, 41-49 
children, risk of cancer other than 
lung cancer, 102-104 
cotinine in body fluids as measure 
of nicotine absorption, 205 
cotinine level in saliva, blood, and 
urine as ETS exposure marker, 
36 
cumulative, duration, and intensity 
influences health risks, 33 
disease risk estimation, value of bi- 
ological markers of ETS absorp 
tion, 200-201 
ETS vapor phase components, re- 
tention, 126-127 
exposure to sidestream and main- 
stream smoke components, 8 
eye and nasal irritation, smoke 
concentration vs. duration as 
factors, 235 
health effects and public attitudes 
as factors in smoking restric- 
tions, 265 
health hazards, increasing evidence 
as factor in regulation, 282, 286 
health risks, 6-7, 107-108 
infants and children, bronchitis 
and pneumonia risk, 38, 42-44 
infants and children, respiratory 
system effects, 38-59 
inflammatory cell numbers and 
functions in smokers, inferences, 
244-245 
irritant effects in nonsmokers in 
restaurants and offices, 232 
irritation from gas phase VS. whole 
sidestream smoke, 236238 
lung cancer dose-response relation- 
ship, problems in exposure deter 
mination, 92-93 
lung cancer in spouses of smokers, 
prospective and case-control 
studies (table). 71 
lung cancer in wives of smokers. 





lung cancer relationship, relative 
risk, 72 
lung cancer risk, American Cancer 
Society Cohort Study, 76-77 
lung cancer risk assessment, impor- 
tance of definition of exposure, 
92 
lung cancer risk, bias in case-con- 
trol studies (table), 98 
lung cancer risk, epidemiological 
evidence, 97-98 
lung cancer risk, evidence from 
case-control studies, 97 
lung cancer risk factor in children, 
90-91 
lung cancer risk factor in non- 
smokers, 13 
lung cancer risk in nonsmokers, 
Hong Kong case-control studies, 
80-81 
lung cancer risk in spouses of 
smokers, Louisiana case-control 
study, 79-80 
lung cancer risk in spouses of 
smokers, Scottish study, 77-78 
lung cancer risk in wives of smok- 
ers, Greek castiontrol study, 
78-79 
lung cancer risk relationship, case- 
control studies (table), 68-70 
lung cancer risk relationship, Los 
Angeles County study, 83 
lung cancer risk relationship, pre- 
liminary findings of U.S. study, 
62 
lung cancer risk relationship, pro- 
spective studies (table), 67 
lung cancer risk relationship, sum- 
mary and conclusions, 96-102 
lung cancer risk relationship, the 
Four Hospitals case-control 
study, 84-86 
lung cancer risk relationship, the 
German case-control study, 90 
lung cancer risk relationship, the 
Japanese case-control study, 66- 
89 
lung cancer risk relationship, the 
Swedish case-control study, 89- 
90 
lung cancer risk relationship, the 




lung cancer risk, study power of 
case-control studies (table), 99- 
100 
lung disease risk, extrapolation 
from risk in smokers, 30-31 
lung function effects in adult non- 
smokers, 60, 62 
lung function effects in adults (ta- 
ble), 61 
lung function effects in healthy 
adults (table), 64 
mathematical models of lung can- 
cer risk, 93-96 
middle ear effusions and diseases 
in children, risk relationship, 
58-59 
misclassification of smoking status 
and exposure as factors in deter- 
mining risk, -7, 72-73 
nicotine and cotinine levels as ex- 
posure markers under real-life 
conditions, 207 
nicotine and cotinine to quantify 
ET!3 exposure, 208, 215 
organization of the 1966 Report, 5 
personal monitoring to measure ex- 
posure, 33-34 
personal monitors to measure KTS 
concentrations, 164-167 
public and workplace smoking re- 
strictions, conclusions of 1966 re 
port, 324 
public awareness of health hazards 
as factor in changing attitudes, 
320 
quantitative and qualitative differ- 
ences in exposure from active 
smoking, 23-24 
questionnaires for estimating expo- 
sure, uses and limitations, 34-35 
research recommendations, 321-323 
respirable suspended particulate 
levels as marker of smoke expo- 
sure, 8 
respiratory system effects in chil- 
dren, caswontrol studies, 43-44 
respiratory system effects in chil- 
dren, cross-sectional studies, 43 
respiratory system effects in in- 
fants and children, longitudinal 
studies, 38, 42-43 
State legislation in 1970s aimed at 
protecting nonsmokers, 267 
INDEX 
INVOLUNTARY SMOKINC--Contd. 
summary and conclusions of 1986 
report, 12-13 
thiocyanate levels not specific for 
exposure, 203 
toxicity, mathematical model for 
estimating using “cigarette 
equivalents”, 198-200 
urinary nicotine and expired car- 
bon monoxide in nonsmokers fol- 
lowing exposure, 207 
workplace, lung cancer risk rela- 
tionship, 91-92 
workplaces, current status of smok- 
ing regulations, 285-303 
IRRITATION 
(See also RESPIRATORY SYMP- 
TOMS) 
acute effects of ETS exposure, 229 
239 
allergic persons, ETS exposure ef- 
fect, 239 
annoying and irritating effects of 
ETS, 231-239 
children exposed to E’I’S, 239 
ETS exposure effects, conclusions, 
252 
nonsmokers, experimental studies 
of ETS exposure effects, 233-239 
LABORATORY SMOKING 
chemical analysis of sidestream 
smoke in special chambers, 127- 
129, 132 
mainstream and sidestream compo- 
sition data collection, 125 
mainstream smoke particle size dis- 
tribution (table). 184-185 
particle size of mainstream smoke 
aerosol, measurement, 182-183, 
186 
sidestream smoke particle size dis- 
tribution (table), 186 
LEGISLATION 
(See also SMOKING REGULA- 
TIONS) 
average restrictiveness of State 
laws, 1960-1985 (figure), 276 
comprehensiveness index of State 
laws, 327-328 
current State smoking regulations, 
variations, 268-270 
early restrictions as moral crusade 
and fire protection, 266-267 
LEGISLATION--Contd. 
emphasis shift and increase in 
State legislation during the 
1970s. 267 
Federal, State, and local to restrict 
smoking, 266-278 
impact on smoking behavior, as- 
sessment, 306-307 
local, California’s nonsmokers’ 
rights movement as factor, 277 
Minnesota, landmark Clean Indoor 
Air Act of 1975, model for other 
States, 267 
nonsmoking sections in restaurants 
mandated by State laws, 260 
rate of new State legislation con- 
tinues into 1986s 268 
regional variation in State laws 
against smoking (table), 277 
restrictions and bans on smoking, 
16 
review of impact on smoking be- 
havior, 32&321 
smoking regulations, conclusions of 
1986 report, 324 
social norms and public attitudes 
as factors in passage, 321 
State and local laws and Federal 
regulation in health care facili- 
ties, 284-285 
State and local laws on public 
smoking, influence on private 
sector, 295 
State and local smoking control 
statutes, implementation evalu- 
ation, 316318 
State, increase in comprehensive- 
ness of smoking regulations 
since 1970, 275 
State laws regulating smoking in 
public places and workplaces &a- 
ble), 271-274 
State laws restricting smoking, 
197&1965 (table), 269 
States with no regulations against 
smoking, 268 
student smoking, legal incentive for 
regulation by schools, 282 
tobacco-producing States have less 
restrictive laws on smoking, 
275-276 





workplace smoking, private sector, 
State and local laws, 285 
workplace smoking regulation, vari- 
ations in State laws, 270, 275 
LEUKEMIA 
children of women who smoked 
during pregnancy, risk relation- 
ship, 103-104 
LEUKOCYTES 
polymorphonuclear. lung disease 
risk relationship in smokers, 
243-244 
LUNG CANCER 
(See also CANCER) 
animals exposed to cigarette 
smoke, 248-249 
confounding variables in studies of 
ETS risk in nonsmokers, 36 
ETS as risk factor in nonsmokers, 
8-10 
ETS exposure as risk in nonsmok- 
ers, Hong Kong case-control 
studies, 80-81 
ETS risk relationship, need for 
more accurate estimates of expo- 
sure, 102 
involuntary smokers, study power 
of case-control studies (table), 
99-100 
involuntary smoking as factor, 
American Cancer Society Cohort 
Study, 76-77 
involuntary smoking as factor, Los 
Angeles County study, 83 
involuntary smoking as factor, pre- 
liminary findings of U.S. study, 
82 
involuntary smoking as factor, rela- 
tive risk, 72 
involuntary smoking as factor, the 
Four Hospitals case-control 
study, 84-86 
involuntary smoking as factor, the 
German case-control study, 90 
involuntary smoking as factor, the 
Japanese case-control study, 8% 
89 
involuntary smoking as factor, the 




involuntary smoking as factor, the 
United Kingdom case-control 
study, 86-86 
involuntary smoking as risk factor, 
bias in case-control studies (ta- 
ble), 98 
involuntary smoking as risk factor, 
case-control studies (table), 68- 
70 
involuntary smoking as risk factor, 
prospective studies (table), 67 
involuntary smoking as risk factor, 
summary and conclusions, 96- 
102, 107 
involuntary smoking dose-response 
relationship, problems in expo- 
sure determination, 92-93 
mathematical models of ETS expo- 
sure risk in nonsmokers, 93-96 
methodological issues in assessing 
involuntary smoking risk, 66-67, 
72-73 
mortality in nonsmoking wives of 
smokers, 27 
nonsmokers, case-control study evi- 
dence of ETS exposure as risk 
factor, 97 
nonsmokers, epidemiological evi- 
dence of KTS exposure as risk 
factor, 97-98 
nonsmokers, involuntary smoking 
as risk factor, 13, 66-101 
nonsmokers, projection of EX’S risk 
from relationship with smoking 
in smokers, 26-27 
nonsmoking spouses of smokers, 
Louisiana case-control study, 79- 
80 
nonsmoking spouses of smokers, po- 
tential bias in Japanese study, 
74-75 
nonsmoking spouses of smokers, 
Scottish study, 77-78 
nonsmoking wives of smokers, Jap 
anese prospective study, 73-76 
nonuniform carcinogenic particle 
deposition as possible risk factor, 
192 
parental smoking as risk factor, 
90-91 
sample size of concern in studies of 
nonsmokers, 22 
smoking as major risk factor, 6 
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LUNG CANCER-Contd. 
spousal smoking as risk factor, pro- 
spective and case-control studies 
(table), 71 
women married to smokers, Greek 
case-control study, 78-79 
LUNG DISEASES 
(See also RESPIRATORY TRACT 
DISEASES) 
active smokers, extrapolation of 
risk in involuntary smokers, 30 
bronchiolitis, early pathologic le- 
sions in smokers, 241 
LUNG FUNCTION 
adult asthmatic nonsmokers ex- 
posed to cigarette smoke, 63, 65 
adults exposed to involuntary 
smoking (table), 61 
asymptomatic adults, long-term 
workplace exposure as risk fac- 
tor, 60 
children and adolescents who start 
to smoke, 28 
children and adults, conclusions 
about ETS exposure risk, 107 
children, information needed on re- 
lationship with ET’S exposure, 32 
children, involuntary smoking risk 
relationship (table), 50-52 
children, maternal smoking rela- 
tionship, 49, 53-54 
healthy nonsmokers exposed to cig- 
arette smoke (table), 64 
nonsmokers, ETS as factor in de- 
cline, 10 
nonsmokers, extrapolation of ETS 
risk from risks in smokers, 27 
LUNGS 
(See also RESPIRATORY SYSTEM) 
carbon monoxide deposition kinetics 
as factor in variations in concen- 
tration, 201-202 
children of parents who smoke, 
possible long-term effects, 44 
cigarette smoking effect, implica- 
tions for chronic ETS exposure, 
239 
cigarette smoking effects, summary, 
246-247 
inflammatory cell function, experi- 
mental models of cigarette 
smoke inhalation, 245-246 
LUNGS-Contd. 
inflammatory cells, cigarette smok- 
ing effect, 241-246 
inflammatory lesions in smokers 
vs. nonsmokers, 245 
parenchyma alterations in smokers, 
246 
parenchyma destruction by poly- 
morphonuclear elastase in smok- 
ers, 243 
regional deposition of mainstream 
smoke particles in smokers, 189, 
191 
respirable particle deposition, non- 
uniformity. 191-192 
sidestream smoke particle deposi- 
tion, mass median diameter as 
factor, 187 
MAINSTREAM SMOKE 
(See akro CIGARETTE SMOKE; 
SIDESTREAM SMOKE; SMOKE 
STREAMS; TOBACCO SMOKE) 
condensates, in vitro assays of mu- 
tagenic activity, 250-251 
definition, 7 
electrical charge as factor in parti- 
cle deposition, 187 
particle size distribution studies, 
140 
particle size distribution (table), 
184-185 
regional deposition in respiratory 
tract of smokers, 189, 191 
respiratory system deposition vs. 
sidestream smoke (table), I90 
MATERNAL SMOKING 
(See nlso PARENTAL SMOKING) 
asthmatic children, risk relation- 
ship, 55-58 
brain tumors in children, risk rela- 
tionship, 104 
cancer other than lung cancer in 
children, risk relationship, 103- 
104 
health risks for fetus and neonate, 
6 
leukemia in children of women 
who smoked during pregnancy. 
103 
lung function in children, risk rela- 
tionship, 49, 53-54 
lung function in children, risk rela- 




respiratory illness in children, 
case-control studies of risk, 43- 
44 
respiratory illness in children, 
cross-sectional studies of risk, 43 
respiratory illness in infants and 
children, 38, 42-43 
MATHEMATICAL MODELS 
airways deposition of sidestream 
smoke suggested, 217 
humidity effect on particle size and 
deposition, 187-188 
lung cancer risk of ETS exposure, 
93-96 
particle deposition patterns, effect 
of cigarette tar content, 191 
regional deposition of polydisperse 
aerosols, 189 
respirable suspended particulate 
constituent of ETS for exposure 
prediction, 165 
respiratory tract deposition of side- 
stream smoke particles, 186-187 
tracheobronchial smoke particle de 
position prediction, age as factor, 
192 
MINNESOTA 
landmark Clean Indoor Air Act, 
model for other States, 267 
public approval of 1975 Clean In- 
door Air Act, 318-319 
MORTALITY 
cancers other than lung cancer, 
standard ratios for wives of 
smokers, 102 
lung cancer, establishing risk in 
nonsmokers, 95-97 
lung cancer in ETS exposed non- 
smokers, American Cancer Soci- 
ety Cohort Study, 76-77 
lung cancer in nonsmoking wives 
of smokers, 27 
lung cancer in spouses of smokers, 
Scottish study, 77-78 
lung cancer in wives of smokers, 
Japanese prospective study, 73- 
76 
maternal smoking as risk factor 
for infant mortality, 6 
348 
MOTIVATION 
cessation of smoking, public atti- 
tudes and restrictions as rein- 
forcement, 305 
worker safety not health as factor 
in early smoking regulations, 
287 
workplace smoking policies, effect 
on smoking cessation attempts, 
313-314 
workplace smoking regulation, 295- 
296 
NICOTINE 
(See also TOBACCO SMOKE CON- 
STITUENTS) 
absorption in nonsmokers to assess 
lung cancer risk, 9 
absorption in populations suggests 
ETS exposure is common, 15 
acute toxicity in animals as factor 
in smoke carcinogenicity testing, 
247 
atmospheric levels as marker of 
ETS exposure, 33 
biological fluid levels, promising 
tracer of ETS exposure, 165-166 
blood levels, metabolism, and excre- 
tion rate to determikne intake, 
203-204 
body fluid levels as marker of 
smoke exposure in nonsmokers, 
8 
body fluid levels increase with re- 
ported El’s exposure, 15, 217 
body fluid levels specificity for to- 
bacco or tobacco smoke expo- 
sure, 204 
BTS as source in general environ- 
ment, 14, 169 
ETS exposure determination, speci- 
ficity, 147 
ETS exposure quantification, 208, 
215 
ETS tracer, need for proper valida- 
tion, 168 
measurement under realistic condi- 
tions (table), 155-156 
personal air monitoring for intake 
determination, 216 
plasma and urine levels from in- 
travenous infusion vs. ETS expo- 
sure in nonsmokers, 215 
INDEX 
NICOTINELContd. 
plasma,* urine, saliva levels in non- 
smokers vs. active smokers, 209- 
210, 216 
suspended particulate levels as 
measurement of ETS exposure, 
193 
tobacco smoke exposure determina- 
tion, absorption, distribution, me 
tabolism, 203-205 
vapor phase of sidestream vs. 
mainstream smoke, 127 
NITROGEN OXIDES 
carcinogenic potential of oxides of 
nitrogen in sidestream smoke, 
129 
irritant in ETS, 229 
measurement under realistic condi- 
tions (table), 157 
nitrogen dioxide in sidestream 
smoke, carcinogenic potential, 
129 
NITROSAMINE CONTENT 
N-nitrosamines in sidestream vs. 
mainstream smoke, 129 
NITROSAMINES 
ETS as only source of some N-ni- 
trosamine compounds in general 
environment, 169 
ETS exposure determination, speci- 
ficity, 147 
measurement under realistic condi- 
tions (table), 158 
sidestream smoke levels higher 
than in mainstream smoke, 14 
NONSMOKERS 
absorption of smoke constituents 
under experimental and natural 
exposure, 206-207 
blood cotinine levels, nicotine injec- 
tion vs. smoke exposure, 215-216 
California nonsmokers’ rights move- 
ment as factor in local smoking 
regulation, 277 
cardiovascular disease, prospective 
and case-control studies of ETS 
risk, 105-106 
chronic ETS exposure, inferred risk 
for respiratory epithelium, 24& 
241 
cotinine elimination half-life VS. 
smokers, 205-206 
NONSMOKERS-Contd. 
emphysema risk vs. smokers, genet- 
ic predisposition as factor, 246 
ETS as lung cancer risk factor, 
problems in exposure determina- 
tion, 92-93 
ETSexposed, plasma, urine, saliva 
cotinine vs. active smokers &a- 
ble), 211-214 
ETS-exposed, plasma, urine, saliva 
nicotine vs. active smokers (ta- 
ble), 209-210 
ETS exposure, experimental studies 
of irritant effects, 233-239 
ETS exposure, relationships with 
active smoking provide insight 
into risks, 26-28 
ETS exposure toxicity, mathemati- 
cal model using “cigarette equiv- 
alents”, 193-200 
ETS exposure, wide variations, 14 
health risks of ETS exposure, con- 
clusions, 107-108 
health risks of involuntary smok- 
ing, summary and conclusions, 
12-13 
irritant effects of involuntary 
smoking in restaurants and of- 
fices, 232 
irritation from sidestream smoke 
vs. gas phase sidestream smoke, 
236238 
irritation from smoke exposure, 
concentration vs. duration as 
factors, 235 
lung cancer, establishing risk of 
ETS exposure, 95 
lung cancer, ETS exposure as fac- 
tor, Four Hospitals case-control 
study, 64-66 
lung cancer, ETS exposure as fac- 
tor, German case-control study, 
90 
lung cancer, ETS exposure as fac- 
tor, Hong Kong case-control 
study, 80-81 
lung cancer, ETS exposure as fac- 
tor, Japanese case-control study. 
88-89 
lung cancer, ETS exposure as fac- 





lung cancer, ETS exposure as fac- 
tor, preliminary findings of U.S. 
study, 82 
NONSMOKERS-Co&d. 
plasma, saliva, and urine nicotine 
and cotinine levels vs. active 
smokers, 216 
lung cancer, ETS exposure as fac- 
tor, Swedish case-control study, 
89-90 
lung cancer, ETS exposure as fac- 
tor, United Kingdom case-con- 
trol study, 36-88 
lung cancer in spouses of smokers, 
prospective and case-control 
studies (table), 71 
lung cancer, involuntary smoking 
as risk factor, 13 
lung cancer risk from ET’S expo- 
sure, S-10 
preferential hiring, most restrictive 
smoking policy, 301302 
private, local, governmental actions 
for protection from smoke expo 
sure, 265 
lung cancer risk from ETS as pro- 
jection of relationship of smok- 
ing in smokers, 26-27 
lung cancer risk in spouses of 
smokers, Japanese prospective 
study, 73-76 
lung cancer risk in spouses of 
smokers, Louisiana case-control 
study, 79-30 
respirable suspended particulates in 
JZT!kxposed vs. nonexposed, 169 
review of impact of smoking re- 
strictions on attitudes, 320 
separation from smokers for risk 
reduction, effectiveness, 11-12 
State antismoking legislation in 
1970s aimed at protection, 267 
temporal and spatial distribution of 
smokers in ETS exposure deter- 
mination, 145-146 
urinary cotinine levels in ETS-ex- 
posed vs. nonexposed men, 207 
urinary nicotine and expired car- 
bon monoxide, effects of smoke 
exposure, 267 
lung cancer risk in spouses of 
smokers, Scottish study, 77-78 
lung cancer risk of ETS exposure, 
American Cancer Society Cohort 
Study, 76-77 
workplace bans for maximum pro- 
tection, momentum growing 
among large employers, 301 
workplace demands for clean air as 
motivation for smoking regula- 
tions, 296 
lung cancer risk of involuntary 
smoking, case-control studies (ta- 
ble), 68-70 
workplace smoking as eye irritant, 
233 
lung cancer risk of involuntary 
smoking, more accurate data 
needed, 102 
workplace smoking as lung cancer 
risk factor, 91-92 
NOSE 
lung function in healthy adults ex- 
posed to cigarette smoke (table), 
64 
mathematical models of lung can- 
cer risk with ETS exposure, 93- 
96 
misclassification of status and ETS 
exposure as factors in determin- 
ing risk, 66-67, 72-73 
nicotine and cotinine to quantify 
ETS exposure, 208, 215 
odor perception and irritation, in- 
fluence of room temperature and 
humidity, 234 
annoying and irritating effects of 
ETS exposure, 231, 235 
ET’S particle deposition, effect of 
nasal inhalation, 189 
smoke concentration vs. exposure 
duration as factors in irritation. 
235 
PARENTAL SMOKING 
(See also MATERNAL SMOKING) 
cancers other than lung cancer in 
children, risk relationship, 102- 
105 
plasma and urine nicotine levels, 
intravenous vs. ETS exposure ef- 
fect, 215 
cough, phlegm, and wheezing in 
children, 44, 47-49 
lung cancer risk relationship, 90-91 
lung function in children, relation- 
ship (table), 50-52 
350 
PARENTAL SMOKING-Cad. 
lung function in children, risk rela- 
tionship, 53-54 
middle ear effusions and diseases 
in children, risk relationship, 
5849 
respiratory illness in infants and 
children, 38, 42-44 
respiratory symptoms in children, 
13 
respiratory symptoms in children, 
relationship (table), 45-46 
respiratory system effects in chil- 
dren, 38-59 
saliva cotinine concentrations in 
children, effect, 207-208 
Passive Smoking See INVOLUN- 
TARY SMOKING 
PHYSICAL ACTIVITY 
EXS deposition increase with in- 
creasing activity, 187 
PREGNANCY 
fetal exposure to tobacco smoke 
constituents, possible effects, 31- 
32 
leukemia risk in children of smok- 
ers, 103 
PUBLIC PLACES 
(See also HOSPITALS; WORK- 
PLACE) 
current status of smoking regula- 
tions mix of public and private 
actions, 265-266 
employee attitudes before smoking 
policy implementation, 311 
health care facilities, public sup 
port of smoking restrictions, 284 
health care facilities, smoking regu- 
lations, 283-285 
hotels and motels, smoking regula- 
tions, 231-282 
impact of public and workplace 
policies restricting smoking, 303- 
321 
interstate transportation, smoking 
regulated at Federal level, 278 
legislation restricting smoking, 
evaluation of impact, 316-318 
local smoking regulations, 277-278 
public transportation, smoking reg- 
ulations, 278-279 
PUBLIC PLACXS-Contd. 
research recommendations on ef- 
fects of smoking regulations, 321 
restaurants, opposition, acceptance, 
and implementation of smoking 
restrictions, 280 
restaurants, smoking regulations, 
279-281 
retail stores, smoking regulations, 
279 
schools, smoking regulations, 282- 
283 
smoking regulation, State laws (ta- 
ble), 271-274 
smoking regulations, conclusions of 
1986 report, 324 
smoking regulations, factors in ac- 
ceptability, 266 
smoking regulations in specific 
public places, 278-285 
smoking regulations, public approv- 
al, national and regional polls, 
318-319 
smoking restrictions, variations in 
current State legislation, 268- 
270 
State laws regulating smoking, 
comprehensiveness index, 327- 
323 
State legislation to restrict smok- 
ing, increase during the 1970s 
267 
States restrict smoking in transpor- 
tation, hospitals, elevators, and 
others, 269 
total suspended particulates (table), 
194-195 
PULMONARY ALVEOLAR MAC 
ROPHAGBS 
lung injury relationship in smok- 
ers, 241-243, 245 
protease-antiprotease balance in 
lungs of smokers, influence, 
242-243 
respiratory bronchioles of smoke-ex- 
posed animals, 245-246 
PYRIDINES 
sidestream vs. mainstream smoke 
levels, 129 
RADIATION 
decay products of radon in tobacco 
smoke, 132, 134 
ETS radioactivity, 134 
INDEX 
351 
REDUCTION OF SMOKING 
(See also CESSATION OF SMOK- 
ING) 
public attitudes and smoking poli- 
cies as indirect influences, 304 
305 
RESPIRATORY SYMPTOMS-ConM. 
cough, phlegm, wheezing in chil- 
dren, parental smoking as factor, 
44, 4749 
involuntary smokers, 31 
RESIDENCES 
total suspended particulates (table), 
195-196 
RESPIRATORY SYSTEM 
(See also LUNGS) 
animals, carcinogenicity of cigarette 
smoke, 247-248 
RESPIRABLE SUSPENDED PAR- 
TICULATES 
breathing pattern and particle size 
distribution effect on ETS dose, 
25 
enclosed places, ETS role, 169 
ETS-exposed and nonexposed sam- 
ples, percentage distribution, 167 
hospital before and after adopting 
restrictive smoking policy, 311 
irritants in ETS, 229 
marker for RTS exposure, 33-34 
personal monitors to measure ETS 
exposure, 166-168 
residental levels as function of 
number of smokers (table), 164 
respiratory disease risk in children 
of smokers, 192 
breathing patterns as factor in 
sidestream smoke deposition, 187 
bronchoconstriction in children, pa- 
rental smoking as risk factor, 
5558 
bronchoconstriction in normal 
adults exposed to involuntary 
smoking, 63 
INDEX 
cigarette smoking effects, implica 
tions for involuntary smoking 
risks, 239-241 
tracheobronchial deposition in in- 
fants vs. adults, prediction, 192 
RESPIRATORY FUNCTION TESTS 
children, involuntary smoking as 
risk factor, 53-54 
nonsmokers exposed to involuntary 
smoking, 62-63 
deposition and absorption of tobac- 
co smoke constituents, 181-216 
deposition of mainstream and side- 
stream smoke, 25 
enzyme activity in smoke-exposed 
animals, 245 
predicted levels, relationship with 
number of cigarettes smoked, 29 
epithelial cells, dose-response effect 
of cigarette smoking, 239 
ETS deposition, 193-216 
ETS dose, product of mass in in- 
haled air and deposition frac- 
tion, 193 
RESPIRATORY SYMPTOiifS 
(See also COUGH; IRRITATION; 
NOSE) 
annoying and irritating effect of 
ETS exposure, 231-232, 236-239 
children and adolescents who start 
to smoke, 27 
hyperplasia and metaplasia in tra- 
chea and bronchi of smokeex- 
posed animals, 248 
involuntary smoking effects, 37-65 
mass deposition of ET’S, estimation, 
193 
children and adults, ETS exposure 
as factor, conclusions, 167 
children, parental smoking as fac- 
tor, 13 
children, relationship with involun- 
tary smoke exposure (table), 45 
46 
cough, phlegm, and wheezing in 
adults, ETS exposure as risk not 
established, 60 
nasal vs. mouth inhalation of RTS, 
effect on particle deposition, 189 
nose, throat, and airway irritation 
from smoke exposure, 11 
particle size of cigarette smoke as 
factor in deposition, 182 
puffing and inhalation patterns as 
factor in particle deposition, 183 
regional deposition of smoke parti- 
cles, 189, 191 
352 
sidestream and mainstream .smoke 
deposition (table), 196 
INDEX 
RESPIRATORY SYSTEM-Contd. 
sidestream smoke particle deposi- 
tion, 186-189 
smoke particle size as factor in re- 
gional deposition, 189, 191-192 
RESPIRATORY TRACT CANCER 
animals exposed to cigarette 
smoke, 248 
RESPIRATORY TRACT DISEASES 
acute illness in children, parental 
smoking as risk factor, 38, 42-44 
asthma in children, maternal 
smoking as risk factor, 55-58 
children, case-control studies of pa- 
ternal smoking as risk factor, 
43-44 
children, nonuniform deposition of 
smoke particles as risk factor, 
192 
children, parental smoking as fac- 
tor, 13 
children, parental smoking as risk 
factor, 38-59 
early childhood, involuntary smok- 
ing relationship (table), 3941 
involuntary smoking as risk factor, 
10 
nonsmoking adults and children, 
involuntary smoking as factor, 
37-66 
pneumonia in children of smokers, 
conclusions about risk, 107 
population characteristics as factor 
in ETS risk, 28 
smoking as major risk factor, 6 
RESPIRATORY TRACT INFEC 
TIONS 
children of smokers, conclusions 
about risk, 107 
infants, ETS exposure as risk fac- 
tor, 31 
SALIVA 
cotinine level as marker for ET’S 
exposure in nonsmokers, 36 
cotinine levels in ET&exposed non- 
smokers vs. active smokers (ta- 
ble), 211-214 
nicotine and cotinine levels to 
quantify ETS exposure, 208, 215 
nicotine levels as sidestream smoke 
exposure indicator, 204-205 
SALIVA-Contd. 
nicotine levels in ETS-exposed non- 
smokers vs. active smokers (ta- 
bleJ, 209-210 
nicotine levels in nonsmokers vs. 
smokers, 216 
SIDESTREAM SMOKE 
(See also CIGARETTE SMOKE; 
MAINSTREAM SMOKE; 
SMOKE STREAMS; TOBACCO 
SMOKE) 
bioassays needed to determine gen- 
otoxicity, 252 
carbon monoxide and carbon diox- 
ide levels vs. mainstream smoke, 
129 
carcinogen levels vs. mainstream 
smoke, 24 
carcinogenic potential, effect of lev- 
els of oxides of nitrogen, 129 
carcinogenicity vs. mainstream 
smoke in animal models, 252 
chemical analysis, 127-129, 132 
chemical composition as factor in 
estimating exposure using “ciga- 
rette equivalents”, 199 
component levels, combustion tem- 
perature effect vs. mainstream 
smoke, 128129 
constituent formation vs. main- 
stream smoke, 7-8 
definition, 7 
experimental and mathematical 
models show deposition in air- 
ways, 217 
formaldehyde and acrolein concen- 
trations above occupational lim- 
its, 230 
formation and physiochemical na- 
ture, 127 
inhalation effects in laboratory ani- 
mals not reported, toxicity fac- 
tor, 249 
irritation in nonsmokers vs. gas 
phase sidestream smoke vs. acro- 
lein, 236-237 
irritation of nonsmokers in labora- 
tory, ventilation as factor, 234- 
235 
laboratory collection devices, 125 
126 




mass median diameter, effect on 
deposition in respiratory tract, 
187 
mathematical models of particle de- 
position in respiratory tract, 
186-187 
nicotine in vapor phase vs. main- 
stream smoke, 127 
particle distribution in respiratory 
tract, 186-189 
particle size distribution studies (ta- 
ble), 138 
particle size distribution (table), 
186 
particles, number and size distribu- 
tion, 137, 139 
particulate matter vs. mainstream 
smoke, 129, 132 
particulate phase as major determi- 
nant of irritation in nonsmokers, 
237-238 
physiochemical nature and spec- 
trum of carcinogens, summary, 
251-252 
regional deposition in respiratory 
tract, particle size as factor, 189, 
191-192 
respiratory system deposition vs. 
mainstream smoke (table), 190 
saliva nicotine levels as indicator 
of exposure, 204-205 
toxic and carcinogenic agents, 21 
toxic and carcinogenic compounds, 
14 
toxic and carcinogenic compounds 
vs. mainstream smoke, conclu- 
sions, 169 
tumor induction by condensate on 
mouse skin vs. mainstream 
smoke condensate, 250 
vapor and particulate phase con- 
stituents, sidestream to main- 
stream ratio (table), 130-131 
SMOKE INHALATION, ANIMAL 
carcinogenicity testing, 247-250 
laryngeal leukoplakias in hamsters, 
24a249 
lung and respiratory cancers in 
mice and rata, 248 
lung inflammatory cell function, 
experimental models, 245-246 
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SMOKE STREAMS 
(See also CIGARETTE SMOKE; 
MAINSTREAM SMOKE; SIDE 
STREAM SMOKE; TOBACCO 
SMOKE) 
combustion temperature effect on 
components of side&ream vs. 
mainstream smoke, 128-129 
mainstream and sidestream smoke, 
comparison, 23-25 
mainstream smoke vs. ETS, chemi- 
cal composition, 135, 137 
mainstream vs. sidestream smoke 
from unfiltered cigarette, com- 
parison (table), 128 
particulate matter in mainstream 
and sidestream smoke, 129, 132 
sidestream and mainstream smoke 
inhalation by smokers and invol- 
untary smokers, 126127 
toxic and carcinogenic agents in in- 
door mainstream vs. ETS (table), 
136 
vapor and particulate phase con- 
stituents, sidestream to main- 
stream ratio (table), 130-131 
SMOKING 
immune system effects, 244 
public knowledge and attitudes, 
policy impact assessment by sur- 
veys, 367 
public places and workplaces, State 
regulations (table), 271-274 
regulatory approaches of State and 
local governments, 278 
SMOKING CHARACTERISTICS 
compensatory smoking by workers 
following smoking policy imple- 
mentation, 312-313 
machine smoking simulation, incon- 
sistency with current patterns, 
126127 
puffing and inhalation effect on 
particle deposition, vs. machine 
smoking, 183 
SMOKING CONTROL PROGRAMS 
evaluation, methodological consider- 
ations, study design as factor, 
306-308 
guides on how to adopt and imple- 
ment regulatory policies, 302 
SMOKING CONTROL 
PROGRAMS-Contd. 
“individual solution” approach to 
control workplace smoking, 298 
separating smokers and nonsmok- 
ers, improving workplace ventila- 
tion, 299 
workplace cessation of smoking 
programs as part of control poli- 
cies, 297 
workplace restrictions on where 
smoking is allowed, variations, 
299-300 
SMOKING HABIT 
consumption decline, effect of pub- 
lic attitudes and social norms, 
321 
population group differences in 
EXS exposure determination, 
145146 
research recommendations on effect 
of smoking restrictions, 322 
smoking restrictions with most im- 
pact on behavior, research need- 
ed, 323 
SMOKING MACHINES 
We also LABORATORY SMOK- 
ING) 
human smoking simulation incon 
sistent with current patterns, 
126-127 
standard conditions for machine 
smoking cigarettes, 125 
SMOKING REGULATIONS 
(See akro LEGISLATION) 
assessment of effect on air quality, 
307 
average restrictiveness of State 
laws, 1960-1985 (figure,, 276 
case-control studies of impact on 
human behavior, evaluation, 306 
current State legislation, variations, 
268270 
designated smoking or no-smoking 
areas to control workplace smok- 
ing, 299-300 
employer-mandated policies in the 
private sector, opposition, 296- 
297 
enforcement costs, experience con- 
tradicts tobacco industry esti- 
mates, 316 
SMOKING REGULATIONS-ConM. 
geographic variability of State laws 
on smoking in public places (fig- 
ure), 270 
health care facilities, 283-285 
health care facilities, public sup 
port, 284 
health care facilities, variations in 
policies, 284-285 
hospitals, awareness and compli- 
ance, 309-310 
hospitals, effect on air quality, 311 
hospitals, employee approval of pol- 
icies, 312 
hospitals, positively worded signs 
and enforcement factors in com- 
pliance, 310 
hospitals, review of current evi- 
dence of impact, 308-309 
hotels and motels, private initiative 
in response to perceived demand, 
281-282 
hotels and motels, public support, 
281-282 
impact on air quality, behavior, at- 
titudes, 303-321 
implementation, 309-310 
implementation, assessment of im- 
pact, 307-308 
implementation of workplace poli- 
cies, 302-303 
implementation, smokers’ support 
as factor, 303-304 
legislation to restrict smoking in 
public places, 266-276 
local legislative restrictions, 277- 
278 
local restrictions, California’s non- 
smokers’ rights movement as 
factor, 277 
nonsmoker’s exposure to second- 
hand smoke, assessment of im- 
pact, 306 
policy components that impact on 
smoking behavior, research need- 
ed, 323 
preferential hiring of nonsmokers 
as most restrictive policy, 301- 
302 
public and private organizations. 
employees’ attitudes, 311-312 
public and workplace. conclusions 
of 1986 report, 324 
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SMOKING REGULATIONS-Contd. 
public and workplace control poli- 
cies, indirect effects, 304-306 
public and workplace restrictions, 
review of impact, 303-321 
public approval, national and re- 
gional polls, 318-319 
public awareness, compliance, and 
enforcement of violations in im- 
plementation, 303 
public places and workplaces, Fed- 
eral, State, and local action, 15- 
16 
public places and workplaces, State 
laws (table), 271-274 
public places, current status mix of 
public and private actions, 265% 
266 
public places, factors in acceptabili- 
ty, 266 
public places, role of public atti- 
tudes and social norms, 321 
public support, 16 
public transportation, 278-279 
regional variation in State laws 
against smoking (table), 277 
research must consider policy char- 
acteristics. institution, and popu- 
lation, 321323 
research recommendations, 321-323 
restaurants, 279-281 
restaurants, opposition, acceptance, 
and implementation, 280 
retail stores, 279 
review of impact on attitudes and 
social norms, 319-320 
schools, difficulties in enforcement, 
283 
schools, double standard of teacher 
smoking vs. student restrictions, 
283 
schools, traditionally not to reduce 
sidestream smoke exposure, 282 
social phenomenon, impact infor- 
mation lacking, need for re- 
search, 323 
specific public places, 278-285 
State and local governments, re- 
strictions, 12 
State and local statutes, implemen- 
tation evaluation, 316-318 




State laws restricting smoking, 
1970-1935 (table), 269 
State legislation, emphasis shift 
and increase during the 19709, 
267 
State legislation in 1970s aimed at 
protecting nonsmokers, 267 
State legislation, increase in 
comprehensiveness, 275 
States with no smoking legislation, 
268 
tobacco-producing States, fewer 
enacted and less restrictive, 275 
276 
worker safety as motivation for 
early policies, 287 
workplace ban, complexity of assur- 
ing compliance, 301-302 
workplace bans, usually preceded 
by progressively stricter regula- 
tions, 300-301 
workplace, barriers to adopting pol- 
icies, 296-297 
workplace, categories of policies, 
298 
workplace compliance with local or- 
dinances, type of business as fac- 
tor, 317 
workplace, current evidence of im- 
pact, 308-309 
workplace, current status, 285-303 
workplace, early controversy in the 
private sector, 286 
workplace, economic considerations 
apparently not a factor, 296 
workplace, effect on smoking cessa- 
tion motivation and success, 
313-315 
workplace, employee attitudes be 
fore policy implementation, 311 
workplace, impact on absenteeism, 
health care costs, productivity, 
turnover, 315-316 
workplace, impact on health care 
and maintenance costs, 305 
workplace, influence of nonsmok- 
ers‘ demand for clean air, 286 
workplace, nature, scope, and prev- 
alence in the 1980s. 294-295 
workplace, policy implementation 
effect on smokers’ behavior, 312- 
313 
SMOKING REGULATIONS-Contd. 
workplace, prevalence, 286-287, 
294-295 
workplace, public vs. private sector, 
270 
workplace, worker health, State 
legislation, nonsmokers’ demands 
as factors, 295-296 
workplace, workforce size, industry 
type, geographic location as fac- 
tors, 295 
workplaces, survey data 1977-1986 
(table), 288-293 
SMOKING STATUS 
(See also SMOKING HABIT) 
misclassification as factor in deter- 
mining EI’S risk, 98, 101 
misclassification as factor in deter- 
mining health risks of involun- 
tary smoking, 6667, 72-73 
SMOKING SURVEYS 
workplaces, 287, 294-295 
STATISTICS 
significance testing of ETS risks, 
36-37 
TARS, CIGAREX-TE 
carcinogenicity testing in animals, 
247-243 
chemical assay for human exposure 
to components, research goal, 
217 
tumor induction on mouse skin, 
sidestream vs. mainstream con- 
densates, 250 
TABS, TOBACCO 
particulates measured under realis- 
tic conditions (table), 159-162 
sidestream smoke particle size dis- 
tribution studies (table), 138 
THIOCYANATES 
sources, metabolism, elimination, 
half-life, 202-203 
TOBACCO SMOKE 
(See also CIGARETI’E SMOKE; 
MAINSTREAM SMOKE; SIDE 
STREAM SMOKE; SMOKE 
STREAMS) 
absorption during active smoking 
vs. involuntary smoking, 215-216 
TOBACCO SMOKE-Contd. 
biological markers of smoke absorp 
tion in smokers and nonsmokers, 
181 
machine vs. human smoking, non- 
comparability of chemical and 
physiochemical data, 135 
mainstream vs. environmental, 
characteristics, 6 
nicotine in vapor phase, sidestream 
vs. mainstream, 127 
odor perception and irritation, in- 
fluence of room temperature and 
humidity, 234 
particle sire distribution of main- 
stream smoke (table), l&1-185 
particle size distribution of side- 
stream smoke (table), 186 
quantitatively determined com- 
pounds in sidestream and main- 
stream smoke, 128 
radioactivity, 132, 134 
residuals, measured under realistic 
conditions (table), 163 
vapor phase, retention by smokers 
vs. involuntary smokers, 126-127 
workplace air pollution, contribu- 
tion (table), 233 
TOBACCO SMOKE CONSTITU- 
ENTS 
(See also COTININE; NICOTINE) 
absorption in nonsmokers under 
experimental and natural expo- 
sures, 206-207 
chemical assay for human exposure 
to tar components. research goal, 
217 
deposition and absorption, 181-216 
deposition fraction of individual 
components needed to determine 
disease risk, ZOO 
STS and mainstream differences as 
factor in exposure of nonsmokers 
vs. smokers, 201 
ETS exposure quantification, 208, 
215 
irritants also produced by other 
sources, 229-230 
irritants in ET& 229 
nicotine, absorption, distribution, 




TOBACCO SMOKE CONSTITU- 
ENTS-Cad. 
particle deposition in lung areas, 
nonuniformity, cancer risk rela- 
tionship, 192 
trapping devices to analyze individ- 
ual components, 126 
TOBACCO SMOKE PARTICU- 
LATES 
carcinogenicity testing in animals, 
247-248 
indoor concentrations by cigarette 
smoking under laboratory condi- 
tions (table), 197 
irritation in nonsmokers vs. gas 
phase of sidestream smoke, 237- 
238 
potential toxicity estimation using 
“cigarette equivalents”, deficien- 
cies, 199 
total suspended particulates in in- 
door working and living environ- 
ments (table), 194-196 
URINE 
cotinine level as marker for ETS 
exposure in nonsmokers, 36 
cotinine levels in BTS-exposed non- 
smokers vs. active smokers (ta- 
ble), 211-214 
cotinine levels in ETS-exposed vs. 
nonexposed men, 207 
mutagenic activity not good mea- 
sure of tar absorption, 206 
nicotine and cotinine levels to 
quantify ETS exposure, 208, 215 
nicotine excretion, individual me- 
tabolism as factor in smokers 
and nonsmokers, 203-205 
nicotine levels in BTS-exposed non- 
smokers vs. active smokers &a- 
ble), 209-210 
nicotine levels in nonsmokers vs. 
smokers, 216 
VENTILATION 
ETS components elimination, major 
factor, 146-147, 164-165 
ETS, determinant of exposure, 11 
ETS, effect on levels, 229 
ETS, factor in estimating human 
exposure, 139, 141-142 
involuntary smoking exposure, fac- 
tor, 67 
restaurants, inadequate control of 
ETS levels, 279 
358 
VENTILATION-ConM. 
sidestream smoke in laboratory, ef- 
fect on perceived irritation in 
nonsmokers, 234-235 
WOMEN 
cancers other than lung cancer in 
nonsmokers married to smokers, 
102 
lung cancer in wives of smokers, 
Greek case-control study, 78-79 
lung cancer, involuntary smoking 
as factor, German case-control 
study, 90 
lung cancer risk in wives of smok- 
ers, Japanese prospective study, 
73-76 
lung cancer risk with ETS expo- 
sure, Hong Kong case-control 
studies, 60-81 
WORKPLACE 
(See also PUBLIC PLACES) 
barriers to adopting smoking poli- 
cies, 296-297 
carbon monoxide, nitrogen, and 
particulate matter levels due to 
tobacco smoke, 232 
categories of smoking policies, 298 
compliance with local smoking or- 
dinances, type of business as fac- 
tor, 317 
health care and maintenance cost 
reduction as benefit of smoking 
policy, 305 
hospitals, employee approval of 
smoking policies, 312 
involuntary smoking, irritant ef- 
fects, 232 
irritants, tobacco smoke and other 
sources, 229-230 
preferential hiring of nonsmokers 
as most restrictive smoking poli- 
cy, 301-302 
research recommendations on effect 
of smoking regulations, 321 
safety as motivation for early regu- 
lations against smoking, 287 
smoking policies, survey data 1977- 
1986 (table), 288-293 
smoking restrictions, conclusions of 
1986 report, 324 
State laws regulating smoking, 




surveys of smoking policies, 287, 
294-295 
tobacco smoke contribution to air 
pollution (table), 233 
total suspended particulates (table), 
194-195 
WORKPLACE SMOKING 
(See also ENVIRONMENTAL TO- 
BACCO SMOKE; INVOLUN- 
TARY SMOKING1 
bans, usually preceded by progres- 
sively stricter regulations, 30% 
301 
business type as factor in compli- 
ance with local smoking ordi- 
nances, 317 
cessation programs as part of pri- 
vate sector smoking control, 297 
control by restricting where smok- 
ing is allowed, variations, 299 
300 
H’S exposure determination, factor, 
142 
eye irritation reported in nonsmok- 
ers, 233 
government offices, smoking regula- 
tion increasing, 285 
guides on how to adopt and imple- 
ment smoking policies, 302 
hospitals, awareness and compli- 
ance of employees, 309-310 
hospitals, review of current evi- 
dence on impact of smoking reg-‘ 
ulations, 308-309 
impact of public and workplace re- 
strictions, 303-321 
WORKPLACE SMOKING-Contd. 
“individual solution” approach to 
regulation, 298 
legislated restriction, early contro- 
versy, 286 
lung cancer risk factor in non- 
smokers, 91-92 
lung function effects of exposure in 
nonsmokers, 60 
motivation for regulation, 295-296 
nature, scope, and prevalence of 
regulation in the 1980s 294-295 
policy implementation effect on 
smokers, 312313 
private sector regulation, legislation 
and public support as factors, 
295 
private sector, State and local leg- 
islation, 285 
regulation, impact on absenteeism, 
health care costs, productivity, 
turnover, 315-316 
regulations, current status, 285-303 
regulations supported by smokers 
and nonsmokers, 285 
regulations, workforce size, geo- 
graphic location, type of indus- 
try as factors, 295 
restrictions, 16 
restrictions, voluntary vs. govern- 
mental, 12 
schools, restrictions to reduce facul- 
ty/staff exposure to EXS, 282 
State regulation, public vs. private 
sector, 270 
State regulations (table), 271-274 
urinary cotinine levels as marker 
of exposure in nonsmokers, 207 
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